<tstset trglang="any" setid="test" srclang="any">
<doc sysid="Edinburgh" docid="doc">
<seg id="1">"this document is a summary of the European Council of the European Parliament (EPAR), in which explains how the Committee for Humanitarian Products (CHMP) is applied to the recommendations concerning the application of medication."</seg>
<seg id="2">"if you need more information about your disease or their treatment, please read the packages (also part of the EPAR) or contact your doctor or pharmacist."</seg>
<seg id="3">"for more information about the recommendations of the CHMP, please read the scientific discussion (also part of the EPAR)."</seg>
<seg id="4">"it is available as 5 mg, 10 mg, 15 mg, and 30 mg tablets, than 10 mg, 15 mg, and 30 mg of melting point (tablets), as a solution to take (1 mg / ml) and as a injection solution (7.5 mg / ml)."</seg>
<seg id="5">"for example, a psychological disorder and spanning of things which are not present), Misstrust and other reasons; • Bieber-I-disorder, a psychological disorder, in which the patients mansions (periods of non-non-smokers) have a normal mood."</seg>
<seg id="6">"it is used to treat patients suffering from severe pain to severe anxiety and prevention of patients suffering from patients suffering from patients suffering from patients suffering from patients suffering from patients suffering from patients suffering from patients suffering from patients suffering from patients suffering from patients suffering from patients suffering from patients suffering from patients suffering from patients suffering from patients suffering from patients suffering from patients suffering from patients suffering from patients suffering from patients suffering from patients suffering from patients suffering from patients suffering from patients suffering from patients suffering from patients suffering from patients suffering from patients suffering from patients</seg>
<seg id="7">The injection solution will apply to fast control of increased ounces or behavioural disorders when the drug consumption is not possible.</seg>
<seg id="8">"at both diseases, the solution can be applied to the test or the melting-tablettution for patients, which prepares out of tablets."</seg>
<seg id="9">"patients who are able to use other medicines that are being built into the same as how to do, the dose should be adapted to the dose."</seg>
<seg id="10">"this affected the signal transmission between brain cells by" neotransmitter ",". chemical substances which enable the communication of nerve cells. "</seg>
<seg id="11">Aripidzol is probably probably known as "partial agonist" for the receptors for the neotransmitter dopamine and 5-hydroxytryptamine (also serotonin).</seg>
<seg id="12">"this means that Aripidzol like 5-hydroxytryptamine and dopamine, but in less than the neurotransmitter to activate the receptors."</seg>
<seg id="13">Dopamine and 5-hydroxytryptamine in schizophrenia and bipolarized disorder plays a role to normalize the activity of the brain, causing mental or manic symptoms and their return will be prevented. "</seg>
<seg id="14">The efficacy of how to prevent the symptoms of symptoms was investigated in three studies of up to one year.</seg>
<seg id="15">"the efficacy of injunction solution was performed in two trials at 805 patients with schizophrenia or similar diseases, which compared to increased accidents, over a period of two hours with a placebo."</seg>
<seg id="16">"in a further study, destabilished over twelve weeks to 347 patients with Haloperidol, in another study the effectiveness of destabilify and placebo, to prevent access to 160 patients where the manic symptoms have already been stabilized."</seg>
<seg id="17">"the efficacy of destabilify injections in a study on 301 patients with bipoly disorder, which was compared to increased ounces (another antipsychotic medicine) and placebo over a period of two hours."</seg>
<seg id="18">"in all studies, change in patients with a standard skala for bipolar disorder, or the number of patients treated to the treatment."</seg>
<seg id="19">The company led to examine studies to investigate how the body the melting-tabletins and the solution to take the solution.</seg>
<seg id="20">"in the two studies in the two studies with the injection solution showed patients suffering from 5.25 mg, 9,75 mg, or 15 mg, a significant reduction of symptoms than the patients who were a placebo."</seg>
<seg id="21">For the treatment of bipolar disorder increases in four of five short-term studies in four of the five short-term studies and placebo.</seg>
<seg id="22">"in addition to 74 weeks, more effective than placebo invests in patients with previously treated patients and when it was in addition to a existing treatment."</seg>
<seg id="23">"furthermore, it is also effective as placebo-injections in 10- or 15 mg capsules more effective as placebo, and were similar to Lorazepam."</seg>
<seg id="24">"the most commonly used side effects of destabilify (observed in 1 to 10 of 100 patients), heaters, blends (scaffection), vomiting, diarrhees (scaffection), tiredness (scaffection), tiredness (scaffection), tiredness, insomnia, insomnia, insomnia, insomnia, insomnia, insomatic (sleep disorders) and angs."</seg>
<seg id="25">"the Committee for Human Physicians (CHMP) came to the end that the advantages of schizophrenia and from medium-serious episodes during the treatment of schizophrenia, and during the prevention of a new mantra-I-disorder, and when the prevention of a new mantra..."</seg>
<seg id="26">"in addition, the Committee also came to the result that the advantages of the injection solution in rapid control of increased risk and behavioural disorders with schizophrenia or in patients with mania-I-disorder when a orale therapy is not suitable for risks."</seg>
<seg id="27">"in June 2004, the European Commission sent the European Commission to Otsuka Pharmaceutical Europe Ltd."</seg>
<seg id="28">"when patients were shown in patients with Aripidzol, (see section 5.1)."</seg>
<seg id="29">The recommended starting dose for destabilify amounts to 10 or 15 mg / day at a maintenance dose of 15 mg / day once every day is independent of the meals.</seg>
<seg id="30">"an increased effectiveness of Dosibilities via a daily dose of 15 mg, although individual patients can benefit from a higher dose."</seg>
<seg id="31">The recommended starting dose for destabilify amounts to 15 mg once daily, regardless of meals as a monotherapy or combination therapy (see section 5.1). "</seg>
<seg id="32">The efficacy of schizophrenia in the treatment of schizophrenia and bipolar disorder was not detected in patients with 65 years.</seg>
<seg id="33">"in regard to the greater sensitivity of these patients, a lower initialdosis should be considered if clinical factors are justified (see paragraph 4.4)."</seg>
<seg id="34">"if the CYP3A4-inductor is set out of the combination therapy, the Aripizzzol dose should be reduced to the recommended dose (see paragraph 4.5)."</seg>
<seg id="35">"in some cases, psychotic illnesses and affectionate disturbances and has been reported in some cases after the beginning or after changing of antipsychotic therapy, also in treatment with Aripidzol (see section 4.8)."</seg>
<seg id="36">Results of a epidemiological study showed that patients with bipolar disorder was not increased in patients with bipolar disorder (Aripidzol compared to other antipsychotica.</seg>
<seg id="37">"Aripidzol should be applied to patients with known carcinogenic diseases (Myokardal infections, cardiovascular disease) or hypertension (including acute and maligne form)."</seg>
<seg id="38">"3 late dyskinesia: in clinical trials, a year or less permeated, there were occasional reports about during treatment with Aripidzol."</seg>
<seg id="39">"when a patient treated treated patients and symptoms of a late dyskies should be observed, the dose should reduce the dose or treatment."</seg>
<seg id="40">"if a patient signs and symptoms developed into a MNS or a clear fever without an additional clinical manifestation of MNS, all antipsychotics, including destabilify."</seg>
<seg id="41">"therefore Aripidzol in patients with crampsinks in the Anamnese or at home, which are used with crampfanings in connection with crampfanings."</seg>
<seg id="42">"56 - 99 years old) with neuropsyzol in patients with patients suffering from Alzheimer's disease, patients treated with Aripidzol patients have been treated to placebo compared to placebo."</seg>
<seg id="43">"however, however, in one of these studies, a study with the current dosage, a significant relationship between the dosage and the anaesthesic events are treated with Aripidzol."</seg>
<seg id="44">"hyperglycemia, in some cases, extremely, associated with Ketoosis, or hyperosmolarem Coma or death, was treated with atypical antipsychotic ingredients."</seg>
<seg id="45">There are no exact risk potential for hyperglycemia-oriented events with destabilify and other atypical antipsychotic medication treatment.</seg>
<seg id="46">"with diabetes mellitus, Polyphagie and weakness), patients with diabetes mellitus or with risk factors for diabetes mellitus should be monitored regularly in relation to a reduction of glucose levels."</seg>
<seg id="47">"in general, patients with bipoly mania are known to patients with bipoly mania due to bipoly mania because weight of antipsychotic diseases, which result in weight gain and could lead to serious complications."</seg>
<seg id="48">"due to the primary effect of Aripizzzol at the central nervous system, if Aripidzol in combination with alcohol or other central medication is determined (see section 4.8)."</seg>
<seg id="49">"the H2 Antagonist is Famous, a magnet-acid-blocker, reduces the resorption rate of Aripitizol, but this effect is not relevant as clinically relevant."</seg>
<seg id="50">"in a clinical study with healthy subjects, a highly effective CYP2D6 inhibitor (Chinidin) the AUC of Aripidzol at 107%, while the CMAx remained unchanged."</seg>
<seg id="51">"it is expected to expect other highly effective optical inhibitors of CYP2D6, such as fluoxetin and paroxetin, similar effects, and therefore should be similar to Dosisreinductors."</seg>
<seg id="52">"using CYP2D6 'bad' (=" "December") Metabolism can result the common application with highly effective inhibitors of CYP3A4 in higher plasma concentrations of Aripidzol compared to CYP2D6 Standard Metabolism. "</seg>
<seg id="53">"when using the common gift of Ketoconazol or other highly effective CYP3A4-inhibitors, it should be considered potential for the potential benefits of potential risks for the patient."</seg>
<seg id="54">Other high-effective inhibitors of CYP3A4 such as Itraconazol and HIV proteins may also be similar to similar effects.</seg>
<seg id="55">"after set the CYP2D6- or 3A4 inhibitors, the dosage of destabilify the dosage of the accompanying therapy."</seg>
<seg id="56">"Diltiazem or Escapopram, or CYP2D6 together with abilished, can be used with an increase of Aripipelzol- concentrations."</seg>
<seg id="57">Clinical trials showed 10-30 mg Aripidzol per day no significant effect on the Metabolism of the substrates of CYP2D6 (Dextrophide-Ratio); 2C9 (Ombudrazol) and 3A4 (Dextrophil) and 3A4 (Dextrophide).</seg>
<seg id="58">Patients should be able to notify their doctor if they are pregnant or pregnant during treatment with Aripidzol.</seg>
<seg id="59">"due to insufficient data base for safety in people and due to the reproduction of the animal studies, this medicine may not apply this medicine in pregnancy."</seg>
<seg id="60">"however, however, in other antipsychotics, the patient should be warned, dangerous machinery, including power-vehicles, to operate, until they are sure that Aripidzol can no negative influence."</seg>
<seg id="61">The following side effects were frequent (≥ 1 / 100) on placebo or were classified as possible medical side effects (*).</seg>
<seg id="62">The frequency of the bottom of the side effects are defined by the following criteria: frequently (&gt; 1 / 100); occasionally (&gt; 1 / 100); occasionally (&gt; 1 / 10, &lt; 1 / 100). "</seg>
<seg id="63">"schizophrenia - In a controlled long-term study on 52 weeks came to patients who were treated with Aripidzol, a total lower Inciism (25,8%) of EPS including parinsonism, Akathony and Dyskinesia, compared with patients who were treated with Haloperidol (57,3%)."</seg>
<seg id="64">"in a placebo controlled study on 26 weeks, the Induction of eps 19% in patients with placebo treatment and 13.1% in patients under placebo."</seg>
<seg id="65">"in a different controlled study study about 26 weeks, the Independence of eps 14.8% in patients who were treated with Aripidzol, and 15.1% in patients under Olanzapin therapy."</seg>
<seg id="66">"in a controlled study of a 3 weeks, the Incidence of EPS 23,5% in patients under Aripipelzol- Treatment and 53,3% in patients under Haloperidol treatment."</seg>
<seg id="67">"in another study on 12 weeks, the Incification of eps 26,6% in patients under Aripizzzol treatment and 17.6% for those under lithium-treatment."</seg>
<seg id="68">"in the long term conservation phase of 26 weeks at a placebo controlled study, the Independence of eps 18.2% for patients under Aripipelzol- Treatment and 15.7% for placebo patients."</seg>
<seg id="69">A comparison between the patient groups under Aripidzol and placebo.</seg>
<seg id="70">"the Cpk (Kreatin Phosphokinase), generally temporarily and asymptomatic, were observed in 3.5% of the placebo-treated patients."</seg>
<seg id="71">"results appear ordered" "by relevance" "or" "by date" "(publication date),"</seg>
<seg id="72">"in clinical trials and since the launch, unauthorised overdose with Aripiprazol alone in adult patients with estimated cans of up to 1260 mg and without death."</seg>
<seg id="73">"data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data. why buy this report? * Get a detailed picture of the Baby Food market; * Pinpoint growth sectors and identify factors driving change; * Understand the competitive environment, the market's major players and leading brands;"</seg>
<seg id="74">"for this reason, it is advisable that the efficacy of Aripiprazol in schizophrenia and biogas-I-disorder over the combination of a partial effect on dopamine D2- and Serotonin 5HT1ae receptors and a antagonist effect on Serotonin 5HT2a receptors."</seg>
<seg id="75">"Aripidzol showed a high Affinity to dopamine D2- and 5HT2a recipes, as well as an excessive affinity for dopamine D4-, for the alpha-1-adrenders and the histamine H1recipes."</seg>
<seg id="76">"in the gift of Aripiprazl in Dosification of 0.5 to 30 mg once daily on a daily dose showed a doscope-dependent reduction of 11C-Racloprid, a D2 / D3 receptor-Ligence, at the Nucleus caudatus and the coup."</seg>
<seg id="77">"in three placebo-controlled short-term studies (4 to 6 weeks), with positive or negative symptoms showed a statistically significant improvement of mental symptoms."</seg>
<seg id="78">"in a Haloperidol controlled study was in a week 52 of the percentage of the patients who were born in both groups (Aripidzol 77% and Haloperidol 73%)."</seg>
<seg id="79">"current values of measurement, which were defined as a secondary study, including PANSS and the Montgomery-Asberg- Depresection rates, showed a significant better better than in Haloperidol."</seg>
<seg id="80">"in a placebo controlled study on 26 weeks to stabilized patients with chronic schizophrenia showed a significant reduction of return rate, which was at 34% in the Aripitizol group and at 57% in placebo."</seg>
<seg id="81">"in a Olanzapin-controlled, multinational double-blind study in schizophrenia about 26 weeks, the 314 patients were reduced by at least 7% compared to the output value (i.e. an increase of at least 5,6 kg at a average weight of ca."</seg>
<seg id="82">"in two placebo-controlled monotherapy studies with a flexible dosage of 3 weeks after patients with a manic or mixed choir of the Bistro-I-disorder, Aripiprazl showed a placebo effect on placebo symptoms over 3 weeks."</seg>
<seg id="83">"in a placebo controlled trial study over 3 weeks, with a reduction in patients with a manic or mixed choir of the bee-I-disorder, Aripidzol to placebo does not exceed placebo effectiveness."</seg>
<seg id="84">"in two placeboards and active-controlled monotherapy studies on 12 weeks after patients with a manic or mixed choir of a Bistro-I-disorder, with or without psychologists, showed Aripiprazl to placebo effect in week 3 and a lasting effect that was comparable with the lithium or Haloperidol in week 12."</seg>
<seg id="85">Aripidzol also pointed out in week 12 a comparable share of patients with symptomatic cancellations of the mania on such as lithium or Haloperidol.</seg>
<seg id="86">"in a placebo controlled study on 6 weeks of patients with a manic or mixed choir of a Bistro-I-disorder, with or without mental features, the accompanying therapy with Aripidzol and an excessive effectiveness in therapeutic target of patients with lithium or Valproat."</seg>
<seg id="87">"10 In a placebo controlled study over 26 weeks followed by a long term phase of a long term phase of a long-term phase in a stabilization phase before the prevention of a bipolar loss, the prevention of a bipolar return to placebo."</seg>
<seg id="88">"based on in vitro studies are the enzymes CYP3A4 and CYP2D6 for the stretching and hydroxylinzol, the N-Dealkyeler is responsible by CYP3A4 catalytic."</seg>
<seg id="89">"the middle of Eliminationshalbeit time is located 75 hours for Aripidzol near Rotary Metabolism via CYP2D6 and at least 146 hours at 'bad' (=" "December" ") Metabolism via CYP2D6."</seg>
<seg id="90">"in Aripidzol, there are no differences in the pharmacokinetics between male and female healthy subjects as well as a pharmacokinetic investigation."</seg>
<seg id="91">A Popteen-specific evaluations of the pharmacokinetics have no note to clinically significant differences in the ethanol or the effect of the smoking room on the pharmacokinees of Aripidzol.</seg>
<seg id="92">The pharmacokinetic properties of Aripidzol and elydro-Aripidzol were similar to patients with severe kidney failure in comparison to young healthy subjects.</seg>
<seg id="93">"a single dose of liver cirrhosis (Child-Pugh Class A, B and C) showed no significant effect on the pharmacokinetics of Aripitizol and elydro-Aripiprazl, but the study conducted only 3 patients with liver cirrhosis of the class C, which is not possible to pull on their metabolic capacity."</seg>
<seg id="94">"based on the conventional studies on the conventional studies of safety, toxicity, toxicity at reproductive, reproductive, genicity, genotoxicity, genotoxicity, and of arerosion potential."</seg>
<seg id="95">Toxic effects were significant significant effects only at dosing stations or expositions that have considerably exceeded the maximum dosage or exposure during the people that they are only limited to the clinical application only for clinical use.</seg>
<seg id="96">Effects of a doscope-dependent on toxicity (Lipofuscine pigment) in rats according to 104 weeks after 104 weeks after 104 weeks (AUC) in the recommended maximum Steady-State Exposition (AUC) at the recommended retail price (AUC) at the recommended maximum dose of humans (AUC).</seg>
<seg id="97">"furthermore, a cholelitis is also used as a result of the flow of sulphide conjugations of sulfate from 25 to 125 mg / kg / day (1 to 394) in the recommended retail dose of 25 to 125 mg / kg / day (1 to 3times of the recommended dose of dose based on mg / m2)."</seg>
<seg id="98">"however, in the human nature of the highest recommended daily dose of 30 mg of concentrations of sulphide Konjugate of hydroxy- Aripiprazol no more than 6% of concentrations that were found in the study of 39 weeks in the Galle of Monkeys, and are far under the border values (6%) in vitro fertilization."</seg>
<seg id="99">"in rabbits, these effects according to Dosies who led to Expositions of 3- and 11mm of the middle steady-State AUC at the recommended retail price, observed."</seg>
<seg id="100">"PerforenBlister packaging for many individual dots made of aluminium in folding cartons with 14 x 1, 28 x 1, 49 x 1, 98 x 1, 98 x 1 tablets."</seg>
<seg id="101">"15 late dyskinesia: in clinical trials, a year or less permeated, there was no reports about during treatment with Aripidzol."</seg>
<seg id="102">"for this reason, it is advisable that the efficacy of Aripiprazol in schizophrenia and biogas-I-disorder over the combination of a partial effect on dopamine D2- and Serotonin 5HT1ae receptors and a antagonist effect on Serotonin 5HT2a receptors."</seg>
<seg id="103">"22 In a placebo controlled study of 26 weeks followed by a long term phase of a long term phase of a long-term phase in a stabilization phase before the prevention of a bipolar loss, the prevention of a bipolar return to placebo."</seg>
<seg id="104">"27 late dyskinesia: in clinical trials, a year or less permeated, there was no reports about during treatment with Aripidzol."</seg>
<seg id="105">"for this reason, it is advisable that the efficacy of Aripiprazol in schizophrenia and biogas-I-disorder over the combination of a partial effect on dopamine D2- and Serotonin 5HT1ae receptors and a antagonist effect on Serotonin 5HT2a receptors."</seg>
<seg id="106">"34 In a placebo controlled study of 26 weeks followed by a long term phase of a long term phase of a long-term phase in a stabilization phase before the prevention of a bipolar loss, the prevention of a bipolar return to placebo."</seg>
<seg id="107">"39 late dyskinesia: in clinical trials, a year or less permeated, there were occasional reports about during treatment with Aripidzol."</seg>
<seg id="108">"for this reason, it is advisable that the efficacy of Aripiprazol in schizophrenia and biogas-I-disorder over the combination of a partial effect on dopamine D2- and Serotonin 5HT1ae receptors and a antagonist effect on Serotonin 5HT2a receptors."</seg>
<seg id="109">"46 In a placebo controlled study of 26 weeks followed by a long term phase of a long term phase of a long-term phase in a stabilization phase before the prevention of a bipolar loss, the prevention of a bipolar return to placebo."</seg>
<seg id="110">The recommended starting dose for Aripizzzol is 10 or 15 mg / day at a maintenance dose of 15 mg / day once every day is independent of the meals.</seg>
<seg id="111">Patients who have difficulties under canals of abilify tablets can take the melting-tableted tablets (see section 5.2).</seg>
<seg id="112">"in some cases, psychotic diseases have been heard in some cases after the beginning or after changing of antipsychotic therapy, also in treatment with Aripidzol (see section 4.8)."</seg>
<seg id="113">"late dyskinesia: in clinical trials, a year or less permeated, there was no reports about during treatment with Aripidzol."</seg>
<seg id="114">"clinical manifestation of a MNS are high fever, muscle stimulations and blood pressure, tability and blood pressure."</seg>
<seg id="115">"in general, patients with bipolarized patients and patients with bipoly mania due to bipoly mania, the application of antipsychotika, the application of antipsychotics, which result in weight of weight and could lead to serious complications."</seg>
<seg id="116">Patients should be able to notify their doctor if they are pregnant or pregnant during treatment with Aripidzol</seg>
<seg id="117">The following side effects were frequent (≥ 1 / 100) on placebo or were classified as possible medical side effects of medication (*).</seg>
<seg id="118">"in two placebo-controlled monotherapy studies with a flexible dosage of 3 weeks after patients with a manic or mixed choir of the Bistro-I-disorder, Aripiprazl showed a placebo effect on placebo symptoms over 3 weeks."</seg>
<seg id="119">"58 In a placebo controlled study on 6 weeks of patients with a manic or mixed choir of a Bistro-I-disorder, with or without mental features, the accompanying therapy with Aripidzol and an excessive effectiveness in therapeutic target in comparison with lithium-ion or Valproat."</seg>
<seg id="120">"in a placebo controlled study of 26 weeks followed by a long term phase of a long term phase of a long-term phase of the patients with Aripidzol during a stabilization phase before the prevention of a bipolar return, mainly in the prevention of a bipolar return to placebo."</seg>
<seg id="121">"in rabbits, these effects according to Dosification, which were used to Expositions of 3- and 11mm of the middle steady-State AUC at the recommended clinical trials"</seg>
<seg id="122">Patients who have difficulties under canals of abilify tablets can take the melting-tableted tablets (see section 5.2).</seg>
<seg id="123">"late dyskinesia: in clinical trials, a year or less permeated, there was no reports about during treatment with Aripidzol."</seg>
<seg id="124">"71 In a placebo controlled study on 6 weeks of patients with a manic or mixed choir of a Bistro-I-disorder, with or without mental features, the accompanying therapy with Aripidzol and an excessive effectiveness in therapeutic target of patients with lithium or Valproat."</seg>
<seg id="125">Patients who have difficulties under canals of abilify tablets can take the melting-tableted tablets (see section 5.2).</seg>
<seg id="126">"late dyskinesia: in clinical trials, a year or less permeated, there was no reports about during treatment with Aripidzol."</seg>
<seg id="127">"data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data. why buy this report? * Get a detailed picture of the Consumer Health market; * Pinpoint growth sectors and identify factors driving change; * Understand the competitive environment, the market's major players and leading brands;"</seg>
<seg id="128">"organically grown ml 400 mg of methyl-4-hydroxybenzoat (E218) per ml 0.2 mg Propyl-4-hydroxybenzoat (E216) per ml."</seg>
<seg id="129">The recommended starting dose for destabilify amounts to 15 mg once daily, regardless of meals as a monotherapy or combination therapy (see section 5.1). "</seg>
<seg id="130">"during patients who already received Aripidzol, the therapy will be continued with the same dose."</seg>
<seg id="131">"late dyskinesia: in clinical trials, a year or less permeated, there was no reports about during treatment with Aripidzol."</seg>
<seg id="132">"hyperglycemia, in some cases, extremely, associated with Ketoosis, or hyperosmolarem Coma or death, was treated with atypical antipsychotic ingredients."</seg>
<seg id="133">There are no exact risk potential for hyperglycemia-oriented events with destabilify and other atypical antipsychotic medication treatment.</seg>
<seg id="134">"92 In a clinical study with healthy subjects, a highly effective CYP2D6 inhibitor (Chinidin) the AUC of Aripidzol at 107%, while the CMAx remained unchanged."</seg>
<seg id="135">"Diltiazem or Escapopram, or CYP2D6 together with abilished, can be used with an increase of Aripipelzol- concentrations."</seg>
<seg id="136">"as a result of a controlled trial period, there was a controlled trial period of 12 weeks, the Incidence of EPS 23,5% in patients under Aripipelzol-."</seg>
<seg id="137">"for this reason, it is advisable that the efficacy of Aripiprazol in schizophrenia and biogas-I-disorder over the combination of a partial effect on dopamine D2- and Serotonin 5HT1ae receptors and a antagonist effect on Serotonin 5HT2a receptors."</seg>
<seg id="138">"in a Olanzapin-controlled, multinational double-blind study in schizophrenia about 26 weeks, the 314 patients were reduced by at least 7% compared to the output value (i.e. an increase of at least 5,6 kg at a average weight of ca."</seg>
<seg id="139">"97 In a placebo controlled trial study over 3 weeks, with a mania or mixed choir of the Bistro-I-disorder, Aripiprazl-disorder was no exaggerated effectiveness."</seg>
<seg id="140">"in a relative bending study study, in the pharmacokinetics of 30 mg Aripious zol as a solution to take 30 mg Aripidzol in tabloid form, was the relationship between the geometrical CMAx medium value of the solution and the value of the tablets at 122% (N = 30)."</seg>
<seg id="141">"99 By the recommended dose of sulphide conjugations of sulphide conjugations from 25 to 125 mg / kg / day (1 to 376 of the average steady-State-position (AUC) in the recommended dose of the recommended dose from 25 to 125 mg / kg / day (1 to 3hours of the recommended dose of dose based on mg / m2)."</seg>
<seg id="142">"in rabbits, these effects according to Dosies who led to Expositions of 3- and 11mm of the middle steady-State AUC at the recommended retail price, observed."</seg>
<seg id="143">"in patients with schizophrenia or patients with chemotherapy in patients with schizophrenia or patients with mania episodes of the bee-I-disorder, if an orale therapy is not installed."</seg>
<seg id="144">"as soon as it is clinically placed, the treatment of Aripizzzol injectors are finished and started with the oratory application of Aripidzol."</seg>
<seg id="145">"in order to reduce the Resorption and the variability, a injection in the M. deltoideus or deep in the gleus-maximus muscle is recommended under control of adipous regions."</seg>
<seg id="146">A lower dose of 5.25 mg (0.7 ml) may vary depending on the individual clinical status among the individual clinical status of medication (see paragraph 4.5).</seg>
<seg id="147">"if there is a further processing treatment with Aripidzol indices, see the summary of the characteristics of the drug using to destabilify tablets."</seg>
<seg id="148">There are no investigations on the efficacy of Aripiprazl injections in patients with Agians and behavioural disorders which have been caused by schizophrenia and manicality of the bistro-I-disorder.</seg>
<seg id="149">"in case a parenteral therapy with bencoding therapy in addition to Aripidzol injectors solution, should be observed in accordance with extreme vibrations or blood pressure. (see paragraph 4.5)."</seg>
<seg id="150">Investigations on safety and efficacy of Aripiprazl injectors are used for patients with alcohol or medication (caused by illegal or illegal drugs).</seg>
<seg id="151">"Aripidzol should be applied to patients with known carcinogenic diseases (Myokardal infections, cardiovascular disease) or hypertension (including acute and maligne form)."</seg>
<seg id="152">"late dyskinesia: in clinical trials, a year or less permeated, there was no reports about during treatment with Aripidzol."</seg>
<seg id="153">"clinical manifestation of a MNS are high fever, muscle contraction, changing consciousness and blood pressure, stealing and blood pressure dysfunction)."</seg>
<seg id="154">"with diabetes mellitus, Polyphagie and weakness), patients with diabetes mellitus or with risk factors for diabetes mellitus should be monitored regularly in relation to a reduction of glucose levels."</seg>
<seg id="155">"in general, patients with bipolarized patients and patients with bipoly Manie is known as a side effect, the application of antipsychotics, which result in weight reduction and could lead to serious complications."</seg>
<seg id="156">"however, the intensity of the Sedation is greater compared with the following some gift of Aripidzol, in a study, in the healthy subjects of Aripiprazl (15 mg dose) and the same time Lorazepam (2 mg dose)."</seg>
<seg id="157">"105 The H2 Antagonist is Famous, a stomach acid-blocker, reduces the resorption rate of Aripitizol, but this effect is not relevant as clinically relevant."</seg>
<seg id="158">"using CYP2D6 'bad' (=" "December") Metabolism can result in comparison with highly effective inhibitors of CYP3A4 in higher plasma concentrations of Aripidzol. "</seg>
<seg id="159">Other highly effective inhibitors of CYP3A4 such as Itraconazol and HERE V- Proteasative inhibitors that should be similar to similar effects.</seg>
<seg id="160">"after set the CYP2D6- or 3A4 inhibitors, the dosage of destabilify the dosage of the accompanying therapy."</seg>
<seg id="161">"106 Lorazepam (2 mg dose) insinus (2 mg dose), the intensity of the Sedation was bigger compared with the following a gift of Aripidzol."</seg>
<seg id="162">The following side effects were classified in clinical trials with Aripidzol injectors solution to (≥ 1 / 100) as under placebo or as possible medical side effects (*) (see section 5.1):</seg>
<seg id="163">"the frequency of the bottom of the side effects are defined by the following criteria: frequently (≥ 1 / 100, &lt; 1 / 10); occasionally (≥ 1 / 10, &lt; 1 / 100); occasionally (≥ 1 / 10, &lt; 1 / 100)."</seg>
<seg id="164">107 The following side effects were frequent (≥ 1 / 100) as a placebo or in clinical trials with oral studies (see section 5.1):</seg>
<seg id="165">"in a placebo controlled study on 26 weeks, the Incification of eps 19% in patients under the placebo - treatment and 13.1% in patients under placebo."</seg>
<seg id="166">"in another study on 12 weeks, the Incification of eps is 26.6% in patients under Aripipelzol- Treatment and 17.6% for those under lithium-treatment."</seg>
<seg id="167">"in the long term conservation phase of 26 weeks at a placebo controlled study, the Independence of eps 18.2% for patients under Aripidzol treatment and 15.7% for placebo patients."</seg>
<seg id="168">A comparison between the patient groups under Aripidzol and placebo.</seg>
<seg id="169">"the Cpk (Kreatinphospkinase), generally temporarily and asymptomatic, were observed in 3.5% of the placebo-treated patients."</seg>
<seg id="170">"results appear ordered" "by relevance" "or" "by date" "(publication date),"</seg>
<seg id="171">"110 and behavioural disorders was the Aripitizol injector solution with statistically significant improvements of Agians / contentiveness, compared with placebo and was similar to Haloperidol."</seg>
<seg id="172">"in a placebo controlled trial period (24 h) with five-polarized disorder and behavioral disorders, the Aripidzol injecting solution was associated with a statistically significant improvement in comparison to placebo and similar to the Lorazepam- reference arm."</seg>
<seg id="173">"the mean average improvement of the output value on the PANSS Excitement Component) was 5.8 for placebo, 9,6 for placebo, 9,6 for placebo and 8,7 for Aripitizol."</seg>
<seg id="174">"in analyses of sub-groups in patients with severe agitation, a similar efficacy in relation to the overall view, but a statistical Signifiori could be found due to a reduced patient."</seg>
<seg id="175">"results appear ordered" "by relevance" "or" "by date" "(publication date),"</seg>
<seg id="176">"in a Haloperidol controlled study was a week 52 of the percentage of the aged patients who were born in both groups (Aripidzol 77% (oral) and Haloperidol 73%)."</seg>
<seg id="177">"current values of measurement, which were defined as a secondary study, including PANSS and the Montgomery Asberg-Deployment rates, showed a significant better improvement than in Haloperidol."</seg>
<seg id="178">"in a placebo controlled study on 26 weeks of stabilized patients with chronic schizophrenia showed a significant reduction of return rate, which was at 34% in the Aripipelzol- (oral) group and at 57% under placebo."</seg>
<seg id="179">"in a Olanzapin-controlled, multinational double-blind study in schizophrenia about 26 weeks, the 314 patients were reduced by at least 7% compared to the output value (i.e. an increase of at least 5,6 kg at a average weight of ca."</seg>
<seg id="180">"111 In a placebo controlled study on 6 weeks of patients with a manic or mixed choir of a bee-I-disorder, with or without mental features, the accompanying therapy with Aripidzol is an excessive effectiveness of therapeutic symptoms compared to Monotherapy with lithium or Valproat."</seg>
<seg id="181">"in a placebo controlled study on 26 weeks followed by a 74-week course of a 74-week course, with Aripidzol during a stabilization phase before the prevention of a bipolar return to placebo."</seg>
<seg id="182">"Aripidzol AUC is the first 2 hours after intramusular injectors 90% larger than AUC, which was similar to the same dose as a tablet; the systemic exposure was similar to the two formulations."</seg>
<seg id="183">"in 2 studies with healthy subjects, the medium time is up to the maximum plasma mask at 1 to 3 hours after application."</seg>
<seg id="184">The gift of Aripiprazl injectionism solution was tolerated by rats and monkeys.</seg>
<seg id="185">"in studies for reproduction of intravenous application, no safety-relevant concerns on maternal-position, the 15- (rabbits) and 29 times (rabbits) are about the maximum human therapeutic exposure of 30 mg."</seg>
<seg id="186">"based on the conventional studies with Aripidzol (oral) for security spells, toxicity at reproductive, reproductive, genicity, genotoxicity, genotoxicity, genotoxicity, and of arerosion potential."</seg>
<seg id="187">Toxic effects were significant significant effects only at dosing stations or expositions that significantly exceeded the maximum dosage or exposure during man. so that they have only limited or no meaning for clinical application only limited or no meaning.</seg>
<seg id="188">The effects of a doscope-dependent on toxicity (Lipofuscine pigment) in rats according to 104 weeks after 104 weeks after 104 weeks (AUC) at the recommended retail volume (AUC) at the recommended retail price (AUC) at the recommended retail price (AUC) at the recommended maximum dose (AUC).</seg>
<seg id="189">"furthermore, a cholelitis is also used as a result of the flow of sulphide conjugations of sulfate from 25 to 125 mg / kg / day (1 to 3 times) in the recommended dose of dose by 25 to 125 mg / kg / day (1 to 3) of the recommended dose of dose based on mg / m2)."</seg>
<seg id="190">"in rabbits, these effects according to Dosification, which were performed to Expositions of 3- and 11-year of the middle-class AUC at the recommended retail procedure, observed."</seg>
<seg id="191">Firm of the Year for Insolvency Administration Schneider Geiwitz & Partner Firm of the Year for Tax Gleiss Lutz Firm of the Year for Tax Gleiss Lutz</seg>
<seg id="192">"accordingly, CHMP Guideline on Risk Management Systems for Medicinal Products for human use" must be submitted to the latest risk management plan at the same time with the next periodic Safety update Report (PSUR). "</seg>
<seg id="193">"data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data. why buy this report? * Get a detailed picture of the Consumer Health market; * Pinpoint growth sectors and identify factors driving change; * Understand the competitive environment, the market's major players and leading brands;"</seg>
<seg id="194">14 x 1 tablets 28 x 1 tablets 49 x 1 tablets 98 x 1 tablets</seg>
<seg id="195">EU / 1 / 04 / 276 / 001 14 x 1 tablets EU / 1 / 04 / 276 30 x 1 tablets EU / 1 / 04 / 276 30 x 1 tablets EU / 1 / 04 / 005 98 x 1 tablets</seg>
<seg id="196">EU / 1 / 04 / 276 / 014 x 1 tablets EU / 1 / 04 / 276 / 008 x 1 tablets EU / 1 / 04 / 276 / 010 98 x 1 tablets</seg>
<seg id="197">EU / 1 / 04 / 276 / 011 14 x 1 tablets EU / 1 / 04 / 014 49 x 1 tablets EU / 1 / 04 / 014 98 x 1 tablets EU / 1 / 04 / 015 98 x 1 tablets</seg>
<seg id="198">EU / 1 / 04 / 276 / 016 14 x 1 tablets EU / 1 / 04 / 276 / 018 28 x 1 tablets EU / 1 / 04 / 020 98 x 1 tablets EU / 1 / 04 / 020 98 x 1 tablets</seg>
<seg id="199">"if one of the listed side effects are considerably affected or you notice that no side effects that are not indicated in this use information, please inform your doctor or pharmacist."</seg>
<seg id="200">"it is applied for the treatment of adults who suffer from a disease, characterized by symptoms such as the horns, in or pigment of things that are not present, Misstrust, and incoherent language, incoherent behaviour and despair."</seg>
<seg id="201">"it is used for adults to have excessive energy to have excessive energy, too much less sleep than usually, very fast stress with fast changing ideas and sometimes strong friction."</seg>
<seg id="202">"patients with diabetes (diabetes) or cases of diabetes (sugar disease) in the family, diabetes or vascular disease, especially in the face of heart or vascular disease in the family, stroke or kidney disease in the family, stroke or kidney disease in the family, stroke or temporary formation of the brain (transitories / TIA), normal blood pressure."</seg>
<seg id="203">"if you suffer as an older patient in dementia (loss of memory or other intellectual abilities), you should have to know if you ever have a stroke or temporary blood circulation of the brain."</seg>
<seg id="204">"inform your doctor if you are connected to muscular stiffness or stiffness with high fever, cheeses, changeable condition or very soft or irregular heart rate."</seg>
<seg id="205">Children and young people do not apply to children and adolescents with children under 18 years of age.</seg>
<seg id="206">"if you prefer to use other medicines, please inform your doctor or pharmacist if you are allowed other medicines to apply or use other medicines, even if there are no prescription drugs."</seg>
<seg id="207">"medicine for treatment of cardiovascular disorders of antidepressants or herbal medicines that are used to treat chronic diseases such as HIV infection, antibacterial infections, to treat epilepsy in the treatment of epilepsy."</seg>
<seg id="208">"if you are pregnant, you should not take care if you are pregnant, unless you are discussed with your doctor."</seg>
<seg id="209">"transport and filling of machines you should not drive car and no tools or machines, until you know how to do it."</seg>
<seg id="210">Please take this medicine only after consultation with your doctor if you are familiar with your doctor.</seg>
<seg id="211">Please speak with your doctor or pharmacist if you have the impression that the effects of abilify or too weak or too weak.</seg>
<seg id="212">"even if you feel better, change or contact the daily dose of abilify without your doctor before."</seg>
<seg id="213">"if you have a bigger quantity of destabilify, when you should specify that you should find more about your doctor (or if someone else might have some of your abilify tablets), please contact your doctor."</seg>
<seg id="214">"if you have forgotten your medicine if you have forgotten your dose, take the forgotten dose as soon as you think you do not believe in one day the double dose."</seg>
<seg id="215">"frequent side effects (at more than 1 of 100, less than 1 of 10 treatment) uncontrolled disorders, headache, nausea, vomiting, vomiting, vomiting, vomiting, straightening, water problems, water problems, water problems and blurred vision."</seg>
<seg id="216">"occasional side effects (in more than 1 of 1,000, less than 1 of 100 treatments) Some persons may feel comfortable, especially if they are out of one or sitting position, or they can find an accelerated pulse."</seg>
<seg id="217">Please inform your doctor or pharmacist if one of the listed side effects may be affected or side effects that are not indicated in this use.</seg>
<seg id="218">How to convert and content of your pack 5 mg tablets are rectangular and blue with predefined by A-007 and 5 on one side.</seg>
<seg id="219">"inform your doctor if you are connected to muscular stiffness or stiffness with high fever, cheeses, changeable condition or very soft or irregular heart rate."</seg>
<seg id="220">"even if you feel better, change or contact the daily dose of abilify without your doctor before."</seg>
<seg id="221">"how to convert and content of the package, fy 10 mg tablets are rectangular and rosafar, with preorder from A-008 and 10 on one side."</seg>
<seg id="222">"inform your doctor if you are connected to muscular stiffness or stiffness with high fever, cheeses, changeable condition or very soft or irregular heart rate."</seg>
<seg id="223">"even if you feel better, change or contact the daily dose of abilify without your doctor before."</seg>
<seg id="224">"how to convert and content of your pack 15 mg tablets are round and yellow, with precondition of A-009 and 15 on one side."</seg>
<seg id="225">"inform your doctor if you are connected to muscular stiffness or stiffness with high fever, cheeses, changeable condition or very soft or irregular heart rate."</seg>
<seg id="226">"even if you feel better, change or contact the daily dose of abilify without your doctor before."</seg>
<seg id="227">"how to convert and content of the pack of 30 mg tablets are round and rosafar, with preorder from A-011 and 30 on one side."</seg>
<seg id="228">"171 If you suffer as an older patient in dementia (loss of memory or other intellectual abilities), you should have to tell whether you ever have a stroke or temporary blood circulation of the brain."</seg>
<seg id="229">"inform your doctor if you are connected to muscular stiffness or stiffness with high fever, cheeses, changeable condition or very soft or irregular heart rate."</seg>
<seg id="230">Important information on certain other parts of destabilify patients who are not phenylalanine may be observed in the source of phenylalanine as source for phenylalanine.</seg>
<seg id="231">"in order immediately after opening the Blister packaging, the tablet with dry hands and place the melting of the tongue on the tongue."</seg>
<seg id="232">"even if you feel better, change or contact the daily dose of abilify without your doctor before."</seg>
<seg id="233">If you have a bigger quantity of destabilify you should specify that you should specify that you should specify that you should specify your doctor or if someone else is different from your doctor or if someone else is different from your doctor or if someone else is different from your doctor or if someone else is different from your doctor or if someone else is different from your doctor or if someone else is different from your doctor or if someone else is different from your doctor or if someone else is different from your doctor or if someone else is different from your doctor or if someone else is different from your doctor or if someone else is different from your doctor or if someone else is different from your doctor or if someone else is different from your doctor or if someone else is different from your doctor or if someone else is different from your doctor or if someone else is different from your doctor (or if someone else is different from your</seg>
<seg id="234">"calcium, magnesium chloride, Xylitol, microcrystine cellulose, Xylitol, microcrystine cellulose, Avalon, Acesulfam-Kalium, grape acid, magnesium chloride, iron (III) - oxide (E172)."</seg>
<seg id="235">"how to convert and content of the package The abilify 10 mg of melting-tabletts are round and rosafar, with predefined" "A" "on one page and" 10 "on the other."</seg>
<seg id="236">"177 If you suffer as an older patient in dementia (loss of memory or other intellectual abilities), you should have to tell whether you ever have a stroke or temporary blood circulation of the brain."</seg>
<seg id="237">"inform your doctor if you are connected to muscular stiffness or stiffness with high fever, cheeses, changeable condition or very soft or irregular heart rate."</seg>
<seg id="238">"calcium, magnesium oxide (III) - hydroxid oxide (III) - hydroxid-oxide (III) - hydroxid-oxide (III) - hydroxid-oxide x H2O (E172)."</seg>
<seg id="239">"how to convert and content of the package - destabilify 15 mg of melt tables are round and yellow, with predefined" "A" "on one side and" "15" on one side and "" 15 "on the other."</seg>
<seg id="240">"183 If you suffer as an older patient in dementia (loss of memory or other intellectual abilities), you should have to tell whether you ever have a stroke or temporary blood circulation of the brain."</seg>
<seg id="241">"inform your doctor if you are connected to muscular stiffness or stiffness with high fever, cheeses, changeable condition or very soft or irregular heart rate."</seg>
<seg id="242">"how to convert and content of the package The abilify 30 mg of melting-tabletts are round and rosafar, with predefined" "A" "on one side and" 30 "on the other."</seg>
<seg id="243">"inform your doctor if you are connected to muscular stiffness or stiffness with high fever, cheeses, changeable condition or very soft or irregular heart rate."</seg>
<seg id="244">"transport and filling of machines you should not drive car and no tools or machines, until you know how to do it."</seg>
<seg id="245">190 Important information on certain other parts of destabilify any other parts of destabilify any other components that contains 200 mg Fructose and 400 mg Sudrise.</seg>
<seg id="246">"if you are aware of your doctor, you will contact your doctor before you are taking this medication."</seg>
<seg id="247">The dose to destabilify solutions must be measured with the measured measurement plate or the cooked 2 ml tpipette which are included in the package.</seg>
<seg id="248">Please speak with your doctor or pharmacist if you have the impression that the effects of abilify or too weak or too weak.</seg>
<seg id="249">"if you have a bigger quantity of destabilify, you should specify that you should specify that you should specify that you're more quickly to take advantage of your doctor (or if someone else is able to take advantage of your doctor), contact your doctor."</seg>
<seg id="250">"dinoscopic, fructose, glycerol, lactic acid, methyl-4-hydroxybenzoat (E216), propyl-4-hydroxybenzoat (E216), sodium-4-hydroxybenzoat (E216), sodium-4-hydroxybenzoat (E216), sodium-4-hydroxybenzoat (E216), sodium-4-hydroxybenzoat (E216), sodium-4-hydroxybenzoat (E216), sodium-4-hydroxybenzoat (E216), sodium-4-hydroxybenzoat (E216), sodium-4-hydroxybenzoat (E216), sodium-4-hydroxybenzoat (E216), sodium-4-hydroxybenzoat (E216), sodium-4-hydroxybenzoat (E216), sodium-4-hydroxybenzoat (E216), sodium-4-hydroxybenzoat (E216), propyl-4-hydroxybenzoat (E216), sodium hydroxid,</seg>
<seg id="251">"how to convert and content of the package contains 1 mg / ml solution for insertion is a clear, coloured to light yellow and 50 ml, 150 ml or 480 ml"</seg>
<seg id="252">"health care solution will apply to the rapid treatment of increased ounces and despair behaviour that are identified as symptoms of a disease, which are identified as symptoms of symptoms of symptoms that are not present, Misstrust, and incoherent language, incoherent behaviour and despair."</seg>
<seg id="253">"people with this disease may also be depressed, guilty, or anonymously. excessive energy to have much less sleep than usually, very fast reaction with changing ideas and sometimes strong friction."</seg>
<seg id="254">"inform your doctor if you are connected to muscular stiffness or stiffness with high fever, cheeses, changeable condition or very soft or irregular heart rate."</seg>
<seg id="255">"if you are able to use other medicines, please inform your doctor or pharmacist if you are allowed other medicines to apply or use other medicines, even if there are no prescription drugs."</seg>
<seg id="256">"medicine for treatment of cardiovascular disorders of antidepressants or herbal medicines that are used to treat chronic diseases such as HIV infection, antibacterial infections, to treat epilepsy in the treatment of epilepsy."</seg>
<seg id="257">"196 pregnancy and free time you should not apply if you are pregnant, unless you are discussed with your doctor."</seg>
<seg id="258">"transport and filling of machines you should not drive car and no tools or machines, if you make use of the application of destabilify injections."</seg>
<seg id="259">"if you have concerns that you want more destabilify injection solution, please contact your doctor or care about your doctor or care."</seg>
<seg id="260">"frequent side effects (in more than 1 of 100, less than 1 of 10 treatment) of destabilify injections, tiredness, headache, headache, diarrhea, nausea and vomiting."</seg>
<seg id="261">"occasional side effects (in more than 1 of 1,000, less than 1 of 100 treatments) Some persons may have a altered blood pressure, especially when moving out of the lians or seats, or a fast pulse, a dry matter in the mouth or a fast pulse."</seg>
<seg id="262">"frequent side effects (at more than 1 of 100, less than 1 of 10 treatment) uncontrolled body movements, headache, vomiting, vomiting, higher salidity, sleep problems, straightening, straightening, water problems, water problems, water problems."</seg>
<seg id="263">"if you need more information about your disease or their treatment, please read the packages (also part of the EPAR) or contact your doctor or pharmacist."</seg>
<seg id="264">"it is also possible to use Zytostatica as well as the supervision of a qualified onkologists in the application of cytostatika (abortion of cells) specialized departments."</seg>
<seg id="265">Patients who occur if certain side effects on blood or the nervous system can be reduced or the treatment can be interrupted.</seg>
<seg id="266">Source: http: / / www.emea.europa.eu - http: / / www.emea.europa.eu - http: / / www.emea.europa.eu - http: / / www.emea.europa.eu - http: / / www.emea.europa.eu.</seg>
<seg id="267">"results appear ordered" "by relevance" "or" "by date" "(publication date),"</seg>
<seg id="268">"results appear ordered" "by relevance" "or" "by date" "(publication date),"</seg>
<seg id="269">"overall, in the main study 72 (31%) of the lympxane treatment in the treatment of patients treated to the treatment of 37 (16%) of the 225 (16%) of the 225 (16%) of the 225 (16%)."</seg>
<seg id="270">"only the patients who were treated with metastatic breast cancer, there were no difference between the medicines and survival of the disease and survival."</seg>
<seg id="271">"* Understand the competitive environment, the market's major players and leading brands; * Use five-year forecasts to assess how the market is predicted to develop."</seg>
<seg id="272">"it may also be applied to patients who have been applied in patients, the breastfeeding or before the beginning of the treatment of low-philologists in the blood."</seg>
<seg id="273">"the Committee for Human Physicians (CHMP) signed up that the first treatment is no longer contradictory than conventional Paclitaxel contained medicine, and that it must be identified with other medicines to reduce side effects."</seg>
<seg id="274">"in January 2008, the European Commission said the European Commission for the companies Mentioned Bioscience Limited will be an approval for the inbreeding of nxane in the entire European Union."</seg>
<seg id="275">"nopane monotherapy is missing for the treatment of metastatic breast cancer in patients, with which the first-line treatment of metastatic disease is failed and for which a uniform Anthracycline therapy is not shown (see also Section 4.4)."</seg>
<seg id="276">"in patients with serious neutrality (neutrophilation, &lt; 0.050 x 109 / l via a period of a week or longer) or more sensorical Neuropathy, the dose should be reduced to 220 mg / m2."</seg>
<seg id="277">"results appear ordered" "by relevance" "or" "by date" "(publication date),"</seg>
<seg id="278">"there are currently no longer sufficient data for the recommendation of Dosisadaptions in patients with light to moderate impairment of liver function (see paragraph 4.4th and 5.2)."</seg>
<seg id="279">There are no studies with patients with insufficient kidney function and there are currently no longer sufficient data for patients with impairment of kidney function (see section 5.2).</seg>
<seg id="280">"ixane is not recommended for the application in children under 18 years, due to sufficient data to inconceivable and effectiveness."</seg>
<seg id="281">"maclitaxel is a Albumin nanoparists, which might be much more pharmacological features as other formulations of paclitaxel (see section 5.1 and 5.2)."</seg>
<seg id="282">"if an allergic reaction, the medicine should be set immediately and a symptomatic treatment, and the patient should not be treated with Paclitaxel."</seg>
<seg id="283">"after the patient should not be reconstructed in the patient's blood vessels, until the neutrroporous number is returned to &gt; 1.5 x 109 / l, and the Thrombocytenance is again on &gt; 100 x 109 / l."</seg>
<seg id="284">Patients with severe liver dysfunction (Bilirubin &gt; 5 x ULN or ASL / ALT &gt; 10 x ULN) should not be treated with cutxane.</seg>
<seg id="285">"in conjunction with respiratory diseases, carotoxicity is not unusual, especially in patients with fruit disease or lung disease or lung disease."</seg>
<seg id="286">"in case of patients after the gift of pomxane nausea, vomiting and diarrhoea, these are treated with the usual antiemetics and consignments."</seg>
<seg id="287">"it is also essential for pregnant women who are not effective in pregnant women who are not effective in pregnant women who are unable to practice, except the treatment of the mother with Paclitaxel."</seg>
<seg id="288">"women in the medium-sized age should be observed during and up to 1 month after treatment with pomxane, a reliable removal method."</seg>
<seg id="289">Male patients who are treated with pomxane will be recommended during and up to six months after the treatment of no child.</seg>
<seg id="290">Male patients should be able to consult the treatment of a sperm treatment since due to the therapy with pomxane the possibility of misappropriated infertility.</seg>
<seg id="291">Cutxane can cause side effects such as tiredness (very often) and digestibility (often) which may result in traffic and ability to serve machines.</seg>
<seg id="292">"in the following are the most common and most important cases of side effects that were listed at 229 patients with metastatic breast cancer in the pivotal clinical phase III study once all three weeks with 260 mg / m2 Abrasives were treated."</seg>
<seg id="293">Neutrality was the most important chmatological toxicity (at 79% of patients) and was quickly resealed and doscope; leucopenie was reported at 71% of the patients.</seg>
<seg id="294">"if you want to send us a question about this product, simply complete all the fields marked * and click" "Send". ""</seg>
<seg id="295">"table 1 Demand for wheat meal in the country in question, 2008-2014 (US dollars)"</seg>
<seg id="296">"(≥ 1 / 10); often (≥ 1 / 100, &lt; 1 / 10); occasionally (≥ 1 / 10, &lt; 1 / 100); rare (≥ 1 / 10,000, &lt; 1 / 100); very rare (&lt; 1 / 10,000); very rare (&lt; 1 / 10,000)."</seg>
<seg id="297">"occasionally: increased blood pressure, weight reduction, increased lactine hydrogenase in blood, increased blood sugar, increased phosphor in blood, reduced phosphor in blood, reduced phosphor in blood vessels:"</seg>
<seg id="298">"Dyspagie, blended, paused mouth, dry mouth, egg, egg, egg and pain in the mouth, baguette in lower pain, infection, blood vessels and urinary passages:"</seg>
<seg id="299">"pain in the chest muscles, weakness of the muscles, genital pain, muscle pain, pain in the ski muscles, flanges, pain in the limbs, muscle ulcers, often:"</seg>
<seg id="300">1. the frequency of the oversensitive detection rate is based on a definitive case in a population of 789 patients.</seg>
<seg id="301">"since these events are reported on a voluntary basis during the clinical practice, no estimates of the actual frequency possible and there was no kausal context with these events."</seg>
<seg id="302">Paclitaxel is a Antimikrotubic agent that promotes the costing of the microtubines from the Tubular indices and the microtubic caused by inhibiting of their deportees.</seg>
<seg id="303">"this stabilization leads to an inhibiting of the normal dynamic-organization of the mistrerotubultural network, which is essential for the vitale interphase and the mitoci cell functions."</seg>
<seg id="304">It is known that Albuminto the Transcytose of plasma components in the endothelial cells and in the context of in vitro studies it has been proven that the presence of Albumin the transport of Paclitaxel is carried out by the endothelial cells.</seg>
<seg id="305">"it is assumed that this improved transsclerous transport through the gp-60 treatment, and due to the well-known Proteins of SPARC (Segted protein acidic protein in cysteine) is a Paclitaxel accumulation in the field of tumors."</seg>
<seg id="306">"the application of Abraxane for metastatic sclercarcinoma is treated with data from 106 patients in two single-based studies and of 454 patients, which were supported in a randomised phase III comparative study."</seg>
<seg id="307">"in a study were 43 patients with metastatic breast cancer with nexane, which was given in form of infusion about 30 minutes with a dose of 175 mg / m2."</seg>
<seg id="308">"in the second study, a dose of 300 mg / m2 as infusion about 30 minutes to 63 patients with metastatic breast cancer."</seg>
<seg id="309">"this multicentric study was carried out in patients with metastatic breast cancer (N = 225), either in form of solvent-based Paclitaxel 175 mg / m2 as 3-hour infusion (N = 225) or in the form of abraxane 260 mg / m2 as a 30-minute infusion (N = 229)."</seg>
<seg id="310">"in the study, 64% of patients had a significant general condition (ECOG 1 or 2), 79% of visceral metastases and 76% had more than 3 Metastoestants."</seg>
<seg id="311">"over 14% of the patients had not received chemotherapy, 27% had only a fluorescent chemotherapy, 40% because of metastasibility and 19% because of metastasibility and the fluorine treatment."</seg>
<seg id="312">"9 The results for general response rate and time until the progression of the disease as well as progressive free survival and survival for patients who are &gt; first-line therapy, below are below."</seg>
<seg id="313">Neotoxicity towards Paclitaxel was evaluated by enhancing a degree of patients who are evaluated at a point during treatment.</seg>
<seg id="314">"the natural course of peripheral Neuropathie to the resonance on baseline due to the accumulated toxicity of aromxane after &gt; 6 treatment plants, it is still unknown."</seg>
<seg id="315">"the pharmacokinetics of total weight Paclitaxel to 30- and 180-minül Infusions, with a dose of 80 to 375 mg / m2 was determined in clinical trials."</seg>
<seg id="316">The active ingredient (AUC) increased exponentially of 2653 to 16736 ng.h / ml based on a dose of 80 to 300 mg / m2.</seg>
<seg id="317">10. intravenous gift of pomxane in patients with metastatic breast cancer in the recommended clinical dose of 260 mg / m2 took the Paclitaxel plasma concentrations on multiphasic way.</seg>
<seg id="318">"the medium-sized volume amounted to 632 l / m2; the high distribution volume provides a wide range of vascular distribution, and / or crossover networks of Paclitaxel."</seg>
<seg id="319">"in a study with patients with advanced solid tumors, the pharmacokinetic properties of Paclitaxel after intravenous infusion was compared with the values after a 3-hour injection of 175 mg / m2 soluble Paclitaxel."</seg>
<seg id="320">"the Clearance of Paclitaxel was higher (43%) as after a solvent-based Paclitaxel injectors, and also the distribution volume was at Abraxane higher (53%)."</seg>
<seg id="321">"published in the published literature on in vitro studies of humanoid liver microscopy, and two smaller metals (3" -p-hydroxypaclitaxel and 6α -3 "-p-Dihydroxypaclitaxel)."</seg>
<seg id="322">After a 30 minutes infusion of 260 mg / m2 Abraxane in patients with metastatic sclercarcinoma and 3 "p hydroxypaclitaxel and 3" p hydroxypaclitaxel and 3 "p-hydroxypaclitaxel and 3" p hydroxypaclitaxel and 3 "p hydroxypaclitaxel and 3" p hydroxypaclitaxel.</seg>
<seg id="323">"in the age of over 75 years, only a few dates are available, since only 3 patients of this age group participated in the pharmacokinetic analysis."</seg>
<seg id="324">The chemical and physical stability was detected at 2 ° C - 8 ° C in original box and a high light.</seg>
<seg id="325">"Paclitaxel is a cytotoxical medicine, and as well as other potential toxic substances should be avoided."</seg>
<seg id="326">"using a sterilen syringe, slowly over a period of at least 1 minute per 500 ml of 9 mg / ml (0.9%) sodium chloride-infusion solution."</seg>
<seg id="327">"after complete the solution, the flow of a solution should rest at least 5 minutes to ensure a good difference of the solids."</seg>
<seg id="328">"then the flow bottle is done for at least 2 minutes slowly and carefully trained and / or inverted, until a complete resusboard of the pulse is done."</seg>
<seg id="329">"in case of alteration or sinkage, the flow bottle must be gently gently gently to be gently gently to achieve a complete resusboard."</seg>
<seg id="330">"for the patients necessary for an exact total dossider volume of the 5-mg / ml suspension, and the corresponding amount of the regenerative cutxane in a empty, steroen PVC- or non-PVC infusions are injected."</seg>
<seg id="331">Firm of the Year for Insolvency Administration Schneider Geiwitz & Partner Firm of the Year for Tax Gleiss Lutz Firm of the Year for White Collar Crime Redeker Sellner Dahs</seg>
<seg id="332">Risk Management Risk Management (RMP) can be described in the pharmaceutical industry (RMP) and further pharmaceutical operations in the pharmaceutical industry (RMP) and the following updates of RMP which are agreed with the CHMP.</seg>
<seg id="333">"according to CHMP directive on risk management systems for the application on humans, the updated RMP at the same time with the next periodic Safety update Report (PSR) will be submitted."</seg>
<seg id="334">"in addition, a updated RMP • If a new information is related to the current safety specification, the pharmaceutical industry plan or risk assessment (pharmaceutical agents or risk inimetry) • On request of the EMEA"</seg>
<seg id="335">"8 hours in the fridge in the water bottle, when it is stored in the cardboard box to protect the content from light."</seg>
<seg id="336">"pomxane is used for the treatment of Mammacarcinoma, if other therapies were attempted, but if you are not successful for Anthracycline therapies in question."</seg>
<seg id="337">"if you are sensitive (allergic) to Paclitaxel or one of the other components of jxane, the output values for neutrons of &lt; 1.5 x 109 / l - your doctor will inform you about it)"</seg>
<seg id="338">"if you have an excessive kidney function, if you have an insufficient kidney function if you suffer from severe liver problems • if you have serious liver problems • if you have heart problems?"</seg>
<seg id="339">"in application of Abraxane with other medicines please inform the doctor if you use other medicines, even if it may not be prescription drugs, because these may cause problems with respiratory xane."</seg>
<seg id="340">"women in the medium-sized age should be observed during and up to 1 month after treatment with pomxane, a reliable removal method."</seg>
<seg id="341">"in addition, they should be able to advise before the treatment of a sperm treatment since it consists of a loss of infertility."</seg>
<seg id="342">Traffic signs and the filling of machines obxane can cause side effects such as tiredness (very often) and joints (often) which can be used on traffic signs and ability to serve machines.</seg>
<seg id="343">"if you receive any other medicines, you should be able to advise you to drive or serve machines from your doctor."</seg>
<seg id="344">"22 • Minimum effect on the peripheral nerves (pain and dobulation) • pain in one or several joints • pain in the muscles of the muscles • nausea, blood flow • weakness and tiredness"</seg>
<seg id="345">"the common side effects (at least 1 of 100 patients) are: • skin irritation, muscle pain, cardiovascular disease or pain therapy, pain or abdominal pain, pain, pain or pain, pain, pain or pain, pain or pain, mouth, mouth, pain disorders, pain disorders, mouth and sleep disorders."</seg>
<seg id="346">"results appear ordered" "by relevance" "or" "by date" "(publication date),"</seg>
<seg id="347">Please inform your doctor or pharmacist if one of the listed side effects may be affected or side effects that are not indicated in this use.</seg>
<seg id="348">"if they are not used immediately, it can be stored in the flow bottle up to 8 hours in the fridge (2 ° C - 8 ° C), when it is stored in the cardboard box to protect the content from light."</seg>
<seg id="349">"each flow bottle contains 100 mg of Paclitaxel. • After the reconstruction of the suspension 5 mg Paclitaxel. • The other part is part of the suspension solution from man (contains sodium, sodium caprylate and N Acetyltryptophan)."</seg>
<seg id="350">Precautions for preparation and application of Paclitaxel is a cytotoxical medicine and as well as other potential toxic substances.</seg>
<seg id="351">"using a sterilen syringe, slowly over a period of 1 minute 30 ml of 9 mg / ml (0.9%) sodium chloride-infusion solution."</seg>
<seg id="352">"afterwards the flow bottle is done for at least 2 minutes slowly and careful, and / or inverter until a complete resusboard of the pulse is done."</seg>
<seg id="353">"for the patients necessary for an exact total dossider volume of the 5 mg / ml suspension, and the corresponding amount of reactivated carbon sulxane in a empty, sterilding PVC-Infusions type IV injizers."</seg>
<seg id="354">Parser medicines should be made before the application of the application of visibility.</seg>
<seg id="355">"stability unlock water up to the packing date stable, when the flow bottle is stable in circulation, to protect the content from light."</seg>
<seg id="356">"stability of rebalanced suspension in the blood flow, the first reconstruction should be filled into an infusion bag."</seg>
<seg id="357">Member states must ensure that the owner of the approval of the company will bring the medical assistance in dialysis centres and retail outlets with the following information and materials:</seg>
<seg id="358">"• Collaborative approach • summary of the characteristics of the drug by means (technical information), labeling and packet test. • With clear presentation of the correct application of the correct application of the product."</seg>
<seg id="359">"this means that Abseamed a biological medicine is similar to the European Union (EU), and the same substance contains (also" reference implementation ")."</seg>
<seg id="360">"patients with normal blood vessels are used in conjunction with a blood transfusion complications, if a blood loss is not possible, and where a blood loss of 900 to 1 800 ml can be expected."</seg>
<seg id="361">The treatment with Abseamed must be taken under the supervision of a doctor's experience in the treatment of patients with diseases.</seg>
<seg id="362">Patients with kidney problems and patients associated with kidney problems and patients who want to injected a self-blood circulation is Abseamed into a vene.</seg>
<seg id="363">"the injection system can also be made by the patient or supervisor, if they have a suitable guidance."</seg>
<seg id="364">Patients with chronic kidney disease or patients who receive chemotherapy in the recommended area (between 10 and 12 grams per deciliter in adults or between 9.5 and 11 g / dl on children).</seg>
<seg id="365">The iron values of all patients are to control of the treatment to ensure that no iron deficiency exists and iron supplements should be given during the whole treatment.</seg>
<seg id="366">Patients who receive chemotherapy in patients with kidney problems can be caused by a pathophysical disease or that the body is not sufficient to the body's body's own Erypoietin.</seg>
<seg id="367">Posted by betabug at 17: 17 | Comments (0) | Trackbacks (0)</seg>
<seg id="368">"it is produced by a cell, in which a gene (DNA) was produced in the formation of epoetin alfa."</seg>
<seg id="369">Abseamed was compared with 479 patients with 479 patients suffering from kidney problems.</seg>
<seg id="370">"at least eight weeks, Eprex / Erypo have been opened to a Vene injected before they were killed or continue Eprex / Erypo."</seg>
<seg id="371">Main indicator for the effectiveness was the change of the hemoglobbular values between the beginning of the study and the transfer period in weeks 25 to 29.</seg>
<seg id="372">"in addition, the results of a study conducted by Eprex / Erypo with those of Eprex / Erypo at 114 cancer patients were investigated."</seg>
<seg id="373">"in the study with patients suffering from patients suffering from kidney problems, the hemoglobal values were maintained in the same dimensions as to those patients who continue Eprex / Erypo."</seg>
<seg id="374">"compared to patients who continue Eprex / Erypo, a rise of 0.063 g / dl of the output value of 12.0 g / dl."</seg>
<seg id="375">"the most common side effects of Abseamed is an increase of blood pressure, occasionally occasionally symptoms of symptoms (brain problems) such as sudden, stechomination headaches and fortification."</seg>
<seg id="376">Abseamed should not be applied to patients who may be oversensitive (allergic) against epoxy alfa or one of the other components.</seg>
<seg id="377">"Abseamed as a injection under the skin is not recommended for treatment of kidney problems, as further studies are required to ensure that no allergic reactions are triggered."</seg>
<seg id="378">"the Committee for Human Physicians (CHMP) came to the end that for Abseamed according to the regulations of the European Union of proof, the medicine is a comparable quality and safety profile as Eprex / Erypo."</seg>
<seg id="379">"Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems."</seg>
<seg id="380">Firm of the Year for Insolvency Administration Schneider Geiwitz & Partner Firm of the Year for Tax Gleiss Lutz</seg>
<seg id="381">"treatment of anemia and reduction of transfusion requirements in adults with solid tumors, malignant lymphoma, or multiplem myeloma, which consists of chemotherapy as well as the risk of transfusion (such as carcinogenic status, pre-existing anemia at the beginning of chemotherapy)."</seg>
<seg id="382">"treatment should only be performed in patients with medium-serious anaemia (hemoglobin [Hb] 10 - 13 g / dl [6.2 - 8,1 mmol / l], no iron deficiency."</seg>
<seg id="383">"for reduction of foreign blut, Abseamed from a large electro-orthopedic surgery in adults without iron deficiency may be expected in which a high risk of transfusion applications are expected."</seg>
<seg id="384">HB 10-13 g / dl) and a wide blood loss of 900-1800 ml are used to participate in an autonomous blood program.</seg>
<seg id="385">"the hemoglobin-target concentration is between 10 and 12 g / dl (6,2 - 7.5 mmol / l), except for papatatric patients, except for papatatric patients, with which the hemispheres concentration between 9.5 and 11 g / dl (5.9 - 6,8 mmol / l)."</seg>
<seg id="386">"depending on age, gender and overall disease may be different; therefore the assessment of individual clinical trials and disease is required by the doctor."</seg>
<seg id="387">A rise of hemoglobin around more than 2 g / dl (1.25 mmol / l) over a period of four weeks should be avoided.</seg>
<seg id="388">"due to the variability between patients, patients can occasionally occur at a patient at a patient level via or under the hemispheres."</seg>
<seg id="389">"in view of this hemispheres, a corresponding Dosismanagement should be tried to reach hemoglobin-target concentrations of 10 g / dl (6,2 mmol / l) up to 12 g / dl (7.5 mmol / l)."</seg>
<seg id="390">"if the hemispheres worth more than 2 g / dl (1.25 mmol / l) each month, or when the permanent hemispheres value 12 g / dl (7.5 mmol / l), is the epoetin-alfa dose to reduce 25%."</seg>
<seg id="391">Patients should be monitored levels to ensure that epoetin alfa is required to ensure the control of the anaemia and the anesympsymptoms are needed.</seg>
<seg id="392">"the present results indicate that patients with initial hb value (&lt; 6 g / dl or &lt; 3.75 mmol / l) may result higher yields as patients, when the initial attack is less difficult (Hb &gt; 8 g / dl or &gt; 5 mmol / l)."</seg>
<seg id="393">"results appear ordered" "by relevance" "or" "by date" "(publication date),"</seg>
<seg id="394">Initial dose 50 I.E. / kg times per week by intravenous application if necessary with a Dosisincrease of 25 I.E. / kg (three times a week) until the desired target is reached (this should be done in increments of at least 4 weeks).</seg>
<seg id="395">"anaesesympsymptoms and subsequent symptoms can be different depending on age, gender and total disease, therefore, the assessment of individual clinical trials and disease is required by the doctor."</seg>
<seg id="396">"in view of this hemispheres, a corresponding Dosismanagement should be tried to reach hemoglobin-target concentrations of 10 g / dl (6,2 mmol / l) up to 12 g / dl (7.5 mmol / l)."</seg>
<seg id="397">Patients should be monitored levels to ensure that epoetin alfa is required for control of the anesympsymptoms.</seg>
<seg id="398">"when after 4 treatment weeks of the hemispheres, at least 1 g / dl (0.62 mmol / l) or the Retikal number, should the dose of 150 I.E. / kg of times per week or 450 I.E. / kg once per week."</seg>
<seg id="399">"when the hemisbell binge &lt; 1 g / dl (&lt; 0.062 mmol / l) and the Retikal number &lt; 40,000 cells / µl, the dose of 300 I.E. / kg of times per week."</seg>
<seg id="400">If after another 4 treatment weeks with 300 I.E. / kg times each week of the hemispheres worth ≥ 1 g / dl (≥ 0.62 mmol / l) or the Reduction of ≥ 300 I.E. / kg of times per week.</seg>
<seg id="401">"on the other hand, the hemispheres worth &lt; 1 g / dl (&lt; 0.062 mmol / l) or the Reduction of &lt; 40,000 cells / µl compared to the output value, is an attraction to the epoetin-alfa therapy."</seg>
<seg id="402">Patients with light anemia (hemmatokram 33 - 39%) which is needed to obtain a dose of 600 I.E. / kg body weight twice weekly for 3 weeks before the operating procedure.</seg>
<seg id="403">"with the Eisenach process, as early as possible - e.g. some weeks before the beginning of the autologists, program - started to be started in the beginning of the Abseamed therapy."</seg>
<seg id="404">"6 The recommended dosage is 600 I.E. / kg epoetin alfa, the once weekly over three weeks (day 21, 14 and 7) before the operating procedure and the day of the surgery (day 0)."</seg>
<seg id="405">"in addition, epoxy resin generated 300 I.E. / kg at 10 successive days prior to the day of the surgery as well as 4 days after the day of the surgery as well as 4 days."</seg>
<seg id="406">"at the end of the Dialysis on the end of the Dialysis through the hose of a Fistelnadel, followed by 10 ml isotonic cooking solution to rinse the hose and a sufficient injections of drug use in the cycle."</seg>
<seg id="407">"medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine, medicine</seg>
<seg id="408">"heart infants or stroke during a month before the treatment, instabile angina pectoris, increased risk of deep vaultine (e.g. anamese-known venous thrombosis)."</seg>
<seg id="409">"patients who are intended to participate in patients who are intended to participate in an autonomous orthopedic program, the application of epoetin alfa is the application of epoetin tissue, peripheral disease, vascular disease, vascular disease, vascular disease or cerebrovascular disease."</seg>
<seg id="410">Firm of the Year for Insolvency Administration Schneider Geiwitz & Partner Firm of the Year for Tax Gleiss Lutz</seg>
<seg id="411">"patients with sudden loss loss, defined as a reduction of hemoglobal values (1 - 2 g / dl per month) with increased demand of transfusions, blood loss, infections or inflammation, blood loss and haemolysis) are investigated."</seg>
<seg id="412">"when the Reticulocytes, under consideration of the aemia (i.e. the Reticulocytes" index "), the Thrombocytic and leukocytes are normal, and if no other reason of a drug loss is found, the Anti-Eryser-antibodies and an investigation of the bone marks to diagnosis of a PRCA."</seg>
<seg id="413">The data to the immunologic application of Abseamed application of Abseamed for patients with a risk of anaesu-induced PRCA (patients with renal anaemia) are not sufficient.</seg>
<seg id="414">8. patients with chronic kidney disease should not be exceeded the upper limit of the hemoglobin destination zone.</seg>
<seg id="415">Clinical trials were observed in clinical trials and risk of serious carcinogenic events (ESA) with a hemispheres of stimulating bacteria (ESA) with a hemispheres - target movement of over 12 g / dl (7.5 mmol / l) were given.</seg>
<seg id="416">"controlled clinical trials have no significant benefit, which is due to the gift of epoxy concentrations and avoiding blood transfusions and avoiding blood transfusions."</seg>
<seg id="417">The hemispheres should amount about 1 g / dl (0.62 mmol / l) each month and should not exceed 2 g / dl (1.25 mmol / l) per month.</seg>
<seg id="418">Patients with chronic kidney disease and clinically suffering coronary cardiovascular disease or dust-failure should not be exceeded the upper limit of the hemoglobin destination zone.</seg>
<seg id="419">"according to the present study, the treatment of anaemia with epoetin in adults with kidney failure, which are not dialyst for adults, the progression of kidney failure is not accelerated."</seg>
<seg id="420">"data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data. why buy this report? * Get a detailed picture of the Consumer Health market; * Pinpoint growth sectors and identify factors driving change; * Understand the competitive environment, the market's major players and leading brands;"</seg>
<seg id="421">"if the Hb increase is larger than 2 g / dl (1.25 mmol / l) each month or a Hb value of 13 g / dl (8,1 mmol / l) each month or a Hb value of 13 g / dl (8,1 mmol / l)."</seg>
<seg id="422">The decision for the application recombinable Erythropoetine should be able to take advantage of the specific risk of the respective patients that should be taken into consideration in the specific clinical context.</seg>
<seg id="423">"patients who are planned for a larger electro-orthopedic procedure, if possible, prior to the epoetin-alfa therapy, the cause of anaemia can be treated confidentially."</seg>
<seg id="424">"patients who receive a greater electro-orthopedic intervention, as they receive a higher risk of thromnutrient and vascular diseases, especially with an adequate risk of cardiovascular disease."</seg>
<seg id="425">"in addition, it cannot be excluded that the treatment with epoetin alfa is worth a higher risk of postoperative care / vascular events."</seg>
<seg id="426">"in several controlled trials, epoetine has not been demonstrated that they are able to improve tumor structures with symptomatic anemia to improve the overall risk or risk of tumour."</seg>
<seg id="427">"4 months in patients with metastatic breast cancer, chemotherapy has been carried out, when a hemoglobin-target concentration of 12 - 14 g / dl (7.5 - 8,7 mmol / l)."</seg>
<seg id="428">Epoetin alfa combined with Ciclospores should be adapted to the blood mirror of Ciclosporin and the Ciclosporindosis can be adapted to the increasing hemmatocyte.</seg>
<seg id="429">"in vitro investigations on tumor cells, no references to an interaction between epoetin alfa and G-CSF or GM-CSF as well as a proliferation differentiation or proliferation."</seg>
<seg id="430">"diseases such as myocarcinoma, vascular diseases such as myocardiale and anaesthesia, cardiovascular disease and 11 blood clashes in artificial kidneys."</seg>
<seg id="431">The most common side effects during the treatment with epoetin alfa is a doscope of blood pressure or the deterioration of a existing hypertension.</seg>
<seg id="432">An elevated inrombovascular events (see paragraph 4.4 and Section 4.8 - General) was observed under the treatment of Erythropoetries.</seg>
<seg id="433">Independent patients with carcinogenic patients with carcinogenic cardiovascular disease after repeated blood donations at thromatic message and vascular complications.</seg>
<seg id="434">"the metamorous epoxy alfa is identical to the amino acids and carbohydrates in amino acids and carbohydrates, which was isolated from the urine of anaesthesia."</seg>
<seg id="435">"it could be done with help of cultures of human bone marketed, that epoetin alfa is stimulated that epoxy alese is not influenced and the leucopoese is not influenced."</seg>
<seg id="436">"389 patients with hemogblastine, 144 non-Hodgkinases, 144 non-Hodgkinome, 64 gynecological tumors, 22 prostate cancer cell carcinoma, 21 prostate cancer cell carcinoma and 30 more)."</seg>
<seg id="437">1895 patients with solid tumors (683 Mammacarcinoma, 260 gynecological tumors, 300 gastrokological tumors, 300 gastrointestinal tumors, and 478 other) and 802 patients with hemogblast. "</seg>
<seg id="438">"one of these studies were investigated in five large controlled trials, with a total of 2833 patients; four of these studies were double-blind-controlled trials and controlled studies."</seg>
<seg id="439">"in the open study, there is no difference in the overall survival between the associated with recombinant melanoma patients and the control of control."</seg>
<seg id="440">"in these studies in these studies in these studies in these studies have been resistant to patients with an anaemia due to several more common malignome, an uncertain, statistically significant higher sterilisation than in the controls."</seg>
<seg id="441">The overall survival in the studies could not be explained by differences in relation to Thrombal and so-related complications.</seg>
<seg id="442">"there is a higher risk of thromboast events at tumours, which can be treated with recombinatory Erythropotin, and a negative impact on the overall survival cannot be excluded."</seg>
<seg id="443">"it is not clear how far from these results are treated to the application of recombined human humanae, who are treated with chemotherapy as well as a few patients with these characteristics, as well as a few patients with these characteristics."</seg>
<seg id="444">Epoxy-alfa regulations after repeated intravenous application showed a half hours of healthy subjects and a somewhat extended half-time period of about 5 hours in patients with kidney failure.</seg>
<seg id="445">"after submitting injections, Serum injections are the Serum mirror by epoetin alfa much lower than the Serum mirror, which will be reached after intravenous injectors."</seg>
<seg id="446">"there is no Kumulation: the Serum mirror remain equal, regardless of whether they are 24 hours after the first gift or 24 hours after the last gift or 24 hours after the last gift."</seg>
<seg id="447">Bone treatment is a known complication of chronic kidney disease in humans and could be caused by secondary hyperparathyreoidiol or unknown factors.</seg>
<seg id="448">"in a study on hemenalysis, the three years of epoetin was treated with epoetin in the control group with Dialysis, which were not increased with epoetin alfa."</seg>
<seg id="449">"14 In the experimental studies with annotted of the use of the application, epoetin led the epoetin alfa to diminish body weight, to a delay of the Ossification and an increase of the bad sterilisation."</seg>
<seg id="450">"these reports are based on in vitro experiments with cells from humanistic tumor tissue, which are liable for clinical situation but of insignificant Signififié."</seg>
<seg id="451">The patient can be used for a period of maximum 3 days outside of cooling liquid and not above 25 ° C.</seg>
<seg id="452">"the syringes are provided with a graduate level, and the level volume is shown by a repeated label, so that if necessary, the measurement of partial quantities is possible."</seg>
<seg id="453">The treatment with Abseamed has to be taken under supervision of physicians that have experience in the treatment of patients with the above mentioned indications.</seg>
<seg id="454">"21 The recommended dosage is 600 I.E. / kg epoetin alfa, the once weekly over three weeks (day 21, 14 and 7) before the operating procedure and the day of the surgery (day 0)."</seg>
<seg id="455">23 With patients with chronic kidney disease should not be exceeded the upper limit of the hemoglobin destination zone.</seg>
<seg id="456">The hemispheres should amount about 1 g / dl (0.62 mmol / l) each month and should not exceed 2 g / dl (1.25 mmol / l) per month.</seg>
<seg id="457">"diseases such as myocarcinoma, vascular diseases such as myocardiale as myocarcinoma, kidney beans and 26 blood clashes in artificial kidneys."</seg>
<seg id="458">An elevated inrombovascular events (see paragraph 4.4 and Section 4.8 - General) was observed under the treatment of Erythropoetries.</seg>
<seg id="459">"389 patients with hemogblastine, 144 non-Hodgkinases, 144 non-Hodgkinome, 64 gynecological tumors, 22 prostate cancer cell carcinoma, 21 prostate cancer cell carcinoma and 30 more)."</seg>
<seg id="460">"29 In the experimental studies with annum of the use of the use of the application, epoetin led the epoetin alfa to diminish body weight, to a delay of the Ossification and an increase of the bad sterilisation."</seg>
<seg id="461">The patient can be used for a period of maximum 3 days outside of cooling liquid and not above 25 ° C.</seg>
<seg id="462">"36 The recommended dosage is 600 I.E. / kg epoetin alfa, the once weekly over three weeks (day 21, 14 and 7) before the operating procedure and the day of the surgery (day 0)."</seg>
<seg id="463">38 In patients with chronic kidney disease should not be exceeded the upper limit of the hemoglobin destination zone.</seg>
<seg id="464">The hemispheres should amount about 1 g / dl (0.62 mmol / l) each month and should not exceed 2 g / dl (1.25 mmol / l) per month.</seg>
<seg id="465">"diseases such as myocarcinoma, vascular diseases such as myocardials, macros and 41 blood cells in artificial kidneys, proliferating Thrombum, lung disease and 41 blood clashes in artificial kidneys, patients under epoetin alfa, were reported in patients under Erytin alfa."</seg>
<seg id="466">An elevated inrombovascular events (see paragraph 4.4 and Section 4.8 - General) was observed under the treatment of Erythropoetries.</seg>
<seg id="467">"389 patients with hemogblastine, 144 non-Hodgkinases, 144 non-Hodgkinome, 64 gynecological tumors, 22 prostate cancer cell carcinoma, 21 prostate cancer cell carcinoma and 30 more)."</seg>
<seg id="468">"44 In the experimental studies with annum of the use of the use of the application, epoetin led the epoetin alfa to diminish body weight, to a delay of the Ossification and an increase of the bad sterilisation."</seg>
<seg id="469">The patient can be used for a period of maximum 3 days outside of cooling liquid and not above 25 ° C.</seg>
<seg id="470">"51 The recommended dosage is 600 I.E. / kg epoetin alfa, which is once weekly on three weeks (day 21, 14 and 7) before the operating procedure and the day of the surgery (day 0)."</seg>
<seg id="471">53 In patients with chronic kidney disease should not be exceeded the upper limit of the hemoglobin destination zone.</seg>
<seg id="472">The hemispheres should amount about 1 g / dl (0.62 mmol / l) each month and should not exceed 2 g / dl (1.25 mmol / l) per month.</seg>
<seg id="473">"diseases such as myocarcinoma, vascular diseases such as myocardiale and anaesthesia, macros and 56 blood cells in artificial kidneys."</seg>
<seg id="474">An elevated inrombovascular events (see paragraph 4.4 and Section 4.8 - General) was observed under the treatment of Erythropoetries.</seg>
<seg id="475">"389 patients with hemogblastine, 144 non-Hodgkinases, 144 non-Hodgkinome, 64 gynecological tumors, 22 prostate cancer cell carcinoma, 21 prostate cancer cell carcinoma and 30 more)."</seg>
<seg id="476">"59 In the experimental studies with annotted of the use of the application, epoetin led the epoetin alfa to diminish body weight, to a delay of the Ossification and an increase of the bad sterilisation."</seg>
<seg id="477">The patient can be used for a period of maximum 3 days outside of cooling liquid and not above 25 ° C.</seg>
<seg id="478">"66 The recommended dosage is 600 I.E. / kg epoetin alfa, the once weekly over three weeks (day 21, 14 and 7) before the operating procedure and the day of the surgery (day 0)."</seg>
<seg id="479">68 In patients with chronic kidney disease should not be exceeded the upper limit of the hemoglobin destination zone.</seg>
<seg id="480">The hemispheres should amount about 1 g / dl (0.62 mmol / l) each month and should not exceed 2 g / dl (1.25 mmol / l) per month.</seg>
<seg id="481">"diseases such as myocarcinoma, vascular diseases such as myocardiale as myocarcinoma, kidney beans and 71 blood clashes in artificial kidneys."</seg>
<seg id="482">An elevated inrombovascular events (see paragraph 4.4 and Section 4.8 - General) was observed under the treatment of Erythropoetries.</seg>
<seg id="483">"389 patients with hemogblastine, 144 non-Hodgkinases, 144 non-Hodgkinome, 64 gynecological tumors, 22 prostate cancer cell carcinoma, 21 prostate cancer cell carcinoma and 30 more)."</seg>
<seg id="484">"74 In the experimental studies with annotted of the use of the application, epoetin led the epoetin alfa to diminish body weight, to a delay of the Ossification and an increase of the bad sterilisation."</seg>
<seg id="485">The patient can be used for a period of maximum 3 days outside of cooling liquid and not above 25 ° C.</seg>
<seg id="486">"81 The recommended dosage is 600 I.E. / kg epoetin alfa, the once weekly over three weeks (day 21, 14 and 7) before the operating procedure and the day of the surgery (day 0)."</seg>
<seg id="487">83 In patients with chronic kidney disease should not be exceeded the upper limit of the hemoglobin destination zone.</seg>
<seg id="488">The hemispheres should amount about 1 g / dl (0.62 mmol / l) each month and should not exceed 2 g / dl (1.25 mmol / l) per month.</seg>
<seg id="489">"diseases such as myocarcinoma, vascular diseases such as myocardials, macros and 86 blood cells, retinopathy and 86 blood cells in artificial kidneys were reported to patients under Erytin alfa."</seg>
<seg id="490">An elevated inrombovascular events (see paragraph 4.4 and Section 4.8 - General) was observed under the treatment of Erythropoetries.</seg>
<seg id="491">"389 patients with hemogblastine, 144 non-Hodgkinases, 144 non-Hodgkinome, 64 gynecological tumors, 22 prostate cancer cell carcinoma, 21 prostate cancer cell carcinoma and 30 more)."</seg>
<seg id="492">"89 In the experimental studies with annotted of the use of the application, epoetin led the epoetin alfa to diminish body weight, to a delay of the Ossification and an increase of the bad sterilisation."</seg>
<seg id="493">The patient can be used for a period of maximum 3 days outside of cooling liquid and not above 25 ° C.</seg>
<seg id="494">"96 The recommended dosage is 600 I.E. / kg epoetin alfa, the once weekly over three weeks (day 21, 14 and 7) before the operating procedure and the day of the surgery (day 0)."</seg>
<seg id="495">98 In patients with chronic kidney disease should not be exceeded the upper limit of the hemoglobin destination zone.</seg>
<seg id="496">The hemispheres should amount about 1 g / dl (0.62 mmol / l) each month and should not exceed 2 g / dl (1.25 mmol / l) per month.</seg>
<seg id="497">"diseases such as myocarcinoma, vascular diseases such as myocardials, cerebral events, cerebony thrombal, lung disease, retinal thrombum, lung disease and 101 blood clashes in artificial eyes, in patients under Erytin alfa, in patients under Erytin alfa."</seg>
<seg id="498">An elevated inrombovascular events (see paragraph 4.4 and Section 4.8 - General) was observed under the treatment of Erythropoetries.</seg>
<seg id="499">"389 patients with hemogblastine, 144 non-Hodgkinases, 144 non-Hodgkinome, 64 gynecological tumors, 22 prostate cancer cell carcinoma, 21 prostate cancer cell carcinoma and 30 more)."</seg>
<seg id="500">"104 In the experimental studies with annotted of the use of the application, epoetin led the epoetin alfa to diminish body weight, to a delay of the Ossification and an increase of the bad sterilisation."</seg>
<seg id="501">The patient can be used for a period of maximum 3 days outside of cooling liquid and not above 25 ° C.</seg>
<seg id="502">"111 The recommended dosage is 600 I.E. / kg epoetin alfa, the once weekly over three weeks (day 21, 14 and 7) before the operating procedure and the day of the surgery (day 0)."</seg>
<seg id="503">113 In patients with chronic kidney disease should not be exceeded the upper limit of the hemoglobin destination zone.</seg>
<seg id="504">The hemispheres should amount about 1 g / dl (0.62 mmol / l) each month and should not exceed 2 g / dl (1.25 mmol / l) per month.</seg>
<seg id="505">"diseases such as myocarcinoma, vascular diseases such as myocardiale and dyocardial, cardiovascular disease, lung disease and 116 blood cells in artificial kidneys, infected patients under epoetin alfa, were reported in patients under Erytin alfa."</seg>
<seg id="506">An elevated inrombovascular events (see paragraph 4.4 and Section 4.8 - General) was observed under the treatment of Erythropoetries.</seg>
<seg id="507">"389 patients with hemogblastine, 144 non-Hodgkinases, 144 non-Hodgkinome, 64 gynecological tumors, 22 prostate cancer cell carcinoma, 21 prostate cancer cell carcinoma and 30 more)."</seg>
<seg id="508">"119 In the experimental studies with annotted of the use of the application, epoetin led the epoetin alfa to diminish body weight, to a delay of the Ossification and an increase of the bad sterilisation."</seg>
<seg id="509">The patient can be used for a period of maximum 3 days outside of cooling liquid and not above 25 ° C.</seg>
<seg id="510">"126 The recommended dosage is 600 I.E. / kg epoetin alfa, who is once weekly on three weeks (day 21, 14 and 7) before the operating procedure and the day of the surgery (day 0)."</seg>
<seg id="511">128 In patients with chronic kidney disease should not be exceeded the upper limit of the hemoglobin destination zone.</seg>
<seg id="512">The hemispheres should amount about 1 g / dl (0.62 mmol / l) each month and should not exceed 2 g / dl (1.25 mmol / l) per month.</seg>
<seg id="513">"diseases such as myocarcinoma, vascular diseases such as myocardiale as myocarcinoma, cardiovascular disease, lung disease and 131 blood cells in artificial kidneys were reported in patients under Erytin alfa."</seg>
<seg id="514">An elevated inrombovascular events (see paragraph 4.4 and Section 4.8 - General) was observed under the treatment of Erythropoetries.</seg>
<seg id="515">"389 patients with hemogblastine, 144 non-Hodgkinases, 144 non-Hodgkinome, 64 gynecological tumors, 22 prostate cancer cell carcinoma, 21 prostate cancer cell carcinoma and 30 more)."</seg>
<seg id="516">"results appear ordered" "by relevance" "or" "by date" "(publication date),"</seg>
<seg id="517">The patient can be used for a period of maximum 3 days outside of cooling liquid and not above 25 ° C.</seg>
<seg id="518">141 The recommended dosage is 600 I.E. / kg epoetin alfa that is once weekly on three weeks (day 21, 14 and 7) before the operating procedure and the day of the surgery (day 0). "</seg>
<seg id="519">143 In patients with chronic kidney disease should not be exceeded the upper limit of the hemoglobin destination zone.</seg>
<seg id="520">The hemispheres should amount about 1 g / dl (0.62 mmol / l) each month and should not exceed 2 g / dl (1.25 mmol / l) per month.</seg>
<seg id="521">"diseases such as myocarcinoma, vascular diseases such as myocardiale and macros, retinopathy, deep venous throomy, lung disease and 146 blood clashes in artificial kidneys."</seg>
<seg id="522">An elevated inrombovascular events (see paragraph 4.4 and Section 4.8 - General) was observed under the treatment of Erythropoetries.</seg>
<seg id="523">"389 patients with hemogblastine, 144 non-Hodgkinases, 144 non-Hodgkinome, 64 gynecological tumors, 22 prostate cancer cell carcinoma, 21 prostate cancer cell carcinoma and 30 more)."</seg>
<seg id="524">"149 In the experimental studies with annotted of the use of the application, epoetin led epoetin alfa to diminish body weight, to a delay of the Ossification and an increase of the bad sterilisation."</seg>
<seg id="525">The patient can be used for a period of maximum 3 days outside of cooling liquid and not above 25 ° C.</seg>
<seg id="526">"the owner of the approval for the inbox has to take place from the market and by agreement with the appropriate authorities of the Member States, the medical experts in Dialysis centres and packaging materials. • With clear presentation of the correct application of the product by means of the correct application of the product."</seg>
<seg id="527">Firm of the Year for Insolvency Administration Schneider Geiwitz & Partner Firm of the Year for Tax Gleiss Lutz</seg>
<seg id="528">Firm of the Year for Insolvency Administration Schneider Geiwitz & Partner Firm of the Year for Tax Gleiss Lutz Firm of the Year for Tax Gleiss Lutz</seg>
<seg id="529">"according to CHMP Guideline on Risk Management Systems for Medicinal products for human use" "at the next updated report about the Unsuccessful Safety update Report, PSR)."</seg>
<seg id="530">"in addition, a updated RMP will be submitted to the current security specifications (Safety Specification), the pharmaceutical manufacturers and the measures for risk reduction (the pharmaceutical, pharmaceutical or risk reduction)."</seg>
<seg id="531">"• within one month prior to your treatment a heart attack or a stroke of angina Pectoris (first produced or reinforced breast pain), if you have already seen a blood flow in the veins (deep-rombbell)."</seg>
<seg id="532">"the heart of the heart of the heart (coronary heart disease), the arteries of legs or arms (peripheral arterial disease), the chocolates (vascular disease) or the brain (zerebrovascular disease)."</seg>
<seg id="533">"during the treatment with Abseamed, it can occur within a normal doscope with a slight dossification of blood vessels, which forms another treatment for further treatment."</seg>
<seg id="534">Your doctor will perform regular blood examinations to control the number of blood vessels during the first 8 weeks of the treatment regularly.</seg>
<seg id="535">"iron deficiency, resolution of red blood cells (Hideolysis), blood loss, vitamin B12- or folklore, should be taken into consideration and before the start of the therapy with Abseamed."</seg>
<seg id="536">"data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data. why buy this report? * Use five-year forecasts to assess how the market is predicted to develop."</seg>
<seg id="537">"if you suffer from Eryphon blastopenie, he will send your therapy with Abseamed Cancel and set up how your anaemia will be treated."</seg>
<seg id="538">"therefore, Abseamed through injection in a Vene (intravenous), if you are treated due to an anaemia due to a kidney disease."</seg>
<seg id="539">A high hemispheres worth the risk of problems with the heart or blood vessels.</seg>
<seg id="540">"for increased or decrease the potassium, your physician will be considered a interruption of the treatment with Abseamed up to the calibers."</seg>
<seg id="541">"if you suffer from chronic kidney disease and clinically isolated heart disease, your doctor will ensure that your hemispheres will not exceed a certain value."</seg>
<seg id="542">"according to the present study, the treatment of blood poisoned with Abseamed with chronic kidney disease, which is not dialyst for adults with chronic kidney disease, which is not dialysis, the progression of kidney failure."</seg>
<seg id="543">A 2-week delay between epoetin-alfa-gift and the desired effect should be taken into consideration for assessing the effectiveness of Abseamed.</seg>
<seg id="544">200 your doctor will determine your values of red blood dyes (hemoglobin) and your seamed dose according to the risk of blood pressure (thrommessage event) as possible.</seg>
<seg id="545">"this risk should be thoroughly tested against the treatment of epoetin, in particular, if you have increased risk of thrombooming events, e.g. if you are low risk of thrombovascular disease (e.g. a deep-vascular disease or pneumonia)."</seg>
<seg id="546">"if you have cancer patients, know that Abseamed like a growth factor for blends, and under certain circumstances the tumor can affect the tumour."</seg>
<seg id="547">"if you have a larger orthopedic surgery should be examined before treatment at the beginning of treatment, the cause of your anaemia can be treated confidentially."</seg>
<seg id="548">"if your values of red blood dys (hemoglobin) is too high, you should not receive the risk of blood pressure after surgery."</seg>
<seg id="549">Please inform your doctor or pharmacist if you are allowed to use other medicines / apply or apply if there are no prescription drugs.</seg>
<seg id="550">"when you use Ciclosporin (medium to suppression of the immune system) during your treatment with Abseamed, your physician will be able to measure certain blood levels in order to measure the blood mirror of Ciclospores."</seg>
<seg id="551">Laboratory examinations have no interaction between epoetin alfa and G-CSF or GM-CSF (G-CSF and GM-CSF are means to build the immune system for example in cancer - chemotherapy or with HIV).</seg>
<seg id="552">"depending on how your blood flow can be adjusted to the treatment, the dose can be adjusted to all four weeks, up to your condition under control."</seg>
<seg id="553">Your doctor will be able to verify the treatment of the treatment and ensure that the medicine is correct and your hemispheres worth a certain value.</seg>
<seg id="554">"as soon as you are good, you will receive regular updates from Abseamed between 25 and 50 I.E. / kg twice weekly, distributed to two equal injections."</seg>
<seg id="555">Your doctor will be able to check regular mail tests to check the treatment of the treatment and secure that your hemispheres worth a certain value.</seg>
<seg id="556">"depending on how the anaemia can be adjusted to the treatment, the dose can be adjusted to all four weeks, until the condition is under control."</seg>
<seg id="557">"to ensure this, and ensure that the hemispheres worth a certain value, the treatment of regular blood therapy."</seg>
<seg id="558">"when it is necessary to shorten the treatment time before the surgery, a dose of 300 I.E. / kg to 10 successive days prior to the operation, the day of the operation and further 4 days after surgery."</seg>
<seg id="559">"however, you can learn if your doctor will also be able to learn how to use Abseamed itself under the skin."</seg>
<seg id="560">"facets, which offer an easy way to limit your search,"</seg>
<seg id="561">"the eye and the lips (Quinel-oil) and shockens allergic reaction with symptoms such as Kristening, itching, itching, heat and accelerated pulse were reported in rare cases."</seg>
<seg id="562">It means that no longer periods of red blood cells can be formed (see section "special note of the application of Abseamed is required.)</seg>
<seg id="563">"after repeated blood donations, it can be independent from the treatment with Abseamed - to the blood of blood formation (thromselvascular disease)."</seg>
<seg id="564">The treatment with Abseamed can be seen with an increased risk of blood formation after surgery (postoperative thrombovascular events).</seg>
<seg id="565">Inform your doctor or pharmacist if one of the listed side effects are considerably affected or if you notice side effects that are not indicated in this use.</seg>
<seg id="566">"when a syringe from the refrigerator, the room temperature is reached (up to 25 ° C), it must be used within 3 days or will be discarded."</seg>
<seg id="567">Aclasta is applied for treatment of the following diseases: • Osteoporosis (a disease which makes the bone loss) in women after the exchange years as well as men.</seg>
<seg id="568">"patients with a high questionnaire (bone formation) are applied, including patients who have recently discovered a low interest in the bone; • Morbus Paget of the bone, a disease which changed the normal course of the bone growth."</seg>
<seg id="569">"in addition, patients with Morbus Paget at least 500 mg of calcium twice daily for at least 10 days after treatment. patients with hip fracture should receive a large dose of vitamin D (50 000 to 125 000 IE)."</seg>
<seg id="570">"the main symptoms of paracetamol or Ibuprofen (remedy against inflammation) in the three days after the infusion symptoms, such as fever, muscle pain, grippelike symptoms, articulation and headache, reduce pain and headache."</seg>
<seg id="571">"for the treatment of the Moran Paget may only be used by physicians, who have experience in the treatment of these disease."</seg>
<seg id="572">Firm of the Year for Insolvency Administration Schneider Geiwitz & Partner Firm of the Year for Tax Gleiss Lutz</seg>
<seg id="573">"the first study were almost 8 000 older women with osteoporosis, and it was investigated the number of vertebulators and hip fractures over a period of three years."</seg>
<seg id="574">"the second study conducted the two 127 men and women with osteoporosis over 50 years, which recently had been investigated the number of fractures over a period of up to five years."</seg>
<seg id="575">"at Morbus Paget was tested in two studies at a total of 357 patients, and six months long with Risedronate (another Bisphosphate)."</seg>
<seg id="576">Main indicator for the effectiveness was whether the content of alkaline phosphatase in the Serum (a enzyme, the bone substance use) in blood is a normalized or at least 75% compared to the output value. "</seg>
<seg id="577">"in the study with older women, the risk of spine fractures in patients with Aclasta (without any other osteoporosis) is reduced by a period of three years compared to placebo."</seg>
<seg id="578">"compared to all patients with Aclasta (with or without other osteoporosis), the risk of hip fractures was reduced by 41%."</seg>
<seg id="579">In the study with men and women with hip fracture had 9% of patients under Aclasta (92 of 1 065) compared to 13% of patients under placebo (139 of 1 062).</seg>
<seg id="580">Most of the side effects of Aclasta arrived within the first three days after the infusion and are less often less frequently.</seg>
<seg id="581">Aclasta may not be applied to patients who may be oversensitive (allergic) against coledronacid or other Bisphosphate or other bisphosphate.</seg>
<seg id="582">"in case of all Bisphosphate, patients are subject to the risk of kidney disease, reactions to the risk of kidney disease and osteoneksis (Abdie of bone tissue) in the jaw."</seg>
<seg id="583">"the manufacturer of Aclasta offers counseling material for physicians to apply the Aclasta for treatment of osteoporosis, the notes contains, as well as similar material for patients in which the side effects of medication should be explained by the doctor."</seg>
<seg id="584">"in April 2005, the European Commission presented the European Commission of Novartis Europharm Limited, an approval of Aclasta in the entire European Union."</seg>
<seg id="585">Conditions OF THE HOLE OF THE HOTO THE OF THE HOTO THE HOTO THE HOTO THE HOTO THE HOTO THE HOTO THE HOTO THE HOTO THE HOTO THE HOTO THE HOTO THE HOTO THE HOTO THE HOTO THE HOTO THE HOTO THE HOTO THE HOTO THE HOTO THE HOTO THE HOTO THE HOTO THE HOTO THE HOTO THE HOTO THE HOTO THE HOTO THE HOTO THE HOTO THE HOTO THE HOTO THE HOTO THE HOTO THE HOTO THE HOTO THE HOTO THE HOTO THE HOTO THE HOTO THE HOTO THE HOTO THE HOTO THE HOTO THE HOTO THE HOTO THE HOTO THE HOTO THE HOTO THE HOTO THE HOTO THE HOTO THE HOTO THE HOTO THE HOTO THE</seg>
<seg id="586">Treatment of osteoporosis in postmenopausal women and men with an increased risk of fractures, including patients with a recently discovered low-traumatic hip action. "</seg>
<seg id="587">"the patient's patient care should be provided, and the following core message: • The package deals of calcium and vitamin D, used physical activity, non-smokers and a healthy diet • Important and symptoms of serious side effects • Wann in medical or nursing assistance."</seg>
<seg id="588">Treatment of osteoporosis • at postmenopausal women • with increased risk of fractures, including patients with a recently discovered low-traumatic hip action. "</seg>
<seg id="589">For treatment of postmenopausal osteoporosis and osteoporosis in males is recommended a intravenous infusion of 5 mg of Aclasta once annually.</seg>
<seg id="590">"in patients with a low-traumatic hip action, the infusion of the infusion of Aclasta is recommended two or more weeks after the operating supply of the hip fracture (see section 5.1)."</seg>
<seg id="591">"for the treatment of the Moran Paget should be produced by physicians, experience in the treatment of the Morbus Paget."</seg>
<seg id="592">After a treatment of Morbus Paget with Aclasta (see section 5.1).</seg>
<seg id="593">"additionally, it is advisable to make an adequate access of calcium, according to a minimum of 500 mg of calcium, for at least 10 days after the gift of Aclasta (see paragraph 4.4)."</seg>
<seg id="594">"in patients with a recently, low-traumatic hip fracture, a initialdosis of 50,000 to 125.000 I.E. oral or intoxication of vitamin D before the first Aclasta infusion is recommended."</seg>
<seg id="595">The frequency of symptoms which occur within the first three days after the appointment of Aclasta may be reduced by the gift of paracetamol or Ibuprofen shortly after application of Aclasta.</seg>
<seg id="596">"patients with kidney function (see section 4.4) for patients with a creatinin Clearance &lt; 35 ml / min, Aclasta is not recommended, since limited clinical experiences for these patients."</seg>
<seg id="597">"older patients (≥ 65 years) A Dosis--is not necessary, as the bending process, distribution and Elimination in older patients similar to younger patients."</seg>
<seg id="598">Children and youth Aclasta is not recommended for the application for children and adolescents under 18 years.</seg>
<seg id="599">Aclasta is not recommended for patients with severe kidney disease (Kreatinin-Clearance &lt; 35 ml / min).</seg>
<seg id="600">A pre-existing Hypokalzemia is the beginning of the therapy with Aclasta to treat calcium and vitamin D (see paragraph 4.3).</seg>
<seg id="601">"due to the quick release of the effect of Zoledronyacid to the bone tissue can become a temporary, mitable hypokalzanaemia which is usually included within the first 10 days after the infusion of Aclasta (see section 4.8)."</seg>
<seg id="602">"additionally, it is advisable to make an adequate access of calcium, according to a minimum of 500 mg of calcium, for at least 10 days after the gift of Aclasta (see paragraph 4.2)."</seg>
<seg id="603">"cancer patients, chemotherapy, treatment with cortitigoids, poor oral hygiene) should be used before a application of bisphenonic dental treatment."</seg>
<seg id="604">"for patients who require dental handles, no data available, whether the interruption of the treatment with bisphosphate is reduced the risk of osteonekrosen in the orthosis area."</seg>
<seg id="605">The clinical assessment by the treatment doctor should be based on the treatment of any patients and are based on a individual benefit of risk assessment.</seg>
<seg id="606">The frequency of symptoms which occur within the first three days after completion of Aclasta may be reduced by the gift of paracetamol or Ibuprofen shortly after the application of Aclasta (see paragraph 4.2).</seg>
<seg id="607">"the frequency of as serious side effects were reported in patients, the acetabsta was increased (1.3%) (51 of 3.862) compared to patients, the placebo (0.6%) (22 of 3.852) (22 of 3.852)."</seg>
<seg id="608">"in Osteoporosis studies (PFT, HORIZON - recurrent Fracture Trial (2,6%) and placebo (2,6%) and placebo (2,1%)."</seg>
<seg id="609">"frequent (≥ 1 / 10), common (≥ 1 / 100), occasional (≥ 1 / 10, &lt; 1 / 100), rare (≥ 1 / 100), rare (≥ 1 / 100), rare (≥ 1 / 100), rare (≥ 1 / 100), rare (≥ 1 / 100), rare (≥ 1 / 100), rare (≥ 1 / 100), rare (≥ 1 / 100), rare (≥ 1 / 100), rare (≥ 1 / 100), rare (≥ 1 / 100), rare (≥ 1 / 100), rare (≥ 1 / 100), rare (≥ 1 / 100), rare (≥ 1 / 100), rare (≥ 1 / 100), rare (≥ 1 / 100), rare (≥ 1 / 100), rare (≥ 1 / 100), rare (≥ 1 / 100)</seg>
<seg id="610">Kidney dysfunction Zoledronacid has been renamed with kidney function (i.e. an increase of the serum creatinins) and in rare cases as an acute kidney function.</seg>
<seg id="611">The change of the creatinin Clearance (annually) and the appearance of kidney disease as well as a limited kidney function were comparable to osteoporosis via three years.</seg>
<seg id="612">A temporary increase in the Serum creatinins within 10 days after a period of 10% of the patients treated with placebo-treated patients.</seg>
<seg id="613">"based on the evaluation of the laboratory, the temporary injic calcium concentration (less than 2,10 mmol / l), with 2.3% of Aclasta in a large clinical study were treated with Aclasta in a large clinical study compared to 21% of Aclasta in a large clinical study."</seg>
<seg id="614">"all patients received sufficient quantities of vitamin D and calcium in the study on postmenopausal osteoporosis, in the study to prevent clinical fractures after a hip fracture and in Morbus-Paget studies (see paragraph 4.2)."</seg>
<seg id="615">"in the study to prevent clinical fractures according to a recently littens hip fracture, the majority of patients have a initialdosis vitamin D before the appointment of Aclasta (see paragraph 4.2)."</seg>
<seg id="616">"local reactions have been discovered by Zoledronacid in a large clinical study in a large clinical study, such as Roman, swelling, and / or pain, reported (0.7%)."</seg>
<seg id="617">"osteonekrosen in orthodontics, especially in cancer patients, has been treated with bisphosphonic acid, including Zoledronyacid."</seg>
<seg id="618">"many of these patients had signs of local infections, including Osteomyelitis, and the majority of the reports on cancer patients or other dental technicians."</seg>
<seg id="619">"7 study with 7.736 patients (Osteoneked) in the joint area with Aclasta, with placebo-treated patients."</seg>
<seg id="620">"in the case of an overdose, which leads to a clinically relevant Hypokaline, can be reached by the gift of orating calcium and / or a intravenous infusion of calcium."</seg>
<seg id="621">"results appear ordered" "by relevance" "or" "by date" "(publication date),"</seg>
<seg id="622">"effects on the morphometric of the body fractures (see Table 2), after a year of three years as well as after one year the frequency of one or several new spine fractures (see Table 2)."</seg>
<seg id="623">The patients with placebo patients were compared with placebo patients (p &lt; 0.00001).</seg>
<seg id="624">Effects on hip fractures Aclasta was an equal effect of three years in one around 41% (95% CI, 17% up to 58%) reduced risk for hip fractures results. "</seg>
<seg id="625">"effect on the bone density (BMD) Aclasta increased the bone density to the lungs and the distal radius compared to all times (6, 12, 24 and 36 months)."</seg>
<seg id="626">"9 increase the bone density of the lungs in order to 6,7%, the total surface by 6,0%, the threshold of 5,1%, and the distal radius at 3,2%."</seg>
<seg id="627">Bone histology at 152 postmenopausal patients who were treated with Aclasta (N = 82) or placebo (N = 70) or placebo (N = 70).</seg>
<seg id="628">A microcomputer tomography (µCT) analysis showed to placebo treatment in comparison to placebo.</seg>
<seg id="629">"periodontic phosphatase (BSAP), the N-terminal group in the Serum and the beta-C-Telopeptid (b-CTX) in the Serum and the beta-C-Telopeptid (b-CTX) in the Serum and the beta-C-Telopeptid (b-CTX) in the Serum."</seg>
<seg id="630">The treatment with an annual 5-mg dose of Aclasta reduced BSAP after 12 months compared to the output value and was maintained at 28% below the output of up to 36 months.</seg>
<seg id="631">P1NP was significant at 61% below the output of 12 months after 12 months and was held below 52% below the output of up to 36 months.</seg>
<seg id="632">B-CTX was significant at 61% below the output times after 12 months and was kept at 55% below the output of up to 36 months.</seg>
<seg id="633">"vitamin D mirror were not routinely measured, but the majority of patients received an initial dose of vitamin D (50,000 to 125.000 I.U.) 2 weeks before the infusion."</seg>
<seg id="634">"in addition to 10% (101 patients) in the placebo group, compared with 13% (141 patients) in placebo group."</seg>
<seg id="635">Effect on the bone mineral density (BMD) in the HORIZON-rft study increased the Aclasta treatment in comparison to placebo treatment in comparison to placebo-treatment.</seg>
<seg id="636">The Aclasta treatment has led about 24 months compared to placebo treatment for the placebo treatment.</seg>
<seg id="637">"for clinical efficacy in males in the HORIZON-rft study were randomised and in 185 patients, the BMD after 24 months was assessed after 24 months."</seg>
<seg id="638">"the study was not designed to show a reduction in clinical fractures in males; the frequency of clinical fractures was 7,5% of Aclasta-treated men in comparison to 8,7% on placebo."</seg>
<seg id="639">"in another study on males (study, OLOL446M2308) was once an annual start of Aclasta compared to the once weekly gift of Alendronate, which was not underestimated after 24 months compared to the output value."</seg>
<seg id="640">"clinical efficacy of the treatment at Morbus Paget of the bone marlasta was investigated in patients with radiological investigations (medium Serum mirror of the bone phosphatase according to 2,63.3-specific upper normal normal normal normal conditions (study)."</seg>
<seg id="641">11 The effectiveness of an infusion of 5 mg Zoledronoric acid compared to the consumption of 30 mg Risedronate once daily during 2 months was detected in two six years of comparative studies.</seg>
<seg id="642">"in the combined results, after 6 months a similar decrease of pain strength and pain control compared to the output value for Aclasta and Risedronate."</seg>
<seg id="643">Patients who were classified at the end of the sixteenth-study study as an antibodies were classified (on the therapy) could be recorded in a follow-up phase.</seg>
<seg id="644">"results appear ordered" "by relevance" "or" "by date" "(publication date),"</seg>
<seg id="645">"unique and multiple 5 and 15 minutes increased infusions of 2, 4, 8 and 16 mg Zoledronacid in 64 patients."</seg>
<seg id="646">"after 24 h and &lt; 1% after 24 h, followed by a long-term phase, no longer than 0.1% of the maximum value."</seg>
<seg id="647">"quick biphasant disappearance made of the big circulation with half hours t ½ α 0,24 and t ½ million 1,87 hours, followed by a long Elimination phase with a terminal Eliminationshalbswerstime t ½ -146 hours."</seg>
<seg id="648">"the early-distribution phases (α and β, with the above-½ -values), probably the rapid resorption in the bone and the outflow of the kidneys."</seg>
<seg id="649">"in the first 24 hours you can find 39 ± 16% of the ultimate dose of urine, while the rest is bound to bone tissue."</seg>
<seg id="650">"the total body-Clearance is independent from the dosage 5,04 ± 2.5 l / h and remains uninfluenced by gender, age, breed or body weight."</seg>
<seg id="651">An extension of the infusion time of 5 to 15 minutes led to decrease the tioledrones - concentration at 30% at the end of infusion, but no impact on the area under curve (plasma concentrations). "</seg>
<seg id="652">A diminish Clearance of cytochrom-P450-Enzymatic systems are unlikely because Zoledronoric acid is unlikely because Zoledronoric acid is unlikely because it is a weak or no direct and / or irreversible inhibitor of the P450-</seg>
<seg id="653">"for special patients (see paragraph 4.2) The renal Clearance of Zoledronacid correlated with the Kreatinin Clearance, namely 75 ± 33% of the Kreatinin Clearance, and was treated with 64 ± 29 ml / min (range 22 to 143 ml / min)."</seg>
<seg id="654">This results in a light (Clcr = 50- 80 ml / min) and an excessive kidney function up to 35 ml / min no Dosistic acid needs.</seg>
<seg id="655">Since for heavy kidney stones (Kreatinol Clearance &lt; 30 ml / min) only limited data are possible for this population no statements are possible.</seg>
<seg id="656">Acute toxicity is the highest non-active intravenous individual dosis due to mice 10 mg / kg body weight and at rats 0.6 mg / kg body weight.</seg>
<seg id="657">"studies on women have been created by 1.0 mg / kg (based on AUC), a period of 15 minutes, a period of 15 minutes, good and without a renal separation."</seg>
<seg id="658">"chronic pain and chronic toxicity in studies with intravenous application, the renal denomination of Zoledronoric acid was observed in intervall, in intervall of 2- 3 weeks (a cumulative dose, which corresponds to the 776 of the human-therapeutic therapeutic position in the AUC, which is equivalent to the AUC)."</seg>
<seg id="659">"results appear ordered" "by relevance" "or" "by date" "(publication date),"</seg>
<seg id="660">"the most common symptoms and studies with repeated application was a multiplicity of primary metabolism in the metaphyse of the long bone of animals in the growth phase with almost all dosing, antiresortive effect of substance."</seg>
<seg id="661">"at the same time, one teratogenesis of the bacteria from 0,2 mg / kg as outer and inner (visceral) misconceptions and such a skeleton."</seg>
<seg id="662">"in rabbit, no teratoid effects or embryo-fetal effects, although the mashed toxicity in 0.1 mg / kg due to lower Serum calcium mirror."</seg>
<seg id="663">"if the medicine is not directly used, the user is responsible for the storage time after preparation and the conditions before the application; normally should 24 h at 2 ° C up to 8 ° C."</seg>
<seg id="664">Aclasta is supplied as pack with a bottle of packaging unit or as bundles of 5 packages which contain a bottle.</seg>
<seg id="665">Treatment of osteoporosis in postmenopausal women and men with an increased risk of fractures, including patients with a recently discovered low-traumatic hip action. "</seg>
<seg id="666">"the patient's patient care function should be provided and the following core message: • The package deals are provided in pregnancy and vitamin D, the physical activity of non-smokers and a healthy diet 17 • Important signs and symptoms of serious side effects • Wann in medical or nursing assistance."</seg>
<seg id="667">"July 2007, supplemented on 29 September 2006, in the module 1.8.1 of the approval entry into force, and works before and during the product market."</seg>
<seg id="668">Risco-Management Plan The owner of approval for the insured is obliged to perform the studies and the additional activities to the pharmaceutical industry (RMP) in module 1.8.2 of the approval entry and all the following through the CHMP received versions of the RMP.</seg>
<seg id="669">"Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems."</seg>
<seg id="670">"• This report provides you with valuable data on the actual market situation, trends and future outlook for furniture in the country in question, 2015-2019 (US dollars)"</seg>
<seg id="671">"Zoledronesia is a representative of a sub-class class which is called Bisphosphate, and is used for treatment of osteoporosis in postmenopausal women, osteoporosis in postmenopausal women, the osteoporosis in postmenopausal women, the osteoporosis in postmenopausal women, the osteoporosis in postmenopausal women, the osteoporosis in postmenopausal women, the osteoporosis in postmenopausal women, the osteoporosis in postmenopausal women, the osteoporosis in postmenopausal women, the osteoporosis in postmenopausal women, the osteoporosis in postmenopausal women, the osteoporosis in postmenopausal</seg>
<seg id="672">"the blood mirror of gender-shormonen, above all estrogen which are formed out of Androgenic, which will be observed for the gradual loss of bone mass, which is observed in men."</seg>
<seg id="673">"when Mortimer Paget is done to quickly, and new bone material is not built, what the bone material is used as normal."</seg>
<seg id="674">"Aclasta, a normal bone formation is normalized, thus a normal bone formation and thus gives strength again."</seg>
<seg id="675">"if you are in dental treatment or a dental surgery, inform your doctor that you will be treated with Aclasta."</seg>
<seg id="676">"for application of Aclasta with other medicines, inform your doctor or use other medicines if you use other medicines / apply or use other medicines, even if there are no prescription drugs."</seg>
<seg id="677">"for your doctor is particularly important to know if you are taking medicine, from which they are known to kidneys."</seg>
<seg id="678">"for application of Aclasta together with food supplements and drinks, you need to take advantage of your doctor before and after treatment with Aclasta."</seg>
<seg id="679">Osteoporosis The usual dose is 5 mg once per year which is given you by your doctor or care staff as infusion.</seg>
<seg id="680">"if you have broken the hip, it is recommended to make use of Aclasta two or more weeks after the operating supply of the hip."</seg>
<seg id="681">"Morbus Paget The usual dose is 5 mg, which is given you by your doctor or care staff as infusion."</seg>
<seg id="682">"as Aclasta for a long time, you'll need to make a further dose only after a year or longer."</seg>
<seg id="683">It is important to follow this instructions exactly to follow the calcium mirror in your blood into the time after the infusion.</seg>
<seg id="684">"at Morbus Paget can be read more than one year, and your doctor will inform you if you need a renewed treatment."</seg>
<seg id="685">"if the services provided by Aclasta, Says you will receive your doctor or hospital in conjunction with your doctor or hospital in order to arrange a new date."</seg>
<seg id="686">"before finishing the treatment with Aclasta, please take the appointment of the treatment with Aclasta, please take your next doctor and discuss this with your doctor."</seg>
<seg id="687">Side effects in connection with the first infusion very frequently (in more than 30% of patients) are often less common.</seg>
<seg id="688">"fever and solids, muscle, or joint pain and headache, within the first three days after the appointment of Aclasta."</seg>
<seg id="689">"currently, it is unclear whether Aclasta is caused to this unregular heart attack, but you should notice it to your doctor if you have such symptoms after you receive Aclasta."</seg>
<seg id="690">"blood signs because of a low calcience concentration in blood, such as muscular dystrophy or scary feeling, especially in the area around the mouth."</seg>
<seg id="691">"irritation, tiredness, tiredness, tiredness, irritation, irritation, irritation, irritation, irritation, irritation, redness, redness, redness, redness, redness, redness, redness, redness, redness, redness, redness, redness, redness, redness, redness, redness, redness, redness, redness, redness, redness, redness, redness, redness, redness, skin irritation, skin irritation, skin irritation, skin irritation, skin irritation, skin irritation, skin irritation, skin irritation, skin irritation, skin irritation, skin irritation, skin irritation, skin irritation, skin irritation, skin irritation, skin irritation, redness, redness, skin irritation, skin irritation, skin irritation, skin irritation, skin irritation, skin irritation, skin irritation, skin irritation, skin irritation, skin irritation, skin irritation, skin irritation, skin irritation, skin irritation, skin irritation, skin irritation, skin irritation, skin irritation, skin irritation, skin irritation, skin irritation, skin irritation, skin irritation, skin irritation, skin irritation, skin irritation, skin irritation, redness, redness, redness, redness, redness, redness, redness, redness, skin irritation, skin irritation, skin irritation, skin irritation, skin irritation, skin irritation, skin irritation, skin irritation, skin irritation, skin irritation, skin irritation, skin irritation, skin irritation, skin irritation, skin irritation, skin irritation, skin irritation, skin irritation, skin irritation, skin irritation, skin irritation, skin irritation, skin irritation, skin irritation, redness, redness, redness, redness, redness, redness, skin irritation, skin irritation, skin irritation, skin irritation, skin irritation, skin irritation, skin irritation, skin irritation</seg>
<seg id="692">"continuous pain and / or not healing wounds in the mouth or on the jaw, especially in patients who have been treated with bisphosphonic because of other illnesses."</seg>
<seg id="693">"they are allergic to allergic reactions, including less cases of respiratory problems, Nineveh and Angioara (like example, swelling in the face, the tongue, or in the throat), was reported."</seg>
<seg id="694">"please inform your doctor, pharmacist or health personnel, if one of the listed side effects you will affect or you side effects that are not listed in this use information."</seg>
<seg id="695">"if the medicine is not directly used, the user is responsible for the storage time and conditions of application. normally, 24 h at 2 ° C up to 8 ° C."</seg>
<seg id="696">"in patients with a few minutes, low-traumatic hip fracture is recommended to make the infusion of Aclasta two or more weeks after the operating supply of the hip fracture."</seg>
<seg id="697">This is particularly important in patients who receive a diuretic therapy.</seg>
<seg id="698">"due to the quick release of the effect of Zoledronyacid to the bone tissue can become a temporary, sometimes symptomatic, hypokalzanaemia are commonly used within the first 10 days after the infusion of Aclasta."</seg>
<seg id="699">"in addition, it is advisable to make an adequate access of calcium, according to at least twice daily 500 mg of calcium, for at least 10 days after the gift of Aclasta."</seg>
<seg id="700">The infusion of vitamin D was recommended by the infusion of vitamin D before the infusion of Aclasta.</seg>
<seg id="701">"if you need more information about your disease or their treatment, please read the packages (also part of the EPAR) or contact your doctor or pharmacist."</seg>
<seg id="702">"ACOMPLIA is used in addition to a diet and movement for treating adult patients, • the weight of obesity (body temperature index - BMI) of 30 kg / m ² or more."</seg>
<seg id="703">"in addition, four studies were performed over 7 000 patients where ACOMPLIA was used compared to a placebo."</seg>
<seg id="704">"* Understand the competitive environment, the market's major players and leading brands; * Use five-year forecasts to assess how the market is predicted to develop."</seg>
<seg id="705">"what risk is associated with ACOMPLIA, the most common side effects of ACOMPLIA, who were found during studies (more than 1 of 10 patients) were found, Nausea (nausea) and infections of the upper respiratory weeds."</seg>
<seg id="706">"patients cannot be applied to patients with anti-depressants, as it is the risk of depression, and among other things in a small minority of depression."</seg>
<seg id="707">"results appear ordered" "by relevance" "or" "by date" "(publication date),"</seg>
<seg id="708">"the Committee for Human Physicians (CHMP) came to the end that the efficacy of ACOMPLIA was able to reduce the efficacy of ACOMPLIA in terms of weight reduction in patients with Adipositas or overweight.</seg>
<seg id="709">"patients are applied to patients suffering from health and non-cosmetic reasons (by providing extra-explanatory for patients and doctors), and for the Arz..."</seg>
<seg id="710">He added to the diet and movement for the treatment of Adipositas (BMI ≥ 30 kg / m ²) or an important patient (BMI &gt; 27 kg / m ²) which offers a variety of risk factors such as type-2 diabetes or Dyslipidaemia (see section 5.1).</seg>
<seg id="711">ACOMPLIA is not recommended for use with children and adolescents under 18 years.</seg>
<seg id="712">"attention european and german buyers: we allow you to bid on this auction, but you need to add the vat of 19%. shipping to a german destination is7 euros. [...]"</seg>
<seg id="713">"in the case of depressant and depressant faults may not be applied in Rimonabant, unless the benefit of the treatment in individual cases, the risk of treatment in individual cases weighs the risk (see paragraph 4.3 and 4.8)."</seg>
<seg id="714">"in addition to patients suffering from obesity - no need risks, depressants may occur."</seg>
<seg id="715">Or other nearby persons are to be added that it is necessary to monitor the curiosity of such symptoms and immediately after medical advice if these symptoms occur.</seg>
<seg id="716">• Election patients The effectiveness and unthinkable of Rimonabant at treatment of patients over 75 years were not enough.</seg>
<seg id="717">Patients with a carcinogenic event (Myokardal infants or stroke engines etc.) before less than 6 months were included in Rimonabant.</seg>
<seg id="718">"Rifampicin, Phenytoin, Phenomarbital, Carbamazepin, St. John's wort) is assumed that the simultaneous translation of potent CYP3A4-inductors the plasma concentrations of Rimonabant"</seg>
<seg id="719">"for more information, please search for your company name with the function below. when your company is not yet listed, you need to add the vat of 19%. shipping to a german destination is7 euros. [...]"</seg>
<seg id="720">"results appear ordered" "by relevance" "or" "by date" "(publication date),"</seg>
<seg id="721">"when the case study was statistically significant higher than the corridors (for unwanted effects ≥ 1%) or if they are clinically relevant, (for unwanted effects &lt; 1%)."</seg>
<seg id="722">"sometimes (≥ 10%); often (≥ 1, &lt; 10%); occasionally (≥ 0.1, &lt; 1%); rare (≥ 0.01, &lt; 0.1%); very t"</seg>
<seg id="723">"in a limited number of persons, in which a limited number of persons were drawn from up to 300 mg, only a slight symptoms were observed."</seg>
<seg id="724">The patients had a BMI ≥ 30 kg / m ² and BMI &gt; 27 kg / m ² and simultaneously an existing hypertension and / or Dyslipideity.</seg>
<seg id="725">"n weight loss after a year was for ACOMPLIA 20 mg 6.5 kg, related to the higher value, compared to 1.6 kg for placebo group (differences -4,9 kg -5,3; -4,4, p &lt; 0.001)."</seg>
<seg id="726">"patients who were treated with ACOMPLIA 20 mg, and 1.2 kg in the placebo group (differences -3.8 kg; CI95% -4,4, -3.3; p &lt; 0.001)."</seg>
<seg id="727">"after 2 years, the difference between ACOMPLIA and placebo -4,2 kg (CI95% -5.0%; -3,4, p &lt; 0.001). EIM"</seg>
<seg id="728">"results appear ordered" "by relevance" "or" "by date" "(publication date),"</seg>
<seg id="729">"in Rimonabant 20 mg, a average waste of triglycantly was seen from 6,9% (output value triglycantly 1.62 mmol / l) compared to a rise of 5,8%"</seg>
<seg id="730">"in a second study in patients with a Adipositas, which was absolute change of the HbA1c (serenade), was the absolute change of the HbA1c-value (with a output value of 7,9% for both groups) after 6 months -0.8 for Rimonabant 20 mg and -0.3 under placebo"</seg>
<seg id="731">The percentage of the patients who had a HbAsm- value of &lt; 7% was reached in the Rimonabant Group and 35% in the placebo group.</seg>
<seg id="732">"the difference in the middle weight change between the 20 mg- and the placebo group was 3,8 kg (CI95% -5.0, -2.1) &lt; 0,001). LN"</seg>
<seg id="733">Improvement of the HbA1c-value in patients receiving the Rimonabant 20 mg (50%) due to the direct effects of Rimonabant and about 50% due to weight loss ratio and about 50% due to weight loss.</seg>
<seg id="734">"if you want to send us a question about this product, simply complete all the fields marked * and click" "Send". ""</seg>
<seg id="735">"results appear ordered" "by relevance" "or" "by date" "(publication date),"</seg>
<seg id="736">"patients with black skin color may have a up to 31% lower CMAx and one at 43% lower AUC, as a patient of other ethnic minorities."</seg>
<seg id="737">"popular with a total of 21% higher CMAx and one around 27% higher than 27% higher than 25% higher,"</seg>
<seg id="738">5.3. clinical data for security in clinical trials were observed that are not relevant in clinical trials were evaluated as possibly relevant for clinical use.</seg>
<seg id="739">"in some cases, however, in some instances, the beginning of the vulsion with movable stress is linked to animals using the animals."</seg>
<seg id="740">"Rimonabant has been given Rimonabant on a longer period before the Paaration (9 weeks), which is allowed to have a recovery from the initials of Rimonabant, so no unwanted effects on the ferrous or cymbal disorders were observed."</seg>
<seg id="741">- Save time and money with the readily accessible key market data included in the report.</seg>
<seg id="742">"in a study on rats to preventive and postnatal development, a exposure with Rimonabant in utero and with lactation is no changes in learning behavior or memory."</seg>
<seg id="743">Click on the picture to view it in original size in a new window.</seg>
<seg id="744">"La On the packaging system must be responsible for the name and address of the manufacturer, which is responsible for the release of the relevant data."</seg>
<seg id="745">26 The subject of medical events such as deportations or voice changes were given to patients suffering from the ACOMPLIA (see paragraph.</seg>
<seg id="746">"if you have symptoms of depression (see below) during treatment with ACOMPLIA, contact your doctor and break the treatment."</seg>
<seg id="747">"visual acuity, irritation, anxiety, itching, irritability, muscle pain (Ischialgie), memory loss, visual pain (Ischialgie), changed sensitivity, pain, gripping, articulation, articulation, articulation, articulation, articulation, articulation, articular pathology. EIM"</seg>
<seg id="748">Please consult your doctor or pharmacist if one of the listed side effects you may read or side effects that are not indicated in this use.</seg>
<seg id="749">Abstract Judicial Review of Statutes (BvL) (Number of result: 1) July (Number of result: 2)</seg>
<seg id="750">Actos is applied to treatment of type-2 diabetes (also known as non-induced diabetes). • It can be applied to patients with a different diabduction). • It can be used together with a different Diabetypsy (Dualtherapy).</seg>
<seg id="751">"in addition to Metformin patients (especially significant patients) are applied to patients with metformin alone in the highest number of patients."</seg>
<seg id="752">"in combination with a Sullivecoms or insulin, the previous dose of Sullivylharnels or insulin can be retained at the beginning of the Actos treatment (low blood sugar); here the dose of sulphylharnects or insulin is reduced."</seg>
<seg id="753">This means that the physical body can be done better in better way and the blood glucose levels should be better.</seg>
<seg id="754">"for more than 1 400 patients, the efficacy of Actos in Tripletherapy was investigated. in addition, patients received a combination of metformin with a Sulfontaine, in addition to 3.5 years either Actos or placebo."</seg>
<seg id="755">"in the studies the concentration of a substance in blood (glykosylized hemoglobin, HbA1c) measured, which indicates how good the blood sugar is set."</seg>
<seg id="756">"Actos led to a reduction of the HbA1c-value, which indicates the blood glucose levels of 15 mg, 30 mg, and 45 mg."</seg>
<seg id="757">"at the end of the tripletherapy study showed the effect of the additional gift of Actos for existing treatment with metformin and a sulphylamine in a reduction of HbA1c values around 0.94%, while the additional gift of placebo to a reduction of 0,35%."</seg>
<seg id="758">"in a small study, which was investigated in the combination of Actos and insulin at 289 patients, the patients receiving Actos in addition to insulin injections, a reduction of the HbA1c values of 0.69% after 6 months, compared with a placebo."</seg>
<seg id="759">"the most common side effects in connection with Actos were visual dysfunction, infections of upper respiratory system (cold), weight reduction and hypoesthesia (reduced sensitivity to friction)."</seg>
<seg id="760">"Actos should be applied to patients with liver problems, even in patients with liver problems such as liver problems, cardiac disease or diabetic Ketoosis - acid or blood flow - in the blood)."</seg>
<seg id="761">It was decided that Actos is not shown as an alternative to the standard treatment with metformin patients with metformin patients.</seg>
<seg id="762">"October 2000, the European Commission sent the European Commission of Takeda Europe R & D Centre Limited an approval for action from Actos in the entire European Union."</seg>
<seg id="763">"the tablets are white to white, round, curved, and carry on one side the marking" "15" and on the other side the "" ACTOS. "" "</seg>
<seg id="764">"Pioglitazon is also displayed for combination with insulin in patients with type 2 diabetes mellitus, their blood sugar with insulin in inadequate, and with those metering in due to contraindications or incompatible. (see paragraph 4.4)."</seg>
<seg id="765">"for the application of Pioglitazon in patients under 18 years, no data is available, therefore the application in this age group is not recommended."</seg>
<seg id="766">Patients who start by the presence at least one risk factor (e.g. fruit juice or symptomatic coronary heart disease) should begin to increase the treatment with the lowest possible dose and increase the dose of dose.</seg>
<seg id="767">"patients should be observed at signs and symptoms of a heart failure, especially those with reduced cardiovascular disease."</seg>
<seg id="768">"patients should be observed at signs and symptoms of a heart failure, weight loss, weight loss, if pioglitazon can be applied in combination with insulin."</seg>
<seg id="769">A carcinogenic Outcome study with Pioglitazon in patients under 75 years with type 2 diabetes mellitus and pre-existing advanced macroscopic disorder was performed.</seg>
<seg id="770">"in this study, an increase of reports about Herculinity, which was not meant to be an increase of Mortality in the study."</seg>
<seg id="771">"patients with increased risk of liver enzymes (ALT &gt; 2.5 x upper boundary of the standard area) or with other signs of liver disease may not be used for Pioglitazon."</seg>
<seg id="772">"if the ALT-mirror up to 3 levels of the upper limit of the standard range, the liver cells are as soon as possible."</seg>
<seg id="773">"if a patient symptoms are developing, such as unthinkable nausea, vomiting, dehydration and / or dark Harn, are the liver cells of liver cells."</seg>
<seg id="774">The decision whether the treatment of the patient with pioglitazon should be continued until the process of clinical assessment should be directed by the clinical assessment.</seg>
<seg id="775">"in clinical trials with Pioglitazon was a doscope-dependent weight reduction, which can be observed by fat deposits and in some cases with a liquid degradation."</seg>
<seg id="776">"as a result of a hemispheric, among the therapy with Pioglitazon a slight reduction of the middle hemoglobal values (relative reduction of 4%) and hemmatocrits (relative value of 4.7%)."</seg>
<seg id="777">"similar changes were observed in comparable controlled trials with Pioglitazon at 3-4% and the hemmatocrits around 3-4% and the hemmatocrits around 1-2% and the hemmatocrits around 1-2%)."</seg>
<seg id="778">"as a result of increased risk of insulin sensitive, the Pioglitazon as orale 2-way therapy therapy with a sulphylamino acid or two-term therapy therapy with insulin, the risk of a doscope-dependent Hypoglycemia."</seg>
<seg id="779">"after the launch of the treatment with Thiazolidindian, including Pioglitazon, including the appearance of diabetic maculaodems with a reduction of visual acuity."</seg>
<seg id="780">"it is unclear whether there is a direct connection between the use of Pioglitazon and the occurrence of maculaics, if patients should be aware of a maculatherapy, if patients may be considered to be considered."</seg>
<seg id="781">"in a combined analysis of messages of messages of messages from randomised, controlled, double-blind clinical trials over a period of up to 3.5 years with more than 8.100 patients who were treated with Pioglitazon were treated with Pioglitazon."</seg>
<seg id="782">"this paper investigates the impact of non-take-up for two hypothetical scenarios, namely increasing and decreasing the base amount of social assistance in Germany by €100 per month. IAB-Discussion Paper 20 / 2015"</seg>
<seg id="783">"in the Proactive study, a study over 3.5 years of study of carcinogenic events that were compared with 23 / 905 (2.5%; 0,5 Fraktures per 100 patient years) of patients who were treated with a comparison."</seg>
<seg id="784">Patients should be aware of the possibility of a pregnancy and if a patient has a pregnancy or use this entry is the treatment of treatment (see paragraph 4.6).</seg>
<seg id="785">Studies have shown that pioglitazon does not have a relevant effects on the pharmacokinetics or pharmaceutical dynamics of Digicin, Warning, Phenomoumon and Metformin. "</seg>
<seg id="786">"interactions with medication that are termed by these enzymes, e.g. orale contractiva, cycloporin, calcium carbonate and HMGCoA-Reinductors are not expected."</seg>
<seg id="787">The simultaneous application of Pioglitazon with mixtures (a cytochrom P450 2C8- inhibitor) results in an increase of AUC from Pioglitazon to ensure the 3 times.</seg>
<seg id="788">Simultaneous application of Pioglitazon with Rifampicin (a cytochrom P450 2C8-inductor) results in a reduction of AUC from Pioglitazon um 54%.</seg>
<seg id="789">This is due to treating a treatment with Pioglitazon the pregnancy and increased insulin resistance in pregnancy and increased the availability of the metabolism and reduces the availability of the metabolic rate.</seg>
<seg id="790">"data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data. why buy this report? * Get a detailed picture of the Baby Food market; * Pinpoint growth sectors and identify factors driving change; * Understand the competitive environment, the market's major players and leading brands;"</seg>
<seg id="791">"this lead to a temporary change of the turboors and the bending side of the lens, as they can also be observed with other hypocritters."</seg>
<seg id="792">"in clinical trials with Pioglitazon, ALT-Anchorates over the three times the upper limit of the standard range is often common in comparison with metals, or sulphylamino acids."</seg>
<seg id="793">"in a Outcome study in patients with pre-existing advanced macroscopic disorder was the frequency of a severe heart failure under Pioglitazon um 1.6% higher than under placebo, if Pioglitazon."</seg>
<seg id="794">"since the launch of Heroglitazon, however, more often than Pioglitazon in combination with insulin, or in patients with heart failure in Anamnese has been applied."</seg>
<seg id="795">"with more than 8,000 patients suffering from randomised, controlled, double-blind clinical trials across a period of up to 3.5 years with more than 8,000 patients in patients with comparative treated patients."</seg>
<seg id="796">"in the over a period of 3.5 years of current proactive study, Fraktures at 44 / 870 (5.1%) of the patient with 23 / 905 (2.5%) of patients who were treated with a comparison."</seg>
<seg id="797">"in addition to the reported maximum dosis of 120 mg / day of four days, then 180 mg / day over seven days were no symptoms."</seg>
<seg id="798">Pioglitazon seems to work on a activation of specific core-infection processes (PPAR-HC)) which leads to an increased insect of liver and fat and Skelettmuscular cells.</seg>
<seg id="799">"in the case of insulin resistance, Pioglitazon the gluten development in the liver reduces the peripheral cyanists in the case of insulin resistance."</seg>
<seg id="800">"a clinical study with Pioglitazon and Gliclazid as Monotherapy has led over two years to examine the time until the time of the therapeutic effect (defines as HbA1c ≥ 8,0% after the first 6 treatment period)."</seg>
<seg id="801">"at the time after two years after the treatment, a blood glucose control (defines as HbA1c &lt; 8,0%) by Pioglitazon at 69% of the treated patients (compared to 50% of the patients under Gliclazid)."</seg>
<seg id="802">"in a case-controlled study of 12 months, patients, whose blood sugar have been adjusted despite three months after three months, at Pioglitazon or placebo."</seg>
<seg id="803">"in patients under Pioglitazon reduced the medium HbA1c - value to 0.45%, compared with the patients who continue to continue to insect insulin."</seg>
<seg id="804">"in clinical trials at Pioglitazon, a statistically significant decrease of the Albumin / Kreatinin-Quotiator compared to the output values."</seg>
<seg id="805">"the effect of Pioglitazon (Monotherapy with 45 mg of placebo) was checked in a small, based on 18 weeks tests to type-2 diabetes."</seg>
<seg id="806">"in most clinical trials were compared to placebo a reduction of the total plasma triglyphs and a rise of the HDL- cholesterol levels as well as slightly, but clinically not significantly increased LDL- cholesterol levels."</seg>
<seg id="807">"in clinical studies on a period of up to two years ago Pioglitazon compared to placebo, Metformin or Gliclazid, the overall plasticizer and the free fatty acids and increased the HDL cholesterol levels."</seg>
<seg id="808">"compared to placebo, under Pioglitazon no statistically significant increase of the LDL cholesterol levels have been increased during metering and Gliclazid."</seg>
<seg id="809">"in a study on 20 weeks reduced pioglitazon not only the Nashtag triglycerias, but also improved the postoperatic triglycerias."</seg>
<seg id="810">"in the proactive study, a cardiovascular disease was randomised, 5238 patients with type 2 diabetes mellitus and pre-existing advanced disease treatment in groups that have already received a period of up to 3.5 years in addition to existing antidiabetic and carcinogenic therapy."</seg>
<seg id="811">"according to orical application, Pioglitazon quickly resorised, the peak concentration camp is usually 2 hours after application."</seg>
<seg id="812">"on this basis, the contribution of M-IV to the effectiveness of the effectiveness of Pioglitazon, is minimized against the relative effectiveness of M-II."</seg>
<seg id="813">"in interaction studies, Pioglitazon is no relevant effect on the pharmacokinetics or pharmaceutical dynamics of Digicin, Warning, Phenomoumon and Metformin."</seg>
<seg id="814">The simultaneous application of Pioglitazon with Gemtochrom (a cytochrom P450 2C8-inductor) or with Rifampicin (a cytochrom P450 2C8-inductor) or reduces the plasma concentrations of Pioglitazon (see paragraph 4.5).</seg>
<seg id="815">"after oranglitazon during the people, Marker mainly was found mainly in the piglet (55%), and a lower extent in the Harn (45%)."</seg>
<seg id="816">"the average plasma-Eliminationshalbeit time is 5-6 hours, and the entire active metabolites lies at 16 - 23 hours."</seg>
<seg id="817">The plasma concentrations of Pioglitazon and its metabolites are low in patients with reduced kidney function.</seg>
<seg id="818">"in toxic doses of mice, rats, dogs and monkeys to relieve plasma volume magnification with hemophilia, anaemia and reconneccentric heart rate."</seg>
<seg id="819">"this is due to the treatment with Pioglitazon used in the gestation of hyperinsuline and increased insulin resistance to the womensation and increased availability of the metabolism and reduces the availability of the metabolic rate."</seg>
<seg id="820">"during long-term studies (up to 2 years), the rats increased by hypertension (at male and female rats) and tumors (at male rats) of the urinary epithelium."</seg>
<seg id="821">In a animal model of the family-friendly polynoms (FAP) led the treatment with two other Thiazolidindians to an elevated frequency of colony.</seg>
<seg id="822">"the tablets are white to white, round, flat and wear on one side the marking" "30" and on the other side the "" ACTOS. "" "</seg>
<seg id="823">"this paper investigates the impact of non-take-up for two hypothetical scenarios, namely increasing and decreasing the base amount of social assistance in Germany by €100 per month. IAB-Discussion Paper 20 / 2015"</seg>
<seg id="824">"in the Proactive study, a study over 3.5 years of study of carcinogenic events that were compared with 23 / 905 (2.5%; 0,5 Fraktures per 100 patient years) of patients who were treated with a comparison."</seg>
<seg id="825">"in a further study on two years, the effects of a combination therapy of metals were investigated using a pioglitazon or Gliclazid."</seg>
<seg id="826">In clinical trials on 1 year showed a statistically significant decrease of the Albumin / Kreatinin-Quotiations compared to the output values.</seg>
<seg id="827">"in a study on 20 weeks reduced pioglitazon not only the Natians-triglycerias, but also improved the posterior triglycerias compared to the Hepatic Tryglizerid synthesis."</seg>
<seg id="828">"although the study showed that the purpose of its primary endpoint, which is a combination of the overall expression, non-deadly Myocardial infectorisation and reaskularisation of the leg arteries, put the results close to the treatment of Pioglitazon no kardiovarian long-term risks."</seg>
<seg id="829">"the tablets are white to white, round, flat and wear on one side the marking" 45 "and on the other side the" "ACTOS." ""</seg>
<seg id="830">"with more than 8,000 patients who were treated with Pioglitazon were treated with more than 1.100 patients suffering from a period of up to 3.5 years with more than 8,000 patients suffering from a period of up to 3.5 years."</seg>
<seg id="831">"in the Proactive study, a study over 3.5 years of study of carcinogenic events that were compared with 23 / 905 (2.5%; 0,5 Fraktures per 100 patient years) of patients who were treated with a comparison."</seg>
<seg id="832">"in a study on 20 weeks reduced pioglitazon not only the Nayans-triglycerias, but also improved the posterior triglyceridially."</seg>
<seg id="833">"on the packaging unit, name and address of the manufacturer, which is responsible for the release of the relevant data."</seg>
<seg id="834">Firm of the Year for Insolvency Administration Schneider Geiwitz & Partner Firm of the Year for Tax Gleiss Lutz</seg>
<seg id="835">It must be a updated risk management plan according to CHMP-Guideline on Risk Management Systems for Medicinal Products for Human Use.</seg>
<seg id="836">"if you are an type 2 diabetes, Actos 15 mg tablets make control of your blood glucose levels by using a better performance of the body's own insulin."</seg>
<seg id="837">"if you are aware that you suffer from a sugar intoxication, please contact us by Actos 15mg tablets your doctor."</seg>
<seg id="838">Please inform your doctor or pharmacist if you use other medicines or to recently added any medication if you are not prescription drugs.</seg>
<seg id="839">"if you use Actos 15 mg tablets in combination with other medicines for treatment of diabetes (such as insulin, chlorine amide, Glibenzene, Gliclazid, tolar amide), your doctor will have to give you the dose of your medication."</seg>
<seg id="840">"some patients with long-term type 2 diabetes mellitus and heart disease or early stroke that were treated with Actos and insulin, developed a heart failure."</seg>
<seg id="841">"in clinical trials, in which pioglitazon with other oralised antidiabetics or placebo (effective-free tablets) was compared with women (but not at men), the pioglitazon took a higher number of bone marines."</seg>
<seg id="842">"if you have accidentally deleted by many tablets, or if any other or a child your medication must be taken into contact with a doctor or pharmacist in conjunction with a doctor or pharmacist."</seg>
<seg id="843">"as Actos looks and content of the package Actos 15 mg tablets are white to white, round, curved tablets with the marking" 15 "on one side and the" "ACTOS" on the other side. "</seg>
<seg id="844">"if you are an type 2 diabetes, Actos 30 mg tablets make control of your blood glucose levels by using a better performance of the body's own insulin."</seg>
<seg id="845">"if you are aware that you suffer from a sugar intoxication, please contact Actos 30mg tablets your doctor."</seg>
<seg id="846">"if you use Actos 30 mg tablets in combination with other medicines for treatment of diabetes (such as insulin, chlorine amide, Glibenclamide, Gliclazid, tolar amide), your doctor will have to give you the dose of your medication."</seg>
<seg id="847">"61 Information you see as soon as possible your doctor if you are signs of a heart failure, such as unusual dubbing or quick weight loss (Ödeme)."</seg>
<seg id="848">"in clinical trials, in which pioglitazon with other oralised antidiabetics or placebo (effective-free tablets) was compared with women (but not at men), the pioglitazon took a higher number of bone marines."</seg>
<seg id="849">"as Actos looks and content of the pack Actos 30 mg tablets are white to white, round, flat tablets with the marking" 30 "on one side and the" "ACTOS" on the other side. "</seg>
<seg id="850">"if you are an type 2 diabetes, Actos 45 mg tablets make control of your blood glucose levels by using a better performance of the body's own insulin."</seg>
<seg id="851">"if you are aware that you suffer from a sugar intoxication, please contact us by Actos 45mg tablets your doctor."</seg>
<seg id="852">"if you have Actos 45 mg tablets in combination with other medicines for treatment of diabetes (such as insulin, chlorine amide, Glibenzene, Gliclazid, tolar amide), your doctor will reduce your medicine."</seg>
<seg id="853">"66 In some patients with long-term type 2 diabetes mellitus and heart disease or fruit disease, which have been treated with Actos and insulin."</seg>
<seg id="854">"inform you as soon as possible your doctor if you are signs of a heart failure, such as unusual dubbing or quick weight loss (Ödeme)."</seg>
<seg id="855">"in clinical trials, in which pioglitazon with other oralised antidiabetics or placebo (effective-free tablets) was compared with women (but not at men), the pioglitazon took a higher number of bone marines."</seg>
<seg id="856">"67 If one of the listed side effects are considerably affected or you notice that no side effects that are not indicated in this use information, please inform your doctor or pharmacist."</seg>
<seg id="857">"as Actos looks and content of the package Actos 45 mg tablets are white to white, round, flat tablets with the marking" 45 "on one side and the" "ACTOS" on the other side. "</seg>
<seg id="858">"this document is a summary of the European Council of the European Parliament (EPAR), in which explains how the Committee for Humanitarian Products (CHMP) is applied to the recommendations concerning the application of medication."</seg>
<seg id="859">"if you need more information about your medical condition, please read the packages (also part of the EPAR) or contact a doctor or pharmacist."</seg>
<seg id="860">"if you wish for further information on the recommendations of the CHMP, please read the scientific discussion (also part of the EPAR)."</seg>
<seg id="861">"results appear ordered" "by relevance" "or" "by date" "(publication date),"</seg>
<seg id="862">Actraphane is normally once or twice daily when a rapid initiale effect is required together with a longer lasting effect.</seg>
<seg id="863">"(44-20) 74 18 84 173 E-mail: email @ emea.eu.int, http: / / www.emea.eu.int, http: / / www.emea.eu.int"</seg>
<seg id="864">"Actraphane became a total of 294 patients with type-1 diabetes, in which the abdominal belt is no insulin in the body, and type-2 diabetes, in which the body is not able to use insulin."</seg>
<seg id="865">"in the study, after 12 weeks the concentration of a substance (glykosylized hemoglobin (HbA1c) measured, which indicates how good the blood sugar is set."</seg>
<seg id="866">Actraphane led to a decrease of the HbA1c-Spiegels that make the blood glucose levels similar to a other metamortization.</seg>
<seg id="867">Actraphane should not be applied to patients who may be oversensitive (allergic) to Human insulin (rDNA) or one of the other components.</seg>
<seg id="868">"furthermore, the cans of Actraphane may be adapted if it is given together with a number of other medicines that may result in blood sugar (the complete list of packages)."</seg>
<seg id="869">The Committee for Human Physicians (CHMP) came to the end that the advantages of Actraphane in the treatment of diabetes compared to the risks.</seg>
<seg id="870">"October 2002, the European Commission on Novo Norge A / S will bring an approval for Intraphane in the entire European Union."</seg>
<seg id="871">Pre-mixed insulin products are normally once used or twice daily when a rapid initiale effect is required together with a longer lasting effect.</seg>
<seg id="872">The injection pump needs to be at least 6 seconds under the skin to ensure that the entire dose has injected.</seg>
<seg id="873">"patients, their blood glucose adjustment is significantly improved by means of an intensive insular treatment, the Hypoglycemia can occur and should be processed correctly."</seg>
<seg id="874">"every change in strength, brand (manufacturers), insect type (quickly effective, biphasical, long-effective insulin) and / or manufacturing method (by recombinant DNA) and / or manufacturing method (by recombinant DNA) and / or manufacturing method (by recombinant DNA) and / or manufacturing method (by recombinant DNA) and / or manufacturing method (by recombinant DNA) and / or manufacturing method (by recombinant DNA)."</seg>
<seg id="875">"in case of change to Actraphane when the patient is required, it may be necessary for the first dosage or after the first weeks or months after the period of months or months."</seg>
<seg id="876">"some patients, with the hypocrisp reactions after a change of animals in human insulin, reported that the early warning symptoms of a hypoglycemia are less pronounced or different than in their previous insulin."</seg>
<seg id="877">"prior to travel, the patient should be informed about several time zones, the patient should be aware of the advice of his doctor, as such trips can lead to insulin and meals to other times."</seg>
<seg id="878">The doctor needs to take advantage of possible interactions with the treatment of therapy and its patients.</seg>
<seg id="879">4 Soviet Hypoglycemia as well as Hyperglycemia that can occur in a non-controlled diabetic therapy may increase the risk of misappropriation and fruit tod in utero.</seg>
<seg id="880">Heavy hypoglyphs can lead to consciousness and / or crampfanatics with temporary or permanent disorders of the brain function and even death.</seg>
<seg id="881">"peripheral diseases of the nervous system has been done - peripheral neuropathy can be associated with complaints that are associated with complaints that are referred to as acute painful tortured Neuropathy."</seg>
<seg id="882">5 A Intensification of insulin therapy with a temporary improvement of blood glucose is associated with a temporary injections of diabetic retinopathy.</seg>
<seg id="883">"librystrophie In the injunction of the skin, a librystrophie will be able to change a lickystrophie."</seg>
<seg id="884">"general diseases and complaints relating to the injunction of the injunction of the injunction of the injunction of the injection point, local oversensitivity, pain, pain and hemorom at the injection point) occur."</seg>
<seg id="885">"diseases of immune system produced - Urtikaria, Exeter, rare - Anaphylaktic reactions, angiogenesis, gastrointestinal disorders, angiogenesis, gastrointestinal disorders, blood pressure, blood pressure, and Oasis / consciousness."</seg>
<seg id="886">"however, Hypoglycemia can be infinitely variable: • Acid Hypoglyphs can be treated through the orale feed of glucose and glucose foods.</seg>
<seg id="887">"if you have any queries, please contact us on Tel.: + 49 5764 318 444. or contact us per email."</seg>
<seg id="888">The effect begins within half an hour that is achieved within 2 to 8 hours and the entire active duration is up to 24 hours.</seg>
<seg id="889">Resortive profile is that the product is based on a mixture of insulin products using faster or delayed resorption.</seg>
<seg id="890">A series of split (hydrolysis) places on the Humphuline molecules were actively affected by the split-educated metabolites.</seg>
<seg id="891">"based on the conventional studies on the conventional studies to safety spells, toxicity, toxicity, carotoxicity, for carcinogenic potential and for reproductive data."</seg>
<seg id="892">It is recommended - after the Actraphane flow bottle made from the fridge - the temperature of insulated to room temperature (not above 25 ° C) before it is possible according to the manual for the first use.</seg>
<seg id="893">"some patients, with the hypocrisp reactions after a change of animals in human insulin, reported that the early warning symptoms of a hypoglycemia are less pronounced or different than in their previous insulin."</seg>
<seg id="894">The doctor needs to take advantage of possible interactions with the treatment of therapy and its patients.</seg>
<seg id="895">"12 Soviet Hypoglycemia as well as Hyperglycemia, which may occur in a non-controlled diabetic therapy, increase the risk of misappropriation and fruit tod in utero."</seg>
<seg id="896">13 A Intensification of insulin therapy with a temporary improvement of blood glucose is associated with a temporary injections of diabetic retinopathy.</seg>
<seg id="897">The terminal half-half-time (t ½) is therefore a measure of resortion as a measure of the caloration of insulin from the plasma (insulin in blood circulation) in the blood circulation of only a few minutes).</seg>
<seg id="898">It is recommended - after the Actraphane flow bottle made from the fridge - the temperature of insulated to room temperature (not above 25 ° C) before it is possible according to the manual for the first use.</seg>
<seg id="899">"some patients, with the hypocrisp reactions after a change of animals in human insulin, reported that the early warning symptoms of a hypoglycemia are less pronounced or different than in their previous insulin."</seg>
<seg id="900">"20 Soviet Hypoglycemia as well as Hyperglycemia, which may occur in a non-controlled diabetic therapy, increase the risk of misappropriation and fruit tod in utero."</seg>
<seg id="901">21 A Intensification of insulin therapy with a temporary improvement of blood glucose is associated with a temporary injunction of diabetic retinopathy.</seg>
<seg id="902">"diseases of immune system produced - Urtikaria, Exeter, rare - Anaphylaktic reactions, angiogenesis, gastrointestinal disorders, angiogenesis, gastrointestinal disorders, blood pressure, blood pressure, and Oasis / consciousness."</seg>
<seg id="903">Cartridges are only used together with products that are compatible with them and ensure a safe and effective function of the cartridge.</seg>
<seg id="904">It is recommended - after Actraphane Penfill out of the fridge - the temperature of insulated to room temperature (not above 25 ° C) before it is possible according to the manual for the first use.</seg>
<seg id="905">"some patients, with the hypocrisp reactions after a change of animals in human insulin, reported that the early warning symptoms of a hypoglycemia are less pronounced or different than in their previous insulin."</seg>
<seg id="906">28 Soviet Hypokemia is a hyperglycemia that may occur at a non-controlled digestive therapy may increase the risk of misappropriation and fruit tod in utero.</seg>
<seg id="907">29 A Intensification of insulin therapy with a temporary improvement of blood glucose is associated with a temporary injections of diabetic retinopathy.</seg>
<seg id="908">"some patients, with the hypocrisp reactions after a change of animals in human insulin, reported that the early warning symptoms of a hypoglycemia are less pronounced or different than in their previous insulin."</seg>
<seg id="909">36 Soviet Hypokemia is a hyperglycemia that may occur at a non-controlled digestive therapy, increase the risk of misappropriation and fruit tod in utero. "</seg>
<seg id="910">37 A Intensification of insulin therapy with a temporary improvement of blood glucose is associated with a temporary injections of diabetic retinopathy.</seg>
<seg id="911">"44 Soviet Hypokemia as well as Hyperglycemia, which may occur in a non-controlled diabetic therapy, increase the risk of misappropriation and fruit tod in utero."</seg>
<seg id="912">45 A Intensification of insulin therapy with a temporary improvement of blood glucose is associated with a temporary injections of diabetic retinopathy.</seg>
<seg id="913">"some patients, with the hypocrisp reactions after a change of animals in human insulin, reported that the early warning symptoms of a hypoglycemia are less pronounced or different than in their previous insulin."</seg>
<seg id="914">"52 Soviet Hypoglycemia as well as Hyperglycemia, which may occur in a non-controlled diabetic therapy, increase the risk of misappropriation and fruit tod in utero."</seg>
<seg id="915">53 A Intensification of insulin therapy with a temporary improvement of blood glucose is associated with a temporary injections of diabetic retinopathy.</seg>
<seg id="916">"the injection devices must be prepared before the injection, so that the Dosisregulator should be prepared to zero back and a insect box at the top of the injectors."</seg>
<seg id="917">"59 patients, whose blood glucose adjustment is significantly improved by means of an intensive insular treatment, the Hypoglycemia can occur and should be identified during the period of time."</seg>
<seg id="918">"however, Hypoglycemia is a hyperglycemia that may occur in a non-controlled diabetic therapy, increase the risk of misappropriation and fruit tod in utero."</seg>
<seg id="919">An intensification of insulin therapy with a temporary improvement of blood glucose is associated with a temporary injections of diabetic retinopathy.</seg>
<seg id="920">"diseases of immune system produced - Urtikaria, Exeter, rare - Anaphylaktic reactions, angiogenesis, gastrointestinal disorders, angiogenesis, gastrointestinal disorders, blood pressure, blood pressure, and Oasis / consciousness."</seg>
<seg id="921">"this manufacturing industry may only be used together with products that are compatible with them, and ensure a safe and effective function of the manufacturing process."</seg>
<seg id="922">It is recommended - after Actraphane Novolets from the fridge - the temperature of insulated to room temperature (not above 25 ° C) before it is possible according to the manual for the first use.</seg>
<seg id="923">"67 patients, their blood glucose adjustment is significantly improved by means of an intensive insular treatment, the Hypoglycemia can occur and should be identified during the period of time."</seg>
<seg id="924">"75 patients, whose blood glucose adjustment is significantly improved by means of an intensive insular treatment, the Hypoglycemia can occur and should be identified during the period of time."</seg>
<seg id="925">"83 patients, their blood glucose adjustment is significantly improved by means of an intensive insular treatment, the Hypoglycemia can occur and should be identified during the period of time."</seg>
<seg id="926">"91 patients, their blood glucose adjustment is significantly improved by means of an intensive insular treatment, the Hypoglycemia can occur and should be identified during the period of time."</seg>
<seg id="927">"over 99 patients, their blood glucose adjustment is significantly improved by means of an intensive insulin therapy, the Hypoglesiaemia can occur and should be processed correctly."</seg>
<seg id="928">"every change in strength, brand (manufacturers), insect type (quickly effective, biphasical, long-effective insulin) and / or manufacturing method (by recombinant DNA) and / or manufacturing method (by recombinant DNA) and / or manufacturing method (by recombinant DNA) and / or manufacturing method (by recombinant DNA) and / or manufacturing method (by recombinant DNA)."</seg>
<seg id="929">It is recommended - after Actraphane Innodes from the fridge - the temperature of the insulated to room temperature (not above 25 ° C) before it is possible according to the manual for the first use.</seg>
<seg id="930">It is recommended - after Actraphane FlexPen made from the fridge - the temperature of insulated to room temperature (not above 25 ° C) before the manual is used for the first use.</seg>
<seg id="931">"on the packaging unit, name and address of the manufacturer, which is responsible for the release of the relevant data."</seg>
<seg id="932">"you have to be logged in to write a review on this product, simply complete all the fields marked * and click" "Send". ""</seg>
<seg id="933">Subcutaneous application for interruptions are intended for use with insulin injectors from Novo Norge to fix the instructions resusphane 10 Penexchange must be used only from one person</seg>
<seg id="934">Your email address will not be published. required fields are marked *</seg>
<seg id="935">Subcutaneous application for interruptions are intended for use with insulin injectors from Novo Norge to fix the instructions resusphane 20 pension may only be used only from one person</seg>
<seg id="936">Subcutaneous application for interruptions are intended for use with insulin injectors from Novo Norge to fix the instructions resusphane 30 Penholder can only be used by one person</seg>
<seg id="937">Subcutaneous application to be used for application with insinability devices from Novo NorDisk are provided for use with insulin inverter devices. Actraphane 40 Penexchange must be used only from one person</seg>
<seg id="938">Subcutaneous application to be used for application with insinability devices from Novo Norge to fix the instructions resusphane 50 Penexchange must be used only from one person</seg>
<seg id="939">"if you are already our customer, please log in using your e-mail address and your password.:"</seg>
<seg id="940">Your e-mail address will not be published. required fields are marked *</seg>
<seg id="941">"if you are already our customer, please log in using your e-mail address and your password.:"</seg>
<seg id="942">"if you are already our customer, please log in using your e-mail address and your password.:"</seg>
<seg id="943">"if you want to send us a question about this product, simply complete all the fields marked * and click" "Send". ""</seg>
<seg id="944">"if you are already our customer, please log in using your e-mail address and your password.:"</seg>
<seg id="945">"if you want to send us a question about this product, simply complete all the fields marked * and click" "Send". ""</seg>
<seg id="946">This means that about half an hour after you have applied your blood sugar levels and that the effect is about 24 hours.</seg>
<seg id="947">► if you are allergic (excessive) to this insulated product, Metacresol or one of the other components (see section 7 Other information). "</seg>
<seg id="948">Pay attention to 5 which side effects are possible? symptoms of Lyme disease if you feel the first signs of a hypoglyaemia (symptoms of a substrate).</seg>
<seg id="949">"if your doctor has a change of an insulated or brand, you may have to be adapted by your doctor."</seg>
<seg id="950">► How to check the template using the label, whether it is in order to be the right insect type of rubber mixing with a medical Tulip. "</seg>
<seg id="951">"if this is not totally invisible when you get the water bottle, please enter the flow bottle to your pharmacy. if it was not correctly placed on your pharmacy, if it is not correctly able to keep it evenly evenly, or not to be evacuated."</seg>
<seg id="952">Use the injection technique that allows you to make your doctor or your slides in your skin to ensure that the complete dose is injected in your skin to ensure that the full dose is injected.</seg>
<seg id="953">"the warning signs of a substrate can suddenly occur, and may be his: kage sweat, cold-pain, nausea, nausea, nausea, nausea, fat, fat, confusion, confusion, concentration difficulties."</seg>
<seg id="954">"tell your relatives, friends and tight work that they will bring you in the case of consciousness into the stable side effects and immediately get a doctor."</seg>
<seg id="955">"you may not give you anything to eat or drink, because you could not be treated to drink or even to death. ► If you have a heavy submitting, or even to death, if you have a substitching with consciousness or frequently, seek your doctor."</seg>
<seg id="956">"you can restore the consciousness faster, if you are the hormone glucagon of one person who is familiar with the gift is injected."</seg>
<seg id="957">This can happen: • If you have a lot of insulin in injizzes • If you do too little or a meal - if you feel more than otherwise physically.</seg>
<seg id="958">"reinforced urinary tract, Durst, Appeduelessness, nausea or vomiting, malignity or tiredness, dry skin, oral care and fructose (after acetone) riechelessness."</seg>
<seg id="959">• You have forgotten Injizations by less than you need a infection or fever • more food than usual • less physical exercise than usual.</seg>
<seg id="960">"if you often give a injection at the same place, it can be used in this place the lower fat tissue (Lipatrophie) or take away (Lipópertrophie)."</seg>
<seg id="961">"if you notice your skin on your skin at the injection point, please report on your doctor or your slides in addition, as these reactions can affect your insulin or the recording of your insulin, if you have injected in such a place."</seg>
<seg id="962">"if you are looking for a doctor on • If the symptoms of any power on other parts of the body, or • if you suddenly feel uncomfortable and you feel comfortable, nausea (vomiting), respiratory tract, heart rate, or you have to have the impression that are simply useless."</seg>
<seg id="963">You may have a very rare severe allergic reaction to Actraphane or one of its components (so-called systemic reaction).</seg>
<seg id="964">"if one of the listed side effects are considerably affected or you notice that no side effects that are not indicated in this use information, please inform your doctor if your Diabetesize or your pharmacist."</seg>
<seg id="965">What Actraphane 30 contains - The active ingredient is controlled by recombinant DNA technology in human beings (30% as an soluble insulin and 70% as Isophan-insulin).</seg>
<seg id="966">"as Actraphane looks and content of the package The injectors will be delivered as gloomy, white, winged suspension in packages with 1 or 5 throughput bottles to 10 ml."</seg>
<seg id="967">Use the injection technique that allows you to make your doctor or your slides in your skin to ensure that the complete dose is injected in your skin to ensure that the full dose is injected.</seg>
<seg id="968">"it is recommended - after it was removed from the refrigerator - the temperature of blood flow on room temperature, before the use of insulin in accordance with the User manual for the first use."</seg>
<seg id="969">"as Actraphane looks and content of the package The injectors will be delivered as gloomy, white, winged suspension in packages with 1 or 5 throughput bottles to 10 ml."</seg>
<seg id="970">► Checkout using the label, whether it is in order to check the right insintintment with the rubber cartridge, including the rubber-bens (Stoppers). "</seg>
<seg id="971">Use them not to see if any damage is visible or a gap between the rubber band and the white band of the label is visible.</seg>
<seg id="972">"for further information, please refer to the instructions of your insinability system. ► Benches you always keep the rubber pads with a medical Tulip. ► Benches are always used for any injectors a new injectors to avoid contamination."</seg>
<seg id="973">"► in insininfusion pumps, if the pension or the device that contains the pension, it is possible to preserve the risk of insulin in ► if it is not correctly able to keep the risk of risk of insulin."</seg>
<seg id="974">"if you are treated with Actraphane 10 Pennies and another insulin blades, you should use two insulin injectors, each one for every insulin type."</seg>
<seg id="975">"before you use the cartridge in the insulator system, move it at least 20 times between positions and b on and from (see picture), so that the glass ball is made from one end of the cartridge."</seg>
<seg id="976">Use the injection technique that allows you to remove your doctor or your slides into your skin to ensure that the complete dose was injected in your skin to ensure that the complete dose was injected to remove the injectors.</seg>
<seg id="977">"183 Sawes your relatives, friends and tight work that they will bring you in the case of consciousness into the stable side effects and immediately get a doctor."</seg>
<seg id="978">• You have forgotten Injizations by less than you need a infection or fever • more food than usual • less physical exercise than usual.</seg>
<seg id="979">"if one of the listed side effects are considerably affected or you notice that no side effects that are not indicated in this use information, please inform your doctor if your Diabetesize or your pharmacist."</seg>
<seg id="980">"it is recommended - after it was removed from the refrigerator - the temperature of the pension is placed on room temperature, before the use of insulin in accordance with the User manual for the first use."</seg>
<seg id="981">185 Baking the cartridges always in the cardboard box if you don't use them to protect them from light.</seg>
<seg id="982">What Actraphane 10 contains - The active ingredient is controlled by recombinant DNA technology in human beings (10% as an soluble insulin and 90% as Isophan-insulin).</seg>
<seg id="983">"as Actraphane looks and content of the package The injectors will be delivered as gloomy, white, winged suspension in packages with 1, 5 or 10 cartridges."</seg>
<seg id="984">"for further information, please refer to the instructions of your insinability system. ► Benches you always keep the rubber pads with a medical Tulip. ► Benches are always used for any injectors a new injectors to avoid contamination."</seg>
<seg id="985">"if you are treated with Actraphane 20 pension and a different insulin blades, you should use two insulin injections, each one for every insulin type."</seg>
<seg id="986">"189 Saver your relatives, friends and tight work that they will bring you in the case of consciousness into the stable side effects and immediately get a doctor."</seg>
<seg id="987">"if one of the listed side effects are considerably affected or you notice that no side effects that are not indicated in this use information, please inform your doctor if your Diabetesize or your pharmacist."</seg>
<seg id="988">Skip to Main Content 4.0.18 © 2005-2015 - All rights reserved</seg>
<seg id="989">What Actraphane 20 contains - The active ingredient is controlled by recombinant DNA technology in human health (20% as an soluble insulin and 80% as Isophan-insulin).</seg>
<seg id="990">"as Actraphane looks and content of the package The injectors will be delivered as gloomy, white, winged suspension in packages with 1, 5 or 10 cartridges."</seg>
<seg id="991">"for further information, please refer to the instructions of your insinability system. ► Benches you always keep the rubber pads with a medical Tulip. ► Benches are always used for any injectors a new injectors to avoid contamination."</seg>
<seg id="992">"if you are treated with Actraphane 30 Pennies and another insulin blades, you should use two insulin injectors, each one for every insulin type."</seg>
<seg id="993">"195 Sagen you make your relatives, friends and tight work that they will bring you in the case of consciousness into the stable side effects and immediately get a doctor."</seg>
<seg id="994">"if one of the listed side effects are considerably affected or you notice that no side effects that are not indicated in this use information, please inform your doctor if your Diabetesize or your pharmacist."</seg>
<seg id="995">"197 maintainer you always use the cartridges on, if you don't use it to protect it from light."</seg>
<seg id="996">"manufacturer's manufacturer may be identified using the Chargen designation, which are identified on the laser-sheet and on the label, are identified:"</seg>
<seg id="997">"in case of the second and third place of Chargen-designation the drawing combination W5, S6, P5, K7, K7 or ZF is the manufacturer Novo Norx A / S, Novo Allé, DK- 2880 Baggage, Denmark"</seg>
<seg id="998">"in case of the second and third place of Chargen sales designation H7 or T6, the manufacturer Novo NorDisk Production SAS, 45, Avenue d'Orléans, F-28002 Chartres, France."</seg>
<seg id="999">"for further information, please refer to the instructions of your insul intoxication system. ► Benches you always get a new injectors in order to avoid contamination."</seg>
<seg id="1000">"if you are treated with Actraphane 40 pension and a different insulin blades, you should use two insulin injections, each one for every insulin type."</seg>
<seg id="1001">"201 Sagen you make your relatives, friends and tight work that they will bring you in the case of consciousness into the stable side effects and immediately get a doctor."</seg>
<seg id="1002">"if one of the listed side effects are considerably affected or you notice that no side effects that are not indicated in this use information, please inform your doctor if your Diabetesize or your pharmacist."</seg>
<seg id="1003">"if you do not want to protect the cartridges in a carton box, if you don't use it to protect it from light."</seg>
<seg id="1004">What Actraphane 40 contains - The active ingredient is controlled by recombinant DNA technology in human beings (40% as soluble insulin and 60% as Isophan-insulin).</seg>
<seg id="1005">"for further information, please refer to the instructions of your insul intoxication system. ► Benches you always get a new injectors in order to avoid contamination."</seg>
<seg id="1006">"if you are treated with Actraphane 50 Pennies and another insulin insulin, you should use two insulin injectors, each one for every insulin type."</seg>
<seg id="1007">"before you use the pension cartridge to the insulated cartridge, move it at least 20 times between positions and b on and from (see figure), so that the glass ball of the cartridge is at the end of the cartridge."</seg>
<seg id="1008">"207 Sagen, your relatives, friends and tight work that they will bring you in the case of consciousness into the stable side effects and immediately get a doctor."</seg>
<seg id="1009">"if one of the listed side effects are considerably affected or you notice that no side effects that are not indicated in this use information, please inform your doctor if your Diabetesize or your pharmacist."</seg>
<seg id="1010">"209 maintainer you always use the cartridges on, if you don't use it to protect it from light."</seg>
<seg id="1011">What Actraphane 50 contains - The active ingredient is controlled by recombinant DNA technology in human health (50% as an soluble insulin and 50% as Isophan-insulin).</seg>
<seg id="1012">"antioxidant, epithelial dysfunction (MAO-Hemmer), Betec-inhibitors (MAO-Hemmer, anticular enzymes, anaesthesia, sulphatic pathoids, caretamathometics, codecimid, octaol, ocamotid, octaotid, ocreotid, ocreotid, ocreotid, ocreotid, ocreotid, ocreotid, ocreotid, octopotid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid,</seg>
<seg id="1013">"if you check it using the label, whether it is to avoid the correct Insul integer type, it is always possible to avoid contamination of contamination."</seg>
<seg id="1014">"► in insininfusion pumps, if the Novois is left behind, damaged or detectable, is the risk of risk of insulin in ► if it is not correctly able to preserve the risk of risk of insulin."</seg>
<seg id="1015">"the warning signs of a substrate can suddenly occur, and may be his: kage sweat, cold-pain, nausea, nausea, nausea, nausea, fat, fat, confusion, confusion, concentration difficulties."</seg>
<seg id="1016">"214 If one of the listed side effects are considerably affected or you notice that no side effects that are not indicated in this use information, please inform your doctor if your Diabetesize or your pharmacist."</seg>
<seg id="1017">"in use as well as replacement parts, such as replacement parts, such as replacement parts, such as replacement parts, are not used in the fridge."</seg>
<seg id="1018">"it is recommended - after leaving from the refrigerator - the temperature of Novois, the temperature of the Novois, before the use of insulin, before the use of insulin in accordance with the User manual for the first use."</seg>
<seg id="1019">Let the screw cap of your Novolets you get into use when Novois is not in use to protect the insulin in front of light.</seg>
<seg id="1020">"as Actraphane looks and content of the package The injectors will be delivered as gloomy, white, winged suspension in packages with 5 or 10 manufacturing processes according to 3 ml."</seg>
<seg id="1021">"prior to every injection, it is possible to check whether or at least 12 units of insulin in the cartridge is ensured that a uniform blend is ensured."</seg>
<seg id="1022">Go to the top of the page Skip user information</seg>
<seg id="1023">"if air bubbles are present in the cartridge, you will continue to hold back in the cartridge (figure C) • While the injectors continue to hold a click into direction of the injection (figure D) • For the injectors in direction of the injection pump (figure D) • On the top of the injectors."</seg>
<seg id="1024">"• Using the seal folder again, that the digit 0 to the dosing of the dosing system (figure E) • contests, whether the printing knob is completely sealed."</seg>
<seg id="1025">"if not, turn the seal button until the press knob is completely removed. • Hold your Actraphane 10 Novolets you wish."</seg>
<seg id="1026">"if the printing knob is not free to the outside, insulin is pressed, insulin is pressed from the injection point, will be pressed to the scale on the seal cover 0, 2, 4, 8, 10, 12, 16, 16, and 18 units."</seg>
<seg id="1027">"the press button moves after outside, while you turn off the seal off the scale below 20, 40 and 60 units."</seg>
<seg id="1028">"check the correct dose • check the number on the seal box directly next to the dosing stamp • If you set the two figures to set up the correct dose, turn off the lock button forward or backward until you can set the correct number of units."</seg>
<seg id="1029">"otherwise, insulin in the injection point and the dose is not correct • If you try to set a dose of more than 78 units, perform the following steps:"</seg>
<seg id="1030">Then take the seal board and set it so again that the 0 of the dosing stamp is above.</seg>
<seg id="1031">"if the injection point is done, only during the injectors on the press button. • Hold it was drawn up to the injection point, until the injectors was drawn out of the skin, until the injectors was drawn from the skin."</seg>
<seg id="1032">"if not, turn the seal button until the press knob is completely removed and then drive it as in the use of the printing ink, you can listen to the pressures of the print button."</seg>
<seg id="1033">It is possibly not exactly you can set any dosage that is higher than the number of the amount in the cartridge. you can use the residual quantities to estimate how much insulin is still remains.</seg>
<seg id="1034">"antioxidant, epithelial dysfunction (MAO-Hemmer), Betec-inhibitors (MAO-Hemmer, anticular enzymes, anaesthesia, sulphatic pathoids, caretamathometics, codecimid, octaol, ocamotid, octaotid, ocreotid, ocreotid, ocreotid, ocreotid, ocreotid, ocreotid, ocreotid, octopotid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid,</seg>
<seg id="1035">"224 If one of the listed side effects are considerably affected or you notice that no side effects that are not indicated in this use information, please inform your doctor if your Diabetesize or your pharmacist."</seg>
<seg id="1036">"226 At each injection of each injection, check whether at least 12 units of insulin in the cartridge, so that a uniform blend is ensured."</seg>
<seg id="1037">Go to the top of the page Skip user information</seg>
<seg id="1038">"if air bubbles are present in the cartridge, you will continue to keep the cartridge at the top in the cartridge (figure C) • While the injectors continue to hold a click into direction of the injection (figure D) • For you to hold the press button on the top of the injectors."</seg>
<seg id="1039">"if not, turn the seal button, until the press knob is completely removed, • Hold your Actraphane 20 Novolets you wish."</seg>
<seg id="1040">"antioxidant, epithelial dysfunction (MAO-Hemmer), Betec-inhibitors (MAO-Hemmer, anticular enzymes, anaesthesia, sulphatic pathoids, caretamathometics, codecimid, octaol, ocamotid, octaotid, ocreotid, ocreotid, ocreotid, ocreotid, ocreotid, ocreotid, ocreotid, octopotid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid,</seg>
<seg id="1041">"234 If one of the listed side effects are considerably affected or you notice that no side effects that are not indicated in this use information, please inform your doctor who are not in this use information, please consult your doctor."</seg>
<seg id="1042">"236 Before each injection unit, check whether at least 12 units of insulin in the cartridge, so that a uniform blend is ensured."</seg>
<seg id="1043">Go to the top of the page Skip user information</seg>
<seg id="1044">"when air bubbles are present, these will continue to hold back to the cartridge (figure C) • While the injectors continue to hold a click into direction of the injection (figure D) • For the injectors in direction of the injection pump (figure D) • For the injunction of the injectors."</seg>
<seg id="1045">"if not, turn the seal button until the press knob is completely removed. • Hold your Actraphane 30 Novolets let you complete."</seg>
<seg id="1046">"antioxidant, epithelial dysfunction (MAO-Hemmer), Betec-inhibitors (MAO-Hemmer, anticular enzymes, anaesthesia, sulphatic pathoids, caretamathometics, codecimid, octaol, ocamotid, octaotid, ocreotid, ocreotid, ocreotid, ocreotid, ocreotid, ocreotid, ocreotid, octopotid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid,</seg>
<seg id="1047">"244 If one of the listed side effects are considerably affected or you notice that no side effects that are not indicated in this use information, please inform your doctor if your Diabetesize or your pharmacist."</seg>
<seg id="1048">"246 Before each injection unit, check whether at least 12 units of insulin in the cartridge, so that a uniform blend is ensured."</seg>
<seg id="1049">Go to the top of the page Skip user information</seg>
<seg id="1050">"if air bubbles are present, these will continue to hold the cartridge in the cartridge (figure C) • While the injectors continue to hold a click into direction of the injection (figure D) • For the injectors in direction of the injection pump (figure D) • On the top of the injectors."</seg>
<seg id="1051">"if not, turn the seal button, until the press knob is completely removed, • Hold your Actraphane 40 Novolets you wish."</seg>
<seg id="1052">"antioxidant, epithelial dysfunction (MAO-Hemmer), Betec-inhibitors (MAO-Hemmer, anticular enzymes, anaesthesia, sulphatic pathoids, caretamathometics, codecimid, octaol, ocamotid, octaotid, ocreotid, ocreotid, ocreotid, ocreotid, ocreotid, ocreotid, ocreotid, octopotid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid,</seg>
<seg id="1053">"254 If one of the listed side effects are considerably affected or you notice that no side effects that are not indicated in this use information, please inform your doctor if your Diabetesize or your pharmacist."</seg>
<seg id="1054">"it is recommended - after leaving from the refrigerator - the temperature of Novois, the temperature of the Novois, before the use of insulin, before the use of insulin in accordance with the User manual for the first use."</seg>
<seg id="1055">"256 of any injectors, check whether at least 12 units of insulin in the cartridge, so that a uniform blend is ensured."</seg>
<seg id="1056">Go to the top of the page Skip user information</seg>
<seg id="1057">"when air bubbles are present, these will continue to hold back to the cartridge (figure C) • While the injectors continue to hold a click in direction of the head (figure D) • For the injectors in direction of the injection point (figure D) • For the injunction of the injectors."</seg>
<seg id="1058">"if not, turn the seal button until the press knob is completely removed. • Hold your Actraphane 50 Novolets you wish."</seg>
<seg id="1059">"antioxidant, epithelial dysfunction (MAO-Hemmer), Betec-inhibitors (MAO-Hemmer, anticular enzymes, anaesthesia, sulphatic pathoids, caretamathometics, codecimid, octaol, ocamotid, octaotid, ocreotid, ocreotid, ocreotid, ocreotid, ocreotid, ocreotid, ocreotid, octopotid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid,</seg>
<seg id="1060">"in the insect case of insulin, it is possible to preserve the risk of insulin in ► if it is not correctly able to preserve the risk of insulin in ► if it is not correctly able to preserve the risk of risk of insulin."</seg>
<seg id="1061">"the warning signs of a substrate can suddenly occur, and may be his: kage sweat, cold-pain, nausea, nausea, nausea, nausea, fat, fat, confusion, confusion, concentration difficulties."</seg>
<seg id="1062">"264 If one of the listed side effects are considerably affected or you notice that no side effects that are not indicated in this use information, please inform your doctor who are not in this use information, please consult your doctor."</seg>
<seg id="1063">"in use as well as replacement parts, such as replacement parts, such as replacement parts, are not used in the fridge."</seg>
<seg id="1064">"it is recommended - after leaving from the refrigerator - the temperature of Innoises production, before the use of insulin, before the insulin is used in accordance with the instructions for the first use."</seg>
<seg id="1065">Let the seal of your Innodes are always put into use when Innovirus is not in use to protect the insulin in front of light.</seg>
<seg id="1066">"as Actraphane looks and content of the package The injectors will be delivered as gloomy, white, winged suspension in packages with 1, 5 or 10 manufacturing processes according to 3 ml."</seg>
<seg id="1067">"the movement must be repeated until the liquid evenly is evacuated by the liquid, which will lead you all the following steps of the injection without delay."</seg>
<seg id="1068">"• disinfect the rubber pads with a medical Tulip • Bench you always have a new injectors in order to avoid contamination and firmly on Actraphane 30 Innoises (figure 1B), and firmly on Actraphane 30 Innoises (figure 1B)."</seg>
<seg id="1069">"• Concentration, whether the printing knob is completely reproduced, and the Dosisregulator to zero is the number of units that you need to be injected in the clockwise direction (figure 2)."</seg>
<seg id="1070">Do not use the residual hardness scale - scale to measure your insindosis • you hear for each individually selected unit.</seg>
<seg id="1071">Lead the injection technique that has shown you your doctor • Give the dose by using the print button completely (figure 3).</seg>
<seg id="1072">"the Dosisregulator works on zero back and you hear air-noise • The injectors must remain at least 6 seconds in order to ensure that the complete insindosis is injected to zero after the injection system, if you do not block the injection pump, remove the injectors, and remove the injectors."</seg>
<seg id="1073">"medical personnel, family members and other counseling must be observed for the distance and disposal of the injectors to avoid unintentionally."</seg>
<seg id="1074">"antioxidant, epithelial dysfunction (MAO-Hemmer), Betec-inhibitors (MAO-Hemmer, anticular enzymes, anaesthesia, sulphatic pathoids, caretamathometics, codecimid, octaol, ocamotid, octaotid, ocreotid, ocreotid, ocreotid, ocreotid, ocreotid, ocreotid, ocreotid, octopotid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid,</seg>
<seg id="1075">"► in insininfusion pumps, if the FlexPen has been left, damaged or broken, is the risk of risk of insulin in ► if it is not correctly able to preserve the risk of risk of insulin."</seg>
<seg id="1076">"if you notice your skin on your skin at the injection point, please report on your doctor or your slides in addition, as these reactions can affect your insulin or the recording of your insulin, if you have injected in such a place."</seg>
<seg id="1077">"274 If one of the listed side effects are considerably affected or you notice that no side effects that are not indicated in this use information, please inform your doctor if your Diabetesize or your pharmacist."</seg>
<seg id="1078">"in use as well as spare parts, such as replacement parts, such as replacement parts, are not used in the fridge."</seg>
<seg id="1079">"it is recommended - after being taken from the refrigerator - the temperature of the FlexPen, the temperature rises to the temperature, before the insulin is used in accordance with the instructions for the first use."</seg>
<seg id="1080">Let the seal of your FlexPen is always up when FlexPen is not in use to protect the insulin in front of light.</seg>
<seg id="1081">"as Actraphane looks and content of the package The injectors will be delivered as gloomy, white, winged suspension in packages with 1, 5 or 10 manufacturing processes according to 3 ml."</seg>
<seg id="1082">"manufacturer's manufacturer may be identified using the Chargen designation, which are identified on the laser-sheet and on the label, are identified:"</seg>
<seg id="1083">"275 • If you are on the second and third place of Chargen-designation the drawing combination W5, S6, K7, K7, K7, K7 or ZF, is the manufacturer Novo NorDisk Production SAS, 45, Avenue d'Orléans, F- 28002 Chartres, France."</seg>
<seg id="1084">"B. because of the positions 1 and 2 twentieth to and from, so that the glass ball will move from one end of the cartridge."</seg>
<seg id="1085">Move the finished positions at least 10 times between positions 1 and 2 and up to the liquid.</seg>
<seg id="1086">"• To reduce the risk of unintentional needle to reduce the inner tube back to the injecting needle, after you have taken out of it."</seg>
<seg id="1087">279 G Hold you use the FlexPen with the injection lever to top and knead a few times with the finger at the cartridge with the fingers to remove existing air bubbles in the cartridge.</seg>
<seg id="1088">"the dosage can be corrected both after the top as well as after down, by using the Dosisers button to turn up to the correct dosage compared to the marking of the ad."</seg>
<seg id="1089">"this document is a summary of the European Council of the European Parliament (EPAR), in which explains how the Committee for Humanitarian Products (CHMP) is applied to the recommendations concerning the application of medication."</seg>
<seg id="1090">"the result is an effective component of Actrapid, insulin in human disease (rDNA), is produced with the procedure of so-called" "combined technology". ""</seg>
<seg id="1091">"(44-20) 74 18 84 173 E-mail: mail @ emea.europa.eu - http: / / www.emea.europa.eu - http: / / www.emea.europa.eu - http: / / www.emea.europa.eu - http: / / www.emea.europa.eu."</seg>
<seg id="1092">Actrapid should not be applied in patients who may be sensitive to insulin in human beings (rDNA) or one of other components.</seg>
<seg id="1093">"furthermore, the cans of Actrapid may be adapted if it is given together with a number of other medicines that may result in blood sugar."</seg>
<seg id="1094">"October 2002, the European Commission on the Company Novo Norge A / S will bring an approval for the Intraitor in the entire European Union."</seg>
<seg id="1095">"when two types of insulin will be mixed up, first the amount of the fast insulin will be done, then the amount of the long-acting insulin."</seg>
<seg id="1096">"3 If the change of Actrapid is required, this may be necessary for the first dosage or in the first weeks or months after the period of months or months."</seg>
<seg id="1097">"prior to travel, the patient should be informed about several time zones, the patient should be aware of the advice of his doctor, as such trips can lead to insulin and meals to other times."</seg>
<seg id="1098">"5 General diseases and disappearances at the same time, local oversensitive resignation of the injection point of insulin treatment can be caused by the injection point (tube, swelling, itching, pain and hemmatom at the injection point)."</seg>
<seg id="1099">"if you have any queries, please contact us on Tel.: + 49 5764 318 444. or contact us per email."</seg>
<seg id="1100">A clinical attempt at a intensive station for treatment of hyperglycemia (blood sugar) about 10 mmol / l) with 204 diabetic and 1344 non-diabetic patients who has shown larger surgical surgery (blood sugar: 4 - 6.1 mmol / l) the Mortality around 42% reduced (8% compared to 4.6%).</seg>
<seg id="1101">"the effect starts within half an hour, the active part is reached from 1.5 to 3.5 hours and the entire active duration is about 7 to 8 hours."</seg>
<seg id="1102">Children and young people are investigated in a smaller number (n = 18) diabetic children (age between 6 and 12 years) and youth (age between 6 and 12 years) and youth (age between 13 and 17 years).</seg>
<seg id="1103">"the data are limited, but the acceptance of pharmacokinetic profile was similar to children and young adults."</seg>
<seg id="1104">"using Actraders in concentrations 0.7% sodium chloride, 5% D-glucose and 10% D- glucose with 40 mmol / l caliumchloride, with a temperature of 24 hours long stable."</seg>
<seg id="1105">"11 If the change of Actrapid is required, this may be necessary for the first dosage or in the first weeks or months after the period of months or months."</seg>
<seg id="1106">"prior to travel, the patient should be informed about several time zones, the patient should be aware of the advice of his doctor, as such trips can lead to insulin and meals to other times."</seg>
<seg id="1107">"13 General diseases and disappearances at the basis of the injunction of the injunction of the injunction of the injection point, local oversensitivity, pain, pain and hemorom at the injection point) occur."</seg>
<seg id="1108">"if you have any queries, please contact us on Tel.: + 49 5764 318 444. or contact us per email."</seg>
<seg id="1109">Children and young people are investigated in a smaller number (n = 18) diabetic children (age between 6 and 12 years) and youth (age between 6 and 12 years) and youth (age between 13 and 17 years).</seg>
<seg id="1110">The intravenous application of Actraders from manufacturing processes or cartridges should be made for the exception and only in situations where no flow bottles are available.</seg>
<seg id="1111">"if the change of Actrac is required, this may be necessary for the first dosage or in the first weeks or months after the period of months or months."</seg>
<seg id="1112">21 diseases of the skin and the lower cell growth - Liliystrophie A librystrophie will be able to change a librystrophie in the injunction within the injections.</seg>
<seg id="1113">Children and young people are investigated in a smaller number (n = 18) diabetic children (age between 6 and 12 years) and youth (age between 6 and 12 years) and youth (age between 13 and 17 years).</seg>
<seg id="1114">29 diseases of the skin and the lower cell growth - Lipodystrophie An librystrophie will be able to change a librystrophie in the injunction within the injections.</seg>
<seg id="1115">"diseases of immune system produced - Urtikaria, Exeter, rare - Anaphylaktic reactions, angiogenesis, gastrointestinal disorders, angiogenesis, gastrointestinal disorders, blood pressure, blood pressure, and Oasis / consciousness."</seg>
<seg id="1116">Children and young people are investigated in a smaller number (n = 18) diabetic children (age between 6 and 12 years) and youth (age between 6 and 12 years) and youth (age between 13 and 17 years).</seg>
<seg id="1117">"diseases of immune system produced - Urtikaria, Exeter, rare - Anaphylaktic reactions, angiogenesis, gastrointestinal disorders, angiogenesis, gastrointestinal disorders, blood pressure, blood pressure, and Oasis / consciousness."</seg>
<seg id="1118">38 A clinical attempt at a intensive station for treatment of hyperglycemia (blood sugar) about 10 mmol / l) with 204 diabetic and 1344 non-diabetic patients who has shown larger surgical surgery (blood sugar: 4 - 6.1 mmol / l) the Mortality around 42% reduced (8% compared to 4.6%).</seg>
<seg id="1119">"diseases of immune system produced - Urtikaria, Exeter, rare - Anaphylaktic reactions, angiogenesis, gastrointestinal disorders, angiogenesis, gastrointestinal disorders, blood pressure, blood pressure, and Oasis / consciousness."</seg>
<seg id="1120">46 A clinical attempt at a intensive station for treatment of hyperglycemia (blood sugar) about 10 mmol / l) with 204 diabetic and 1344 non-diabetic patients who has shown larger surgical surgery (blood sugar: 4 - 6.1 mmol / l) the Mortality around 42% reduced (8% compared to 4.6%).</seg>
<seg id="1121">"you have to register first, to connect to this user."</seg>
<seg id="1122">Subcutaneous application can be used for use with Novo Norv insininverter systems.</seg>
<seg id="1123">Your email address will not be published. required fields are marked *</seg>
<seg id="1124">Subcutaneous application for use with Actrapid Novolets have been used to be used as a combination of Actrapid Novovirus may only be used by one person.</seg>
<seg id="1125">"in the fridge (2 ° C - 8 ° C) Not available, giving up light to the fridge: not in the fridge or over 30 ° C"</seg>
<seg id="1126">Subcutaneous application for use with Actrapid Innodes are intended for the use of Actrapid Innoons only from one person</seg>
<seg id="1127">This means that about half an hour after you have applied your blood sugar levels and that the effect is about 8 hours.</seg>
<seg id="1128">► How to check the template using the label, whether it is in order to be the right insintment type. ► deselect the rubber pads with a medical Tulip. "</seg>
<seg id="1129">"if this is not totally invisible when you get the water bottle, please enter the flow bottle to your pharmacy. if it was not correctly able to preserve the water. (see 6 How is Actraitor?) ► if it is not clear as water and colourless."</seg>
<seg id="1130">Use the injection technique that allows you to make your doctor or your slides in your skin to ensure that the complete dose is injected in your skin to ensure that the full dose is injected.</seg>
<seg id="1131">"83 Saye your relatives, friends and narrow labour, that they will bring you in the case of consciousness into the stable side effects and immediately get a doctor."</seg>
<seg id="1132">You may have a very rare severe allergic reaction to Actrapid or one of its components (so-called systemic reaction).</seg>
<seg id="1133">"the injection solution is supplied as clear, colourless, welling solution in packings with 1 or 5 throughput bottles to 10 ml, depending on the 10 ml."</seg>
<seg id="1134">"89 Saver your relatives, friends and tight work that they will bring you in the case of consciousness into the stable side effects and immediately get a doctor."</seg>
<seg id="1135">"if you check it using the label, if it is the right insintment type, you always check the cartridge including the rubber-bens (Stoppers)."</seg>
<seg id="1136">"► in insininfusion pumps, if the pension or the device that contains the pension is left, damaged or broken; it is the risk of risk of insulin in ► if it is not correct such as water and colourless."</seg>
<seg id="1137">"if you are treated with Actrapid penguin and any other insulin in pennies, you should use two insulin injectors, each one for every insulin type."</seg>
<seg id="1138">Use the injection technique that allows you to remove your doctor or your slides into your skin to ensure that the complete dose was injected in your skin to ensure that the complete dose was injected in order to make sure that the complete dose was injected in order to ensure that the complete dose was injected in order to ensure that the complete dose was injected without any injected injectors.</seg>
<seg id="1139">"• If you are on the second and third place of the file name W5, S6, P5, K7, K7, K7 or ZF, the manufacturer Novo Normal A / S, Novo Allé, DK-2880 Baggage, Denmark"</seg>
<seg id="1140">"• If you are on the second and third place of Chargen sales designation H7 or T6, the manufacturer Novo NorDisk Production SAS, 45, Avenue d" Orléans, F- 28002 Chartres, France. "</seg>
<seg id="1141">"antioxidant, epithelial dysfunction (MAO-Hemmer), Betec-inhibitors (MAO-Hemmer, anticular enzymes, anaesthesia, sulphatic pathoids, caretamathometics, codecimid, octaol, ocamotid, octaotid, ocreotid, ocreotid, ocreotid, ocreotid, ocreotid, ocreotid, ocreotid, octopotid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid,</seg>
<seg id="1142">► How do you check the name of the label whether it is in order to avoid contamination of a new injectors in order to avoid contamination.</seg>
<seg id="1143">► in insininfusion pumps if the Novois left behind it is damaged or broken; it is the risk of risk of insulin in ► if it is not correct such as water and colourless.</seg>
<seg id="1144">This can happen: • If you have a lot of insulin in injizzes • If you do too little or a meal - if you feel more than otherwise physically</seg>
<seg id="1145">Let the screw cap of your Novolets you are being loaded into use when it is not in use to protect him from light.</seg>
<seg id="1146">"• disinfect the rubber pads with a medical Tulip • Bench you always have a new injectors in order to avoid contamination of a NovoFine injectors, to avoid contamination of the injectors in order to avoid contamination of the injectors."</seg>
<seg id="1147">Go to the top of the page Skip user information</seg>
<seg id="1148">"when air bubbles are present, these will continue to keep the injection point in the cartridge (figure B) • If the injectors continue to hold a click on the top of the injection (figure C) • For the injectors, press the press button on the top of the injection pump or a drop of insulin."</seg>
<seg id="1149">"• Using the seal folder so that the digit 0 to the dosing stamp is, (figure D) • contests, whether the printing knob is completely sealed."</seg>
<seg id="1150">"if the printing knob is not free, insulin is pressed."</seg>
<seg id="1151">"the press knob is positioned at the outside, while you turn off the seal button • The scale below the press knob (press scanners skala) shows 20, 40 and 60 units."</seg>
<seg id="1152">"107: select the highest number that you can see the two figures to get the dose to get the dosage, turn forward or backward until you can set the correct number of units."</seg>
<seg id="1153">"turn them up until the printing knob is at the bottom, and you will feel a resistor feel so again that the 0 of the dosing stamp is located."</seg>
<seg id="1154">Make sure to press only during the injection button • Hold you push the press pipe after the injection point out of the injector until the injection point was drawn out of the skin.</seg>
<seg id="1155">"you can set up any dosage that is higher than the number of the recorded units • you can use the residual moisture skala, but you can't use them to add your dose or select your dose or select."</seg>
<seg id="1156">"antioxidant, epithelial dysfunction (MAO-Hemmer), Betec-inhibitors (MAO-Hemmer, anticular enzymes, anaesthesia, sulphatic pathoids, caretamathometics, codecimid, octaol, ocamotid, octaotid, ocreotid, ocreotid, ocreotid, ocreotid, ocreotid, ocreotid, ocreotid, octopotid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid,</seg>
<seg id="1157">► in insininfusion pumps when the Innodes are left behind. it is possible to store insulin. it is the risk of risk of insulin in ► if it is not correct such as water and colourless.</seg>
<seg id="1158">Let the seal of your Innodes are always up when it is not in use to protect him from light.</seg>
<seg id="1159">"• disinfect the rubber pads with a medical Tulip • Bench you always have a new injectors in order to avoid contamination of a NovoFine S injection pump, and firmly on Actrapid Innoons (Figure 1A) • Zip the injectors of the injection bag and the inner cap of the injection moulding."</seg>
<seg id="1160">"the Dosisregulator works on zero back and you hear air-noise • The injectors must remain at least 6 seconds in order to ensure that the complete insulin regulator is injected to zero after the injection system, if you have to remove the injection knob, remove the injectors, remove the injectors, after each injection."</seg>
<seg id="1161">"antioxidant, epithelial dysfunction (MAO-Hemmer), Betec-inhibitors (MAO-Hemmer, anticular enzymes, anaesthesia, sulphatic pathoids, caretamathometics, codecimid, octaol, ocamotid, octaotid, ocreotid, ocreotid, ocreotid, ocreotid, ocreotid, ocreotid, ocreotid, octopotid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid, oceanid,</seg>
<seg id="1162">"121 But if it was not correctly able to store it, (see 6 How is Actrac to preserve?) ► if it is not clear as water and colourless."</seg>
<seg id="1163">"if one of the listed side effects are considerably affected or you notice that no side effects that are not indicated in this use information, please inform your doctor if your Diabetesize or your pharmacist."</seg>
<seg id="1164">Let the seal of your FlexPen is always up when it is not in use to protect him from light.</seg>
<seg id="1165">"F Hold you use the FlexPen with the injection lever to top and knead a few times with the finger at the cartridge, so that existing air bubbles will gather at the cartridge."</seg>
<seg id="1166">"the dosage can be corrected both after the top as well as after down, by using the Dosisers button to turn up to the correct dose to the marking of Dosisch."</seg>
<seg id="1167">"Adenuric is applied in patients who have already been signs of crystal deposits, including arthritis (pain and inflammation in the joints) or gypsy notes (" stones "."</seg>
<seg id="1168">"if the urea can be increased to two to four weeks, the dose can be increased to 120 mg per year, the dose can be increased to 120 mg per week."</seg>
<seg id="1169">"during the first treatment of monate, it is recommended that the patients may occur at least during the first six months of treatment with Adenuric."</seg>
<seg id="1170">The medicine is not recommended in children and patients who had a organ transplant since it was not examined for these groups.</seg>
<seg id="1171">"in the first study, in 1 072 patients, the efficacy of three different Adenuric Dosies (once daily 80, 120 and 240 mg) with the placebo (headcount) and Allopurinol (a different medicine for the treatment of hyperurikaemia)."</seg>
<seg id="1172">"in the second study, two dosing units from Adenuric (once daily 80 and 120 mg) was compared to 762 patients with Allopurinol."</seg>
<seg id="1173">"in both studies, Allopurinol was used in a dose of once daily 300 mg, patients with kidney problems were only 100 mg per day."</seg>
<seg id="1174">"* Understand the competitive environment, the market's major players and leading brands; * Pinpoint growth sectors and identify factors driving change; * Understand the competitive environment, the market's major players and leading brands; * Use five-year forecasts to assess how the market is predicted to develop."</seg>
<seg id="1175">"in the first study, 48% (126 of 262) of patients who took Adenuric in a dose of once per day, and 65% (175 of 269) of the patients, which once per daily 120 mg (175 of 269) of patients suffering from under 6 mg / dl."</seg>
<seg id="1176">"compared to 22% (60 of 268), patients under Allopurinol and any of the 134 patients under placebo."</seg>
<seg id="1177">"the most common side effects of Adenuric (observed in 1 to 10 of 100 patients) are headache, diarrhea, nausea, nausea and normal liver values."</seg>
<seg id="1178">"in particular in patients with heart attack, there may also be increased risk of certain effects that affect the heart and blood vessels."</seg>
<seg id="1179">"the Committee for Human Physicians (CHMP) came to the end that Adenuric at the reduction of urinary blood was more effective than Allopurinol, but also a higher risk of side effects in connection with the heart and blood vessels."</seg>
<seg id="1180">Treatment of chronic hyperuraemia in diseases that have already led to urine deposits (including one of the clinical history of well-known or well-known gypsum and / or a gypsum).</seg>
<seg id="1181">After 2-4 weeks or &gt; 6 mg / dl (357 µMol / l) can be considered at ADENURIC 120 mg 1 x every day.</seg>
<seg id="1182">"in patients with severe kidney function, the efficacy and safety has not been investigated (Kreatinol Clearance &lt; 30 ml / min, see section 5.2)."</seg>
<seg id="1183">Children and adolescents are not recommended for children and adolescents with children and adolescents.</seg>
<seg id="1184">"in Organstreit proceedings regarding the" "Labour Market" "(publication date),"</seg>
<seg id="1185">Cardiovascular diseases in patients with male heart disease or compensating heart failure is not recommended (see paragraph 4.8).</seg>
<seg id="1186">"as with other harnacid medicines, it can be mobilised during the treatment's treatment, because due to the reduction of the Serum hardening deposits in the tissue can be mobilized in the tissue."</seg>
<seg id="1187">In rare cases the absolute concentration of Xanthin syndrome is the absolute concentration of Xanthin in rare cases such as far as far as far as far as far as far as possible in the urgency in rare cases.</seg>
<seg id="1188">Liver disease observed in the clinical trials of the phase 3 were light scanned in patients with cancer patients (3.5%).</seg>
<seg id="1189">"therefore, it is recommended to perform at the beginning of the net treatment and further development depending on clinical trials and a liver function type (see section 5.1)."</seg>
<seg id="1190">Theophyllin Zwas not performed ineffective studies to drug users but it is known that the XO-inhibitors can lead to a rise of the Theophyllination (a inhibitory of the Metabolization of Theophyllin was also reported to other XO inhibitors).</seg>
<seg id="1191">"at subjects, simultaneous translation of Marijuana uxostat and Naproxen 250 mg 2 x every day with an increase of the local uxostats (CMAx 28%, AUC 41% and t1 / 2 26%)."</seg>
<seg id="1192">In clinical trials the application of Naproxen or other NSAR / Cox-2-inhibitors do not occur in connection with a clinical significant increase of unwanted events.</seg>
<seg id="1193">Colchicin / Indometacin / Hydrochlorine garnet can be applied together with Colchicin or Indometacin or indometacin or indometacin or at the same other active ingredient.</seg>
<seg id="1194">"results appear ordered" "by relevance" "or" "by date" "(publication date),"</seg>
<seg id="1195">The hydroxid and aluminium hydroxid and aluminium hydroxid and aluminium hydroxid has been delayed and increased by CMAx by 32% but no significant change in the AUC causes no significant change in the AUC.</seg>
<seg id="1196">"pregnancy data about a very limited number of exponentially, not to side effects of drug abuse at the pregnancy or health of the Fetus / newborn."</seg>
<seg id="1197">"experimental studies do not allow direct or indirect harmful effects on pregnancy, embryonic / fetal development or birth (see paragraph 5.3)."</seg>
<seg id="1198">"in addition, ADENURIC will not be able to be able to be sure that ADENURIC does not affect the performance of the ADENURIC performance."</seg>
<seg id="1199">Table 3 Sales of Impulse and Indulgence Products by Category: volume 2009-2014 Table 2 Sales of Packaged Food by Category:% Value Growth 2009-2014</seg>
<seg id="1200">"in these patients, the risk factors were a arteriossclerotic disease and / or a Myokardal infections or a decompensated heart failure in medical history."</seg>
<seg id="1201">"common (≥ 1 / 100 to &lt; 1 / 10), occasional (≥ 1 / 1000 to &lt; 1 / 100) and rare (≥ 1 / 100) and rare (≥ 1 / 100) and rare (≥ 1 / 100) and rare (≥ 1 / 100) and rare (≥ 1 / 100) and rare (test results) in connection with the medicine, are listed below."</seg>
<seg id="1202">"* * In the clinical trials have been treated with colchicin treated. * * In the clinical trials were no serious infection, or severe irritation."</seg>
<seg id="1203">"results appear ordered" "by relevance" "or" "by date" "(publication date),"</seg>
<seg id="1204">"during the long-term studies, the study of the long-term studies were similar to those which were similar in the studies of the phase 3 reported (see table 1)."</seg>
<seg id="1205">"the following treatments of events were performed in all trials related events (up to 4 years in long-term studies), according to the results (up to 4 years with an exposure time of &gt; 1.900 patient years), the data are occasionally occasionally used."</seg>
<seg id="1206">The following treatments are based in the pivotal studies in the pivotal studies in the pivotal studies of the phase 3 for these cans either or with a lower frequency:</seg>
<seg id="1207">"diabetes, hyperlipidaemia, insomnia, hypnosis, hypnosis, skin irritation, skin irritation, skin irritation, tectile dysfunction, decline of the TSH concentration in blood, increased the number of white blood cells."</seg>
<seg id="1208">The mechanism of urinary tract is used in humans the final product of the Purindemsm and creates the scope of the reaction vessel Hypoxanthin → Xanthin → ureacid.</seg>
<seg id="1209">"results appear ordered" "by relevance" "or" "by date" "(publication date),"</seg>
<seg id="1210">"results appear ordered" "by relevance" "or" "by date" "(publication date),"</seg>
<seg id="1211">"the primary energy point was in every study of the share of the patients, where the last three monthly Serum harnectstheses &lt; 6,0 mg / dl (357 µMol / l)."</seg>
<seg id="1212">"placebo (n = 134), ADENURIC 120 mg 1 x daily (n = 134), ADENURIC 240 mg 1 x daily (n = 134), ADENURIC 240 mg 1 x daily (n = 134), ADENURIC 240 mg 1 x daily (n = 134), ADENURIC 240 mg 1 x daily (n = 134), ADENURIC 240 mg 1 x daily (n = 134), ADENURIC 240 mg 1 x daily (n = 134), ADENURIC 240 mg 1 x daily (n = 134), ADENURIC 240 mg 1 x daily (n = 134), ADENURIC 240 mg 1 x daily (n = 134), ADENURIC 240 mg 1 x daily (n = 134), ADENURIC 240 mg 1 x daily (n = 134), ADENURIC 240 mg 1 x daily (n = 134), ADENURIC 240 mg 1 x daily (n = 134), ADENURIC 240 mg 1 x daily (n = 134), ADENURIC 240 mg 1 x daily (n = 134), ADENURIC 240 mg 1 x daily (n = 134), ADENURIC 240 mg 1 x daily (n = 134), ADENURIC 240 mg 1 x daily (n = 134), ADENURIC 240 mg 1 x daily (n = 134), ADENURIC 240 mg 1 x daily (n = 134), ADENURIC 240 mg 1 x daily (n = 134), ADENURIC 240 mg 1 x daily (n = 134), ADENURIC 240 mg 1 x daily (n = 134), ADENURIC 240 mg 1 x daily (n = 134), ADENURIC 240 mg 1 x daily (n =</seg>
<seg id="1213">"data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data. why buy this report? * Get a detailed picture of the Consumer Health market; * Pinpoint growth sectors and identify factors driving change; * Understand the competitive environment, the market's major players and leading brands;"</seg>
<seg id="1214">"results appear ordered" "by relevance" "or" "by date" "(publication date),"</seg>
<seg id="1215">"patients with Serum creatine values &gt; 1.5 and ≤ 2.0 mg / dl) or 300 mg 1 x daily (n = 509), were produced for analyses. * p &lt; 0.001 | Allopurinol, # p &lt; 0,001-80 mg"</seg>
<seg id="1216">"the reduction of the Serum harnectsiegels to &lt; 6,0 mg / dl (357 µMol / l) was retained at a week 2 observed and permanently over the entire treatment."</seg>
<seg id="1217">"509 patients participated, Allopurinol 300 mg 1 x daily; 10 patients with Serum creatine &gt; 1.5 and &lt; 2.0 mg / dl did 100 mg 1 x daily."</seg>
<seg id="1218">"in the subgroup of patients with kidney function, the effectiveness of the APEX study examined the effectiveness of 40 patients with kidney function."</seg>
<seg id="1219">"with ADENURIC, the primary energy point at 44% (80 mg 1 x daily), 45% (240 mg 1 x daily) and 60% (240 mg 1 x daily) of the patient."</seg>
<seg id="1220">"there were no clinically significant differences in accordance with the percentage of the Serum hardening concentration in subjects, despite their kidney function (58% in the group with severe kidney function and 55% in the group with severe kidney function)."</seg>
<seg id="1221">"in the group of patients with Serum harnacid secretion ≥ 10 mg / dl Etwa 40% of patients (APEX- and FACT study) had been taken into study at the beginning of the beginning (baseline), a Serum capsules of ≥ 10 mg / dl."</seg>
<seg id="1222">"in two years, the term data of the Phase 3 showed that the permanent decrease in the phase 3 showed that less than 3% of patients in the months 16-24 / dl (&lt; 357 µMol / l) a decrease in the months of 16-24 patients."</seg>
<seg id="1223">"this was associated with a reduction of gypsum ratio, which was associated with 54% of the patients a complete disappearance of the summit until the month of 24."</seg>
<seg id="1224">"higher TSH- values (&gt; 5.5 µIE / ml) were observed in patients who received a long term treatment with cancer patients (5.8%) in the open-term long term studies (see section 4.4)."</seg>
<seg id="1225">"at healthy subjects, the maximum plasma concentrations (CMAx) and the surface under the plasma concentrations (CMAx) and the surface under the plasma concentrations of 10 mg up to 120 mg doscope."</seg>
<seg id="1226">"results appear ordered" "by relevance" "or" "by date" "(publication date),"</seg>
<seg id="1227">"after taking a simple or multipler cans of 80 and 120 mg 1 x every day, the CMAx approximately 2.8-3,2 µg / ml and 5.0-5,3 µg / ml."</seg>
<seg id="1228">"however, there was no clinically significant change in the percentage of the serum concentrations of the Serum hardening concentration, if this was tested (multiple cans of 80 mg)."</seg>
<seg id="1229">"at the same time, the distribution of a total of 10-300 mg (Vss / F) is in the area of 29 to 75 l in the area of 29 to 75 l."</seg>
<seg id="1230">"sorry, there is no translation for this news-article."</seg>
<seg id="1231">"in vitro studies at human liver microsomen showed that these antioxidant metabolites are mainly used by CYP1A1, CYP2C8 or CYP2C9 or CYP2C9 or CYP2C9 or CYP2C9 or CYP2C9 or CYP2C9 or CYP2C9 or CYP2C9 or CYP2C9 or CYP2C9 or CYP2C9 or CYP2C9 or CYP2C9 or CYP2C9 or CYP2C9 or CYP2C9 or CYP2C9 or CYP2C9 or CYP2C9 or CYP2C9 or CYP2C9 or CYP2C9 or CYP2C9 or CYP2C9 or CYP2C9 or CYP2C9 or CYP2C9 or CYP2C9 or CYP2C9 or CYP2C9 or CYP2C9</seg>
<seg id="1232">"after taking a 80 mg dose from 14C to the dose, about 49% of the dose of the urine (30%), its well-oxidative metabolites and its conjugate (13%) as well as further unknown metabolites (3%)."</seg>
<seg id="1233">"in addition to the urgency of the urine, about 45% of the dose in the chair referred to (12%), its well-oxidative metabolites and their conjugate (25%) as well as further unknown metabolites (7%)."</seg>
<seg id="1234">"in patients with light, medium and severe kidney disease, the CMAx is not in patients with light, medium or severe kidney failure, the CMAx of Marijuana uxostat is not included in the relationship with normal kidney function."</seg>
<seg id="1235">The middle of the AUC-AUC-AUTH / ml in the group with normal kidney function on 13.2 Lug Becker h / ml in the group with severe kidney function.</seg>
<seg id="1236">"the CMAx and AUC does not significantly improve the CMAx and AUC in patients with light (Child- Pugh-classification A) or medium-heavier (Child-Pugh-classification A) or medium-heavier (Child-Pugh-classification A) or medium-heavier (Child-Pugh-classification A) or medium-heavier (Child-Pugh-classification A) or medium-heavier (Child-Pugh-classification A) or medium-heavier (Child-Pugh-classification A) or medium-heavier (Child-Pugh-classification A) or medium-heavier (Child-Pugh-classification A) or medium-heavier (Child-Pugh-classification A) or medium-heavier (Child-Pugh-classification A) or medium-heavier (Child-Pugh-classification A) or medium-heavier (Child-Pugh-classification A) or medium-heavier (Child-Pugh-classification A) or medium-heavier (Child-Pugh-classification A) or medium-heavier (Child-Pugh-classification A) or medium-heavier (Child-Pugh-classification A) or medium</seg>
<seg id="1237">"data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data. why buy this report? * Get a detailed picture of the Baby Food market; * Pinpoint growth sectors and identify factors driving change; * Understand the competitive environment, the market's major players and leading brands;"</seg>
<seg id="1238">"carcinogen, mutagen, impairment of the Fertility and carcinoma was a statistically significant increase of urinary tract. in connection with Xanthin-stones, with Xanthin-stones in the highly-doves-treated group, with about 11 times of exposure in humans."</seg>
<seg id="1239">"this paper investigates the impact of non-take-up for two hypothetical scenarios, namely increasing and decreasing the base amount of social assistance in Germany by €100 per month. IAB-Discussion Paper 20 / 2015"</seg>
<seg id="1240">It was found that the uxostat at orussian cans of up to 48 mg / kg / day no effect on the Fertility and Reproductive capacity of male and female rats.</seg>
<seg id="1241">"at high doses, which were about 4,3- of the humanoid-position authorities, who went with a reduction of orders and a development delay on the descendants of rats."</seg>
<seg id="1242">Teratological studies in traverse rats with Expositions which about the 4,3 times and in traverse rabbits with Expositions which set about the 13 times of human therapeutic dosage.</seg>
<seg id="1243">Colchicin / Indometacin / Hydrochlorine garnet can be applied together with Colchicin or Indometacin or indometacin or indometacin or at the same other active ingredient.</seg>
<seg id="1244">"* * In the clinical trials have been treated with colchicin treated. * * In the clinical trials were no serious infection, or severe irritation."</seg>
<seg id="1245">"21 Open-long term studies in the open-term studies, 906 patients up to 1 year long, 57 patients up to 3 years and 53 patients up to 4 years, and 53 patients up to 4 years and 53 mg / 120 mg."</seg>
<seg id="1246">"the primary energy point was in every study of the share of the patients, where the last three monthly Serum harnectstheses &lt; 6,0 mg / dl (357 µMol / l)."</seg>
<seg id="1247">"in two years, the term data of the Phase 3 showed that the permanent decrease in the phase 3 showed that less than 3% of patients in the months 16-24 / dl (&lt; 357 µMol / l) a decrease in the months of 16-24 patients."</seg>
<seg id="1248">"data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data. why buy this report? * Get a detailed picture of the Consumer Health market; * Pinpoint growth sectors and identify factors driving change; * Understand the competitive environment, the market's major players and leading brands;"</seg>
<seg id="1249">"* Understand the competitive environment, the market's major players and leading brands; * Use five-year forecasts to assess how the market is predicted to develop."</seg>
<seg id="1250">"carcinogen, mutagen, impairment of the Fertility and carcinoma was a statistically significant increase of urinary tract. in connection with Xanthin-stones, with Xanthin-stones in the highly-doves-treated group, with about 11 times of exposure in humans."</seg>
<seg id="1251">"the owner of the approval of the applicant has been described, that a pharmaceutical kovic-system like in version 2.0 module 1.8.1 of the approval entry is described before the drug will be brought to the transport in the traffic, and so long it is available as the medicine in the traffic."</seg>
<seg id="1252">"according to CHMP Guideline, the CHMP Guideline has to be submitted to the risk management systems for Humanizers with the next periodic Safety update Report (PSR)."</seg>
<seg id="1253">"in addition, an update of the RMP is required • if new information will have a influence on the safety of safety purposes, pharmaceutical manufacturers or activities at risk of risk (pharmaceutical agents or risk inimpregnation) • on request of EMEA."</seg>
<seg id="1254">"in some people, the urinary acid in blood and can reach concentrations that is so high that urinary acid is unsoluble."</seg>
<seg id="1255">"when using the urinary concentration of ADENURIC low, the crystalline is prevented and thus reached this way with the time."</seg>
<seg id="1256">ADENURIC may not be taken into account if you are oversensitive (allergic) against the active drug users and one of the other parts of ADENURIC.</seg>
<seg id="1257">"please inform your doctor before you start using the use of this medication, if you suffer a heart disease or the Lesch-Nyhan syndroms (a rare congenital disorder, which is located at a much urinary acid in the blood)."</seg>
<seg id="1258">"when you start at the moment a plaster case (sudden appearance of heavy pain, pressure sensitivity, valve, heat and articulation), wait until the treatment with ADENURIC will begin with ADENURIC."</seg>
<seg id="1259">"this must not be done with each other, but in particular during the first treatment weeks or - monate, if you are taking ADENURIC."</seg>
<seg id="1260">Your doctor will write you if needed other medicines to treat a gypsy case or to treat the symptoms (such as pain and articulation).</seg>
<seg id="1261">Please inform your doctor or pharmacist if you are allowed to use other medicines / apply or apply if there are no prescription drugs.</seg>
<seg id="1262">It is particularly important that you use your doctor or pharmacist if you are taking medication if you are taking medication (for treatment of cancer) • Theophyllin (for treatment of asthma) • Theophyllin (for treatment of asthma) • Theophyllin (for treatment of asthma) • Theophyllin (for treatment of asthma) • Theophyllin (for treatment of asthma) • Theophyllin (for treatment of asthma) • Theophyllin (for treatment of asthma) • Theophyllin (for treatment of asthma) • Theophyllin (for treatment of asthma) • Theophyllin (for treatment of asthma) • Theophyllin (for treatment of asthma) • Theophyllin (for treatment of asthma) • Theophyllin (for treatment of asthma) • Theophyllin (for treatment of asthma) • Theophyllin (for treatment of asthma) • Theophyllin (for treatment of asthma) • Theophyllin (for treatment of asthma) • Theophyllin (for treatment of asthma) • Theophyllin (for treatment of asthma) • Theophyllin (for treatment of asthma) • Theophyllin (for treatment of asthma) • Theophyllin (for treatment of as</seg>
<seg id="1263">There are no studies on the effects of ADENURIC on the transport and ability to serve machines.</seg>
<seg id="1264">Please take ADENURIC therefore only after consultation with your doctor if you are familiar with your doctor.</seg>
<seg id="1265">"on the back of Blister packaging, the single weekends are printed, so you can check whether you have taken a tablet. • The tablets must be trained and can be taken with or without food."</seg>
<seg id="1266">"if you are experiencing an overdose, contact your doctor or to the staff of the nearest hospital in the hospital."</seg>
<seg id="1267">You have to be logged in to write a review.</seg>
<seg id="1268">"if you are taking the use of ADENURIC, your urinary concentration can be returned again and your complaints can be removed, because the new uratballs can form your joints and kidneys as well as their environment."</seg>
<seg id="1269">"frequent side effects (more than 1 of 100 treatment), but less than 1 of 10 treatment): • Proposing liver testament • leakage • Acid extract • nausea of nausea"</seg>
<seg id="1270">"a rare side effects (more than 1 of 10,000 treatment), but less than 1 of 1,000 treatment): • weakness • nervousness • Durability • Duration of heart rate"</seg>
<seg id="1271">Please inform your doctor or pharmacist if one of the listed side effects may be affected or side effects that are not indicated in this use.</seg>
<seg id="1272">ADENURIC is available in 2 Blister with each 14 tablets (pack with 28 tablets) or in 6 Blister packaging with per 14 tablets (pack with 84 tablets).</seg>
<seg id="1273">"suppliers of machinery, equipment and materials"</seg>
<seg id="1274">"if you want to send us a question about this product, simply complete all the fields marked * and click" "Send". ""</seg>
<seg id="1275">ADROVANCE is used for treating osteoporosis (a disease) in women after menopause.</seg>
<seg id="1276">"the patient must take the tablet with a full glass of water (no mineral water) at least 30 minutes before food, drinking or drinking other medicines (including antazida, calcium and Vitaminsupplements)."</seg>
<seg id="1277">"in order to avoid an irritation of the spokes, the patient should be made up to the first food intake of the day, the early 30 minutes after taking the tablet should not hinder."</seg>
<seg id="1278">"as Alendronate and vitamin D3 already used separately in medicine, the company has been approved in the European Union, the company data from previous studies and published literature."</seg>
<seg id="1279">The company led to a study with 35 men and 682 postmenopausal women with osteoporosis through to increase the effectiveness of ADROVANCE to increase the effectiveness of ADROVANCE.</seg>
<seg id="1280">"after a 15-week treatment, the proportion of patients with low vitamin D mirror were treated with low vitamin D mirror, low (11%) than those who participated in the ADROVANCE (32%)."</seg>
<seg id="1281">Firm of the Year for Insolvency Administration Schneider Geiwitz & Partner Firm of the Year for Tax Gleiss Lutz</seg>
<seg id="1282">"the most commonly used side effects (observed in 1 to 10 of 100 patients) are headache, pain or joints and symptoms of diarrhoea, dye (diarrhoea), diarrhoea (diarrhoea), diarrhoea (diarrhoea), coagility (tipping), straightenant (tilt), straightenant (tidy stomach) and acid-up."</seg>
<seg id="1283">"in patients with etwaiter sensitivity, vitamin D3 or one of the other components may not be applied to ADROVANCE."</seg>
<seg id="1284">"in patients with hypocalcemia, patients with hypocalcemia (low calcialdehyde) or patients who are not at least 30 minutes long."</seg>
<seg id="1285">"January 2007, the European Commission for the Company Merck Truck & Dohe Ltd. is an approval for the company by ADROVANCE in the entire European Union."</seg>
<seg id="1286">"capsule with white or broken white tablets, characterized by the cut of a bone on the one side and" "710" on the other side. "</seg>
<seg id="1287">"ADROVANCE is only with water (not with mineral water) at least 30 minutes before the first food, drink or intoxication (including antazida, calcium and Vitaminine supplements) for the day."</seg>
<seg id="1288">The following hints are exactly to follow to reduce the risk of malophageal friction and associated side effects (see paragraph 4.4):</seg>
<seg id="1289">"• ADROVANCE, according to the requirements of the day, only with a full glass of water (at least 200 ml). • The patient should not leave the tablet or tablet in the mouth, as a risk of oropharyngeale Ulzera. • The patient should not go before the first food intake of the day, the early 30 minutes after taking the tablet."</seg>
<seg id="1290">"B. Parker Sonata, active gastrointestinal disorders or surgical intervention in the upper gastrointestinal disorders, except Pyloroplastics, only under special circumstances (see paragraph 4.3)."</seg>
<seg id="1291">"what is the difference between science and practice? what is the difference between science and practice?" ""</seg>
<seg id="1292">The doctor should therefore look forward to all the signs and symptoms that should be aware of symptoms of symptoms of symptoms of symptoms of symptoms.</seg>
<seg id="1293">"3 The risk of serious trouble-side effects seems to be increased to patients who are not able to use the medicine, or after the occurrence of symptoms that are on a malophageal irritation."</seg>
<seg id="1294">It is very important that all dosing procedures will be passed to the patient and should be understood by the patient (see paragraph 4.2).</seg>
<seg id="1295">"during large-scale clinical trials with Alendronat no increased risk was found, rare (by market) Magura and Duodenalulzera, including some serious issues and complications, reported (see section 4.8)."</seg>
<seg id="1296">"Osteonekson of Kiefers, usually in connection with a tooth-attraction and / or a local infection (including Osteomyelitis), was used for intravenomination."</seg>
<seg id="1297">"there are no data available to provide information, whether the Abuse of bisphenonic therapy for patients who require a lower surgical procedure, the risk of a osteonectic infection is reduced."</seg>
<seg id="1298">"results appear ordered" "by relevance" "or" "by date" "(publication date),"</seg>
<seg id="1299">"patients should take care of the treatment of a dose of ADROVANCE, the tablet at the next morning, after they have noticed it."</seg>
<seg id="1300">"they should not take two tablets at the same day, but the consumption of a tablet per week as originally planned during the period of time."</seg>
<seg id="1301">Other illnesses associated with mineral oil change (such as vitamin D lack and hypoparathyreoidiol) should be treated before the start of the treatment with ADROVANCE.</seg>
<seg id="1302">"Alendronate food and drinks (including mineral water), calcium supplements, antazida and some orale drug may be taken for the same time when they are taken at the same time."</seg>
<seg id="1303">"therefore, patients have to wait at least 30 minutes before they are taking other medicines (see Abbrevi4.2 and 5.2)."</seg>
<seg id="1304">"although specific interaction studies have not been performed, Alendronat clinical trials were taken together with a variety of usually-based medicines, without that clinically relevant interruptions."</seg>
<seg id="1305">ADROVANCE is intended only for the application in postmenopausal women and is therefore not used during pregnancy.</seg>
<seg id="1306">Animal studies with Alendronat does not leave any note on the pregnancy, the embryonic / fetal or postnatal development. "</seg>
<seg id="1307">"Osteonekson of Kiefers was reported in patients under Bisphosphonic, most of the reports are from cancer patients, but was also reported to osteoporosis."</seg>
<seg id="1308">"nevertheless, the Serum Calcules up to &lt; 8,0 mg / dl (2,0 mmol / l) and the Serum phosphate until ≤ 2.0 mg / dl (0.65 mmol / l) in both treatment groups with similar frequency."</seg>
<seg id="1309">"Alendronat Instruction of an oral overdosis, Hypocalcemia, hypophosphataemia and side effects in the upper right of Gastrosis, Sodoth, Sodophagitis, Gastritis or Ulzera occur."</seg>
<seg id="1310">Colecalciferol (vitamin D3) Vitamin D3 is produced in the skin by UV light via the conversion from 7-elydroc to vitamin D3.</seg>
<seg id="1311">"the main effect of 1,25-Dihydroxyas D3 is the increasing of the intestinal clature of calcium and phosphate as well as the regulation of Serum calcium, the renal separation of calcium and bone loss."</seg>
<seg id="1312">"in severe cases, a lack of secondary hyperparathyreodics, hypophile, hypophosphate, weakness of proximal musculature and osteomalazy and so on a further increased risk of risk and bone formation in osteoporosis."</seg>
<seg id="1313">"Bone mineral density) on the spine or hip which is 2.5 standard deviation under the middle value for a normal, young population, or despite the bone density of pathological fracture."</seg>
<seg id="1314">"patients received ADROVANCE in the lower strength (70 mg / 2.800 I.E.), (n = 350) or Fosamax (Alendronate) 70 mg once weekly (n = 275); additional Vitamin C supplements were prohibited."</seg>
<seg id="1315">"after 15-weekly treatment, the middle-level mirror of 25-hydroxy9.D significant higher (26%) in the group under ADROVANCE (70%) in the group under Alendronat alone (46 nmol / l [18,2 ng / ml])."</seg>
<seg id="1316">"if you have any questions about this product, simply complete all the fields marked * and click" "Send". ""</seg>
<seg id="1317">Studies with Alendronate The therapeutic dosage of Alendronat once weekly 70 mg (n = 519) and Alendronat 10 mg daily (n = 370) was detected in a one-year study of postmenopausal women with osteoporosis.</seg>
<seg id="1318">The effects of Alendronate on bone mass and fractions in postmenopausal women were investigated in two phase III studies of identical design (n = 944) as well as in the Fraktur Interventional Study (FIT: n = 6.459).</seg>
<seg id="1319">"in the phase III studies the middle anstition of the BMD with Alendronat 10 mg / day in relation to placebo after 3 years 8.8% on the spine, 5.9% on the vertebony and 7,8% on the trochanter."</seg>
<seg id="1320">"compared to the placebo group, compared to the placebo group, a reduction of 48% (Alendronat 3.2% compared to placebo 6,2% compared to placebo."</seg>
<seg id="1321">"in the two-year-extension of these studies, the composition of the BMD of spine and trochanter continues to hold the BMD of feminists and the whole body."</seg>
<seg id="1322">Fit in two separate controlled trials in which Alendronat daily (5 mg daily over 2 years and then 10 mg daily on 1 or 2 years):</seg>
<seg id="1323">"in this study, the daily gift of Alendronate the appearance of at least one new spine fracture at 47% (Alendronat 7,9% compared to placebo 15,0%)."</seg>
<seg id="1324">Resorption coiled to a intravenous reference dose of Alendronate in women 0.64% for cans between 5 and 70 mg of nobility and two hours before recording of a standardised breakfast.</seg>
<seg id="1325">"the bending feet made according to about 0.46% and 0.39%, if Alendronate has been taken over a standardized breakfast before a standardized breakfast."</seg>
<seg id="1326">At least 30 minutes before the first food or drinking of the day was taken for at least 30 minutes before the first food or drinking of the day.</seg>
<seg id="1327">"in healthy subjects, the gift of orderly prednisone (20 mg of three days a day) is not a clinically important change of the orderly bending of Alendronate (increase in the medium from 20% to 44%)."</seg>
<seg id="1328">"9 distribution studies in rats have found that Alendronate was distributed after intravenous gift of 1 mg / kg temporarily withdrawn, but will be distributed quickly into the bones or with the urine."</seg>
<seg id="1329">The intravenous gift of an individual dose of 14C-Alendronate were about 50% of the radioactive substance within 72 hours with the urine and little or no wireless activity was found in the fetching.</seg>
<seg id="1330">After intravenian gift of a single dose of 10 mg was the renal Clearance of Alendronat 71 ml / min and the systemic Clearance was not 200 ml / min.</seg>
<seg id="1331">Alendronat is not responsible for the acid or basal transport system of the kidneys and therefore is not accepted that it is affected by humans interruptions of other medicines from this transport systems.</seg>
<seg id="1332">Resorption of healthy adult subjects (women and men) came to the gift of ADROVANCE according to the gift of ADROVANCE (AUC0-120 h) for vitamin D3 296.4 ng • h / ml (without causing endogenous vitamin-D3 mirror).</seg>
<seg id="1333">The average maximum concentration in the Serum (CMAx) of vitamin D3 was 5.9 ng / ml and the media time up to the maximum Serum concentration (Tmax) 12 hours.</seg>
<seg id="1334">"at the same time, vitamin D3 is much less than 25% hydroxygens in the liver, and then in the Niere to 1.25-Dihydroxytis D3, the bioactive form, metabolic."</seg>
<seg id="1335">"instead of radioactive wastes in the urine of radioactive plant in the urine after 48 hours 2.4%, in the fetching after 4 days 4.2%, in the fetching after 4 days 4.9%."</seg>
<seg id="1336">"conclusions: clinical studies have shown that the share of Alendronate, which is not in the bones, quickly over the urine."</seg>
<seg id="1337">"although no clinical data could be reduced, however, that the renal Elimination of Alendronate as in the animal try to be reduced in patients with reduced kidney function."</seg>
<seg id="1338">"therefore, patients with reduced kidney function is a somewhat elevated sinequation of alendronate in bones (see paragraph 4.2)."</seg>
<seg id="1339">"Alendronat non-clinical data based on conventional studies on conventional studies to safety splasers, for chronic toxicity, for chronic diseases, and arousses no particular danger for people."</seg>
<seg id="1340">Studies on rats showed that the gift of Alendronate was caused by the appearance of Dystokie with the appearance of Dystokie with the appearance of Dystokie that was caused by hypocalcemia.</seg>
<seg id="1341">"calcium hydrochloride cellulose (E 460) Lactose carbon dioxide and magnesium oxide (E 572) butyl hydroxyctoluene (Greifswald Europe), modified (corn) of aluminum natrisilicum (E 554), modified (E 554), modified (E 554)"</seg>
<seg id="1342">Etui with sealed aluminum / aluminum-Blister in cardboard boxes for 2 (1 Etui with 2 tablets), 4 (3 Etuis with 4 tablets), 12 (3 Etuis with 4 tablets) or 40 (10 Etuis with 4 tablets) tablets. "</seg>
<seg id="1343">"if you want to send us a question about this product, simply complete all the fields marked * and click" "Send". ""</seg>
<seg id="1344">"pastel, white or broken white tablets, characterized by the cut of a bone on one side and" 270 "on the other side."</seg>
<seg id="1345">"• The patient should not hinder the use of ADROVANCE at least 30 minutes. • ADROVANCE should not be taken before the sleep, or before the first name of the day."</seg>
<seg id="1346">The risk of serious trouble-side effects seems to be increased to patients who are not able to use the medicine and / or after the occurrence of symptoms that are on a malophageal irritation.</seg>
<seg id="1347">"during large-scale clinical trials with Alendronat no increased risk was found, rare (by market) Magura and Duodenalulzera, including some serious issues and complications, reported (see section 4.8)."</seg>
<seg id="1348">18 Colecalciferol (vitamin D3) Vitamin D3 is produced in the skin by UV light via the conversion of 7-elyrel to vitamin D3.</seg>
<seg id="1349">"patients received ADROVANCE in the lower strength (70 mg / 2.800 I.E.), (n = 350) or Fosamax (Alendronate) 70 mg once weekly (n = 275); additional Vitamin C supplements were prohibited."</seg>
<seg id="1350">"vitamin D3 (the quantity of vitamin D3 in the higher dose of ADROVANCE) once weekly, was shown in a 24-week study with 619 postmenopausal women with osteoporosis."</seg>
<seg id="1351">"after 24-weekly treatment, the middle-level mirror of 25-hydroxy9.D significant higher in the 5.600-I.E.-Vitamin-D3 group (64 nmol / l [...]) as in the 2.800-I.E.-Vitamin-D3-Group (64 nmol / l [25.5 ng / ml])."</seg>
<seg id="1352">There was no statistically significant difference between the treatment groups at the end of the patient with Hypercalciurie at the end of the 24-week extension.</seg>
<seg id="1353">"3,1% on the entire hip in the group with 70 mg once weekly or in the group of 10 mg daily."</seg>
<seg id="1354">"in this study, the daily gift of Alendronate the appearance of at least one new spine fracture at 47% (Alendronat 7,9% compared to placebo 15,0%)."</seg>
<seg id="1355">"the bending feet took place according to about 0.46% and 0.39%, if Alendronate one or half an hour before a standardized breakfast."</seg>
<seg id="1356">"distribution studies in rats have found that Alendronate is distributed according to intravenian gift of 1 mg / kg temporary, but will be distributed quickly into the bones or with the urine."</seg>
<seg id="1357">Resorption of healthy adult subjects (women and men) came to the gift of ADROVANCE (70 mg / 5.600 I.E.) for vitamin D3 490.2 ng • h / ml (without causing endogenous vitamin-D3 mirror).</seg>
<seg id="1358">The average maximum concentration in the Serum (CMAx) of vitamin D3 was 12.2 ng / ml and the media time until the maximum Serum concentration (Tmax) 10.6 hours.</seg>
<seg id="1359">Smaller quantities are stored in fat and muscle tissue and are stored as vitamin D3 to be used later in the cycle.</seg>
<seg id="1360">"if you want to send us a question about this product, simply complete all the fields marked * and click" "Send". ""</seg>
<seg id="1361">There were no translations available on a saturation of accumulated intraocular infections up to 35 mg / kg in animals.</seg>
<seg id="1362">Etui with sealed aluminum / aluminum tray in cardboard boxes for 2 (1 Etui with 2 tablets) and 12 (3 Etuis with 4 tablets) or 40 (10 Etuis with 4 tablets) tablets.</seg>
<seg id="1363">Firm of the Year for Insolvency Administration Schneider Geiwitz & Partner Firm of the Year for Tax Gleiss Lutz</seg>
<seg id="1364">"risk management plan (RMP) and its relevant updates to the pharmaceutical industry (RMP) and its corresponding updates according to version 1 module 1.8.2 of approval documents are described in detail."</seg>
<seg id="1365">"according to CHMP Guideline, the CHMP Guideline has to be submitted to the risk management systems for human beings with the next periodic Saftey update (PSR)."</seg>
<seg id="1366">"in addition, an update of the RMP required - if new information will have a influence on the safety of safety purposes, pharmaceutical agents, or risk of risk of risk (pharmaceutical agents or risk inimitation) - on request of EMEA."</seg>
<seg id="1367">"take a ADROVANCE tablet as well as before the first food and drinking, taking any other medicine by taking the tablet with a full glass of water (not with mineral water)."</seg>
<seg id="1368">"perhaps you would like to read this later. • If you have any questions, please contact your doctor or pharmacist. • This paper has been added to you personally."</seg>
<seg id="1369">"in the exchange years, ovaries do not have a female hormones, estrogen, more that help to get up to women with women."</seg>
<seg id="1370">"there are usually no pain in the hip, the spine or wrist and can not only pain but also considerable problems such as preventive stance (" wiwenbuck ") and a loss of movement."</seg>
<seg id="1371">"ADROVANCE prevents the loss of bone mass, but also contributes to reduce bone loss."</seg>
<seg id="1372">"if your doctor is not possible, it is not possible to sit at least 30 minutes or stand (4) if your doctor is found that your calcium content in blood is lower."</seg>
<seg id="1373">"40 • If you have problems when you have problems when you have problems when you have cancer, if you have cancer, • If you have a chemotherapy or radiotherapy - if you have a chemotherapy or radiotherapy - if you don't have a chemotherapy treatment or radiation."</seg>
<seg id="1374">"these complaints may occur in particular, if the patient's ADROVANCE tablet does not use with a full glass of water and / or from the beginning of 30 minutes."</seg>
<seg id="1375">"for the use of ADROVANCE in other medicines, antazida and some other medicines to produce the efficacy of ADROVANCE."</seg>
<seg id="1376">"if you are already our customer, please log in using your e-mail address and your password.:"</seg>
<seg id="1377">Please inform your doctor or pharmacist if you use other medicines / use or use other medicines / apply if it is not liable to prescription drugs.</seg>
<seg id="1378">Please take this medicine only after consultation with your doctor if you are familiar with your doctor.</seg>
<seg id="1379">Please follow the note 2) to facilitate the transportation of ADROVANCE tablet into the stomach and to reduce the costs of the ADROVANCE tablet into the stomach (Ösophagus - the water that connects your mouth with the stomach).</seg>
<seg id="1380">• Not available with mineral water (with or without carbon dioxide). • Not with mineral water (with or without carbon dioxide). • Not with mineral water (with or without carbon dioxide). • Non-mineral water (with or without carbon dioxide). • Not with juice or milk.</seg>
<seg id="1381">(3) Legen do not stay away - stay fully equipped (sitting in sitting or walk) - at least 30 minutes long after taking the tablet.</seg>
<seg id="1382">"(5) If you have difficulty or pain at the end, pain behind the chest, pain behind the chest, reluctantly, set up ADROVANCE and search your doctor."</seg>
<seg id="1383">"(6) Warning after the end of your ADROVANCE tablet at least 30 minutes before you take your first food, drinks or other medicines such as Antazida (magidicular drug), calcium or Vitaminamide on this day."</seg>
<seg id="1384">"if you have accidentally checked to many tablets at once, drink a full glass milk and contact your doctor immediately."</seg>
<seg id="1385">"if you have a tablet on the next morning, take a tablet at the next morning, after you have noticed you."</seg>
<seg id="1386">"at the end of the day, the pain in the chest, the pain in the chest, the pain in the chest, the pain in the chest, the pain in the chest, the pain in the chest, the pain and / or joint pain, the pain in the chest, the pain and / or joint pain,"</seg>
<seg id="1387">"occasionally: - nausea, vomiting, • irritations and inflammation of the spokes (Ösophagus) or the stomach (Ösophagus) or the stomach."</seg>
<seg id="1388">"after launch the following side effects (frequency of not known): • (revolutions not known): • (rotation -), the articulation, the joint problems (Osteoneked) in conjunction with delayed wound healing and infections, often after pulling out of teeth, • swellings on hands or legs."</seg>
<seg id="1389">"43 Dabei is helpful, if you have to consider which complaints you had started, and how long it took it."</seg>
<seg id="1390">"the other components are microcrystine cellulose (E 460), Lactose, chromium-sodium chloride, magnesium hydroxyctoluene (Greifswald Euron.) (E 572), Butyl hydroxytoluol (E 554), Butyl hydroxylool (E 554), Butyl hydroxylool (E 554)."</seg>
<seg id="1391">The tablets stand at Etuis with sealed aluminum / aluminum-Blister packaging) • 6 tablets (1 Etui with 4 tablets in aluminium-Blister) • 12 tablets (3 Etuis with 4 tablets in aluminium-Blister) • 12 tablets (10 Etuis with 4 tablets in aluminium-Blister) • 12 tablets (10 Etuis with 4 tablets in aluminium-Blister) • 12 tablets (10 Etuis with 4 tablets in aluminium-Blister) • 12 tablets (10 Etuis with 4 tablets in aluminium-Blister) • 12 tablets (10 Etuis with 4 tablets in aluminium-Blister) • 12 tablets (10 Etuis with 4 tablets in aluminium-Blister) • 12 tablets (10 Etuis with 4 tablets in aluminium-Blister) • 12 tablets (10 Etuis with 4 tablets in aluminium-Blister) • 12 tablets (10 Etuis with 4 tablets in aluminium-Blister) • 12 tablets (10 Etuis with 4 tablets in aluminium-Blister) • 12 tablets (10 Etuis with 4 tablets in aluminium-Blister) • 12 tablets (10 Etuis with 4 tablets in aluminium-Blister) • 12 tablets (10 Etuis with 4 tablets in aluminium-Blister) • 12 tablets (10 Etuis with 4 tablets in aluminium-Blister) • 12 tablets (10 Etuis with 4 tablets in aluminium-Blister) • 12 tablets (10 Etuis with 4 tablets in aluminium-Blister) • 12 tablets (10 Etuis with 4 tablets in aluminium-Blister) • 12 tablets (10 Etuis with 4 tablets in aluminium-Blister) • 12 tablets (10 Etuis with 4 tablets in aluminium-Blister) • 12 tablets (10 Etuis with 4 tablets in aluminium-Blister) • 12 tablets (10</seg>
<seg id="1392">"in the exchange years, ovaries do not have a female hormones, estrogen, more that help to get up to women with women."</seg>
<seg id="1393">"48 • If you have allergies, if you have problems when you have problems when you have problems when you have cancer, • If you have a chemotherapy or radiotherapy - if you have a chemotherapy or radiotherapy - if you have a chemotherapy or radiotherapy - if you don't have a chemotherapy treatment or radiation."</seg>
<seg id="1394">"for the use of ADROVANCE in other medicines, antazida and some other medicines to produce the efficacy of ADROVANCE."</seg>
<seg id="1395">• Not available with mineral water (with or without carbon dioxide). • Non-mineral water (with or without carbon dioxide). • Not with mineral water (with or without carbon dioxide). • Non-mineral water (with or without carbon dioxide). • Not with juice or milk.</seg>
<seg id="1396">"3) Legen do not stay away - stay fully charged (in seats, sitting or walk) - at least 30 minutes long after taking the tablet."</seg>
<seg id="1397">"5) If you have difficulties or pain in pain, pain behind the chest, pain behind the chest, reluctant or worsening the sodburn, use ADROVANCE and search your doctor."</seg>
<seg id="1398">"6) Warning after the end of your ADROVANCE tablet at least 30 minutes before you take your first food, drinks or other medicines such as Antazida (magidicular drug), calcium or Vitaminamide on this day."</seg>
<seg id="1399">"• (rotation -) digestibility, the articulation, • fatigue problems (Osteoneked) in conjunction with delayed wound healing and infections, often after pulling out of teeth, • swellings on hands or legs."</seg>
<seg id="1400">"tablets are available as rectangular, white and broken white tablets, characterized by the cut of a bone on one side and" 270 "on the other side."</seg>
<seg id="1401">Advance is a adult or liver transplant in order to prevent the transplantation of the transplantation through the immune system.</seg>
<seg id="1402">"as Tacrolimus and Prograf / prograft already used in the EU, the company has published the results from before studies with Prograf / prograft as well as data from published literature."</seg>
<seg id="1403">"furthermore, the results of a clinical study conducted in 668 patients with kidney transplant and prograf / prograft / prograft."</seg>
<seg id="1404">Main indicator of the efficacy of the effectiveness was the number of patients with which caused the transplant after treatment of a year (by example, as often a renewed organ transplantation or a recovery of dialysis.). "</seg>
<seg id="1405">"in addition, shorter further studies on 119 patients with liver transplant and 129 patients with liver transplant and 129 patients with liver transplant is investigated."</seg>
<seg id="1406">"* * * * Sorry, this property owner doesn't provide a description in english..."</seg>
<seg id="1407">"patients with chronic sensitivity (cold) against Tacrolimus, macro level antibiotics (such as Erythromycin) or one of other parts may not be applied."</seg>
<seg id="1408">"patients and doctors must be careful if other (especially some herbal) medication, as the Advagraf dose or dose of the same time has to be adjusted accordingly."</seg>
<seg id="1409">"tungsten yellow orange, retarded Yellow-orange Gelatine arms, printed in red ink on the dark yellow capsule position with" "647" "; they contain white powder."</seg>
<seg id="1410">Only doctors that are able to treat cancer therapy and treatment of transplantation cancer should be used to treat this medication or changes in our treatments.</seg>
<seg id="1411">"due to clinically relevant differences in the systemic exposure of Tacrolimus, this can lead to transplantation or an increased amount of side effects, including sub-or overweight."</seg>
<seg id="1412">Patients should always keep the same Tacrolimus formulation and the corresponding daily dosage of the formulation of a transplantation of a transplant of experienced medicine (see Abbreviation 4.4 and 4.8).</seg>
<seg id="1413">"results appear ordered" "by relevance" "or" "by date" "(publication date),"</seg>
<seg id="1414">"the dosage of Advance should be primarily based on clinical assessment of abbreviation and interferences in individual cases and to blood clauses (see below)."</seg>
<seg id="1415">"according to Prograf, the Tacrolimus Talking should be controlled and controlled via two weeks."</seg>
<seg id="1416">"on day 4, systemic Exposition, measured as a valley with both formulations, both with both formulations and transplanted patients."</seg>
<seg id="1417">Careful and repeated controls of the Tacrolimus-Talking are recommended during the first two weeks after transplant under the first two weeks after transplant transplant.</seg>
<seg id="1418">Since Tacrolimus is a substance with low Clearance is a adaptation of the Advance Dosisschas several days until the steady State is reached.</seg>
<seg id="1419">"in case of patients in the first post-operative phase, the Tacrolimus treatment of intravenous (Prograf 5 mg / ml concept for production of an infusion solution) will be introduced with a dose of ca."</seg>
<seg id="1420">"duration of application The suppression of the transplantation, the immune system must not be stated, therefore a maximum duration of orally therapy is not indicated."</seg>
<seg id="1421">"for more information, please search for your company name with the function below. when your company is not yet listed, you need to add the vat of 19%. shipping to a german destination is7 euros. [...]"</seg>
<seg id="1422">Further demigation can be found later as the pharmacokinetics of Tacrolimus in the course of the patient according to the transplantation.</seg>
<seg id="1423">Dosisrecommendations - liver transplant prophylaxis of transplant therapy should begin with 0.10 - 0.20 mg / kg / day as a daily gift on the morning.</seg>
<seg id="1424">Dosisrecommended by Prograf is a transplantation of prograf capsules on a daily basis of Advgraf capsules on a daily basis of the ratio 1: 1 (mg: mg) to be done to the whole day of daily dose.</seg>
<seg id="1425">Kidney and liver transplantation is one of the best results in cardiovascular and liver transplant recommended for the prophylaxis of the transplantation of the transplant.</seg>
<seg id="1426">Heart transplantation of adult patients treated to Advance is an orale Initialdosis of 0.15 mg / kg / day daily.</seg>
<seg id="1427">Other transplantations do not have clinical experience with Advance in lung cancer in a oral initialdosis of 0.10 - 0.15 mg / kg / day and at the intestinal transplantation of 0.3 mg / kg / day and in the intestinal transplantation of 0.3 mg / kg / day.</seg>
<seg id="1428">The patients with severe liver dysfunction in particular patients with reduced liver dysfunction can be necessary in patients with severe liver dysfunction in patients with severe liver dysfunction.</seg>
<seg id="1429">Patients with reduced kidney function as the kidney function has no influence on the pharmacokinetics of Tacrolimus which is not necessary.</seg>
<seg id="1430">"due to the nephrotoxical potential as of Tacrolimus, however, a careful monitoring of kidney function (including a regular determination of the seratincontinous nuclear power and monitoring of the urea) recommended."</seg>
<seg id="1431">Adjustment of Ciclosporin on Advance on a Tacrolimus-based therapy (see Abbreviation 4.4 and 4.5).</seg>
<seg id="1432">Recommendations are based on the control panel in the full-blut The dose should be observed in the clinical assessment of abbreviation and compatibility in the individual cases under supervision of the Full-Tacrolimus-Talking controls.</seg>
<seg id="1433">It is recommended frequent exchange of Tacrolimus valley. during the first two weeks after transplantation, followed by periodic controls during the conservation therapy. "</seg>
<seg id="1434">Blood-Talents of Tacrolimus should also be controlled according to Prograf on Advance of substances which may change the Tacrolimus-full concentration of substances that may be controlled (see paragraph 4.5).</seg>
<seg id="1435">"since Advance was a medicine with a low Clearance, you may need for the dose of several days until the Steady State began."</seg>
<seg id="1436">"the data in clinical trials can make sure that a successful treatment in most cases is possible if the valley level in blood 20 ng / ml not exceed."</seg>
<seg id="1437">"in the first time after liver transplant in the first time after liver transplantations in the first time after liver transplantations in the first time after liver transplantations, in the area of 5 - 20 ng / ml and heart transplanted patients at 10 - 20 ng / ml."</seg>
<seg id="1438">"during the recoloration therapy of liver, kidney and heart transplant were used in the area of 5 - 15 ng / ml."</seg>
<seg id="1439">This has led to serious unwanted events including transplantation or other side effects which can occur in a result of Tacrolimus sub- or overweight.</seg>
<seg id="1440">Patients should always keep the same Tacrolimus formulation and the corresponding daily dosage of the formulation of a transplant of experienced medicine (see Abbreviation 4.2 and 4.8).</seg>
<seg id="1441">"5 For treatment adult patients with transplantation, which proved insufficient to other immunity, there are no clinical data for the retarding development."</seg>
<seg id="1442">"to prophylaxis of the transplantation in adult heart transplant and transplantation in children, there are no clinical data for retarding the formulation of the disease."</seg>
<seg id="1443">"due to possible interactions that may lead to a disaster of Tacrolimus in blood and a weakening of the clinical effects of Tacrolimus, the vegetable preparations (Hypericum perforatum) is included, or other plant cultivation during a treatment with Advances (see paragraph 4.5)."</seg>
<seg id="1444">"patients with Diarrhö is a particularly careful monitoring of the Tacrolimus- concentrations in blood, since the Tacrolimus blood flow was under such circumstances."</seg>
<seg id="1445">"in rare cases, a Kardiomyopathy was used as a Kardiomyopathy chamber or hypertension."</seg>
<seg id="1446">"other factors which increase the risk of such clinical disorders are already existing heart disease, a treatment with cortitigoids, high blood pressure, kidney or liver dysfunction, infections, liquid and oil."</seg>
<seg id="1447">"as with other immunity siva, the effect of solar light or UV light because of possible risk malignant skin changes due to appropriate clothing or use of a sun protection thanks to a high degree of protection."</seg>
<seg id="1448">"if patients suffering from Tacrolimus symptoms, symptoms for pres like headache, altered levels of consciousness, cranes and tendons, should be a radiological examination."</seg>
<seg id="1449">"due to patients with rare editary scactose intolerance, Lactase-lack of gluten intolerance, Lactase-lack or glucose-malactose collage."</seg>
<seg id="1450">The simultaneous application of medication or herbal medicinal plants used as inhibitor or inductors by CYP3A4 is known to increase the metabolism of Tacrolimus and consequently reduce blood values of Tacrolimus or lower the blood values of Tacrolimus.</seg>
<seg id="1451">"it is recommended to monitor the Tacrolimine - blood mirror with simultaneous translation of substances that may change the CYP3A metabolism, to monitor and the Tacrolimus dose to maintenance, and the Tacrolimus dose can be adjusted accordingly (see Abbreviation 4.2 and 4.4)."</seg>
<seg id="1452">"a highly concentrated solution, such as Ketoconazol, Fluconazol and Voriconazol and Voriconazol as well as with the following male antibiotic Aciythromycin and HIV proteins (z)."</seg>
<seg id="1453">Pharmacokinetic studies that the rise of blood mirror mainly caused by the elevated bending of Tacrolimus caused by the inhibiting of gastrointestinal disorders.</seg>
<seg id="1454">The concentration of Tacrolimus can increase the concentration of Tacrolimus in the blood.</seg>
<seg id="1455">Use of Tacrolimus on the metabolism of other medicines Tacrolimus is known as CYP3A4-Hemmer.</seg>
<seg id="1456">As Tacrolimus the Clearance of Steroid contraceptiva can increase the hormones and to increase the hormones.</seg>
<seg id="1457">The results of animal experiments have shown that Tacrolimus potential increases the Clearance of Pentobarbital and Phenazon and their semi precious time.</seg>
<seg id="1458">"results appear ordered" "by relevance" "or" "by date" "(publication date),"</seg>
<seg id="1459">In utero Exposition recommends a monitoring of the curiosity on any harmful effects of Tacrolimus (especially regarding his effect on the kidneys).</seg>
<seg id="1460">"there is the risk of a spring of early childhood (&lt; week 37) and a hyperkaliaemia of the newborn (Inverse 8 of 111 newborn, i.e.:"</seg>
<seg id="1461">The side effects of immunity siva can often be found due to the disease disease of the patient and simultaneous treatment with a variety of other medicines.</seg>
<seg id="1462">"here are the side effects according to their frequency in the order, very often (≥ 1 / 10), occasionally (≥ 1 / 10), occasionally (≥ 1 / 10, ≤ 1 / 10), rarely (≥ 1 / 10, ≤ 1 / 100), very rare (≤ 1 / 10,000, ≤ 1 / 100), very rare (≤ 1 / 10,000, ≤ 1 / 100), very rare (≤ 1 / 10,000, ≤ 1 / 100), very rare (≤ 1 / 10,000, ≤ 1 / 100), very rare (≤ 1 / 10,000, ≤ 1 / 10,000)."</seg>
<seg id="1463">"at the end of the year, we will be happy to have the opportunity to take a look at the heart of the heart of the heart of the heart of the heart of the heart of the heart of the heart of the heart of the heart."</seg>
<seg id="1464">"stomach, diarrative, diarrative and symptoms, stomach ulcers, vomiting, pain in stomach ulcers and symptoms, crates, pain in stomach ulcers and symptoms, lactic chair, signs and symptoms in stomach ulcers - area"</seg>
<seg id="1465">"in patients who are treated with Tacrolimus is treated with Tacrolimus, which is often increased with Tacrolimus, which is often increased with Tacrolimus."</seg>
<seg id="1466">Cases of BK-virus-associative Nephropathie and JC virus and JC virus were reported to patients under immunotherapy therapy (PML).</seg>
<seg id="1467">It was about reduced or bösneoplasms including EBV- associated lymphocytes diseases and skin receptors in conjunction with Tacrolimus.</seg>
<seg id="1468">"due to its high molecular weight, its low water soluble and the high binding to Erythrocytes and plasmaple can be assumed that Tacrolimus cannot be dialysis."</seg>
<seg id="1469">The effects of Tacrolimus can also be held by Tacrolimus by its binding to a cytosectic protein (FKBP12) which is responsible for the connection of the connection in the cell.</seg>
<seg id="1470">This leads to a calcientious inhibitors of signals in the T cells and prevents the transcription of a specific number of lymphokin-genes.</seg>
<seg id="1471">"Tacrolimus emphasised the activation of T cells, and the formation of the T cells, as interleukin-2, interleukin-3, Interleukin-3, and the expression of interleukin-2-rectification."</seg>
<seg id="1472">12 approved arrests in the first 24 weeks in the Advance Group (N = 237) 32.6% and in Prograf group (N = 234) 29.3%.</seg>
<seg id="1473">The patient care rates according to 12 months (14 women, 11 men) and the prograf arm 24 (5 women, 19 males) and the prograf arm 24 (5 women, 19 males) deaths. "</seg>
<seg id="1474">"results appear ordered" "by relevance" "or" "by date" "(publication date),"</seg>
<seg id="1475">"(3 women, 7 men) and the prograf arm 8 (3 women, 7 males) and the prograf arm 8 (3 women, 5 males) deaths."</seg>
<seg id="1476">"the efficacy and safety of prograf, Ciclosporin and Advance was placed in combination with the basiximab antibodies, MMF and corticosteroids, with 638 de novo kidney stones."</seg>
<seg id="1477">Firm of the Year for Insolvency Administration Schneider Geiwitz & Partner Firm of the Year for Tax Gleiss Lutz</seg>
<seg id="1478">"results appear ordered" "by relevance" "or" "by date" "(publication date),"</seg>
<seg id="1479">"in the Advance arm 2 (Men), in the Prograf arm 10 (3 women, 7 men) and in Ciclosporin-arm 6 (3 women, 3 men) deaths."</seg>
<seg id="1480">"results of the primary immune system with Tacrolimus in the form of twice daily angraf capsules after other primary organ transplantations prograf has developed a recognized primary immune system, lung and intestinal transplantations."</seg>
<seg id="1481">"175 patients who were infected with 475 patients suffering from a transplant transplant and in 630 cases after a intestinal transplant, and in 630 cases after a transplant transplant."</seg>
<seg id="1482">"in total, the safety profile of orphic prograf in these published studies show the observations in the large studies, in which Prograf with liver, kidney and heart transplant."</seg>
<seg id="1483">"results appear ordered" "by relevance" "or" "by date" "(publication date),"</seg>
<seg id="1484">"in the first year of transplantation, the Bronchiolitis of literature was less common in the first year of transplant less often (2,86%) of 8,57%)."</seg>
<seg id="1485">"the survival rate after a year was 80.8% in the Tacrolimus- and 83% in Ciclosporin-group (Trevor et al., 3rd ici San Diego, USA, 2004; abstract 22)."</seg>
<seg id="1486">In the patients with Tacrolimus treated patients in 21.7% of the cases of a bronchitis obooks compared to 38.0% under Ciclosporin (p = 0.025).</seg>
<seg id="1487">The number of cases where Ciclosporin on Tacrolimus had to be increased (p = 2) (Keenan et al.) (Keenan et al.) and Ann Thoracic Surg 1995; 60: 580).</seg>
<seg id="1488">"the number of cases where there was no acute transplantation, after 6 months (57,7%) and after 1 year (50%) and after 1 year (50%) and after 1 year (50%) and after 1 year (Trevor et al., J Heart Lung transplant 2001; 20: 511)."</seg>
<seg id="1489">"in a study, the frequency of the origin of a Bronchiolitis obliterature - syndroms with Tacrolimus treated patients."</seg>
<seg id="1490">"a multi-centric study conducted a multi-centric study with orical Prograf, which was given after a randomised procedure of Tacrolimus (n = 103) or ciclosporin (n = 102)."</seg>
<seg id="1491">The orale Initialdosis (by protocol) of Tacrolimus was 0.2 mg / kg / day and was then transferred to the end of the valley station of 8 to 15 ng / ml.</seg>
<seg id="1492">"tumor transplant The published clinical results of a monocentric study conducted with orical Prograf, 75 liver and intestines and 25 multivisceral transplantation) under Tacrolimus and Preventive and 25 multivisceral transplantation) under Tacrolimus and Preventive and 25 multivisceral transplantation) under Tacrolimus and Preventive and 25 multivisceral transplantation) under Tacrolimus and Preventive and 25 multivisceral transplantation) under Tacrolimus and Preventive and 25 multivisceral transplantation) under Tacrolimus and Preventive and 25 multivisceral transplantation) under Tacrolimus and Preventive and 25 multivisceral transplantation) under Tacrolimus and Preventive and 25 multivisceral transplantation) under Tacrolimus and Preventive and 25 multivisceral transplantation) under Tacrolimus and Preventive and 25 multivisceral transplantation) under Tacrolimus and Preventive and 25 multivisceral transplantation) under Tacrolimus and Preventive and 25 multivisceral transplantation) under Tacrolimus and Preventive and 25 multivisceral transplantation) under Tacrolimus and Preventive and 25 multivisceral transplantations</seg>
<seg id="1493">"results appear ordered" "by relevance" "or" "by date" "(publication date),"</seg>
<seg id="1494">Factors such as a lower hemmatology and low protein concentrations which will lead to an increase in the unconstitutional state of Tacrolimus or through a treatment with cortitigoids.</seg>
<seg id="1495">This can be done that the Tacrolimus can be completely reformed in front of the rhinge of almost completely metrics which is carried out mainly via the Galle.</seg>
<seg id="1496">"due to strong patients suffering from prograf (twice daily) in ratio 1: 1 (mg: mg) in ratio 1: 1 (mg: mg), the systemic exposure of Tacrolimus (AUC0-24) was lower than under prograf."</seg>
<seg id="1497">It is recommended frequent exchange of Tacrolimus valley. during the first two weeks after transplantation, followed by periodic controls during the conservation therapy. "</seg>
<seg id="1498">"21 The treatment adult patients with transplantation, which proved insufficient to other immunity, there are no clinical data for the retarding development."</seg>
<seg id="1499">"other factors which increase the risk of such clinical disorders are already existing heart disease, a treatment with cortitigoids, high blood pressure, kidney or liver dysfunction, infections, liquid and oil."</seg>
<seg id="1500">"if you have any questions about this product, simply complete all the fields marked * and click" "Send". ""</seg>
<seg id="1501">"the efficacy and safety of prograf, Ciclosporin and Advance was placed in combination with the basiximab antibodies, MMF and corticosteroids, with 638 de novo kidney stones."</seg>
<seg id="1502">"on the other hand, the white-orange peel-red joints are printed in red ink on the grating red plate with" "687", "they contain white powder."</seg>
<seg id="1503">It is recommended frequent exchange of Tacrolimus valley. during the first two weeks after transplantation, followed by periodic controls during the conservation therapy. "</seg>
<seg id="1504">"37 For treatment adult patients with transplantation, which proved insufficient to other immunity, there are no clinical data for the retarding development."</seg>
<seg id="1505">"other factors which increase the risk of such clinical disorders are already existing heart disease, a treatment with cortitigoids, high blood pressure, kidney or liver dysfunction, infections, liquid and oil."</seg>
<seg id="1506">44 approved arrests in the first 24 weeks in the Advance Group (N = 237) 32.6% and in Prograf group (N = 234) 29.3%.</seg>
<seg id="1507">"the efficacy and safety of prograf, Ciclosporin and Advance was placed in combination with the basiximab antibodies, MMF and corticosteroids, with 638 de novo kidney stones."</seg>
<seg id="1508">"in total, 34 patients were used by Ciclosporin on Tacrolimus during only 6 Tacrolimus patients., transplant 2004; 77: 1221)."</seg>
<seg id="1509">"tumor transplant The published clinical results of a monocentric study conducted with orical Prograf, 75 liver and intestines and 25 multivisceral transplantation) under Tacrolimus and Preventive and 25 multivisceral transplantation) under Tacrolimus and Preventive and 25 multivisceral transplantation) under Tacrolimus and Preventive and 25 multivisceral transplantation) under Tacrolimus and Preventive and 25 multivisceral transplantation) under Tacrolimus and Preventive and 25 multivisceral transplantation) under Tacrolimus and Preventive and 25 multivisceral transplantation) under Tacrolimus and Preventive and 25 multivisceral transplantation) under Tacrolimus and Preventive and 25 multivisceral transplantation) under Tacrolimus and Preventive and 25 multivisceral transplantation) under Tacrolimus and Preventive and 25 multivisceral transplantation) under Tacrolimus and Preventive and 25 multivisceral transplantation) under Tacrolimus and Preventive and 25 multivisceral transplantation) under Tacrolimus and Preventive and 25 multivisceral transplantation) under Tacrolimus and Preventive and 25 multivisceral transplantations</seg>
<seg id="1510">This can be done that the Tacrolimus can be completely reformed in front of the rhinge of almost completely metrics which is carried out mainly via the Galle.</seg>
<seg id="1511">Risk management plan The owner of the approval of the company is committed to the Invigilance plan and additional pharmaceutical administration activities as well as all other updates of the RMP which are approved by CHMP.</seg>
<seg id="1512">"according to CHMP guidelines for the risk management systems for drug use on humans, the updated RMP has to be submitted with the next periodic safety report (periodic Safety update Report, PSR)."</seg>
<seg id="1513">"perhaps you will get involved in the treatment of your liver, kidney, or heart transplant or a other transplantation of your body by an estimated treatment of your body."</seg>
<seg id="1514">If you have other medicines please inform your doctor or pharmacist if you have other medicines or pharmacist if there are no prescription drugs or remedies herbal remedies.</seg>
<seg id="1515">"Amiloride, Triamor Spironolacton), certain pain (so-called unsteroidale antiphlogistics as Ibuprofen), antibodies or medicine for treatment of diabetes mellitus."</seg>
<seg id="1516">"during pregnancy and after a pregnancy, if a pregnancy is planned or already, please ask for your doctor or pharmacist for advice."</seg>
<seg id="1517">"transport and filling of machines you may not apply to the wheel of a vehicle, or tools or machines, if you can feel comfortable or blamed or blurred."</seg>
<seg id="1518">Important information on certain other components of Advance Please take only after relanguage with your doctor if you are known to you by an incompatible with your doctor.</seg>
<seg id="1519">Make sure you always receive the same Tacrolimus medication if you solve your recipe as your specialist has been agreed on a change of Tacrolimus preparation.</seg>
<seg id="1520">"if you receive a medicine, whose look can be changed or the wick rules are altered, please contact us as soon as possible with your treatment doctor or pharmacist so that you have the correct medicine."</seg>
<seg id="1521">Your doctor can determine the correct dosage and time to time it must be corrected regularly regularly.</seg>
<seg id="1522">"if you have taken a larger quantity of Advance, you should have taken a bigger amount of any agraf you can apply immediately to your doctor or the emergency department of the nearest hospital."</seg>
<seg id="1523">"if you have forgotten your doctor if you have forgotten your capsules, take a look at the same day at the same day to the earliest possible date."</seg>
<seg id="1524">"if you take the application by Advance on the treatment with Advance, the risk of risk of a transplant can increase the risk of a transplant."</seg>
<seg id="1525">"" "0.5 mg" and their oranges are filled with "0.5 mg" and their oranges lower part with "" 647 "" and their oranges lower part with "" 647 "." "</seg>
<seg id="1526">"the" "677" "and their oranges are filled with" "677" "and their oranges lower part with" "677" "and their oranges lower part with" "677" "each with white powder."</seg>
<seg id="1527">"the" "687" "and their oranges are filled with" "5 mg" and their oranges lower part with "" 687 "" and their oranges lower part with "" 687 "." "</seg>
<seg id="1528">România Astellas Pharma International Internaliva Moâa Bucurea Bucurea Bucurea Bucurea Bucurea Bucurea Bucurea Bucurea Bucurea Bucurea Bucurea Bucurea Bucurea Bucurea Bucurea Bucurea Bucurea Bucurea Bucurea Bucurea Bucurea Bucurea Bucurea Bucurea Bucurea Bucurea Bucurea Bucurea Bucurea Bucurea Bucurea Bucurea Bucurea Bucurea Bucurea Bucurea Bucurea Bucurea Bucurea Bucurea Bucurea Bucurea Bucurea Bucurea Bucurea Bucurea Bucurea Bucurea Bucurea Bucurea Buc</seg>
<seg id="1529">"if you want to send us a question about this product, simply complete all the fields marked * and click" "Send". ""</seg>
<seg id="1530">"Advate is used for treatment and prevention of blood in patients with hemophilia A (one through the lack of factor VIII-related, congenital blood circulation)."</seg>
<seg id="1531">The dosage and frequency of the application are afterwards to apply to the treatment of blood vessels or the prevention of blood cancers in surgical surgery.</seg>
<seg id="1532">"patients with hemophilia A suffer from a factor VIII-lack of blood cells, such as blood vessels in joints, muscles or internal organs."</seg>
<seg id="1533">Octocog alfa is not produced from human plasma but after a method which is produced as "recombined DNA technology."</seg>
<seg id="1534">"it is produced by a cell, in which a gene (DNA) was produced by the formation of human brain. VIII."</seg>
<seg id="1535">"Advate is a different in the European Union approved drug called Recombinate, similar to the medicine, so that the drug does not contain proteins or animal origin."</seg>
<seg id="1536">"in three additional studies in patients with severe to moderate hemophilia A, including a study with 53 children under six years, the application of medication is investigated."</seg>
<seg id="1537">"in the main study, the effectiveness of Advances in 86% of 510 new blood-sepisodes are awarded with" "excellent" "or" "good". ""</seg>
<seg id="1538">"the most common side effects of Advate (observed in 1 to 10 of 100 patients) are digestible, headache, Pyrexie (fever) and the formation of antibodies."</seg>
<seg id="1539">Advate must not be applied in patients who may be oversensitive (allergic) against the human brain factor VIII, mouse-or Hamsterine or one of the other components. "</seg>
<seg id="1540">"March 2004, the European Commission to the company Baxter AG will bring an approval for the Injury of Advate in the entire European Union."</seg>
<seg id="1541">"dosage: dosage and duration of the substrate therapy, according to the Schweregrad of the factor VIII-Manila, after the place and the degree of blood and the clinical state of the patient."</seg>
<seg id="1542">Table 10 Forecast Sales of Impulse and Indulgence Products by Category: volume 2014-2019</seg>
<seg id="1543">Injection all 12-24 hours (8-24 hours in patients under 6 years) for 3-4 days or longer repeat until the pain and the acute symptoms are removed.</seg>
<seg id="1544">Injection all 8-24 hours (6-12 hours among patients under 6 years) repeat until the risk of the patient is over.</seg>
<seg id="1545">"during the treatment phase, it is recommended for controlling the dosage of the injections and frequency of the injections of the injectors."</seg>
<seg id="1546">"individual patients may differ in their reaction to factor VIII, different in vivo recovery and different levels times."</seg>
<seg id="1547">3 prophylaxis and long term prophylaxis of blood cells in patients with severe hemophilia A should be made between 20 and 40 I.E. from factor VIII per kg body weight at the distance of 2-3 days.</seg>
<seg id="1548">"if the expected factor is not reached, or if the blood is not achieved with an adequate dose, a test must be performed by an adequate dose of inhibitor."</seg>
<seg id="1549">"in patients with high inhibitors, it is possible that the factor VIII-therapy is not effective, so that other therapeutic measures will need."</seg>
<seg id="1550">"if you want to send us a question about this product, simply complete all the fields marked * and click" "Send". ""</seg>
<seg id="1551">The formation of neutral antibodies (inhibitors) against factor VIII is a known complication in treatment of patients with halopathy A.</seg>
<seg id="1552">"these inhibitors have always been quantified against the prokoagulatoric activity of the VIII of IgG immigration, which is quantified in Bezda units (B.E.) per ml Plasma by modifiers (B.E.) per ml Plasma by modifiers (B.E.)."</seg>
<seg id="1553">"the risk of inhibitors to develop, corroborated with the scale of exposure to the factor VIII, and the risk within the first 20 Exposition is the biggest and of genetic and other factors."</seg>
<seg id="1554">"in pre-treated patients (PTPs), with more than 100 Excalipers and anamnesian well-known inhibitors (PTPs), after results of a recombinant str-product on another, the return of (lower trims) inhibitors."</seg>
<seg id="1555">"due to the rare occurrence of the Hoses A at women, they have no experiences yet."</seg>
<seg id="1556">"during the greatest number of patients, inhibitors of ADRs were inhibitors against factor VIII (5 patients), who were a higher risk of formation of inhibitors, headache (5 patients), fever and digestibility (each 3 patients)."</seg>
<seg id="1557">"data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data. why buy this report? * Get a detailed picture of the Baby Food market; * Pinpoint growth sectors and identify factors driving change; * Understand the competitive environment, the market's major players and leading brands; * Use five-year forecasts to assess how the market is predicted to develop."</seg>
<seg id="1558">A) The percentage of the patients was calculated using the sum of individual patients (234) calculated (10 - 14 postoperationday) in a patient under continuous ADVATE infusion.</seg>
<seg id="1559">"during the whole period of time, and both the factor of VIII- mirror at the plasma as well as the Clearance rate showed sufficient values at the 15th posterior day."</seg>
<seg id="1560">"in clinical trials with ADVATE at 145 children and adults 2 with diagnostics conditions A (FVIII ≤ 2%) and previous exposure to factor VIII- concentrations (≥ 150 days), only a patient after 26 sec. (2.4 B.E. in modified Bezda-approach)."</seg>
<seg id="1561">"in addition, at any of the 53 papdiatric patients with age of 6 years and diagnosed medical treatment (FVIII ≤ 2%) after previous exposure to factor VIII- concentrations (≥ 50 days)."</seg>
<seg id="1562">"during the treatment of an ongoing clinical study, 5 of 25 (20%) were treated with ADVATE patients with ADVATE patients."</seg>
<seg id="1563">The immunity of the patient at the traces of condensation proteins has been analysed by the investigation of antibodies against these proteins, laboratory parameters and relevant side effects. "</seg>
<seg id="1564">"the patient showed both a statistically significant decline in anti-CHO cell protein, otherwise there were no signs or symptoms of allergic reaction to an allergic reaction or hypersensitivity."</seg>
<seg id="1565">"in four patients, the tent was chosen by Urgiaria, Pruritus, ruritus, and increased number of eosinc Granulozyten with several repeated products in the framework of the study."</seg>
<seg id="1566">"7 As with other intravenous products, ADVATE has been allergic to the allergic reaction from allergic type, including anaphylaktic / anaphylaktoider reactions (frequency not known)."</seg>
<seg id="1567">"however, the negative factor of the X-X is a factor of the X-X series of X-ray and the X-X series of X-ray and the X-X series in the X-X series."</seg>
<seg id="1568">All pharmacokinetic studies with ADVATE were performed on pre-treated patients with severe or moderate hemophilia A (basic value of the factor VIII-activity ≤ 2%).</seg>
<seg id="1569">The pharmacokinetic parameters are from an Cross-Over study with ADVATE in 100 previously treated patients or &gt; 10 years and are listed below in the table 3.</seg>
<seg id="1570">"table 3: Pharmaceuticals & Healthcare, Global, Revenue ($m), USD Constant, Historic, 2004-2011 158"</seg>
<seg id="1571">"non-clinical data, based on the studies on safety, security and local toxicity and genotoxity, no special risk for people."</seg>
<seg id="1572">"each single cup is made of a flow bottle with powder, a flow bottle with 5 ml solvents (both glass type I with chlorobutyl-rubber sole) and a device for the reconstruction of the reconstruction (BAXJECT II)."</seg>
<seg id="1573">"when the product is stored in the fridge, both throughput bottles with ADVATE powder and solvents out of the fridge and at room temperature (between 15 and 25 ° C)."</seg>
<seg id="1574">A clearly increase of the pulse rate can be reduced by slow down or time of the injector of the injection is immediately again (see Abbreviation 4.4 and 4.8).</seg>
<seg id="1575">14 prophylaxis for long-term prophylaxis of blood cells in patients with severe hemophilia A should be made between 20 and 40 I.E. from factor VIII per kg body weight at the distance of 2-3 days.</seg>
<seg id="1576">"due to the rare occurrence of the Hoses A at women, they have no experiences yet."</seg>
<seg id="1577">"3 new-born (at age of 0-1 month), children (age of 2 month - 2 years), children (age of 2-12 years), young children (age of 12-12 years), adults (more than 16 years)"</seg>
<seg id="1578">In clinical trials with ADVATE an increase of 145 children and adults 4 with diagnostics conditions (FVIII ≤ 2%) and previous exposure to a factor VIII- concentrations (≥ 150 days).</seg>
<seg id="1579">"18 As with other intravenous products were allergic to the allergic type, including anaphylaktic / anaphylaktoider reactions (frequency not known)."</seg>
<seg id="1580">"table 3: Pharmaceuticals & Healthcare, Global, Revenue ($m), USD Constant, Historic, 2004-2011 158"</seg>
<seg id="1581">"non-clinical data, based on the studies on safety, security and local toxicity and genotoxity, no special risk for people."</seg>
<seg id="1582">"25 prophylaxis of long-term prophylaxis of blood vessels in patients with severe hemophilia A should be made between 20 and 40 I.E. from factor VIII per kg body weight at the distance of 2-3 days."</seg>
<seg id="1583">"5 new, born (age of 0-1 month), children (age of 2 month - 2 years), children (age of 2-12 years), young children (age of 12-12 years), adults (more than 16 years)"</seg>
<seg id="1584">"in clinical trials with ADVATE at 145 children and adults 6 with diagnostics conditions A (FVIII ≤ 2%) and previous exposure to factor VIII- concentrations (≥ 150 days), only a patient after 26 sec. (2.4 B.E. in modified Bezda-approach)."</seg>
<seg id="1585">"29 How with other intravenous products was made from allergic type, including anaphylaktic / anaphylaktoider reactions (frequency not known)."</seg>
<seg id="1586">"non-clinical data, based on the studies on safety, security and local toxicity and genotoxity, no special risk for people."</seg>
<seg id="1587">36 prophylaxis In long-term prophylaxis of blood cells in patients with severe hemophilia A should be made between 20 and 40 I.E. from factor VIII per kg body weight at the distance of 2-3 days.</seg>
<seg id="1588">"7 new, born (age of 0-1 month), children (age of 2 month - 2 years), children (age of 2-12 years), young children (age of 12-12 years), adults (more than 16 years)"</seg>
<seg id="1589">In clinical trials with ADVATE an increase of 145 children and adults 8 with diagnostics conditions (FVIII ≤ 2%) and previous exposure to a factor VIII- concentrations (≥ 150 days).</seg>
<seg id="1590">"40 As with other intravenous products were allergic to the allergic type, including anaphylaktic / anaphylaktoider reactions (frequency not known)."</seg>
<seg id="1591">"non-clinical data, based on the studies on safety, security and local toxicity and genotoxity, no special risk for people."</seg>
<seg id="1592">47 prophylaxis In long-term prophylaxis of blood cells in patients with severe hemophilia A should be made between 20 and 40 I.E. from factor VIII per kg body weight at the distance of 2-3 days.</seg>
<seg id="1593">"9 new, born (age of 0-1 month), children (age of 2 month - 2 years), children (age of 2-12 years), young children (age of 12-12 years), adults (more than 16 years)"</seg>
<seg id="1594">"in clinical trials with ADVATE at 145 children and adults 10 with diagnostics conditions A (FVIII ≤ 2%) and previous exposure to factor VIII- concentrations (≥ 150 days), only a patient after 26 sec. (2.4 B.E. in the modified Bezda-approach)."</seg>
<seg id="1595">51 As with other intravenous products were allergic to the allergic reaction from allergic type, including anaphylaktic / anaphylaktoider reactions (frequency not known). "</seg>
<seg id="1596">"non-clinical data, based on the studies on safety, security and local toxicity and genotoxity, no special risk for people."</seg>
<seg id="1597">Deprecated: function ereg _ replace () is deprecated in / www / htdocs / w00cec0c / webEdition / we / include / we _ modules / object / we _ listview _ multiobject.class.php on line 296</seg>
<seg id="1598">"11 new-born (at age of 0-1 month), children (age of 2 month - 2 years), children (age of 2-12 years), young children (age of 12-16 years), adults (more than 16 years)"</seg>
<seg id="1599">"in clinical trials with ADVATE at 145 children and adults 12 with diagnostics conditions A (FVIII ≤ 2%) and previous exposure to factor VIII- concentrations (≥ 150 days), only a patient after 26 sec. (2.4 B.E. in the modified Bezda-approach)."</seg>
<seg id="1600">"62 How with other intravenous products were allergic to the allergic type, including anaphylaktic / anaphylaktoider reactions (frequency not known)."</seg>
<seg id="1601">"non-clinical data, based on the studies on safety, security and local toxicity and genotoxity, no special risk for people."</seg>
<seg id="1602">Firm of the Year for Insolvency Administration Schneider Geiwitz & Partner Firm of the Year for Tax Gleiss Lutz Firm of the Year for White Collar Crime Redeker Sellner Dahs</seg>
<seg id="1603">"as in CHMP directive to the risk of managment plan for Human-medication, these updates will be submitted with the next periodic Safety update Report (PSUR)."</seg>
<seg id="1604">"• when new information is available, the influence on the final safety shinance, the pharmaceutical kovigilance plan or the measures to risk minimise the risk of the risk of the risk of the risk of the risk of the risk of the risk of risk."</seg>
<seg id="1605">"1 water bottle with ADVATE 500 I.E Octocog alfa, 1 flow bottle with 5 ml sterilized water for injectors, 1 BAXJECT II medical product."</seg>
<seg id="1606">"1 water bottle with ADVATE 1000 I.E Octocog alfa, 1 flow bottle with 5 ml sterilized water for injectors, 1 BAXJECT II-medicine"</seg>
<seg id="1607">Special requirements for the application of ADVATE is required to inform your doctor if you have recently been developed by the T-Products if you have been developed by inhibitors.</seg>
<seg id="1608">These symptoms can be early signs of a anaphylaktic shock.</seg>
<seg id="1609">If you are interested in use with other medicines please inform your doctor if you have other medicines or recently added if it is not liable to prescription drugs.</seg>
<seg id="1610">Your doctor will calculate your dose of ADVATE (in international units or I.E.) depending on your physical exercise and your body weight and whether it is used for prevention or treatment of blood.</seg>
<seg id="1611">"patients, the factor-VIII-inhibitors are developing in your plasma in your plasma with ADVATE, this could not be attained in the development of VIII- and blood vessels."</seg>
<seg id="1612">"in conjunction with operations of cathode infections, lower number of red blood cells, tiredness of Glidecs and joints, prolonged blood pressure after distance of a drainage, reduced factor-VIII-mirror and postoperative hemorome."</seg>
<seg id="1613">"(see above) and other allergic reactions (Anaphymie) and other allergic reactions (see above)."</seg>
<seg id="1614">Inform your doctor if one of the listed side effects are considerably affected or if you notice side effects that are not listed in this package.</seg>
<seg id="1615">"Portugal Baxter médico Fêêutica LDA Sintra Business Park Zona Industrial da Aesheira, edifício 10 P-2710-089 Sintra Tel: + 351 21 ° 25 00"</seg>
<seg id="1616">"• The BAXJECT II is not use when its sterile barrier is broken, its packaging is damaged or sign of a manipulation, as in the symbol."</seg>
<seg id="1617">"important note: • Not cellular, before you have received the special training of your doctor or medical property."</seg>
<seg id="1618">"the solution should be slow to slow down with an infusion speed, which is at least 10 ml per minute."</seg>
<seg id="1619">"106 In case of blood loss should be made in the case of the US-mirror, in the corresponding timeframe not under the specified plasmadelic value (in% or in I.E. / ml)."</seg>
<seg id="1620">These symptoms can be early signs of a anaphylaktic shock.</seg>
<seg id="1621">"patients, the factor-VIII-inhibitors are developing in your plasma in your plasma with ADVATE, this could not be attained in the development of VIII- and blood vessels."</seg>
<seg id="1622">"occasional side effects of juckingz, amplified foam, smell, vomiting, nausea, vomiting, vomiting, vomiting, vomiting, dubbing, vomiting, vomiting, skin irritation, extreme burning, extreme burning, extreme burning."</seg>
<seg id="1623">"in case of blood cancellations in the case of blood morals should not be observed under the specified plasmaelic value (in% or in I.E. / ml)."</seg>
<seg id="1624">These symptoms can be early signs of a anaphylaktic shock.</seg>
<seg id="1625">"patients, the factor-VIII-inhibitors are developing in your plasma in your plasma with ADVATE, this could not be attained in the development of VIII- and blood vessels."</seg>
<seg id="1626">"126 In case of blood loss, the factor VIII-mirror should not fall under the specified plasma-scale (in% or in I.E. / ml)."</seg>
<seg id="1627">These symptoms can be early signs of a anaphylaktic shock.</seg>
<seg id="1628">"patients, the factor-VIII-inhibitors are developing in your plasma in your plasma with ADVATE, this could not be attained in the development of VIII- and blood vessels."</seg>
<seg id="1629">136 In case of blood cancellations should not fall in the appropriate time-mirror within the specified time delay (in% or in I.E. / ml).</seg>
<seg id="1630">These symptoms can be early signs of a anaphylaktic shock.</seg>
<seg id="1631">"patients, the factor-VIII-inhibitors are developing in your plasma in your plasma with ADVATE, this could not be attained in the development of VIII- and blood vessels."</seg>
<seg id="1632">146 In case of blood loss in the case of blood flow should not be used in the appropriate time reduction (in% or in I.E. / ml).</seg>
<seg id="1633">These symptoms can be early signs of a anaphylaktic shock.</seg>
<seg id="1634">"patients, the factor-VIII-inhibitors are developing in your plasma in your plasma with ADVATE, this could not be attained in the development of VIII- and blood vessels."</seg>
<seg id="1635">"occasional side effects of juckingz, amplified foam, smell, vomiting, nausea, vomiting, vomiting, vomiting, vomiting, dubbing, vomiting, vomiting, skin irritation, extreme burning, extreme burning, extreme burning."</seg>
<seg id="1636">"(see above) and other allergic reactions (Anaphymie) and other allergic reactions (see above)."</seg>
<seg id="1637">156 In case of blood cancellations should not fall in the appropriate time-mirror within the specified time delay (in% or in I.E. / ml).</seg>
<seg id="1638">"Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems."</seg>
<seg id="1639">"hence, CHMP is required for the basis of the safety fils of ADVATE, which is required by the PSURs all 6 months, decided to inform the approval of the owner of the owner in 5 years."</seg>
<seg id="1640">"in December 2008, Gendux Bio Limited, the Committee for Human Physicians (CHMP) is officially recognized that the company will bring its request to approval for the inscription of Li-Fraumeni cancer."</seg>
<seg id="1641">"however, the breast, the brain, the brain, the bone, or the crossover components (tissue, which connects other structures in the body, and supports)."</seg>
<seg id="1642">"it is a kind of virus, genetically modified so that it may be a virus in the cells of the body."</seg>
<seg id="1643">"at the same time, Adenovirus is a" Adenovirus "which has been changed so that there is no copies of yourself and thus not can cause infection while people."</seg>
<seg id="1644">Advexin would have to be cut directly into the tumors and to form the cancer cells to form the normal p53 protein.</seg>
<seg id="1645">The p53 protein that is formed out of the non-defective DNA and is usually formed to restore DNA and kill the cells if the DNA cannot be restored.</seg>
<seg id="1646">"with Li-Fraumeni cancer, in which the p53-virus is not correct, the p53 protein is not correct, and the cancer cells can grow and share."</seg>
<seg id="1647">"data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data. why buy this report? * Get a detailed picture of the Baby Food market; * Pinpoint growth sectors and identify factors driving change; * Understand the competitive environment, the market's major players and leading brands;"</seg>
<seg id="1648">"after the CHMP, the answers of the company had been checked on him, there were still some questions."</seg>
<seg id="1649">"based on the examination of the initial documents, the CHMP to day 120 is sent to a list of questions that sent to the company."</seg>
<seg id="1650">"according to CHMP, the injection of Advexin in Li-Fraumeni tumors advantages for patients."</seg>
<seg id="1651">"the Committee, also concerns about the processing of medication in the body, as well as safety of medicine."</seg>
<seg id="1652">"in addition, the company has not been proven that scientists can be produced in reliable way and that it is neither for the environment nor for people who come into contact with the patient, harmful."</seg>
<seg id="1653">Firm of the Year for Insolvency Administration Schneider Geiwitz & Partner Firm of the Year for Tax Gleiss Lutz Firm of the Year for White Collar Crime Redeker Sellner Dahs</seg>
<seg id="1654">"the new release of the new" "change" "means that the tablets are so set out that one of the effective parts immediately and the other slowly set up over several hours."</seg>
<seg id="1655">Aerinaze will apply to treat symptoms of seasonal allergic reactions (hay fever) in patients with nose-inflammatory effects.</seg>
<seg id="1656">"in adults and youth from 12 years, the recommended dose of aerinaze twice daily a tablet which should be taken with a glass of water with or without food."</seg>
<seg id="1657">"the duration of the treatment should be as short as possible, as soon as the symptoms, especially the swelling of the nose."</seg>
<seg id="1658">Treatment of more than 10 days is not recommended because the effects of medication is based on the nose of the nose.</seg>
<seg id="1659">The main meshing dimensions were the changes of the hypocritter symptoms which were observed from the beginning of the treatment and during the 15-day treatment.</seg>
<seg id="1660">During the study the patients showed their symptoms all 12 hours in a diary and improved with a standard skala how difficult the symptoms were in the last 12 hours.</seg>
<seg id="1661">"in consideration of all the hypocrisy symptoms except the nose of the nose, the aerinaze symptoms, over a decrease of symptoms around 46.4%, compared with 35.9% in patients receiving pseudoephedrin alone."</seg>
<seg id="1662">"when only the swelling of the nasal transplantation was considered, the patients under aerinaze were investigated."</seg>
<seg id="1663">"the most common side effects of aerinaze (observed at 1 to 10 of 100 patients) are speedometer (cardiac), oral pain, pain, pain, insomatic (Sleeping), sleeping disorders and nervousness."</seg>
<seg id="1664">Aerinaze may may be sensitive (allergic) against Desloratronic, pseudoephedrin or one of the other components, against adrenal active substances or Loratopic (another medicines to treatment of allergies) are not applied. "</seg>
<seg id="1665">Aerinaze may also be applied to patients who suffer in patients with a disease (increased water) and hypertension (high blood pressure), hyperthyreose (overfunction of thyroid), hyperthyreose (overviews of thyroid), or a risk of blood circulation. "</seg>
<seg id="1666">Firm of the Year for Restructuring and Corporate Rescue Freshfields Bruckhaus Deringer Firm of the Year for Insolvency Administration Schneider Geiwitz & Partner Firm of the Year for Tax Gleiss Lutz</seg>
<seg id="1667">"the tablet can be taken with a glass of water, however, to swallow the whole."</seg>
<seg id="1668">Aerinaze should be applied due to the absence of data to unthinkable and effectiveness (see paragraph 5.1) not included in children under 12 years.</seg>
<seg id="1669">The duration of the application is as short as possible and should not be continued after removal of the symptoms.</seg>
<seg id="1670">It is recommended to use the application time to 10 days as long for long-term application the activity of pseudosis depends on time.</seg>
<seg id="1671">"after the decline of the mucous membranes in the upper breathing, the treatment can be continued with Desloratopic as Monotherapy."</seg>
<seg id="1672">"as aerinaze Pseudofedrin contains, the medicine also contains indices in patients who are treated with a monoamine oxidase (MAO), respectively within 2 weeks after finishing such therapy."</seg>
<seg id="1673">"this is caused by pseudositic activity in combined use of pseudosiedrin with other vascular diseases such as Bromocriptin, Percy, Dihyvesotamine or other Dekondria, the peroral or nasal as abominous or nasal as abominous or nasal as abominous or nasal as abduction or nasal as abominous or nasal as abominous or nasal as abominous or nasal as abominous or nasal as abominous or nasal as abominous or nasal as abominous or nasal as abominous or nasal as abominous or nasal as abominous or nasal as abominous or nasal as abominous or nasal as abominous or nasal as abominous or nasal as abominous or nasal as abominous or nasal as abominous or nasal as abominous or nasal as abominous or nasal as abominous or nasal as abominous or nasal as abominous or nasal as abominous or nasal as abominous or nasal as abominous or nasal as abominous or nasal as abominous or nasal as abominous or nasal as abominous or nasal as abominous or nasal as abominous or nasal as abominous or nasal as abominous or nasal as abominous or nasal as abominous or nasal as abominous or nasal as abominous</seg>
<seg id="1674">The safety and the effectiveness of this combination therapy was not checked and the data is not checked for the dosage of the dosage.</seg>
<seg id="1675">The safety and the efficacy of aerinaze were not checked in patients with kidney or liver dysfunction.</seg>
<seg id="1676">"patients need to be informed that the treatment of a hypertonia or a speedometer, a rhythmic dysfunction, nausea or any other neurological symptoms (such as headache or reinforcement of headache)."</seg>
<seg id="1677">Treatment of patients with hypertension glaucoma patients with hypertension glaucoma • patients with hypertension glaucoma • patients with hypertension glaucoma patients with a myokardal infections in Anamnese, diabetes mellitus, turtles or bronchospasmus in Anamnese. "</seg>
<seg id="1678">Aerinaze is at least 48 hours prior to performing dermatological tests as antihistamine as well as positive reactions to compensate or in their extent.</seg>
<seg id="1679">"in the framework of clinical tests with desythromycin or Ketoconazol, however, there were no clinically relevant interactions or changes of plasma concentrations."</seg>
<seg id="1680">"results appear ordered" "by relevance" "or" "by date" "(publication date),"</seg>
<seg id="1681">"for the Metabolism of Desloratzen enzymes has not been identified, so that the interactions with other drugs may not be excluded."</seg>
<seg id="1682">"in-vivo CYP3A4 doesn't happen, and in vitro studies have shown that the medicine CYP2D6 is not conducible and neither a substrate nor an inhibitor of P-glycoprotein."</seg>
<seg id="1683">"the immoral of the application of aerinaze during pregnancy is not guaranteed, experiences from a large number of affected individuals, but no increase the frequency of misappropriation in comparison to the frequency of the normal population."</seg>
<seg id="1684">"since Reproductive studies on animals are not always transferred to the people, and on the basis of the vasoproliferative properties of pseudoephedrin should not apply aerinaze in pregnancy."</seg>
<seg id="1685">"however, the patient should also be aware that it can occur in very rare cases, which can lead to an impairment of the traffic, or the ability to serve as well as the ability to serve machines."</seg>
<seg id="1686">"symptoms can vary between a ZNS-depression treatment (Seals, Apnoe, a cardiac, cardiac, cardiac disease) and a ZNS-stimulation."</seg>
<seg id="1687">"headache, anxiety, values of microwings, muscular, vomiting, vomiting, respiratory failure, vomiting, vomiting, vomiting, vomiting, visual dysfunction and hypertonia or hypotony."</seg>
<seg id="1688">"a ZNS stimulator is particularly likely, as Atropin-typical symptoms (mouth dry, pupillatarre and - dilatation, hyperthermic and gastrointestinal disease)."</seg>
<seg id="1689">"the inhibiting of the creation of probiotic cytokins such as IL-4, IL-6, IL-8 and IL-13 from human Mastine cells, P-Selectin in the endothelial cells."</seg>
<seg id="1690">"with an individual dosis study with adults, Desloratance 5 mg does not have any influence on standard measurement sizes of fluency, or the tasks that are connected with the flies."</seg>
<seg id="1691">"in controlled clinical trials, the recommended dose of 5 mg daily has no increased frequency of sludge compared to placebo."</seg>
<seg id="1692">"the orale application of Pseudosis is an essential effect, like an increase in blood pressure, a speedykarmic or manifestation of a ZNS Erregation."</seg>
<seg id="1693">"it took 1,248 patients at age between 12 and 78 and 78 years with seasonal allergic rhagaze tablets."</seg>
<seg id="1694">"in both studies the histaminantagonist effectiveness of aerinaze tablets, significantly higher than under a monotherapy with Pseudoephedrin via the 2-week treatment period."</seg>
<seg id="1695">"the efficacy of aerinaze tablets in regard to the abellular effect, determined by the nose-swelling effect, was significantly higher than under a monotherapy with Deslorateurs over the 2-week treatment period."</seg>
<seg id="1696">"the efficacy of aerinaze tablets showed in terms of gender, age or ethnic minorities, no significant differences."</seg>
<seg id="1697">"in the framework of a single dose study for the pharmacokinetics of aerinaze, Desloratus is desks within 30 minutes to reach the plasma."</seg>
<seg id="1698">"the Bosch Group comprises Robert Bosch GmbH and its roughly 440 subsidiary and regional companies in the Czech Republic. it employs roughly 360,000 associates worldwide (as per April 1, 2015)."</seg>
<seg id="1699">"in the framework of a pharmacokinetic multi-doscope study, which was carried out with the formulation as a tablet to healthy adult subjects, was found that four subjects of desks was badly damaged."</seg>
<seg id="1700">A components Interaction study shows that the Exposition (CMAx and AUC) by Pseudoephedrin after the number of pseudoephedrin biodegrading was for exposure to the gift of a aerinaze tablet.</seg>
<seg id="1701">"based on the conventional studies on the conventional studies to safety spells, a toxicity in toxicity and to reproductive, the clinical data with Desloratance is not a special dangers for people."</seg>
<seg id="1702">The combination of no greater toxicity than their individual components and the observed effects were in general in general related to the ingredient of Pseudoephedrin.</seg>
<seg id="1703">"in reproductive toxicological studies, the combination of Loratrics / Pseudoephedrin at a dosage of up to 150 mg / kg / day and in rabbit in a dosage of up to 120 mg / kg / day."</seg>
<seg id="1704">March 2007 and in module 1.8.1 of the approval entry was established and works before and during the product is on the market.</seg>
<seg id="1705">Antihistamine immunity to prevent allergic symptoms when they prevent histamine, a body's own substance can develop. "</seg>
<seg id="1706">"aerinaze tablets symptoms, which occur in connection with seasonal allergic rhags (hay fever) occur, like Niesen, real or jugal nose and conjuncture of the nose."</seg>
<seg id="1707">20 Under certain circumstances you can particularly sensitive to the mutilation of pseudoephedrin that is included in this medicine.</seg>
<seg id="1708">"an eye of stomach ulcers (coaxial), an eye of the stomach, the fertilization of the stomach, the fertilization of the stomach muscles, a prostate of the stomach or problems with the liver, kidneys, or the Blase."</seg>
<seg id="1709">Inform your doctor if you occur under the application of aerinaze the following symptoms or diseases: • High blood pressure • Heart mental disorders • nausea and headaches.</seg>
<seg id="1710">If you use aerinaze with other medicines please inform your doctor or pharmacist if you have other medicines or are recently added if it is not liable to prescription drugs.</seg>
<seg id="1711">Transport and filling of machines for application in the recommended dosage is not therefore expected that aerinaze leads or the attention.</seg>
<seg id="1712">If you have taken a larger quantity of aerinaze you should take your doctor or pharmacist if you should have a larger amount of aerinaze you should have.</seg>
<seg id="1713">"if you forget the use of aerinaze you have forgotten your dose of time, get the application as soon as possible, take the next dose to the time at the time."</seg>
<seg id="1714">Please inform your doctor or pharmacist if one of the listed side effects may be affected or side effects that are not indicated in this use.</seg>
<seg id="1715">"heart rate, reelessness with increased physical activity, oral pain, pain, pain, pain, headache, headache, headache, nervousness, nervousness and benomeness."</seg>
<seg id="1716">"nasal infections, stomach pain, stomach pain, stomach pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, irritability, pain and irritability."</seg>
<seg id="1717">"after the launch of Desloratance portfolio, very rare, cases of serious allergic reactions (breathability, pipes of breathing, itching, nuts, etc.)."</seg>
<seg id="1718">"about cases of heart attack, heart disease, abdominal pain, vomiting, stomach pain, vomiting, stomach pain, vomiting, stomach pain, muscles, diarrhoea, damage with increased physical activity, more cases of liver disease and over cases of eye liver values was also rare."</seg>
<seg id="1719">"it is available as 5 mg tablet, 5 mg- and 5 mg (tablets), 2.5 mg- and 5 mg (tablets), 0.5 mg / ml-Sirup and as 0.5 mg / ml solution."</seg>
<seg id="1720">"for children aged up to five years, the dose 1.25 mg once daily, which is in form of 2.5 ml Sirup."</seg>
<seg id="1721">"for children from six to eleven years, the dose 2.5 mg once daily, either in the form of 5 ml syrup."</seg>
<seg id="1722">Aerius was investigated in a total of eight trials with approximately 4 800 adults and young people with allergic reaction (including four studies with seasonal allergic reaction and two studies of patients who were also asthma).</seg>
<seg id="1723">"the efficacy was measured by the change of symptoms (itching, number and size of squares, impairment of sleep and the performance of the day) and after six-weekly treatment."</seg>
<seg id="1724">Other studies are presented to ensure that the body is the Sirup to take the solution to take and the melting point in the same way like the tablets and the application of children.</seg>
<seg id="1725">"if the results of all studies were taken out, the two-week treatment have been taken at a average decrease of symptoms (symptoms) around 25 to 32%, compared to decrease of 12 to 26% in comparison to decrease from 12 to 26% in comparison to decrease of 12 to 26%."</seg>
<seg id="1726">"in the two studies at Urtikaria was the decrease of symptoms after six million treatment with Aerius 58 and 67%, compared with placebo-treated patients."</seg>
<seg id="1727">"Aerius may not be applied to patients who may be oversensitive (allergic) against Desloratopic, Loratore, or one of the other components."</seg>
<seg id="1728">"in January 2001, the European Commission decided to bring an approval for the Inerius of Aerius in the entire European Union."</seg>
<seg id="1729">"a tablet once every day, with one or without a meal, to the lens of the symptoms of allergic rhinitis (including interruptions and Persian initis) and urine. (see below section 5.1)."</seg>
<seg id="1730">There are limited experience in clinical trials related to the effectiveness of Deslorateurs with youth from 12 to 17 years (see Abbreviation 4.8 and 5.1).</seg>
<seg id="1731">"the treatment of interchangeable pathinitis (the appearance of symptoms for less than 4 days per week or less than 4 weeks) should be done according to the signs of disease, and may be re-recorded in accordance with the signs of symptoms."</seg>
<seg id="1732">The symptoms of allergic reaction to 4 or more days per week and more than 4 weeks) can be recommended to the patient during the allergies period.</seg>
<seg id="1733">Clinical trials were found in clinical trials with Desloratopic tablets are not found where Erythromycin or Ketoconazol (see below section 5.1).</seg>
<seg id="1734">"in a clinical trial study at simultaneous use of Aerius and alcohol, the performance of alcohol is not reinforced (see below section 5.1)."</seg>
<seg id="1735">"however, the patient should also be aware that it can occur in very rare cases, which can lead to an impairment of the traffic, or the ability to serve the filling of machines."</seg>
<seg id="1736">"clinical trials in various indications, including allergic reactions of 5 mg daily 3% more side effects in patients with Aerius, were treated with placebo."</seg>
<seg id="1737">The most common side effects that was more often referred to as placebo (1.2%) and headache (0.8%) and headache (0.6%) and headache (0.6%).</seg>
<seg id="1738">"in a clinical study with 578 young patients from 12 to 17 years, the most common number of headaches were treated with 5.9% of patients who were treated with placebo."</seg>
<seg id="1739">"results appear ordered" "by relevance" "or" "by date" "(publication date),"</seg>
<seg id="1740">"this includes both the inhibitors of the creation of probiotic cytokins such as IL-4, IL-6, IL-8 and IL-13 from human Mastine cells, P-Selectin in the endothelial cells."</seg>
<seg id="1741">"in the framework of a clinical study on a clinical study with multi-disciplinary research in a dosage of up to 20 mg daily over 14 days, there was no statistically significant or clinically relevant cardiovascular effect."</seg>
<seg id="1742">"in a clinical study, in Desloratopic study in a dosage of 45 mg daily (the Neal of the clinical dose) over ten days, no extension of the Qtc-Intervalls."</seg>
<seg id="1743">"with an individual doscope - study with adults showed Desloratance 5 mg no influence on standard measurement sizes of the fluffy, or the tasks that are connected to the flies."</seg>
<seg id="1744">"in patients with allergic rhags, Aerius was effective in the lens of the symptoms like Niesen, nasal-tion and itching of the nose, itching flow and redness of the eyes, as well as itching on the palate."</seg>
<seg id="1745">"in addition to the established classification in seasonal and perennial, allergic to the symptoms of symptoms can also be obtained from the duration of symptoms."</seg>
<seg id="1746">Interactive rhaging are defined as the appearance of symptoms for less than 4 days per week or less than 4 weeks.</seg>
<seg id="1747">You are allergic to the symptoms of 4 or more days per week and more than 4 weeks.</seg>
<seg id="1748">"as well as the overall evaluation of the questionnaire of the quality of the quality of the life of Rhino-morphology, Aerius has been generated by seasonal allergic reactions."</seg>
<seg id="1749">"the chronic idiopathic urine was examined for further forms of urine, because the underlying pathophysiology is based on different forms of pathophysiology in the different forms and chronic patients."</seg>
<seg id="1750">"since the history of history is a different factor in all urinary diseases, it is expected that Deslorataria is also reflected in other forms of urine. this will be confirmed by the recommendations of the clinical guidelines."</seg>
<seg id="1751">"in two placebo-controlled studies on 6 weeks for patients with chronic idiopathic urine, Aerius is effective in improvement of Pruritus and the Herculature's size and number of squares at the end of the first roofs."</seg>
<seg id="1752">"as in other studies with antioxidants in chronic idiopathic urine, the minority of patients who are not allowed to antihistaminica, from the study."</seg>
<seg id="1753">More than 50% of the patients treated patients with placebo patients treated with placebo-treated patients.</seg>
<seg id="1754">The treatment with Aerius reduced the fault of sleep and the watchiness which was measured by a 4-point scale of this variable.</seg>
<seg id="1755">"in a pharmacokinetic study, which were comparable to patients with general seasonal allergic reactions in the population was comparable to 4% of the patients a higher concentration of Desloratoms."</seg>
<seg id="1756">There are no translations available for a clinically relevant Kumulation after a daily application of Desloratopic (5- 20 mg) over 14 days before.</seg>
<seg id="1757">"for the metabolism of Desloratore enzymes, however, it has not been identified, such as interactions with other medicines are not allowed to be excluded."</seg>
<seg id="1758">Desloratris in-vivo not CYP3D6 and in vitro studies have shown that the medicine CYP2D6 is not conducible and neither a substrate nor an inhibitor of P-glycoprotein.</seg>
<seg id="1759">"in a single doscope study with Desloratance portfolio (fetthalate, kalorienrich breakfast) not available on availability of Deslorateries."</seg>
<seg id="1760">"the Bosch Group comprises Robert Bosch GmbH and its roughly 360,000 associates worldwide (as per April 1, 2015)."</seg>
<seg id="1761">"based on the conventional studies on the conventional studies, toxicity, toxicity, toxicity at reproductive, Genotoxicity, and to reproductive data with Desloratance is no particular dangers for people."</seg>
<seg id="1762">"coloured film (contains lactose-monohydrate, Hypromely, Titanium oxide,..."</seg>
<seg id="1763">Aerius can be taken independently of the meals in order to identify the symptoms of allergic rhinitis (including intermittens and Persian leachs) and Urtikaria (see below section 5.1).</seg>
<seg id="1764">The return doctor should be aware that most cases of rhinitis in children under 2 years of infection (see under Section 4.4) and that no data will support a treatment of infectious rhags with Aerius.</seg>
<seg id="1765">"in addition to the exclusion of upper respiratory diseases or anatomical anomes, the diagnosis of Anamnese, physical examinations and infection syndrome is a role."</seg>
<seg id="1766">"about 6% of adults and children between 2 and 11 and 11, metadata are limited, and a higher substrate load (see below section 5.2)."</seg>
<seg id="1767">"safety of Aerius Sirup with children between 2 and 11 years, the prometering is identical with the children, the normal metering."</seg>
<seg id="1768">"this medication contains Saccharose and Sorbitol, therefore should not take patients with a new problems of fructose-tolerance, glucose-glucose-absorption, glucose and insufficiency of this medicine."</seg>
<seg id="1769">Clinical trials were found in clinical trials with Aerius tablets are not found where Erythromycin or Ketoconazol (see below section 5.1).</seg>
<seg id="1770">"in a clinical trial study on simultaneous use of Aerius tablets and alcohol, the performance of alcohol is not reinforced (see below section 5.1)."</seg>
<seg id="1771">The total amount of side effects of side effects in children between 2 and 11 years was similar to the placebo group.</seg>
<seg id="1772">"clinical trials with adults and adolescents in various indications, including allergic to patients with Aerius, were treated with placebo."</seg>
<seg id="1773">"in a multi-functional study on adults and youth, with up to 45 mg of Desloratopic (ninja clinical dose) were no clinically relevant effects."</seg>
<seg id="1774">Children aged between 1 and 11 years which came for an antihistamine therapy in question identified a daily Desloratadindosis of 1.25 mg (age between 1 and 5 years) or 2.5 mg (age between 6 and 11 years).</seg>
<seg id="1775">"because the course of allergic co-initis / chronic idiopathic urine, and profile of Desloratoos, and the profile of Desloraty in adults and children are similar to the children of Desloratoos in adults and children."</seg>
<seg id="1776">"in the framework of a clinical study with multidisciplinary study in adults and adolescents, in Desloratopic in a dosage of up to 20 mg daily over 14 days, there was no statistically significant or clinically relevant cardiovascular effect."</seg>
<seg id="1777">"in a clinical study on adults and adolescents, in the Desloratopic study of adults, in a dosage of 45 mg daily (the Neal of the clinical dose) over ten days in adults, no extension of the Qtc-Intervalls."</seg>
<seg id="1778">"in controlled clinical trials, the recommended dose of 5 mg daily for adults and adolescents are no increased frequency of sludge compared to placebo."</seg>
<seg id="1779">"results appear ordered" "by relevance" "or" "by date" "(publication date),"</seg>
<seg id="1780">"in clinical pharmacological studies in adults, it came through simultaneous drinking alcohol, neither to a gain of alcohol-induced power."</seg>
<seg id="1781">"in adult and young patients with allergic rhags, Aerius tablets reduce symptoms of symptoms like Niesen, nasal-tion and itching of the nose, itching flow and redness of the eyes, as well as Juckreiz on palms."</seg>
<seg id="1782">"as well as the overall evaluation of the questionnaire of the quality of the quality of the life of Rhino-morphology, the Aerius tablets effectively reduce the risk of seasonal allergic rhags."</seg>
<seg id="1783">"in two placebo-controlled studies on 6 weeks for patients with chronic idiopathic urine, Aerius is effective in improvement of Pruritus and the Herculature's size and number of squares at the end of the first roofs."</seg>
<seg id="1784">"the spread of this limited metabolic phenotype was comparable to adults (6%) and children between 2 and 11 years (6% adults, 16% children) than in Kaukasians (2% adults, 3% children)."</seg>
<seg id="1785">Firm of the Year for Insolvency Administration Schneider Geiwitz & Partner Firm of the Year for Tax Gleiss Lutz Firm of the Year for White Collar Crime Redeker Sellner Dahs</seg>
<seg id="1786">"the load (AUC) is up to 3 to 6 hours higher and the CMAx approximately 3 to 4times higher with a terminal half-time period of approximately 120 hours."</seg>
<seg id="1787">"data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data. why buy this report? * Get a detailed picture of the Consumer Health market; * Pinpoint growth sectors and identify factors driving change; * Understand the competitive environment, the market's major players and leading brands;"</seg>
<seg id="1788">"12 In various individual dosis studies showed that AUC and CMAx values of Desloratopic patients were comparable to those of adults, the Desloraty-Sirup to a dosage of 5 mg."</seg>
<seg id="1789">"for the metabolism of Desloratore enzymes, however, it was not identified, such as interactions with other medicines can not be excluded."</seg>
<seg id="1790">"Aerius Sirup is available in type III-III Brackets, with more secure Polypropylene, with 30, 50, 60, 120, 150, 150, 150, 150 and 300 ml."</seg>
<seg id="1791">"equipped with a rigid polystyrene measuring spoon, calibrated with 2.5 ml and 5 ml (only for 150 ml bottle)."</seg>
<seg id="1792">"a dose of Aerius lympholisat will take place once every day in the mouth, to reduce the symptoms of allergic rhags (including interruptions and Persian leachs) and Urtikaria (see below section 5.1)."</seg>
<seg id="1793">"immediately before the application, the Blister has been carefully opened and the dose of lyophilisation to take out, without them."</seg>
<seg id="1794">Clinical trials were found in clinical trials with Aerius tablets are not detected in which Erythromycin or Ketoconazol (see below section 5.1).</seg>
<seg id="1795">"clinical trials in various indications, including allergic reactions of 5 mg daily 3% more side effects in patients with Aerius tablets, when patients treated with placebo."</seg>
<seg id="1796">"results appear ordered" "by relevance" "or" "by date" "(publication date),"</seg>
<seg id="1797">"in two individual dosis studies, Aerius Lyinlisations have been documented by clinical laboratory examinations, medical examinations, Vitalsign and EKG-Intervalldata."</seg>
<seg id="1798">"in the framework of a clinical study with multi-disciplinary study in a dosage of up to 20 mg daily over 14 days, there was no statistically significant or clinically relevant cardiovascular effect."</seg>
<seg id="1799">"in a clinical study, in Desloratopic study, in a dosage of 45 mg daily (the Neal of the clinical dose) over ten days, no extension of the Qtc-Intervalls."</seg>
<seg id="1800">"in controlled clinical trials, the recommended dose of 5 mg daily has no increased frequency of sludge compared to placebo."</seg>
<seg id="1801">"with an 17 single dose study with adults, Desloratance 5 mg does not influence on standard - measuring formats of the fluency, including the adjustment of the subjective or the tasks that are connected to the flies."</seg>
<seg id="1802">"in patients with allergic rhags, Aerius tablets reduce symptoms of symptoms like Niesen, nasal-tion and itching of the nose, itching flow and redness of the eyes, as well as Juckreiz on palms."</seg>
<seg id="1803">"as well as the overall evaluation of the questionnaire of the quality of the quality of the life of Rhino-morphology, Aerius has been generated by seasonal allergic reactions."</seg>
<seg id="1804">"18 In a pharmacokinetic study, which were comparable to patients with general seasonal allergic reactions in the population was comparable to 4% of the patients a higher concentration of Desloratoms."</seg>
<seg id="1805">Food has no significant influence on AUC and CMAx by Aerius Lyrics.</seg>
<seg id="1806">Gelatine Mannitol Avalon (E 951) Polymers of color Opatint red (contains iron (III) -oxide (E 172) and Hypromall (E 464) and Hypromless (E 464)</seg>
<seg id="1807">"a Aerius 2.5% melting temperature is once every day in the mouth, to reduce the symptoms of allergic rhinitis (including interruptions and Persian leachs) and Urtikaria (see below section 5.1)."</seg>
<seg id="1808">Two Aerius 2.5 mg melting-tabletts once every day in the mouth are allergic to the symptoms of allergic rhinitis (including interruptions and Persian leinitis) and Uronomaria (see below section 5.1).</seg>
<seg id="1809">There are limited experience in clinical trials related to the effectiveness of Deslorateurs with youth from 12 to 17 years (see Abbreviation 4.8 and 5.1)</seg>
<seg id="1810">"immediately before the application, the Blister has been carefully opened and the dose of the melt can be removed without them."</seg>
<seg id="1811">The efficacy and inhumility of Aerius 2.5 mg melting point during treatment of children under 6 years.</seg>
<seg id="1812">The total amount of side effects of side effects between the Desloratadine Sirup- and the placebo group was equal and did not significantly improve safety profile.</seg>
<seg id="1813">"at the recommended dose, Aerius melting temperature is equivalent to the Aerius 5 mg conventional tablets."</seg>
<seg id="1814">"in the framework of a clinical study with multi-disciplinary study in a dosage of up to 20 mg daily over 14 days, there was no statistically significant or clinical trials."</seg>
<seg id="1815">"with an individual dosis study with adults, Desloratance 5 mg does not influence on standard - measurement sizes of fluency, or the tasks that are connected with the flies."</seg>
<seg id="1816">"the spread of this poorly metabolic phenotype was comparable for adult (6%) and papdiatric patients between 2 and 11 years (6%, children 3%, children 3%), the safety profile of this patient was not too bad."</seg>
<seg id="1817">"this paper investigates the impact of non-take-up for two hypothetical scenarios, namely increasing and decreasing the base amount of social assistance in Germany by €100 per month. IAB-Discussion Paper 20 / 2015"</seg>
<seg id="1818">Aerius 2.5 mg tablets have been tested in papdiatric patients to support the pharmacokinetic data for Aerius melting point for children from 6 to 11 years.</seg>
<seg id="1819">Food has no significant influence on AUC and CMAx by Aerius Aerius Lyrics.</seg>
<seg id="1820">"the overall analysis of the clinical and clinical trials tests for the melting paper, that this formulation is an uncertain risk for local irritations in clinical application."</seg>
<seg id="1821">"if you have any queries, please contact us on Tel.: + 49 5764 318 444. or contact us per email."</seg>
<seg id="1822">"the cold paints is made of polyvinylchloride (PVC) cut in a related polyamide (OPA) film, liable on a aluminium foil, worn on a polyvinylchloride (PVC) film."</seg>
<seg id="1823">"a Aerius 5 mg of melt capacists once every day in the mouth, to reduce the symptoms of allergic rhinitis (including interruptions and Persian initis) and urine. (see below section 5.1)."</seg>
<seg id="1824">"at the recommended dose, Aerius 5 mg sensitive tablets as biodegradable, the Aerius 5 mg of conventional tablets."</seg>
<seg id="1825">"in the framework of a clinical study with multi-disciplinary study in a dosage of up to 20 mg daily over 14 days, there was no statistically significant or clinically relevant cardiovascular effect."</seg>
<seg id="1826">"with an 30 single dose study with adults showed Desloratance 5 mg no influence on standard - measuring sizes of the fluency, including the adjustment of the subjective or the tasks that are connected to the flies."</seg>
<seg id="1827">"in patients with allergic rhags, Aerius tablets reduce symptoms of symptoms like Niesen, nasal-tion and itching of the nose, itching flow and redness of the eyes, as well as Juckreiz on palms."</seg>
<seg id="1828">"in single dosis-crossover studies of Aerius 5 mg sensitive tablets with Aerius 5 mg conventional tablets or Aerius 5 mg lyophilisation, the formulations of biodegradable."</seg>
<seg id="1829">"the overall analysis of the clinical and clinical trials tests for the melting paper, that this formulation is an uncertain risk for local irritations in clinical application."</seg>
<seg id="1830">"the security of Desloratronic in children between 2 and 11 years, the metabolic rate is identical to the children, the normal metering."</seg>
<seg id="1831">"this medication contains Sorbitol, therefore should not take patients with fixed problems of frucTuscan intensity and glucose-absorption, glucose oxidase-absorption and insufficiency of this medicine."</seg>
<seg id="1832">The total amount of side effects of side effects in children between 2 and 11 years was similar to the placebo group.</seg>
<seg id="1833">"in small children between 6 and 23 months were the most common side effects, more often than placebo, diarrhoe (3,7%), fever (2,3%), fever (2,3%)."</seg>
<seg id="1834">"in an additional study, a single dose of 2.5 mg Desloratopic solution do not take any side effects in patients with age between 6 and 11 years."</seg>
<seg id="1835">Firm of the Year for Insolvency Administration Schneider Geiwitz & Partner Firm of the Year for Tax Gleiss Lutz Firm of the Year for Tax Gleiss Lutz</seg>
<seg id="1836">"in controlled clinical trials, the recommended dose of 5 mg daily for adults and adolescents are no increased frequency of sludge compared to placebo."</seg>
<seg id="1837">"in addition to the established classification in seasonal and perennial, allergic against infections, can also be allergic to the duration of symptoms."</seg>
<seg id="1838">"as well as the overall evaluation of the questionnaire of the quality of the quality of the life of Rhino-morphology, the Aerius tablets effectively reduce the resulting from seasonal allergic reactions."</seg>
<seg id="1839">"the spread of this limited metabolic phenotype was comparable to adults (6%) and children between 2 and 11 years (6% adults, 16% children) than in Kaukasians (2% adults, 3% children)."</seg>
<seg id="1840">"since Aerius solution is required to take the same concentration at desloratance portfolio, it was not required to expect the Sirup and tablets."</seg>
<seg id="1841">"in various individual dosis studies showed that AUC and CMAx values of Desloratopic patients were comparable to those of adults, the Desloraty-Sirup to a dosage of 5 mg."</seg>
<seg id="1842">"Sorbitol, Propylenglysis, Sucralose E 2910, Hypromower E 2910, sodium citrate 2 H2O, natural and artificial flavors (Bubble-Gum), water-free Citronised acid, sodium-free Citronised acid, sodium-free Citrongic, sodium."</seg>
<seg id="1843">"Aerius solution will take place with 30, 50, 60, 100, 120, 150, 150, 150, 150, 150, 150, 150, 150, 150, 150 and 300 ml in type III Braunglasers with a soft-proof polyethylene-proof coat."</seg>
<seg id="1844">All packaging sizes except the 150 ml package size are offered by a measuring spoon with markings for dosing units of 2.5 ml and 5 ml.</seg>
<seg id="1845">The 150 ml package size is a measuring spoon or an applicability for use with scalp of 2.5 ml and 5 ml.</seg>
<seg id="1846">"subsequently, the approval of the approval of the approval of the approval are regularly updated regularly over the unthinkable reports of a drug by all two years, except it will be something of the CHMP."</seg>
<seg id="1847">1 movie tablettered 5 film tabletterior 14 film tabletterten film tabletterten film tabletterten film tabletterten film tables</seg>
<seg id="1848">1 movie tablettered 5 film tabletterior 14 film tabletterten film tabletterten film tabletterten film tabletterten film tables</seg>
<seg id="1849">Sirup 30 ml with 1 measuring spoon 60 ml with 1 measuring spoon 150 ml with 1 measuring spoon 150 ml with 1 measuring spoon 150 ml with 1 measuring spoon 150 ml with 1 measuring spoon 150 ml with 1 measuring spoon 150 ml with 1 measuring spoon</seg>
<seg id="1850">30 ml with 1 measuring spoon 60 ml with 1 measuring spoon 150 ml with 1 measuring spoon 150 ml with 1 measuring spoon 150 ml with 1 measuring spoon 150 ml with 1 measuring spoon 150 ml with 1 measuring spoon</seg>
<seg id="1851">1 dosage lyophilisat to take part 1 cans lyophilisat for the take 20 cans lyophilisat for the take 20 cans lyophilisat for the take 20 cans lyophilisat for taking a 100 cans lyophilisat for taking a 100 cans lyophilisat for the use of 100 cans lyophilisat for taking a 100 cans lyophilisat for the use of 100 cans lyophilisat for taking a 100 cans lyophilisat for the use of 100 cans lyophilisat for the use of 100 cans lyophilisat for the use of 100 cans lyophilisat for the use 100 cans lyophilisat for the use of 100 cans lyophilisat for the use of 100 cans lyophilisat for the use 100 cans lyophilisat for the use 100 cans lyophilisat for the use 100 cans lyophilisat for the use 100 cans lyophilisat for the use 100 cans lyophilisat for the use 100 cans lyophilisat for the use 100 cans lyophilisat for the use 100 cans lyophilisat for the use 100 cans lyophilisat for the use 100 cans lyophilisat for the use 100 cans lyophilisat for the use 100 cans lyophilisat for the use 100 cans lyophilisat for the use 100 cans lyophilisat for the use 100 cans lyophilisat for the use 100 cans lyophilisat for the use 100 cans lyophilisat for the use 100 cans lyophilisat for the use 100 cans lyophilisat for the use 100 cans lyophilisat for the use 100 cans lyophilisat for the use 100 cans lyophilis</seg>
<seg id="1852">5 melting-tabletterten melt tabletterated 30 melting-tabletterated 30 melting tabletterior 90 melting-tabletterior 90 melting-tabletterior 90 melting-tabletterior 90 melting-tabletterior 90 melting-tabletterior 90 melting-tabletterior 90 melting-tabletterior 90 melting-tabletterior 90 melting-tabletterior 90 melting-tabletterior 90 melting-tabletterior 90 melting-tabletterior 90 melting-tabletterior 90 melting-tabletterior 90 melting-tabletterior 90 melting-tabletterior 90 melting-tabletterior 90 melting-tabletterior 90 melting-tabletterior 90 melting-tabletterior 90 melting-tabletterior 90 melting-tabletterior 90 melting-tabletterior 90 melting-tabletterior 90 melting-tabletterated 90 melting-tabletterated 90 melting-tabletterten melting-tabletter</seg>
<seg id="1853">4ml with 1 measuring spoon 60 ml with 1 measuring spoon 150 ml with 1 measuring spoon 150 ml with 1 measuring spoon 150 ml with 1 measuring spoon 150 ml with 1 measuring spoon 150 ml with 1 measuring spoon 150 ml with 1 measuring spoon 150 ml with 1 measuring spoon</seg>
<seg id="1854">The pregnancy and the time questions you during pregnancy and treatment time before taking your doctor or pharmacist for advice.</seg>
<seg id="1855">Transport and filling of machines for application in the recommended dosage is not therefore expected that Aerius leads to Benomoneness or the attention.</seg>
<seg id="1856">"if you have spoken by your doctor, you have an inverter against certain sugar, ask your doctor before you are taking this medicine."</seg>
<seg id="1857">"regarding the treatment duration, your doctor will find the type of allergic rhinitis that you suffer and will determine how long you are using Aerius."</seg>
<seg id="1858">The symptoms less than 4 days per week may occur or less than 4 weeks or less than 4 weeks.</seg>
<seg id="1859">If your allergic rhinitis can occur (the symptoms of 4 or more days per week and more than 4 weeks) can make your doctor give you a longer lasting treatment.</seg>
<seg id="1860">"if you have forgotten your dose of Aerius if you have forgotten your dose time, take it as soon as possible, and follow the normal treatment."</seg>
<seg id="1861">"71 After the market launch of Aerius, there was very rare cases of serious allergic reactions (difficulties during breathing, tubes of breathing, itrots and swelling) and rash."</seg>
<seg id="1862">"in case of cases of heart attack, heart disease, abdominal pain, vomiting, vomiting, diarrhobic, diarrhobic, diarrhobic, diarrhobic, diarrhobic, diarrhobic, diarrhobic, diarrhobic, diarrhoea, diarrhoea, diarrhoea, diarrhoea, diarrhoea, diarrhoea, diarrhoea, diarrhoea, diarrhoea, diarrhoea, diarrhoea, diarrhoea, diarrhoea, diarrhoea, diarrhoea, diarrhoea, diarrhoea, diarrhoea, diarrhoea, diarrhoea, diarrhoea, diarrhoea, diarrhoea, diarrhoea, diarrhoea, diarrhoea, diarrhoea, diarrhoea, diarrhoea, diarrhoea, diarrhoea, diarrhe</seg>
<seg id="1863">"contains lactosos monohydrate, Hypromless, Titanium oxide, with gol 400, indigocarmin (E 132)), coloured film (contains hypromall), colourless wax."</seg>
<seg id="1864">"Aerius 5 mg film table with 1, 2, 3, 5, 7, 10, 20, 20, 20, 30, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90,</seg>
<seg id="1865">"Aerius Sirup is shown for children aged between 1 and 11 years, young people (12 years and older) and adults, older people included."</seg>
<seg id="1866">Important information about certain other components of Aerius Sirup should not use Aerius Sirup when you are allergic to dyes E 110.</seg>
<seg id="1867">Please contact your doctor before you are taking your doctor before you are taking this medicine.</seg>
<seg id="1868">"when the Sirup an applicator of applicator and preparation for the use of scalp, you can use these alternatively, to increase the appropriate amount of sip."</seg>
<seg id="1869">"regarding the treatment duration, your doctor will find the type of allergic rhinitis that you suffer and will determine how long you have to use Aerius Sirup."</seg>
<seg id="1870">"however, during children under 2 years of blood, fever and sleep problems were frequent side effects, during adults and headache and headache, as well as placebo."</seg>
<seg id="1871">"after launch of Aerius, it was very rare about cases of serious allergic reactions (difficulties during breathing, tubes of breathing, itrots and swelling) and rash."</seg>
<seg id="1872">"77 Aerius Sirup is available in bottles with care of 30, 50, 60, 100, 120, 150, 150, 225 and 300 ml."</seg>
<seg id="1873">Aerius Lyinlisation improves the symptoms of allergic rhags (through an omnipotent inflammation of the nose, for example, hay fever or house-dust-allergy). "</seg>
<seg id="1874">"at the use of Aerius lyophilisat, take care of food and drinks Aerius Lyinlisation for one needs not to be taken with water or other liquid."</seg>
<seg id="1875">"regarding the treatment duration, your doctor will find the type of allergic to initis below that you suffer and will determine how long you are allergic to Aerius Lyinlisation."</seg>
<seg id="1876">"81 If you don't forget to forget your dose time, take it as soon as possible, and follow the normal treatment."</seg>
<seg id="1877">"after launch of Aerius, it was very rare about cases of serious allergic reactions (difficulties during breathing, tubes of breathing, itrots and swelling) and rash."</seg>
<seg id="1878">"Aerius lyophilisat is individually used in Blister packaging with 1, 2, 3, 5, 7, 10, 20, 20, 20, 30, 50, 50, 50, 50, 50 or 100 cans of lyophilisations."</seg>
<seg id="1879">"Aerius melting temperature improves the symptoms of allergic reactions (through an omnipotent inflammation of the nose, for example, hay fever or house-dust-mild - Allergy)."</seg>
<seg id="1880">"in addition of Aerius melting furnaces together with food supplements and drinks, Aerius melting powder needs not to be taken with water or other liquid."</seg>
<seg id="1881">"regarding the treatment duration, your doctor will find the type of allergic rhinitis that you suffer and will determine how long you are using Aerius melting-tabletins."</seg>
<seg id="1882">"86 If you forget the use of Aerius melting pasta, if you have forgotten your dose of time, take it as soon as possible, and follow the normal treatment."</seg>
<seg id="1883">"Aerius Necklaces are individually used in Blister packaging with 5, 6, 10, 12, 20, 20, 20, 60, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90, 90,</seg>
<seg id="1884">"in addition of Aerius melting furnaces together with food supplements and drinks, Aerius melting powder needs not to be taken with water or other liquid."</seg>
<seg id="1885">"if you don't forget to forget your dose time, take your dose time, take it as soon as possible, and follow the normal treatment."</seg>
<seg id="1886">"after launch of Aerius, it was very rare about cases of serious allergic reactions (difficulties during breathing, tubes of breathing, itrots and swelling) and rash."</seg>
<seg id="1887">"Aerius solution is displayed for children aged between 1 and 11 years, young people (12 years and older) and adults, older people included."</seg>
<seg id="1888">"if the solution for an application to take an application form for use with scalp, you can use these alternatively, to take advantage of the appropriate amount of solution."</seg>
<seg id="1889">"regarding the treatment duration, your doctor will find the type of allergic rhinitis that you suffer and will determine how long you use Aerius solution to take."</seg>
<seg id="1890">"however, during the children under 2 years, fever and sleep problems were frequent side effects during adults, mouth dry and headache on placebo."</seg>
<seg id="1891">"97 Aerius solution is available in bottles with childless sprains with 30, 50, 60, 100, 120, 150, 150, 225 and 300 ml."</seg>
<seg id="1892">"the 150 ml package size is a measuring spoon or a application for use with scalp of 2,5 ml- and 5 ml cans."</seg>
<seg id="1893">"June 2008, Novartis Vaccines and Diagnostics S.r.l. is officially recognized by the Committee for Human Physicians (CHMP) for the prevention of avid H5N1-Influenza for adults and older people."</seg>
<seg id="1894">Aflunov should be caused by adults and older people to protect against flu which caused by the tribe (type) H5N1 of the Influenza-A virus.</seg>
<seg id="1895">This is a special kind of vaccine that could cause a tribe of Grippevirus who might cause future pandemia.</seg>
<seg id="1896">"a Grippepandemie breaks out, when a new trunk of the Grippevirus occurs, which can be easily transformed from human beings, because the people still have no immunity (no protection)."</seg>
<seg id="1897">"after completing the vaccine, the immune system is detrimental to the vaccine contained in the vaccine and forms of antibodies, and forms antibodies."</seg>
<seg id="1898">This is the immune system later in the position to form a contact with a Grippevirus of this family-body.</seg>
<seg id="1899">"subsequently, the membranes of the virus is used with the" surface antigens "(proteins on the membrane surface that detects human body as a physical organism), cleaned and as an ingredient of the vaccine."</seg>
<seg id="1900">A inspections of some of the study centres showed that the study is not performed according to the "good clinical practice" (GCP).</seg>
<seg id="1901">This allows the scope of clinical data base for evaluation of the vaccines in order to fulfill the demands of the guidelines of the EMEA for preventive vaccines.</seg>
<seg id="1902">"if you need a clinical examination and further information about your treatment, please contact your doctor."</seg>
<seg id="1903">"for more information about the recommendations of the CHMP, please read the scientific discussion (also part of the EPAR)."</seg>
<seg id="1904">"it is caused in combination with other antiviral medicines to treat adults and children over four years, which causes the acquired immune defence of the type 1 (HIV-1) which caused the acquired immune defence (AIDS)."</seg>
<seg id="1905">"for patients, the capsules cannot be swallow as a solution to take place, but this cannot be taken together with Ritonavir since the safety of this combination was not examined."</seg>
<seg id="1906">"Agenerase should be determined only if the doctor tested, which has been tested, which has been corrected, and the likelihood that the virus has been taken to the drug."</seg>
<seg id="1907">The recommended dose for patients over twelve years is 600 mg twice daily.</seg>
<seg id="1908">"in children between four and twelve years and with a body weight of less than 50 kg, the recommended dose of Achemase after the body weight."</seg>
<seg id="1909">"gases are reduced in consumption with other antiviral medicines, the HIV amount in blood and holds it at a low level."</seg>
<seg id="1910">"however, AIDS cannot be avoided, however, the damage of the immune system and thus also the development of AIDS infections and diseases."</seg>
<seg id="1911">"Agenerase was investigated in combination with other antiviral drug, but without Ritonavir, in two main studies with 736 HIV infected adults, which were not treated with proteasiness."</seg>
<seg id="1912">"with low dosile Ritonavir reinforced medicine, Achemase was compared with 206 adults who were compared with other proteasthenia."</seg>
<seg id="1913">Main indicator for the effectiveness of patients with non-infected concentrations of HIV in blood (Viral load) or the change of virusload according to the treatment.</seg>
<seg id="1914">"in the studies with patients who had no proteasiness had been taken up to 48 weeks, after 48 weeks, a virus was less effective than placebo, but Achemase was less effective than indinavir."</seg>
<seg id="1915">"at the same time, Achemase also been treated to the viral load, but of the children who were treated with proteasiness, only very few to the treatment."</seg>
<seg id="1916">"in the study with adults who were treated with proteasticism were treated with Ritchie, the Viral load after 16-weekly treatment as well as other proteins, as well as other proteins:"</seg>
<seg id="1917">"in patients with HIV, which was resistant to four other proteasets, it was resistant to Achemase together with Ritonavir at a more powerful waste of the virusload after four weeks."</seg>
<seg id="1918">"results appear ordered" "by relevance" "or" "by date" "(publication date),"</seg>
<seg id="1919">2 / 3 Agenerated images may not be applied to patients who may be oversensitive (allergic) against amalavir or one of the other components.</seg>
<seg id="1920">Achemase may not be applied in patients who are born in patients who are constructed (a herbal supplement to treatment of depression) or medications that are just as Agenerase in the blood of harmful substances in the blood of harmful substances.</seg>
<seg id="1921">"as in other medicines against HIV, the risk of a librystrophie (changes in the distribution of the body fat), one osteoneksis (Abdie of bone tissue) or an immunologic syndromes (symptoms of infection, which causes a relaxing immune system)."</seg>
<seg id="1922">"the Committee for Human Physicians (CHMP) came to the end that the advantages of Achemase in application in combination with other antiretroviral medications for treatment of HIV-1-infected adults and children over four years, compared to the risks."</seg>
<seg id="1923">"Achemase is generally taken together with the pharmacokinetic amplifiers, but the committee ordered that the benefit of Agenerase in combination with Ritonavir in patients who have no prototype was not detected."</seg>
<seg id="1924">"Achemase was originally admitted under" extraordinary circumstances, since the time of approval from scientific reasons only limited to information. "</seg>
<seg id="1925">"October 2000, the European Commission sent the European Commission for Glaxo Group Limited, an approval for the inbox of Agenerase in the entire European Union."</seg>
<seg id="1926">Agenerase is available in combination with other antiretroviral medications for treating HIV-1- ininfected, proteasculmer (PI) treatment and children from 4 years. "</seg>
<seg id="1927">"for example, Achemase capsules for pharmacokinetic Boosts of Amendavir (see Abbreviation 4.2 and 4.5)."</seg>
<seg id="1928">The use of Amendavir should be made under consideration of the individual viral resistance and the pre-treatment of the patient (see section 5.1).</seg>
<seg id="1929">The bending feet of the Amendavir is as a solution for insertion is 14% less than of Amendavir as a capsule; therefore Achemase capsules and solution can be exchangeable at a milligram of milligram (see section 5.2).</seg>
<seg id="1930">The recommended dose for Achemase capsules is 600 mg Amendavir twice a day together with a 100 mg konavir twice daily in combination with other antiviral viral cancer.</seg>
<seg id="1931">2 If aphroase capsules can be applied without the amplification of Ritonavir (Boosts) must be applied to Achemase (1200 mg twice daily).</seg>
<seg id="1932">The recommended dose for Achemase capsules is 20 mg Amendavir / kg body weight twice daily in combination with other antiretroviral medications until a daily dose of 4mg Amendavir that should not be exceeded. (see paragraph 5.1).</seg>
<seg id="1933">"the pharmacokinetics, efficacy and safety of Achemase in combination with low cans of Ritonavir or other proteins were not examined with children."</seg>
<seg id="1934">"Achemase is not recommended for the application for children under 4 years, due to the absence of data to unthinkable and effectiveness (see section 5.2)."</seg>
<seg id="1935">"based on the pharmacokinetic data, the dose of Achemase capsules should be reduced at 450 mg twice daily and in patients with severe liver dysfunction on 300 mg twice daily."</seg>
<seg id="1936">"the simultaneous application should be done with light or moderate liver dysfunction, in patients with severe liver dysfunction (see paragraph 4.3)."</seg>
<seg id="1937">Achemase cannot be used simultaneously with medication that have a low therapeutic width and also substrates of the Cytochrom P450-Isoyms 3A4 (CYP3A4).</seg>
<seg id="1938">"herbal supplements, St. John's wort (Hypericum perforatum) are included, due to the risk of reduced plasma concentrations and a reduced therapeutic effect of amalavir (see paragraph 4.5)."</seg>
<seg id="1939">Patients should be aware that Achemase or any other antiretroviral therapy does not affect HIV infection or other complications such as HIV infection or other complications of an HIV infection.</seg>
<seg id="1940">"the current anti-viral therapy including the treatment with Achemase does not prevent the risk of HIV to other by sexual contact or contamination with blood."</seg>
<seg id="1941">"for example, Achemase capsules together with low cans of Ritonavir and in combination with other antiretroviral medications (see paragraph 4.2)."</seg>
<seg id="1942">"patients who suffer from chronic hepatitis B or C, and with an antiviral viral therapy, have increased risk of severe liver problems with potentially fatal consequences."</seg>
<seg id="1943">"for the case of simultaneous anti-viral treatment of hepatitis B or C, please read the subject information of this medicine."</seg>
<seg id="1944">"patients with pre-existing liver function including an chronically active hepatitis function, an increased frequency of liver dysfunction, and should be monitored according to clinical practice."</seg>
<seg id="1945">"the simultaneous application of Agenerase and Ritonavica, which are not recommended, it is not recommended, it is not recommended that the possible benefit of a treatment of systemically cortitigoider effects including Morbus Cushing and support of the adrenal function (see paragraph 4.5)."</seg>
<seg id="1946">"since the reduction of the HMG-COA-Reinductase-Hemmer Lovastatin and Simulations are strongly recommended by CYP3A4, it is not recommended for simultaneous risk of myopathy including Rhabdomyolysis."</seg>
<seg id="1947">"4 For a few medicines that may cause serious or life-threatening effects, such as Carbohydrepin, Phenomarbital, phenytoin, tricycle antidepressants, phenytoin, tricyclic antidepressants and warnings (under monitoring of the International Monetary Union Ratio), methods for determination of the drug concentrations."</seg>
<seg id="1948">"patients who use this medicine at the same time, Achemase can be less effective (see paragraph 4.5)."</seg>
<seg id="1949">"due to the possibility of metabolism with Amendavir, the efficacy of hormonal contraceptiva can be changed, however, the information is not sufficient to estimate the type of interactions."</seg>
<seg id="1950">"if methadon at the same time, the patient should therefore be monitored at the same time, the patient should therefore be monitored at Opiatopic symptoms, especially if there is even low doses of Ritonavir."</seg>
<seg id="1951">"because of the possible risk of a toxicity due to the increased risk of a toxicity due to the high dehydrate solution, this darling solution will be applied to children under a age of four years, and should be used with certain patient groups."</seg>
<seg id="1952">Ageneration should be set up to Duration or allergic symptoms of systemic or allergic symptoms (see section 4.8).</seg>
<seg id="1953">"patients who received an antiviral viral therapy including proteasthenia, hyperglycemia or a Exacerbation of a existing diabetes mellitus."</seg>
<seg id="1954">Many of the patients had different diseases to their therapy medicines they were required with the development of a diabetes mellitus or a hyperglycemia.</seg>
<seg id="1955">"B. higher age, and with drug-dependent factors such as a longer lasting antiviral disorders and the associated metabolic disorders."</seg>
<seg id="1956">"for patients (type A and B), which have been treated with proteasiness, reports reports about an increase of blood vessels, including spontaneous views and hemisphere."</seg>
<seg id="1957">"during the time of the introduction of an antiviral viral therapy (ART), an anti-inflammatory reaction to asymptomatic or resistant infections, which leads to severe clinical conditions or degradation of symptoms."</seg>
<seg id="1958">"although a multidisciplinary approach is accepted (including the application of corticosteroids, alcohol consumption, severe immunity, higher body analysis, and / or long-term application of an anti-viral therapy therapy (ART)."</seg>
<seg id="1959">"CYP3A4 substrates with low therapeutic width Ageneration, not at the same time with medication that have a low therapeutic width and also substrates of the Cytochrom P450-Isov 3A4 (CYP3A4)."</seg>
<seg id="1960">"CYP2D6 substrates with low therapeutic width Agenerase with Ritonavir may not be combined together with drug products such as CYP2D6, and for increased plasma cutting with serious and / or life threatening effects."</seg>
<seg id="1961">It was shown that Rifampicin a 82% reduction in the AUC of Amendavir caused to lead to a virological disorders and a resistance.</seg>
<seg id="1962">"in the attempt to increase the lower plasma cutting of other proteins in combination with Ritonavir, very often unwanted effects on the liver."</seg>
<seg id="1963">St. John's wort (Hypericum perforatum) The Serum mirror of Amendavir can be reduced by the simultaneous application of herbal supplements. St. John's wort (Hypericum perforatum).</seg>
<seg id="1964">"when a patient already exists curators, the Amendavid mirror and when possible to check the virusload and the curisites."</seg>
<seg id="1965">It is not necessary if the naviavir is given together with Amendavir (see also Efavirenz below).</seg>
<seg id="1966">"508% increase, for CMAx, when Ritonavir (100 mg twice daily) in combination with Amendavir capsules (600 mg twice daily)."</seg>
<seg id="1967">"in clinical trials, Dosification of 600 mg Amendavir twice daily and Ritonavir 100 mg twice daily, the efficacy and unthinkable of this treatment plan."</seg>
<seg id="1968">52% lower than Amendavir (750 mg twice daily) in combination with Kaletra (400 mg Lopinavir + 100 mg konavir twice daily).</seg>
<seg id="1969">The Cmin values from Amendra (600 mg twice daily) with caletra (600 mg twice daily) with caletra (600 mg twice daily) in combination with 100 mg konavir twice daily).</seg>
<seg id="1970">"a docking recommended for simultaneous translation of Amendavir and Kaletra is not given, however, it is not known, however, it is not known to be known as the efficacy and unthinkable of this combination."</seg>
<seg id="1971">"there was no pharmacokinetic study to use Agenerated images in combination with Didanosin combination, but due to the component of Didanosin and Agenerase at least one hour (see Antazida below)."</seg>
<seg id="1972">"therefore, the gift of Efavirenz in combination with Amendavir (600 mg twice daily) and Ritonavir (100 mg twice daily) and Ritonavir (100 mg twice daily)."</seg>
<seg id="1973">"the treatment with Efavirenz in combination with Amendavir and Saquinavir is not recommended, since the exposure of both proteasets would be low."</seg>
<seg id="1974">The effect of Nevirapin pin on other proteasets and existing limited data can be identified that Nevirapin the Serum concentration of amalavir may occur.</seg>
<seg id="1975">"if this medication is used to be used, as Delavirdin is less effective because of the reduced and possibly subtherapeutic plasmaspire less effective."</seg>
<seg id="1976">"if these medicines are applied together, a thorough clinical and virological monitoring should be made, as a detailed prediction of the combination of amalavir and Ritonavir on Delavirdin is difficult."</seg>
<seg id="1977">Simultaneous translation of the Amendavir and Rivera utin led to a rise of the plasma concentrations (AUC) of Rip utin to 193% and thus to increase side effects with Rip utin's side effects.</seg>
<seg id="1978">"when it comes from clinical reasons, Rivera utin together with Achemase, is recommended to reduce the dosage of Rip utin to at least half of the recommended dose, although there is no clinical data."</seg>
<seg id="1979">Pharmacokinetic studies with Achemase in combination with Erythromycin could not be carried out, but the plasma cutting of both medicines could be increased. "</seg>
<seg id="1980">The simultaneous application of twice daily 700 mg Fetoconazol was once a daily basis to increase the CMAx by Ketoconazol once a day without simultaneous application of Fosamprenazol once a day without simultaneous application of Fosamprenazol once a day without simultaneous application of Fosamprenazol.</seg>
<seg id="1981">"other medicines which are listed below are listed below, including substrates, Hemmer or inductors of CYP3A4, if they are used together with Agenerated images."</seg>
<seg id="1982">"patients should therefore be connected to toxic reactions that are associated with these medicines, if they are applied in combination with Agenerated images."</seg>
<seg id="1983">"based on the data of other proteins, it is advisable to be taken to be taken at the same time as Ageneration."</seg>
<seg id="1984">"simultaneous application of anti-vulsiva, which are known as enzymes (phenytoin, Phenobarbital, Carbamazeptic), with Amendavir can lead to an increase of plasma cutting."</seg>
<seg id="1985">"the Serum concentrations of calcium carbonate, violine pin, pin pin, pin pin, pin pin, pin pin, pin pin, pin pin, pin pin, pin pin, pin pin, pin pin, pin pin, pin pin, pin pin"</seg>
<seg id="1986">(see paragraph 4.4) and amplify their plasma concentrations using PDE5 inhibitors (see paragraph 4.4).</seg>
<seg id="1987">"in a clinical study, in the Ritonavir 100 mg capsules twice daily (4-times daily) over 7 days, the fluticasonprofiled cortisol to approximately 86% abused (90% -Confidence interval 82 to 89%)."</seg>
<seg id="1988">"the simultaneous translation of Agenerase with Ritonavir is not recommended, it is not recommended that the possible benefit of the risk of a treatment systemic corrosive effects (see paragraph 4.4)."</seg>
<seg id="1989">"in HMG-COA-Reinductase inhibitors such as Lovastatine and Simulations, whose fuel-changing of CYP3A4 is dependent on the demand of plasticides at the same time."</seg>
<seg id="1990">"as plasticides of these HMG-COA-Reinductase inhibitors can lead to myopathy including a Rhabdomyolysis, the combined use of these medicines are not recommended."</seg>
<seg id="1991">"it will be a frequent monitoring of the therapeutic dosage to stabilize the mirror, as the plasma concentrations of Cycliporin, Rapamycin and Tacrolimus can be increased (see paragraph 4.4)."</seg>
<seg id="1992">"therefore, Achemase cannot be applied together with oral Midazolam (see paragraph 4.3), during the application of Agenerase with parenteral Midazolam."</seg>
<seg id="1993">Data for simultaneous application of parenteral Midazolam using the other proteasolat by Midazolam around the 3- to 4 times.</seg>
<seg id="1994">"when methadon together with Amendavir, the patient should therefore be monitored at Opiatularly symptoms, especially if there is still low doses of Ritonavir."</seg>
<seg id="1995">"due to the low weight reduction of historic vehicles, there may be no recommendation, such as the Amendavir- dose can be adjusted when amacavir at the same time it is possible to use methadon."</seg>
<seg id="1996">(see paragraph 4.4) for simultaneous removal of the INR (International Standard Series Ratio) due to the possibility of a weakening or reinforcement of antithromboating effect (see paragraph 4.4).</seg>
<seg id="1997">"the effect of an additional fee of Ritonavir on hormonal contrasts is not expected, therefore alternative methods are recommended."</seg>
<seg id="1998">A careful monitoring of therapeutic effects and side effects of tricyclic antidepressants (for example Desipramin and Nortryptilin) is recommended for example Desipramin and Nortryptilin).</seg>
<seg id="1999">This medicine may only be used during pregnancy only after careful consideration of the possible risks for the mother compared to the possible risks of the foetus.</seg>
<seg id="2000">"in the milk of milk, Amendavir-related substances have been detected, however, it is not known whether it is not known whether Amendavir near people into the mother's milk."</seg>
<seg id="2001">"a Reproductive study conducted in the uterus of the Uterus, in the uterus to the end of the breasts of Amendus, showed a reduced increase in the 12 body weight."</seg>
<seg id="2002">The further development of contemplation including Fertilation and Reproductive ability was not affected by the administration of Amendavir.</seg>
<seg id="2003">"in adults and children from 4 years in controlled clinical trials, combined with different other antiretroviral medications were investigated."</seg>
<seg id="2004">"however, most with the Achemase-treatment of side effects were easy to moderate, as early as and led to the treatment of treatment."</seg>
<seg id="2005">"in many of these events, it is not clarified whether they are in connection with the use of Agenerase or another at the same time for HIV treatment applied, or whether they are a result of the disease."</seg>
<seg id="2006">"most of the side-side effects are made from two clinical trials (PROAB3001, PROAB3006), in which with proteasiness no longer treated patients 1200 mg of Ageneration twice daily."</seg>
<seg id="2007">"events (degree 2 to 4) which were included by the investigative laboratory, and with more than 1% of the patients, as well as the treatment of laboratory changes (degree 3 to 4) are listed in the treatment of the patient (degree 3 to 4)."</seg>
<seg id="2008">"the antiviral viral therapy was associated with a redistribution of the body fat (Lipodystrophie) in HIV patients, including a loss of peripherical and visceral fat tissue, hypertrophie of breasts and dormitochrial fat (sticks)."</seg>
<seg id="2009">"under 113 antiviral viral not treated patients, which were treated with amalavir in combination with Lamivudin / Zidovudin in combination with Lamivudin / Zidovudin, was only a case (&lt; 1%)."</seg>
<seg id="2010">"in the study PROAB 3006, at 245 NRTI- recommended patients under Amendavir 7 cases (3%) compared to 27 cases (11%) in Indinavir, in combination with different NRTIs over a medium duration of 56 weeks (p &lt; 0.0001)."</seg>
<seg id="2011">"usually during the second treatment week, usually during the second treatment week, which had to be broken in two weeks, without that the treatment with Amendavir had to be broken."</seg>
<seg id="2012">Cases of Osteonekiah have been reported to patients with commonly known risk factors such as HIV infection or long-term application of a antiviral viral therapy (ART).</seg>
<seg id="2013">"during the time of the introduction of an antiviral viral therapy (ART), an anti-inflammatory reaction to asymptomatic or resistant infections (see section 4.4)."</seg>
<seg id="2014">"with PI pre-treated fluoronavica (100 mg twice daily), type and frequency of side effects (degree 3 to 4) and laboratory changes (degree 3 to 4) and laboratory changes (degree 3 and 4), which were observed under all of some Achemase treatment."</seg>
<seg id="2015">"in the case of a overdose, the patient is able to observe the symptoms of an intoxication (see section 4.8) if required, are necessary measures."</seg>
<seg id="2016">"amalavir binds to the active centre of the HIV-1 proteins and prevents the processimissive viral gagion and Gag-pol- polyprotections, not infectant viral particles."</seg>
<seg id="2017">"the antiviral activity in vitro against HIV-1 IIIB was investigated both an acute and chronic cell lines (MT-4, CEM-CCRF, H9) as well as peripheral blood vessels."</seg>
<seg id="2018">The 50% hemisphere (IC50) of Amendavir is located in the area of 0.012 to 0.008 µm at acute cells and amounts 0.41 µm at acute cells</seg>
<seg id="2019">The correlation between the activity of Amendavir against HIV-1 in vitro and inhibitory of HIV-1 replication at man is still not defined.</seg>
<seg id="2020">"at the treatment of antiviral viral cancer patients with the currently approved Fosamprenavir / Ritonavir-Dosification were rarely observed, as with other Ritonavir microscopic treatments - the mutations are rarely observed."</seg>
<seg id="2021">"during sixteen of 434 antigens viral non-treated patients, the 700mg Fosamprenavir twice daily in the study of 100732."</seg>
<seg id="2022">"a genotypical analysis of the Isolate of 13 of 14 children, including a virologistic culture within the 59-closed, showed a resistance pattern that were similar to adults."</seg>
<seg id="2023">"L10F / I / V, V11I, I10V, I47V, I47V, I47V, I47V, I47V, I47V, I47V, I84V, I84V, I84V, I85V, I85V, I85V, I85V, I85V, I90V, I90M, I90M, I90M, I90M, I93L / M."</seg>
<seg id="2024">"in the study APV30003 and its extension APV30005 (700 mg Fosamprenavir / 100 mg maconavir twice daily: n = 107), with proteasehemently treated patients with virologistic-mutations."</seg>
<seg id="2025">"based on genotypic resistance, based analyses of genotypical interpretability systems can be applied for controlling the activity of the amalavir / Ritonavir / Ritonavir / Ritonavir / Ritonavir."</seg>
<seg id="2026">"results appear ordered" "by relevance" "or" "by date" "(publication date),"</seg>
<seg id="2027">The conclusions regarding the relevance of certain mutations or mutations may be recommended by additional information and it is recommended to use the current interpretational systems for analysis of resistance tests.</seg>
<seg id="2028">"phosavir / Ritonavir or Fosamprenavir / Ritonavir / Ritonavir / Ritonavir / Ritonavir / Ritonavir / Ritonavir / Ritonavir / Ritonavir."</seg>
<seg id="2029">"companies, diagnostic resistance tests, clinically-phatic cut-cut (release points) for FPV / RTV, which can be applied to interpretation of results of a resistance tests."</seg>
<seg id="2030">"each of these four with a reduced sensitivity against the pathological patterns created a certain cross-resistance against amonavir, the sensitivity against Indinavir, the sensitivity against Indinavir, nfinavir and saquinavir remains in general."</seg>
<seg id="2031">"there are currently data for cross-resistance between the Amendavir and other proteins, for all 4 Fosamprenavir resistance, either alone or in combination with other nuts."</seg>
<seg id="2032">"at the base of five and twenty antiviral viral patients, the Fosaviavir / Ritonavir (three of 25 insulation), saunavir / Ritonavir (three of 25 insulation), saunavir / Ritonavir (three of 24 isolates) and Tionavir / Ritonavir (four of 24 insulation)."</seg>
<seg id="2033">"on the other hand, Amendavir represents his activity against some other proteasets-resistant insulation; the receipt of this activity seems to be dependent on the number and from the type of resistance-mutations in the insulation."</seg>
<seg id="2034">Early treatment is recommended to keep the accumulation of a multitude of mutations in limits which may result in subsequent treatment.</seg>
<seg id="2035">"the cover of the efficacy of Achemase in combination with Ritonavir 100 mg twice daily on the study PRO30017, a randomised open study, in which with PI treatment (600 mg twice daily) and nustiosidangera (100 mg twice daily) with Ritonavir (600 mg twice daily) and nustiosidangera (NRTI)."</seg>
<seg id="2036">"one hundred three-six hundred and sixty (n = 163) patients with the proven virus sensitivity compared to Ageneration, at least one of other PI and at least one NRTI have been included in the partial study A von PRO30017."</seg>
<seg id="2037">"the primary analysis confirmed the non-lower analysis of APV / Ritonavir compared to the SOC-PI group in view to the SOC-PI group in view to the SOC-PI group in view to the SOC-PI group (AAUCMB) in the plasma after 16 weeks, with a non-sublimiter of 0,4 log10 copies / ml."</seg>
<seg id="2038">The results of the efficacy of uncontrolled trials is based on two uncontrolled trials with a total 288 HIV infected children aged 2 to 18 years of which 152 with PI were treated.</seg>
<seg id="2039">"in the studies it became a daily basis, 20 mg / kg times daily, 20 mg / kg times daily, 20 mg / kg twice daily, 20 mg / kg twice daily, with the majority of patients 20 mg / kg twice daily."</seg>
<seg id="2040">At least one (78%) or two (42%) or two (42%) or two (42%) were obtained together with Agease NRTIs.</seg>
<seg id="2041">"after 48 weeks, approximately 25% of the study showed a plasma-HIV-1-RNA concentration &lt; 10,000 copies / ml and 9% &lt; 400 copies / ml at a median increase of CD4 cells / mm ³ (n = 74) compared to the output value."</seg>
<seg id="2042">"19 Basics on this data should be considered at the therapy optimisation of the treatment of the treated children of the same value of" unpooed "Achemase."</seg>
<seg id="2043">"after oregar, the average duration (tmax) up to maximum Serum concentration of amalavir about 1 to 2 hours for the capsule and about 0.5 to 1 hour for the solution."</seg>
<seg id="2044">508% increased by 30% when Ritonavir (100 mg twice daily) together with Amendavir (600 mg twice daily) together with Amendavir (600 mg twice daily).</seg>
<seg id="2045">"Amendavir is a 25% reduction in the AUC, but does not have effect on concentration of amalavir 12 hours after dosage (C12)."</seg>
<seg id="2046">"therefore, the minimum concentration in Steady-State (Cmin, ss) from the food intake (Cmin, ss) from the food intake (Cmin, ss) from the food intake."</seg>
<seg id="2047">The additional distribution volume is about 430 l (6 l / kg at a body weight of 70 kg) and can be closed on a large distribution volume of the blood circulation.</seg>
<seg id="2048">"this change leads to a decrease of the overall cycle of the active ingredient in plasma, with the amount of insufficient amblavir that remains unchanged, probably remains unchanged."</seg>
<seg id="2049">"during the absolute concentration of uninterrupted amblavir, the percentage of the free-active part of the free-active situation in the Steady-State over the area of CMAx, ss until Cmin, ss."</seg>
<seg id="2050">"therefore, medicines that CYP3A4 induced or infeed or a substrate of CYP3A4 (see Abbreviation 4.3, 4.4 and 4.5)."</seg>
<seg id="2051">"the gift of Agenerase capsules, either 20 mg / kg twice or 15 mg / kg times daily, leads to a similar daily amalavir-exposure as in adults with an dosage of 1200 mg twice daily."</seg>
<seg id="2052">"amalavir is made from the solution 14% less biologically active ingredient as from the capsules; therefore, Achemase solution and Achemase capsules cannot be exchangeable on a milliliter basis."</seg>
<seg id="2053">"also, the renal Clearance of Ritonavir must be neglected to the effect of a kidney function on the Elimination of Amendavir and Ritonavir."</seg>
<seg id="2054">This treatment plan can lead to amblavir plasma masonry to those who are achieved in healthy subjects after a dose of 1200 mg Amendavir twice daily without any simultaneous removal of Ritonavir.</seg>
<seg id="2055">"in long-term studies on the Kanzerosion with Amendavir of mice and rats, with male animals used for male animals, on the 2.0-wing (Mice) or 3,8- increments (rats) of exposure to the men, after twice a daily gift of 1200 mg Amendavir, said."</seg>
<seg id="2056">The 21 underlying mechanism for the formation of hepatoid cell membranes and carcinoma has not been weakened and the relevance of these observed effects on humans is unclear.</seg>
<seg id="2057">"data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data. why buy this report? * Get a detailed picture of the Baby Food market; * Pinpoint growth sectors and identify factors driving change; * Understand the competitive environment, the market's major players and leading brands;"</seg>
<seg id="2058">"in a standard battery of in-vivo- and in-vitro genotoxidiotic tests, the bacteria-test, micro-test test, micro-Lymphom test, micro-Lymphom test, and of chromosomatic lymphocytes."</seg>
<seg id="2059">This liver-toxic substances can be monitored in clinical health through measurement of AST, ALT and the activity of alkalinity phosphatase. "</seg>
<seg id="2060">"in clinical trials, there is no significant reduction in clinical trials at patients, neither during the application of Agenerase, nor after the end of the treatment."</seg>
<seg id="2061">"studies on toxicity, which have been treated by a age of 4 days, both in the control of the control of animals have a high Mortality."</seg>
<seg id="2062">"when systemic plasma concentrations were significantly higher (rabbits) or do not significantly higher (rats), however, a number of minor changes including Thymuselongation and minor skelongation may be observed on a delayed development."</seg>
<seg id="2063">"24 Throughase capsules can be used without the amplification of Ritonavir (Boosts) must be applied to Achemase (1200 mg twice daily)."</seg>
<seg id="2064">The recommended dose for Achemase capsules is 20 mg Amendavir / kg body weight twice daily in combination with other antiretroviral medications until a daily dose of 4mg Amendavir that should not be exceeded. (see paragraph 5.1).</seg>
<seg id="2065">"simultaneous application should be done with weak or light liver dysfunction, in patients with severe liver dysfunction (see paragraph 4.3)."</seg>
<seg id="2066">"26 For a few medicines that may cause serious or life threatening effects, such as Carbohydrepin, Phenomarbital, phenytoin, tricycle antidepressants, phenytoin, tricyclic antidepressants and warnings (under monitoring of the International Monetary Union Ratio), methods for determination of the drug concentrations."</seg>
<seg id="2067">Agenerase should be set on duration 27 if a rash of systemic or allergic symptoms (see section 4.8).</seg>
<seg id="2068">"a higher risk for a lipoystrophie has been associated with individual factors such as higher age, and with drug-dependent factors such as higher age, and with drug-dependent factors such as a longer lasting antiviral treatment and the associated metabolic disorders."</seg>
<seg id="2069">It was shown that Rifampicin a 82% reduction in the AUC of Amendavir caused to lead to a virological disorders and a resistance.</seg>
<seg id="2070">"508% increase, for CMAx, when Ritonavir (100 mg twice daily) in combination with Amendavir capsules (600 mg twice daily)."</seg>
<seg id="2071">The Cmin values from Amendra (600 mg twice daily) with caletra (600 mg twice daily) with caletra (600 mg twice daily) in combination with 100 mg konavir twice daily).</seg>
<seg id="2072">"a docking recommended for simultaneous translation of Amendavir and Kaletra is not given, however, it is not known, however, it is not known to be known as the efficacy and unthinkable of this combination."</seg>
<seg id="2073">"the treatment with Efavirenz in combination with Amendavir and Saquinavir is not recommended, since the exposure of both proteasets would be low."</seg>
<seg id="2074">"if these medicines are applied together, a thorough clinical and virological monitoring should be made, as a detailed prediction of the combination of amalavir and Ritonavir on Delavirdin is difficult."</seg>
<seg id="2075">"when it comes from clinical reasons, Rivera utin together with Achemase, is recommended to reduce the dosage of Rip utin to at least half of the recommended dose 31, although there is no clinical data."</seg>
<seg id="2076">"the Serum concentrations of calcium carbonate, violine pin, pin pin, pin pin, pin pin, pin pin, pin pin, pin pin, pin pin, pin pin, pin pin, pin pin, pin pin, pin pin, pin pin, pin pin, pin pin, pin pin, pin pin"</seg>
<seg id="2077">"in a clinical study, in the Ritonavir 100 mg capsules twice daily (4-times daily) over 7 days, the fluticasonprofiled cortisol to approximately 86% abused (90% -Confidence interval 82 to 89%)."</seg>
<seg id="2078">(see paragraph 4.4) for simultaneous removal of the INR (International Standard Series Ratio) due to the possibility of a weakening or reinforcement of antithromboating effect (see paragraph 4.4).</seg>
<seg id="2079">The simultaneous translation of Ortho-Novum 1 / 35 (0,035 mg Ethinylestradiol plus 1.0 mg Normandindron) led to a decrease of AUC and Cmin from Amendavir around 22%.</seg>
<seg id="2080">This medicine may only be used during pregnancy only after careful consideration of the possible risks for the mother compared to the possible risks for the fetus.</seg>
<seg id="2081">"a Reproductive study conducted in the uterus of the Uterus, in the uterus to the end of the breasts of Amendus, showed a reduced increase in the body weight."</seg>
<seg id="2082">"in adults and children from 4 years in controlled clinical trials, combined with different other antiretroviral medications were investigated."</seg>
<seg id="2083">"in the case of a overdose, the patient is able to observe the symptoms of an intoxication (see section 4.8) if required, are necessary measures."</seg>
<seg id="2084">"the antiviral activity in vitro against HIV-1 IIIB was investigated both an acute and chronic cell lines (MT-4, CEM-CCRF, H9) as well as peripheral blood vessels."</seg>
<seg id="2085">The 50% hemisphere (IC50) of Amendavir is located in the area of 0.012 to 0.008 µm at acute cells (1 µm = 0.50 µg / ml).</seg>
<seg id="2086">"on the other hand, Amendavir represents his activity against some other proteasets-resistant insulation; the receipt of this activity seems to be dependent on the number and from the type of resistance-mutations in the insulation."</seg>
<seg id="2087">"based on these data should be considered at the therapy optimisation, with PI-treated children the benefit of the benefit of" uncontrolled "Achemase."</seg>
<seg id="2088">"during the absolute concentration of uninterrupted amblavir, the percentage of the free-active part of the free-active situation in the Steady-State over the area of CMAx, ss until Cmin, ss.."</seg>
<seg id="2089">"therefore, medicines that CYP3A4 induced or infeed or a substrate of CYP3A4 (see Abbreviation 4.3, 4.4 and 4.5)."</seg>
<seg id="2090">It is also the renal Clearance of Ritonavir. hence the impact of a kidney function on the Elimination of Amendavir and Ritonavir.</seg>
<seg id="2091">"in long-term studies on the Kanzerosion with Amendavir of mice and rats were killed in male animals, on the 2.0-wing (Mice) or 3,8- €(rats) of exposure on humans after a day of the day of the day."</seg>
<seg id="2092">The underlying mechanism for the formation of hepatoid Adenome and carcinoma has not been weakened and the relevance of the observed effects of people is unclear.</seg>
<seg id="2093">"data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data. why buy this report? * Get a detailed picture of the Baby Food market; * Pinpoint growth sectors and identify factors driving change; * Understand the competitive environment, the market's major players and leading brands;"</seg>
<seg id="2094">"in a standard battery of in-vivo- and in-vitro genotoxidiotic tests, the bacteria-test, micro-test test, micro-Lymphom test, micro-Lymphom test, and the chrome-test test of rats and chromosomal lymphocytes (Ames-Test)."</seg>
<seg id="2095">"studies on toxicity, which have been treated by a age of 4 days, both in the control of the control of animals have a high Mortality."</seg>
<seg id="2096">"these results indicate that the metabolic processes are not full-tolerable, so that Amendavir or other critical components of the formulation (z)."</seg>
<seg id="2097">Agenerase solution is in combination with other antiretroviral medications for treating HIV-1-infected, proteasculmer (PI) treatment and children from 4 years. "</seg>
<seg id="2098">"the benefit of the use of Ritonavir" "Agenerase solution has been treated with PI pre-treated patients with PI pre-treated patients."</seg>
<seg id="2099">The bending feet of the Amendavir is as a solution for insertion is 14% less than of Amendavir as a capsule; therefore Achemase capsules and solution can be exchangeable at a milligram of milligram (see section 5.2).</seg>
<seg id="2100">"patients should, as soon as they are able to swallow the capsules, with the use of the solution to take (see paragraph 4.4)."</seg>
<seg id="2101">The recommended dose for Agenerase solution is 17 mg (1.1 ml) Amendavir / kg body weight three times daily in combination with other antiretroviral medications until a daily dose of 2800 mg Amendavir that should not be exceeded. (see paragraph 5.1).</seg>
<seg id="2102">"in addition, there must be no Dosisrecommended for simultaneous application of Agenerase solution for the simultaneous application of Agenerase solution, this combination with these patient groups can be avoided."</seg>
<seg id="2103">"although a Dosisite is not necessary for Amendavir, it is not necessary to take patients with kidney disease (see paragraph 4.3)."</seg>
<seg id="2104">"due to the potential risk of a toxic reaction as a result of the high Propylene and children under 4 years, when pregnant women, patients with reduced liver function or liver disease and patients with kidney disease."</seg>
<seg id="2105">"the simultaneous control can lead to a comeback inhibitors of this medicine and possibly serious and / or life threatening effects, such as heart disease disorders (z)."</seg>
<seg id="2106">Patients should be aware that Achemase or any other antiretroviral therapy does not lead to a healing of HIV infection or other complications such as HIV infection or other complications of an HIV infection.</seg>
<seg id="2107">"the current anti-viral therapy including the treatment with Achemase does not prevent the risk of HIV to other by sexual contact or contamination with blood."</seg>
<seg id="2108">"for some drugs that may cause serious or life threatening effects, such as Carbohydrepin, Phenomarbital, phenytoin, tricycle antidepressants, phenytoin, tricyclic antidepressants and warnings (under monitoring of the International Monetary Union Ratio), methods for determination of the drug concentrations."</seg>
<seg id="2109">Agenerase should be set on duration if a skin rash of systemic or allergic symptoms (see paragraph 4.8).</seg>
<seg id="2110">"a higher risk for a lipoystrophie has been associated with individual factors such as higher age, and with drug-dependent factors such as higher age, and with medication - 49-dependent factors such as a longer lasting antiviral treatment and the associated metabolic disorders."</seg>
<seg id="2111">"for patients (type A and B), which have been treated with proteasiness, reports reports about an increase of blood vessels, including spontaneous views and hemisphere."</seg>
<seg id="2112">It was shown that Rifampicin a 82% reduction in the AUC of Amendavir caused to lead to a virological disorders and a resistance.</seg>
<seg id="2113">"508% increase, for CMAx, when Ritonavir (100 mg twice daily) in combination with Amendavir capsules (600 mg twice daily)."</seg>
<seg id="2114">(see paragraph 4.4).</seg>
<seg id="2115">"on the basis of the data on 54 other CYP3A4-inhibitors are significantly higher plasma concentrations of Midazolam, significantly higher plasma concentrations of Midazolam."</seg>
<seg id="2116">Potential risk for man is not known as Agenerase solution for a possible toxic reactions of the Fetus to be applied to the proetus. (see paragraph 4.3).</seg>
<seg id="2117">"in the milk of milk, Amendavir-related substances have been detected, however, it is not known whether it is not known whether Amendavir near people into the mother's milk."</seg>
<seg id="2118">A Reproductive study conducted in the uterus of the Uterus to the end of the breasts of the Uterus to the end of the stop of Amendus as a decrease in the treatment of the 55 body weight.</seg>
<seg id="2119">"in adults and children from 4 years in controlled clinical trials, combined with different other antiretroviral medications were investigated."</seg>
<seg id="2120">"in many of these events, it is not clarified whether they are in connection with the use of Agenerase or another at the same time for HIV treatment applied, or whether they are a result of the disease."</seg>
<seg id="2121">"at the treatment of antiviral viral cancer patients with the currently approved Fosamprenavir / Ritonavir-Dosification were rarely observed, as with other Ritonavir microscopic treatments - the mutations are rarely observed."</seg>
<seg id="2122">Early treatment is recommended to keep the progression of a multitude of mutations in limits which may result in subsequent treatment.</seg>
<seg id="2123">62 Basics on this data should be considered at the therapy optimisation of the patients with PI treatment.</seg>
<seg id="2124">The additional distribution volume is about 430 l (6 l / kg at a body weight of 70 kg) and can be close to a large extent of the blood circulation in the tissue cycle.</seg>
<seg id="2125">The underlying mechanism for the origin of hepatoid cell membranes and carcinoma has not been weakened and the relevance of these observed effects on humans is unclear.</seg>
<seg id="2126">"when systemic plasma concentrations were significantly higher (rabbits) or do not significantly higher (rats), however, a number of minor changes including Thymuselongation and minor skelongation may be observed on a delayed development."</seg>
<seg id="2127">"perhaps you would like to read this later. if you have any questions, please contact your doctor or pharmacist."</seg>
<seg id="2128">"if one of the listed side effects may be affected, even if these are the same complaints such as you. − If one of the listed side effects you may read or side effects that are not indicated in this use information, please inform your doctor or pharmacist."</seg>
<seg id="2129">Your physician will normally be used to amplify the effect from Ageneration Sloonavir to strengthen the effect of Agenerase.</seg>
<seg id="2130">The use of Achemase will be based on your physician for your individual viral resistance test and your treatment of treatment.</seg>
<seg id="2131">Inform your doctor if you suffer from above mentioned diseases or any of the above mentioned medication.</seg>
<seg id="2132">"if your doctor is recommended that you are recommended from the treatment of Ritonavir to gain the effect (Boosts), make sure you have read before the treatment of use the use information about Ritonavir carefully."</seg>
<seg id="2133">Do not have sufficient information in order to recommend the application of Agenerase capsules along with Ritonavir for active in the age of 4 to 12 years or generally in patients under 50 kg body weight.</seg>
<seg id="2134">"therefore, it is important that you begin to read the section" Add Agenerated images with other medicines "before you start using the use of Agenerase."</seg>
<seg id="2135">"you may need additional factor to control the blood pressure to control the blood vessels. - With patients who have an antiviral viral therapy, a redistribution, collection or loss of body fat occur."</seg>
<seg id="2136">"if you use certain medicines that can lead to serious side effects such as Carbohydrepin, Phenomycin, phenyarbin, phenyonic antidepressants, tricyclist anti-depressants, tricyclist anti-depressants, tricyclic antidepressants, tricyclic antidepressants, tricyclic antidepressants, tricyclic antidepressants, tricyclic antidepressants, tricyclic antidepressants, tricyclic antidepressants, tricyclic antidepressants, tricyclic antidepressants, tricyclic antidepressants, tricyclic antidepressants, tricyclic antidepressants, tricytopus, tricytopus, tricyclic antidepressants, tricyclic antidepressants, tricyclic antidepressants, tricyclic antidepressants."</seg>
<seg id="2137">It is recommended that HIV-positive women are unable to avoid HIV by HIV.</seg>
<seg id="2138">Transport and processing of machines There were no studies about the influence of Agenerase on the chassis and the ability to serve the filling of machines.</seg>
<seg id="2139">Please take this medicine only after consultation with your doctor if you are familiar with your doctor.</seg>
<seg id="2140">"Didanosin) are advisable to use Didanosin), it is advisable to use this more than one hour before or after treatment."</seg>
<seg id="2141">Dose of Agenerase capsules is 600 mg twice a day together with a 100 mg cronavir twice daily in combination with other antiretroviral medications.</seg>
<seg id="2142">"if your doctor decides that the intake of Ritonavir is not suitable for you, you will have higher frequencies (1200 mg Amendavir twice daily)."</seg>
<seg id="2143">85 Damit Agenerated a large benefit is it is highly important that you have to take your doctor.</seg>
<seg id="2144">"if you have a bigger quantity of Agenerated images, you should have been taken as a dose of Ageneration, you should contact your doctor or pharmacist contact with your doctor or pharmacist contact."</seg>
<seg id="2145">"if you don't forget the use of Agenerase, if you don't forget the use of Agenerase, please take it as soon as you think that you do not know how far."</seg>
<seg id="2146">"in the treatment of an HIV infection, it is not always possible to say whether the side effects caused by Agenerase, by other medicines that are taken at the same time or by the HIV disease itself."</seg>
<seg id="2147">"this medicine can cause severe pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin</seg>
<seg id="2148">"pain, depression, sleep disorders, appraisins in the lips and in mouth, uncontrolled movements in the lips and in the mouth, uncontrolled movements, the transaminases, increase the enzyme of the pancreas called amylase"</seg>
<seg id="2149">"higher blood values for sugar or cholesterol (a particular blood-fat) strengthens blood values of a cloth called Biliruh swelling of the face, the lips and the tongue (Angioese)."</seg>
<seg id="2150">"this may be fat loss on legs, arms, and in the face, a fatty acid on the stomach and in other internal organs, breast reduction and obesity in the neck (" embroidery ")."</seg>
<seg id="2151">Please inform your doctor or pharmacist if one of the listed side effects may be affected or side effects that are not indicated in this use.</seg>
<seg id="2152">"therefore, it is important that you begin to read the section" Add Agenerated images with other medicines "before you start using the use of Agenerase."</seg>
<seg id="2153">"in some patients, such as Osteoneked treatment can be treated as Osteonekiah (Abdie of bone tissue due to insufficient blood supply of bone loss)."</seg>
<seg id="2154">"Didanosin) are advisable to use Didanosin), it is advisable to use this more than one hour before or after treatment."</seg>
<seg id="2155">94 Damit Agenerated a large benefit is it is very important that you have to take your doctor.</seg>
<seg id="2156">"if you don't forget the use of Agenerase, if you don't forget the use of Agenerase, please take it as soon as you think, and do it then."</seg>
<seg id="2157">"this medicine can cause severe pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin</seg>
<seg id="2158">Please inform your doctor or pharmacist if one of the listed side effects may be affected or side effects that are not indicated in this use.</seg>
<seg id="2159">Dose of Agenerase capsules is 600 mg twice a day together with a 100 mg cronavir twice daily in combination with other antiretroviral medications.</seg>
<seg id="2160">"so that Achemase does a large benefit, it is very important that you are taking the whole daily dose that has to take you your doctor."</seg>
<seg id="2161">"if you have bigger quantities of Agenerated images, you should have taken more than the dose of Ageneration, you should contact your doctor or pharmacist contact with your doctor or pharmacist contact."</seg>
<seg id="2162">"the benefit of the use with Ritonavir" "Agenerase solution is not able to take care of the patients with proteasiness of patients with proteasthenium patients."</seg>
<seg id="2163">"for the use low cans of Ritonavir (usually applied to the effect of the effect [Boosts] of Agenerase capsules) together with Agenerase solution, do not take any contact recommendations."</seg>
<seg id="2164">"Ritonavir solution for insertion), or additionally propyl-lycol during the use of Agenerase solution (see also Achemase cannot be taken)."</seg>
<seg id="2165">Your doctor will possibly be in side effects that are associated with the propylenglycolcontent of the Achemase solution to take place in particular when you have a kidney or liver disease.</seg>
<seg id="2166">"111 If you are certain medicines that can lead to serious side effects such as Carbohydrepin, Phenomycin, phenyonic, cycantism, tricytopus, Rapamycin, tricyclist anti-depressants, tricyclic antidepressants, tricyclic antidepressants, tricyclic antidepressants, tricyclic antidepressants, tricyclic antidepressants, tricyclic antidepressants, tricyclic antidepressants, tricyclic antidepressants, tricyclic antidepressants, tricyclic antidepressants, tricyclic antidepressants."</seg>
<seg id="2167">Ritonavir solution for single) or additional propylene oxide is not included in the use of Agenerase cannot be taken (see Agenerase may not be taken).</seg>
<seg id="2168">Important information on specific other components of Achemase solution contains Propylenglysis which can lead to a high doses of side effects.</seg>
<seg id="2169">"Propylenglysis can cause a number of side effects including crampfanatics, coromination, corridors, and the reduction of red blood cells (see also Achemase may not be taken in order to be observed)."</seg>
<seg id="2170">"if you don't forget the use of Agenerase, if you don't forget the use of Agenerase, please take it as soon as you think that you do not know how far."</seg>
<seg id="2171">"this medicine can cause severe pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin, skin</seg>
<seg id="2172">"this may be fat loss on legs, arms, and in the face, a fatty acid on the stomach and in other internal organs, breast reduction and obesity in the neck (" embroidery ")."</seg>
<seg id="2173">"the other components are propyl phosphorlysis, inethyllium-potassium, sodium chloride, sodium chloride, sodium citric acid, sodium citric acid, sodium citric acid, sodium citrate-Dihydrat, gerated water."</seg>
<seg id="2174">"• In case of small basal cell carcinoma, the cream is six weeks to contribute to a maximum of 16 weeks. • In case of small basal cell carcinoma is the cream of six weeks, with four weeks break between the treatment cycles, three times weekly."</seg>
<seg id="2175">"the cream is in front of the sleep-thin layer on the affected skin surfaces, so that they have sufficient time (about eight hours) on the skin before it is washed."</seg>
<seg id="2176">"in all studies, Aldara was compared with a placebo (same cream, but without the active ingredient). • Aldara was tested in four main studies at 923 patients with warts in the genital area of 16 weeks."</seg>
<seg id="2177">"• Aldara was then treated to 724 patients with small basal cell carcinoma in two studies, where patients were treated with small basal cell carcinoma in two studies at the placebo or the placebo."</seg>
<seg id="2178">"• Aldara was tested in two trials of the tumor after twelve weeks. • Aldara was tested in two studies on a total of 505."</seg>
<seg id="2179">"in all studies, Aldara is more effective than the placebo. • With the treatment of warts in the genital area was the full swing rate of 66% up to 80% in placebo-treated patients. • The results of the two studies on basal cell carcinoma showed a full swing rate of 66% to 80% in placebo-group."</seg>
<seg id="2180">The most common side effects of Aldara (observed in more than 1 of 10 patients) are reactions to the use of the cream (pain or itching).</seg>
<seg id="2181">"clinical, non-hyperphonic, not hypertrosis (AKS) in the face or on the head of surgery (AKS) in the face or the number of lumbar, the effectiveness and / or the acceptance of a cryotherapy and other topical treatment options are homogenous or less suitable."</seg>
<seg id="2182">"Monday, Wednesday and Friday or Tuesday, Thursday and Saturday) before arrival and 6 to 10 hours on the skin."</seg>
<seg id="2183">"treatment with Imiquimod-cream is as long as long as possible, until all visible pigs in genital or peripherals are gone, or up to a maximum of 16 weeks per treatment period."</seg>
<seg id="2184">An interruption in the above-treatment process should occur if intensive local inflammations occur (see paragraph 4.4) or if the treatment area is observed.</seg>
<seg id="2185">"when the follow-up examination 4 to 8 weeks after the second treatment period the treatment was only incomplete, should a different therapy should be begun (see paragraph 4.4)."</seg>
<seg id="2186">"when a dose was left, soldering the patient the cream as soon as he / she can continue and then continue with the usual therapy plan."</seg>
<seg id="2187">"Imiquimod-cream is in a thin layer and in a thin layer and into the cleaned, with fetched skin area, until the cream is completely restored."</seg>
<seg id="2188">"in these patients a cancellation must be made between the benefit of a treatment with Imiquimod, and with a possible fusion of their autoimmune diseases."</seg>
<seg id="2189">"in these patients a cancellation must be made between the benefit of a treatment with Imiquimod, and with a possible organist or graft-Hostess response - reaction risk."</seg>
<seg id="2190">"in other studies, in which no daily schedules were carried out, two cases of severe Phimose and a case with one for the cortials were observed."</seg>
<seg id="2191">"during the application of Imiquimod-cream in higher than the recommended retail skin (see section 4.2.) In rare cases, however, however, during rare cases, the treatment is needed and / or to a temporary physical impairment."</seg>
<seg id="2192">"in cases where such reactions occur at the exit of the urethra, some women have difficulty in the waterline that are needed for emergency catheter and treatment of the affected area."</seg>
<seg id="2193">"for the application of Imiquimod-cream directly in connection to a treatment with other reports, such as a treatment with other specialists in genitual and peripherals, there are no clinical experiences."</seg>
<seg id="2194">"limited data are calculated according to a higher rate of feignitures for HIV-positive patients, Imiquimod-cream has a lower effectiveness."</seg>
<seg id="2195">"the treatment of the basal cell carcinoma with Imiquimod within 1 cm to the eye, the nose, the lips or the hair of hair was not examined."</seg>
<seg id="2196">"local skin treatments are often, but the intensity of these reactions occur in general during the treatment of treatment or the reactions are moving to the treatment of Imiquimod-cream."</seg>
<seg id="2197">"if it is necessary due to the complaints of the patient or due to the severity of local skin treatments, a treatment may be made of several days."</seg>
<seg id="2198">"results appear ordered" "by relevance" "or" "by date" "(publication date),"</seg>
<seg id="2199">There are currently no information about long term healing rates of more than 36 months after treatment.</seg>
<seg id="2200">"patients with regenerative and pre-treated BCCs are not recommended in clinical experience, therefore the application is not recommended."</seg>
<seg id="2201">Data from an open clinical study suggests that large tumors (&gt; 7.25 cm2) is a lower probability of response to the Imiquimod therapy.</seg>
<seg id="2202">"Imiquimod has not been investigated for the treatment of Keratopic keratants, inside the nose or the ears or in the lights area within the lights."</seg>
<seg id="2203">"data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data. why buy this report? * Get a detailed picture of the Homeshopping market; * Pinpoint growth sectors and identify factors driving change; * Understand the competitive environment, the market's major players and leading brands;"</seg>
<seg id="2204">"the available data on the actinent keratsis on the subarms and hands, support the effectiveness of this application, therefore, such as such application is not recommended."</seg>
<seg id="2205">"local skin treatments are frequently used, but these reactions occur normally during the treatment of the treatment of intensity or go to the treatment of the therapy with Imiquimod-cream."</seg>
<seg id="2206">"if the local skin affects the patient's big imitation or very strong, the treatment can be exposed to some days."</seg>
<seg id="2207">"from the data of an open clinical study, patients with more than 8 semesters, a lower full heuristic rate was reduced as a patient with less than 8 lumens."</seg>
<seg id="2208">"due to the stimulating properties, Imiquimod cream can be applied to patients who are diagnosed with cancer treatment (see 4.4)."</seg>
<seg id="2209">"animal studies have not direct direct or indirect harmful effects on the pregnancy, the embryonic / fötal development, the binding or postnatal development (see 5.3)."</seg>
<seg id="2210">"although neither the malfunctioning of topical application quantified Serumble (&gt; 5ng / ml), no recommendation to be given during the treatment time."</seg>
<seg id="2211">"the most common values and as probably or may not be used with the application of Imiquimod-cream in connection with the application of Imiquimod-cream in connection with three times weekly treatment, local reactions were treated to the treatment of Feigner (33.7% of the patients with Imiquimod treatment)."</seg>
<seg id="2212">"in connection with the application of the Imiquimod-cream associated with the application of the Imiquimod cream in connection with the application of the application, with a frequency of 28.1%."</seg>
<seg id="2213">"* Understand the competitive environment, the market's major players and leading brands; * Pinpoint growth sectors and identify factors driving change; * Understand the competitive environment, the market's major players and leading brands; * Use five-year forecasts to assess how the market is predicted to develop."</seg>
<seg id="2214">"the most common, as probably or maybe with the application of the Imiquimod-cream in connection with the application of the Imiquimod (22% of the patients with Imiquimod treated patients)."</seg>
<seg id="2215">"results appear ordered" "by relevance" "or" "by date" "(publication date),"</seg>
<seg id="2216">"according to the test plan, these placebo-controlled clinical trials associated with Imiquimod-cream is often used in these placebo-controlled clinical trials with Imiquimod-cream, (23%) and ÖBLÄTTERN / Abschuppen (23%) and ÖBLÄTTERN / Abschuppen (23%). (see paragraph 4.4)."</seg>
<seg id="2217">"according to the test plan, the clinical signs shows that it shows that in these studies with five times weekly treatment with Imiquimod-cream is very often too severe vomiting (31%), severe erosions (13%), and to severe vomiting and cabling (19%)."</seg>
<seg id="2218">"in clinical studies at clinical trials of the application of Imiquimod for the treatment of acute infection, Alois studied with a frequency of 0,4% (5 / 1214) at the treatment of treatment or in the surrounding area."</seg>
<seg id="2219">"the best-one-orale recording of 200 mg Imiquimod, which corresponds to the content of approximately 16 bags could result in nausea, vomiting, headache, myalgies and fever."</seg>
<seg id="2220">"in hypotony, the clinically serious disruptions of &gt; 200 mg came into hypotony that became a hypotony that occurs after orbital or intravenous liquid."</seg>
<seg id="2221">"in a pharmacokinetic investigation, after the topical application of Imiquimod, systematic systemic concentrations of the Alphainterferons and other cytokine."</seg>
<seg id="2222">"results appear ordered" "by relevance" "or" "by date" "(publication date),"</seg>
<seg id="2223">"with 60% of the total 119 results of 119 by Imiquimod therapy for patients with placebo. this was at 20% of the 105 with placebo therapy for patients (95% CI:"</seg>
<seg id="2224">A complete disinfection could be achieved at 23% of 157 patients with placebo-treated male patients (95% CI:</seg>
<seg id="2225">"results appear ordered" "by relevance" "or" "by date" "(publication date),"</seg>
<seg id="2226">The target group can be histologically tested single primary superfizial Basalcell carcinoma with a minimum size of 0.5 cm2 and a maximum diameter of 2 cm.</seg>
<seg id="2227">"data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data. why buy this report? * Get a detailed picture of the Baby Food market; * Pinpoint growth sectors and identify factors driving change; * Understand the competitive environment, the market's major players and leading brands;"</seg>
<seg id="2228">"results appear ordered" "by relevance" "or" "by date" "(publication date),"</seg>
<seg id="2229">"patients had clinically typical, visible, discrete, not hypertension, not hypertension, not hypertension."</seg>
<seg id="2230">The year data from two combined observations for patients with clinical removal after one or two treatment rooms have a Rezied rate of 27% (35 / 128 patients).</seg>
<seg id="2231">"the approved indications of expression, actinent keratsis and Superfizielles Basalcell carcinoma patients are usually not examined and were not examined."</seg>
<seg id="2232">"Aldara cream was studied in four randomised, double-blind placebo-controlled trials at children from 2 to 15 years with Mollushion Contagiosum (Imiquimod n = 576, placebo n = 313)."</seg>
<seg id="2233">"results appear ordered" "by relevance" "or" "by date" "(publication date),"</seg>
<seg id="2234">A minimum system of 5% typical Imiquimod-cream by the skin of 58 patients with acute keratose was observed during the three times weekly use during 16 weeks.</seg>
<seg id="2235">"the highest drug concentrations in the Serum at the end of the week 16, between 9 and 12 hours and betabytes 0.1, 0.2 and 1.6 ng / ml of the application in the face (12.5 mg, 2 bags), and on the hands / arms (75 mg, 6 bags)."</seg>
<seg id="2236">The calculated light time was approximately 10times higher than the 2hourly half time after the subcutaneous application in an earlier study; that indicates a prolonged retention of drug use in the skin.</seg>
<seg id="2237">The data to systemic exposure showed that the resorption of Imiquimod after topical application of patients in the age of 6 - 12 years and comparable to healthy adults and adults with acute keratose or superfidelistic basal cell carcinoma.</seg>
<seg id="2238">"in a four month study on toxicating toxicity at the rats of 0.5 and 2.5 mg / kg kg to significantly reduced weight and increased Milz-weight; also four months, the study has no similar effects in the mouse no similar effects."</seg>
<seg id="2239">A two-year study for carcinogen's carcinogenic to three days per week induced no tumors on the application.</seg>
<seg id="2240">The appropriate mechanism is not known but since Imiquimod has only a low systemic absorption of human skin and not mutation is a risk for people due to systemic exposure as very low.</seg>
<seg id="2241">"the tumor was treated in the group of mice, which was treated with the acting-free cream, earlier and more than in the control group with low UVR."</seg>
<seg id="2242">"there may be other people, even if these are the same symptoms as you. − if one of the listed side effects you may be affected or side effects that are not indicated in this use information, please inform your doctor or pharmacist."</seg>
<seg id="2243">● Feigner (Consiomata accounata) which is formed on the skin in the area of genitals (sexual organs) and Anus (After)) ● surface basal cell carcinoma is a common condition of the skin with very low probability of the spread in other parts of the body.</seg>
<seg id="2244">"treatment: heat treated clarity: very very small inclusions 1.85 cts á EUR 1,170.00 7.9x6.0 mm EUR2,160.00 &lt; &lt; BACK TO CATEGORY tourmaline (rubellite) cut: oval origin: Brazil treatment: untreated"</seg>
<seg id="2245">"acogens are smoking areas of skin that occur during their previous life, which were exposed to people during their previous life."</seg>
<seg id="2246">Aldara should only be used at the flat bottom in the face and on the headaches in patients with a healthy immune system where your doctor decided that Aldara is best for you.</seg>
<seg id="2247">Aldara cream supports your body's own immune system in the production of natural substances that help your body to fight the superficial basal cell carcinoma or for the infection with Feigner responsible virus.</seg>
<seg id="2248">Please consult your doctor if you have problems with your immune system. please contact the doctor if you have problems with your immune system.</seg>
<seg id="2249">"for the treatment of Aldara cream, you do not use the cream as your doctor. if you do not have any more cream than your doctor, you don't have any more cream than your doctor. if you do not have any more cream than your doctor. if you do not have any more cream as your doctor, you will also prepare your cream with a mild soap and water."</seg>
<seg id="2250">"as soon as the reactions are debited, you can manage your doctor if they have no normal blood picture."</seg>
<seg id="2251">"when this daily cleaning under the skin is not carried out, the skin can be performed with increased appearance of the skin, fertilised skin or difficulties."</seg>
<seg id="2252">Contact Aldara cream not in the Urethra (urethra), in the vagina (divorce), the Zervix (utertiterhas) or within the Anus (After). "</seg>
<seg id="2253">You should use this medication based on your immune system so you should use this medicine for no more than one treatment cycle.</seg>
<seg id="2254">If you have sexual intercourse with fetus in the genital area of sexual intercourse is the treatment with Aldara cream after intercourse (not before).</seg>
<seg id="2255">Please inform your doctor or pharmacist if you apply other medicines or pharmacist if there are no prescription drugs.</seg>
<seg id="2256">"breastfeeding during the treatment with Aldara cream is not known whether Imiquimod, in the mother milk."</seg>
<seg id="2257">"the frequency and duration of treatment are at Feigle, basal cell carcinoma and acute keratsis different (see specific instructions for each application)."</seg>
<seg id="2258">"use a thin layer of Aldara cream on the clean, dry skin care with the fetched skin on the skin, until the cream is completely restored."</seg>
<seg id="2259">"men with fetching the skin must go back to the skin, and wash the skin area. (see section 2" What do you need to observe the application of Aldara cream? ")."</seg>
<seg id="2260">Please speak with your doctor or pharmacist if you have the impression that the effect of Aldara is too strong or too weak.</seg>
<seg id="2261">"if you have any queries, please contact us on Tel.: + 49 5764 318 444. or contact us per email."</seg>
<seg id="2262">Very frequent side effects (in less than 1 of 10 patients) expected side effects (at less than 1 of 10 patients) Seltene side effects (at less than 1 of 10 patients)</seg>
<seg id="2263">Inform your doctor / your doctor or your pharmacist / Pharmacies immediately if you don't feel comfortable during the application of Aldara cream.</seg>
<seg id="2264">"if your skin does not react to the treatment with Aldara cream, you should use the cream not to use the skin area with water and a mild soap and your doctor or your pharmacist."</seg>
<seg id="2265">A lower number of blood cells can make it possible for infections; they can make sure that you can make more quickly a blue spot.</seg>
<seg id="2266">Inform your doctor or pharmacist if one of the listed side effects or side effects that are not indicated in this use information.</seg>
<seg id="2267">"in addition, you can feel Juckreiz (32% of patients), breasts (26% of patients) or pain in the areas where you have a cream (8% of the patients)."</seg>
<seg id="2268">"in this case, it is very easy to use all types of diseases, within about 2 weeks after removal of the treatment."</seg>
<seg id="2269">"occasionally, some patients changes in the application area (Wundsekret, inflammation, swelling, infection, dermatitis) or irritability, nausea, dry mouth, dry mouth, grippeasthma and tiredness."</seg>
<seg id="2270">"occasionally, some patients suffer from changes in the application of the application."</seg>
<seg id="2271">Aldurazyme is used for the enzymes of a muffolysaccharides I (MPS I; α -L-Iduronidase lack) to treat the neurological manifestation of disease (the symptoms which cannot be associated with brain or nerves).</seg>
<seg id="2272">"this means that certain substances (glyceraminoglykane, Gam) will not be built in most organs in the body."</seg>
<seg id="2273">"the following non-neurological symptoms of MPS I can occur: enlarged liver, irritating joints, the movements of movement, heart rate, heart disease and eye disorders."</seg>
<seg id="2274">Treatment with Aldurazyme should be monitored by a doctor who has experience in the treatment of patients with MPS I or other metabolic syndrome.</seg>
<seg id="2275">"in order to avoid allergic reaction by Aldurazyme should be made in a hospital or a clinic in a hospital or a clinic in a hospital or a clinic in order to avoid allergic reaction to a allergic reaction."</seg>
<seg id="2276">"* Understand the competitive environment, the market's major players and leading brands; * Pinpoint growth sectors and identify factors driving change; * Understand the competitive environment, the market's major players and leading brands; * Use five-year forecasts to assess how the market is predicted to develop."</seg>
<seg id="2277">"in the study, mainly the safety of medicines, however, was measured by its effectiveness (by its effect in relation to reducing the GAG concentrations in terms of the liver and in relation to the size of the liver."</seg>
<seg id="2278">"for children under five years, Aldurazyme the GAG concentrations in the urine around about 60%, and half of the treated children were a normal liver."</seg>
<seg id="2279">"the most common side effects of Aldurazyme at patients aged over five years (observed in more than 1 of 10 patients) are headache, nausea, abdominal pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain, pain</seg>
<seg id="2280">"very common side effects in patients under five years have increased blood pressure, reduced oxygen saturation (a measuring size of the lung function), fever and bulk frost."</seg>
<seg id="2281">Aldurazyme may be highly sensitive (allergic) to laronidase or one of the other components (anaphylagens response).</seg>
<seg id="2282">"the European drug agency (EMEA) will be announced every year of all new information that may be known, check and update this summary."</seg>
<seg id="2283">"the manufacturer of Aldurazyme, patients receiving Aldurazyme, in accordance with the reactions to infusion and development of antibodies."</seg>
<seg id="2284">"June 2003, the European Commission sent the European Commission to Genzyme Europe B.V., an approval for the company by Aldurazyme in the entire European Union."</seg>
<seg id="2285">Laronidase is a recombinant form of humanistic α -L-Iduronidase and is produced by a combined DNA technology among the use of CHO-acid-cell cultures (Chinese hamsters of the Chinese hamsters).</seg>
<seg id="2286">Aldurazyme is to treat long-term enzymes in patients with a secured diagnosis of a muffolysaccharides I (MPS I, α -L-Iduronidase-lack). (see paragraph 5.1). "</seg>
<seg id="2287">Treatment with Aldurazyme should be done by a doctor's experience in the treatment of patients with MPS I or other therapies.</seg>
<seg id="2288">The initial examination rate of 2 E / kg / h can be increased when the patient is increased to a maximum dose of 43 E / kg / h.</seg>
<seg id="2289">The safety and efficacy of Aldurazyme in adults over 65 years was not determined and recommended for these patients.</seg>
<seg id="2290">The safety and efficacy of Aldurazyme with patients with kidney or liver failure has not been recommended for patients with kidney or liver failure.</seg>
<seg id="2291">With Aldurazyme patients can develop surgical reactions that are defined as each in connection with infusion or to the end of the Infusion day (see paragraph 4.8).</seg>
<seg id="2292">"in this reason, these patients will continue to be monitored at a reasonable level, and the infusion of Aldurazyme should be available in an appropriate clinical environment."</seg>
<seg id="2293">"due to the clinical phase 3 study, almost all patients IgG-antibodies against laronidase, usually within 3 months of treatment."</seg>
<seg id="2294">"patients, antibodies or symptoms of a disease-related reaction, must be treated by Aldurazyme (see Abbreviation 4.3 and 4.8)."</seg>
<seg id="2295">"as little experience in treatment after a longer interruption of the treatment after a longer disruption, due to the increased risk of risk of excessive risk of the treatment after a interruption of the treatment."</seg>
<seg id="2296">60 minutes before the start of infusion with medication (antihistamine and / or antipyretika) to minimize the potential appearance of reaction reactions.</seg>
<seg id="2297">"in case of a slight or medium-serious reaction reaction, the treatment of antihistamine and paracetamol / Ibuprofen will be produced on half of the infusion rate, which is the reaction rate."</seg>
<seg id="2298">"in the case of a single, heavy duty reaction reaction, the infusion must be stopped up to the symptoms, a treatment with antihistamine and paracetamol / Ibuprofen is weakened."</seg>
<seg id="2299">Infusion can be replaced with a reduction of infusion rate in 1 / 2 - 1 / 4 of infusion rate when the reaction occurred.</seg>
<seg id="2300">3 will (antihistamine and paracetamol / Ibuprofen and / or Corticosteroids) as well as reduction of infusion rate in 1 / 2 - 1 / 4 of infusion rate when the pre-balanced reaction occurred.</seg>
<seg id="2301">Aldurazyme should not be applied with chloroquin or Procain because a potential risk of an interval recording of laronidase.</seg>
<seg id="2302">"experimental studies do not allow direct or indirect harmful effects on pregnancy, the embryonic / fetal development, birth and postnatal development (see paragraph 5.3)."</seg>
<seg id="2303">"there is no data on newborn, which were exposed to laronidase over the breast milk, it is recommended to breastfeeding during treatment with Aldurazyme."</seg>
<seg id="2304">Patients in clinical trials were mostly used as infusion-related reactions related to 53% of patients in the phase 3 study (treatment of up to 4 years) and 35% of patients in the study with participants under 5 years (treatment duration up to 1 year).</seg>
<seg id="2305">Unwanted medication based in the age of 5 years or older in the age of 5 years or older in the age of 5 years and older (≥ 1 / 10); often (≥ 1 / 100 to &lt; 1 / 10).</seg>
<seg id="2306">"some patients with severe MPS-I-based participation of the upper respiratory system and lungs in the history of history, including bronchospasms, breathability and facial expression (see paragraph 4.4)."</seg>
<seg id="2307">"children of unskilled drug interactions associated with Aldurazyme, during a phase-2 study with a total of 20 patients aged 5 years, which were listed in the table below 5 years, are listed in the table."</seg>
<seg id="2308">"data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data. why buy this report? * Get a detailed picture of the Baby Food market; * Pinpoint growth sectors and identify factors driving change; * Understand the competitive environment, the market's major players and leading brands;"</seg>
<seg id="2309">"in most cases, the patients came from 3 months after the beginning of the treatment of a Serokonian, with a severe decline in the age of 5 years (average to 26 days after 45 days after the age of 5 years and older)."</seg>
<seg id="2310">"until the end of the phase 3 study (or up to a premature rating from the study) at 13 / 45 patients no patient could not have been found due to Radioesoptrophy (RIP) Assay antibodies, including 3 patients where there was never to Serokonversion."</seg>
<seg id="2311">"patients with errors caused by up to low antibodies, a robust reduction of GAG compels in the Harn, during patients with high antibodies a variable reduction of GAG in the Harn."</seg>
<seg id="2312">"four patients (three in phase 3 study and one in phase 2 study) showed a marginale to low neutral larynastical activity in vitro, which seemed to impose the clinical efficacy and / or reducing GAG in the harp."</seg>
<seg id="2313">"the presence of antibodies seemed to be in connection with the Incidence of undesirable drugs, even if the appearance of undesired drug interactions typically were in time with the formation of IgG-antibodies."</seg>
<seg id="2314">"the justification for the enzyme therapy is in one for the hydrolyse of the accumulated substrates, and the accumulation of a further accumulation of the enzymes."</seg>
<seg id="2315">"after intravenous infusion, Laronidase can be quickly removed from the cycle and from cells into the Lysosome, at the most recent result of Mannose-6-phosphate."</seg>
<seg id="2316">"results appear ordered" "by relevance" "or" "by date" "(publication date),"</seg>
<seg id="2317">"although patients for the study showed that the entire spectrum of disease was destroyed, the majority of the patients from the middle class and only a patient presented the severe phenotype."</seg>
<seg id="2318">"patients were erated if they had a higher expiration volume (FEV) of less than 80% of the expected value, and they had to be able to go to 5 minutes and 5 metres."</seg>
<seg id="2319">The primary endpoints for the efficacy of the efficacy of the modified FEV and the absolute direction in the 6 minus minutants test.</seg>
<seg id="2320">"for more than 100 years (182 weeks), each week is 100 E / kg Aldurazyme."</seg>
<seg id="2321">"after 26 weeks of therapy, with Aldurazyme treated patients at the placebo group, an improvement of the lung function and the bodies in the following table."</seg>
<seg id="2322">At the open trial study showed a improvement and / or maintenance of this effects of up to 208 weeks in the placebo / Aldurazyme group as well as from the following table.</seg>
<seg id="2323">The decrease of the increase percentage of FEV is not significant and the absolute lung disease increased significantly to the body size of the children.</seg>
<seg id="2324">"from 26 patients with a Hepherical treatment, 22 (85%) until the end of the study was a normal liver size."</seg>
<seg id="2325">"within the first 4 weeks, a proliferation of GAG mirror was found in the Harn (µg / mg creatinin), which remained constant until the study."</seg>
<seg id="2326">"in accordance with the heterogeneous disease of disease, the clinically relevant changes was taken into consideration, the clinically relevant changes in the 6-minute walk-test, movement area of the shoulder (58%), no change in 10 patients (22%) and a reduction in 9 patients (20%) and a reduction in 9 patients (20%)."</seg>
<seg id="2327">"a year-year-year study conducted by Aldurazyme at 20 patients (16 patients) were investigated in the study under 5 years (16 patients with the severe failure form and 4 with the middle deformation form)."</seg>
<seg id="2328">"in four patients, the dosage is increased due to increased GAG- mirror in the week 22 in the last 26 weeks on 200 E / kg."</seg>
<seg id="2329">"in several patients, a size of a size (n = 7) and a weight reduction (n = 7 years) and all 4 patients with the middle return form (&lt; 2.5 years) and all 4 patients with the middle return form (&lt; 2.5 years)."</seg>
<seg id="2330">"results appear ordered" "by relevance" "or" "by date" "(publication date),"</seg>
<seg id="2331">"data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data. why buy this report? * Get a detailed picture of the Baby Food market; * Pinpoint growth sectors and identify factors driving change; * Understand the competitive environment, the market's major players and leading brands;"</seg>
<seg id="2332">"in patients with a 200 E / kg intravenous all 2 weeks may have difficulties with weekly infusions, a connected alternative, however, is not detected that the long-term clinical efficacy of these two dosing stations."</seg>
<seg id="2333">"the European Medicines Agency (EMEA) will be used for any new information which are available annually, and if required, the summary of the characteristics of the drug will be updated."</seg>
<seg id="2334">The pharmacokinetic profile in patients under 5 years was similar to older and less strongly affected patients.</seg>
<seg id="2335">"based on the conventional studies on the conventional studies of safety, toxicity, toxicity, toxicity, toxicity at reproductive and reproductive, the clinical data does not have any special dangers for people."</seg>
<seg id="2336">This medicine may not be performed with other medicines which are mixed with other medicines which are mixed with the under 6.6.</seg>
<seg id="2337">"when used ready-to-use use is not used immediately, this is not longer than 24 hours at 2 ° C - 8º C, unless the dilution under controlled and valiant conditions were made."</seg>
<seg id="2338">5 ml concept for the production of a solution in water bottle (type - I-glass) with rods (silicone chlorine rubber) and sealing (aluminium) with tear-off cap (polypropylene).</seg>
<seg id="2339">"10 Preparation of the Aldurazyme-Infusion (using aseptic technique) • Je to body weight of the individual patients, first the number of dilution water should be determined."</seg>
<seg id="2340">Firm of the Year for Restructuring and Corporate Rescue Freshfields Bruckhaus Deringer Firm of the Year for Insolvency Administration Schneider Geiwitz & Partner Firm of the Year for Tax Gleiss Lutz</seg>
<seg id="2341">"results appear ordered" "by relevance" "or" "by date" "(publication date),"</seg>
<seg id="2342">"patients who suffer from MPS I suffer a enzyme called α -L-Iduronidase, which occurs certain substances in the body (glycosaminoglykane), either in low quantity or of this enzyme."</seg>
<seg id="2343">If you are allergic (excessive) compared to the components of Aldurazyme or if you have a severe allergic reaction to Laronidase.</seg>
<seg id="2344">An infusion-related reaction is any side effect that occurs during infusion or until the end of the Infusion day (see Section 4 "What side effects are possible).</seg>
<seg id="2345">"for application of Aldurazyme with other medicines please inform your doctor if you are taking medicine, chloroquin or Procain, because there is a possible risk of a diminished effect of Aldurazyme."</seg>
<seg id="2346">"please inform your doctor or pharmacist if you are taking other medicines, including non-prescription drugs."</seg>
<seg id="2347">For handling - dilution and application of the concept for producing a Infusion solution must be used before the application and is intended for intravenous application (see information for physicians or medical practitioners).</seg>
<seg id="2348">The initial examination rate of 2 E / kg / h can be increased when the patient is increased to a maximum dose of 43 E / kg / h.</seg>
<seg id="2349">"in some patients with severe MPS-I- unjustified participation of the upper respiratory tract and lungs in the history of history, but heavy reactions were to, including bronze chospasms, respiratory and facial muscles."</seg>
<seg id="2350">"if you want to send us a question about this product, simply complete all the fields marked * and click" "Send". ""</seg>
<seg id="2351">"the European drug agency (EMEA) will be used for any new information which are available annually, and if required, the package will be updated."</seg>
<seg id="2352">"when used ready-to-use use is not used immediately, this is not longer than 24 hours at 2 ° C - 8º C, unless the dilution under controlled and valiant conditions were made."</seg>
<seg id="2353">"results appear ordered" "by relevance" "or" "by date" "(publication date),"</seg>
<seg id="2354">"at the same time, Alimta is used together with Cisplatin (a different medicine against cancer), if the cancer has not been removed from cancer, the cancer has already been removed from cancer. • advanced or metastatic" "malignant" "lung cancer, which cannot be removed from the epithelial cells."</seg>
<seg id="2355">"Alimta is used in patients who have not been treated with Cisplatin, and patients who have already been applied in combination with Cisplatin and patients who have already been applied as a few therapy."</seg>
<seg id="2356">"to reduce side effects, patients should take patients during treatment with Alimta a Corticosteroid and acid (a vitamin) and injections of vitamin B12."</seg>
<seg id="2357">"when Alimta, together with Cisplatin, should be given, or after the gift of Cisplatin, in addition, a" Antiemeology "(drug against vomiting) and fluids (in order to prevent the liquid deficiency)."</seg>
<seg id="2358">"patients who occur in patients who are altered or where specific other side effects should occur, the treatment should be reduced or the dose can be reduced."</seg>
<seg id="2359">"in addition, the active form of pincreoretinates lead to the formation of DNA and RNA and prevents the cells."</seg>
<seg id="2360">The conversion of piezo injected into its active form of cancer cells is lighter than in healthy cells which leads to higher levels of medicine by and a longer term duration in cancer cells.</seg>
<seg id="2361">"for the treatment of maligamesendothelioms, Alimta was investigated in a major study of 456 patients who had not received chemotherapy against their disease."</seg>
<seg id="2362">"during the treatment of non-cell lung cancer, the effects of Alimta in a study conducted in 571 patients with local advanced or metastatic disease, which were compared with chemotherapy in cancer patients with the effects of Docetaxel (another drug against cancer)."</seg>
<seg id="2363">"Alimta was compared with Cispline (a further medicine against cancer), and both in combination with Cisplatin in a study on 1 725 patients who had no chemotherapy in lung cancer."</seg>
<seg id="2364">"patients who were treated with Alimta and Cisplatin, were compared to 12.1 month, compared with 9,3 months at all."</seg>
<seg id="2365">"in patients who had already received chemotherapy in patients, the average overlife time with Alimta 8,3 months, compared with 7,9 months in Docetaxel."</seg>
<seg id="2366">"in both studies, patients associated with which cancer is not the record of epithelial cells, at the same level of Alimta long overlife times than with the comparative drug."</seg>
<seg id="2367">"September 2004, the European Commission of Eli Lilly Nederland B.V. will bring an approval for the inscription by Alimta in the entire European Union."</seg>
<seg id="2368">"each flow bottle must be made with 4,2 ml 0,9% of sodium chloride-injection solution (9 mg / ml), which makes a solution of 25 mg / ml."</seg>
<seg id="2369">The corresponding volume of the necessary dosing heads are removed and with 0.9% of sodium chloride injection solution (9 mg / ml) to 100 ml (see paragraph 6.6).</seg>
<seg id="2370">ALIMTA is available in combination with Cisplatin in combination with the first-line therapy of patients with locally advanced or metastatic disease.</seg>
<seg id="2371">ALIMTA in Monotherapy is shown for the treatment in second-line therapy of patients with lo- Kal advanced or metastatic non-condensed bronze.</seg>
<seg id="2372">The recommended dose of ALIMTA 500 mg / m ² of body surface (KOF) is known as an intravenous infusion over a period of 10 minutes on the first day of every 21-day treatment cycle.</seg>
<seg id="2373">The recommended dose of Cisplatin is 75 mg / m ² KOF as infusion about a period of 2 hours a period of 2 hours after completion of the pincrexed- infusion on the first day of every 21-day treatment cycle.</seg>
<seg id="2374">The recommended dose of ALIMTA 500 mg / m ² KOF represents a period of 10 minutes on the first day of every 21-day treatment cycle.</seg>
<seg id="2375">"to the reduction of the frequency and severity of skin care must be given to the day before and on the day of the day, the day of the day and the day after treatment is a corticosteroid."</seg>
<seg id="2376">"during the seven days prior to the first dose of the first dose, the first dose must be taken at least 5 cans, and the consumption must be continued during the whole therapy chamber as well as for further 21 days after the last reactor."</seg>
<seg id="2377">"patients must also have an intrinsic injunction of vitamin B12 (1000 microgram) in the week before the first rectification process, as well as after each third part - handwriting cycle."</seg>
<seg id="2378">"in patients who received a complete blood supply should be created before every gift, including a complete blood-picture, including a differentiation of leukocytes and a Thrombocytes."</seg>
<seg id="2379">Deprecated: function ereg _ replace () is deprecated in / www / htdocs / w00cec0c / webEdition / we / include / we _ modules / object / we _ listview _ multiobject.class.php on line 296</seg>
<seg id="2380">At the beginning of a new treatment cycle must be held at the beginning of a new treatment cycle.</seg>
<seg id="2381">"according to the rest, the patient must be treated according to the information in the tables 1, 2 and 3, which apply for ALIMTA as Monotherapy or in combination with Cisplatin."</seg>
<seg id="2382">These criteria comply with the definition of the National Cancer Institute common toxicity Criteria (CTC v2.0; NCI 1998) ≥ CTC degree 2 blood.</seg>
<seg id="2383">"patients do not develop hemorological toxicity, degrees 3 (except neurotoxicity), the therapy of ALIMTA are interrupted, until the patient is the value before the treatment."</seg>
<seg id="2384">The treatment with ALIMTA must be broken if patients after 2 Dosisreinductides or non-hemorological toxicity or non-hemorological toxicity or non-hemogical toxicity or non-hemoricity degree of 3 or 4 neotoxicity.</seg>
<seg id="2385">"clinical studies have no notice that patients in the age of 65 percent, or in comparison to patients aged between 65 and 65 years."</seg>
<seg id="2386">"ALIMTA is not recommended for the application for children under 18 years, due to sufficient data to inconceivable and effectiveness."</seg>
<seg id="2387">In clinical trials at patients with a creatinin Clearance of ≥ 45 ml / min no Dosisadaptions necessary to go to all patients recommended.</seg>
<seg id="2388">The data base in patients with a creatinin Clearance of 45 ml / min was not recommended; therefore the application is not recommended (see paragraph 4.4).</seg>
<seg id="2389">"however, patients with a liver functional defects were investigated and / or transaminase values of liver metastasis) or &gt; 5.0 mm of the upper limit (in case of liver metastasis) or &gt; 5.0 mm of the upper limit (in the presence of liver metastasis) or &gt; 5.0 mm of the upper limit (in the presence of liver metastasis) or &gt; 5.0 mm of the upper limit (in the presence of liver metastasis) or &gt; 5.0 mm of the upper limit (in the presence of liver metastasis) or &gt; 5.0 mm of the upper limit (in the presence of liver metastasis) or &gt; 5.0 mm of the upper limit (in the presence of liver metastasis) or &gt; 5.0 mm of the upper limit (in the presence of liver metastasis) or &gt; 5.0 mm of the upper limit (in presence of liver metastasis) or &gt; 5.0 mm of the upper limit (in presence of liver metastasis) or &gt; 5.0 mm of the upper limit (in presence of liver metastasis) or &gt; 5.0 mm of the upper limit (in presence of liver metastasis) or &gt; 5.0 mm of the upper limit (in presence of liver metastasis) or &gt;</seg>
<seg id="2390">"patients need to be monitored in patients with regard to the bone, and the number of ≥ 1500 cells / mm ³ and the thrombo- cytenders will reach a value of ≥ 100,000 cells / mm ³."</seg>
<seg id="2391">"a dosisreation for more cycles is based on the Nadir of absolute neutrating capacity, Thrombocytenths and maximum non-adhesive treatments, as they have seen in the previous treatment cycles - (see paragraph 4.2)."</seg>
<seg id="2392">A lower toxicity and a reduction of degree 3 / 4 capmatological and infection with degrees 3 / 4 neutrroscopy was beamed when a pre-treatment with acid-acid and vitamin B12.</seg>
<seg id="2393">"in addition, all patients with piezo injections (see section 4.2)."</seg>
<seg id="2394">"patients with light to medium kidney disease (Kreatinin-Clearance 45 to 79 ml / min), as Ibuprofen and acetylamino acid (&gt; 1.3 g daily) for at least 2 days prior to the treatment of therapy, the day of therapy and miners (see paragraph 4.5)."</seg>
<seg id="2395">"in the case of a few days prior to the treatment, the use of NSAIDs have been planned for at least 5 days prior to the treatment, on the day of therapy and at least 2 days after the therapy."</seg>
<seg id="2396">"many patients receiving these events, appropriate risk factors for the appearance of renal events, including elydratation, pre-existing high blood pressure or diabetes."</seg>
<seg id="2397">"in addition, patients with clinically significant reduction - collection of transforms in transcell protection, a drainage system of the patient's correction treatment."</seg>
<seg id="2398">"in the first half of the year, the Kyokardal events have been reported in clinical trials with Plukardal events in clinical trials with Pavia reformed events in clinical trials with a different cytotoxic activity."</seg>
<seg id="2399">"due to this reason, the simultaneous application is not recommended (except laughter). it is not recommended (see paragraph 4.3 and 4.5)."</seg>
<seg id="2400">"since the possibility of misappropriatability of reproductive disorders, men should be able to keep men before the treatment - ginn, advice concerning the sperm distribution."</seg>
<seg id="2401">"patients with normal kidney function (Kreatinin-Clearance ≥ 80 ml / min), high doses radioidal antiphoric acid in high doses (≥ 1.3 g / day) and acetylbenicylacetate in high doses (≥ 1.3 g daily) and acetylacetamethylacetate in high dosage (≥ 1.3 g daily)."</seg>
<seg id="2402">"therefore, if patients with normal kidney function (Kreatinin-Clearance ≥ 80 ml / min) high doses of NSAIDs or acetylamine acid in high dosage."</seg>
<seg id="2403">Ibuprofen) or Acetylsalicylate cells in high dosage for at least 2 days prior to the treatment of the therapy and miners - 2 days after the treatment of the therapy with piezo injections (see paragraph 4.4).</seg>
<seg id="2404">"data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data. why buy this report? * Get a detailed picture of the Baby Food market; * Pinpoint growth sectors and identify factors driving change; * Understand the competitive environment, the market's major players and leading brands;"</seg>
<seg id="2405">The large intra-individual variability of the body status during the disease and the possibility of interactions between orussian antibodies and antineoplastic chemotherapy requires a greater monitoring frequency of the INR (International Standard Series Ratio) when the decision was made with orussian antibodies.</seg>
<seg id="2406">"data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data. why buy this report? * Get a detailed picture of the Baby Food market; * Pinpoint growth sectors and identify factors driving change; * Understand the competitive environment, the market's major players and leading brands;"</seg>
<seg id="2407">"in the case of pregnancy it may not be used during pregnancy, except if desired, and after careful consideration of the user, for the mother and the risk of the risk for the fetus (see paragraph 4.4)."</seg>
<seg id="2408">"since the possibility of misappropriatability of reproductive disorders, should be noted in the treatment of the treatment for the treatment of the treatment."</seg>
<seg id="2409">"it is not known that PKS are not known to relieve the breast milk, and undisturbing effects of the infectious diseases can not be excluded."</seg>
<seg id="2410">"the following table shows the frequency and severity effects that were randomised in &gt; 5% of 168 patients with mesial iom, and the randomised Cisplatin, and the randomised Cisplatin, randomised cisplatin as Monotherapy."</seg>
<seg id="2411">"results appear ordered" "by relevance" "or" "by date" "(publication date),"</seg>
<seg id="2412">* * * By National Cancer Institute CTC version 2 for any toxicity except the event "Kreatinin Clearance (v2.0; NCI 1998) should have a flavors and hair loss only as a degree 1 or 2 reported.</seg>
<seg id="2413">"for this table, a threshold of 5% may be determined by the recording of all events in which the reported doctor has a connection with pinctive and cisplatin for possible."</seg>
<seg id="2414">"clinical CTC toxicology, which were randomised with &lt; 1% (occasionally) of patients, the randomised cisplatin and publesions have been discovered."</seg>
<seg id="2415">"the following table shows the frequency and severity effects that were randomised by &gt; 5% of 265 patients, the randomised and vitamin B12 were randomised as Monotherapy as Monotherapy as Monotherapy as Monotherapy."</seg>
<seg id="2416">* * Beverages on National Cancer Institute CTC version 2 for any toxicity. * * Beverages on National Cancer Institute CTC (v2.0; NCI 1998) should not be reported to hair loss only as a degree 1 or 2.</seg>
<seg id="2417">"for this table, a threshold of 5% may be determined by the recording of all events in which the reported doctor has a connection with PKS."</seg>
<seg id="2418">"in the meantime, clinically relevant CTC toxicology, which were randomised with &lt; 1% (occasionally) of patients were randomised (occasionally) of the patients, the randomised centricular atrophy."</seg>
<seg id="2419">"the clinically relevant laboratory reagent degree 3 and 4 was compared with the predefined results of three individual assemblies (n = 164) of the phase 2 pincreous phase 3 pintrease-monothermal problems (12.8% compared with 5.9%), and increasing the ageing of Alanintranciase (15.2% compared with 1.9%)."</seg>
<seg id="2420">"these sub-sections are likely to lead the differences in patient care, as the Pha- se 2 trials of chemical metastasis with existing liver metastasis, and / or abnormative output values of liver functional tests."</seg>
<seg id="2421">"the following table shows the frequency and severity of unwanted effects that could be randomised with NSCLC, the randomised Cisplatin and publesions were randomised with NSCLC that randomised cisplatin and mixcitabine."</seg>
<seg id="2422">"11 * P values &lt; 0,05 comparison of pubs / Cispline, and mixcitabine / Cispline, under usage of the" Fisher Exact test. * * * Beakers on National Cancer Institute CTC (v2.0; NCI 1998) shall serve a flavors and hair loss only as a degree 1 or 2 reported. "</seg>
<seg id="2423">"for this table, for the recording of all events in which the reported doctor has been determined and cisplatin for possible, a threshold of 5%."</seg>
<seg id="2424">Clinically relevant toxicity that were randomised with ≥ 1% and ≤ 5% (often) the patients were randomised cisplatin and publesions:</seg>
<seg id="2425">"in some cases, clinically relevant antibodies that were reported in &lt; 1% (occasionally) of the patients, the range- dominized Cisplatin and publesions were investigated."</seg>
<seg id="2426">"in the case of a single cytotoxic disease, Angina pectoris, zerebrovascular diseases and transitory patients were used in klini- trials with Pavia revoort studies, occasionally reported in combination with another cytotoxic activity."</seg>
<seg id="2427">"clinical trials were occasionally used in patients with piezo injections, cases of Coli- TIS (including intestinal and retrace blood, sometimes fatal, intestinal disease and typhlitis) were reported."</seg>
<seg id="2428">"in the case of clinical trials, patients were occasionally used in patients with Pic-implantable treatment of pneumonitis with respiratory failure."</seg>
<seg id="2429">"in case of acute rences, kidney disease or in combination with other chemotherapy agent (see paragraph 4.4)."</seg>
<seg id="2430">"in cases, cases of radiation pneumonia has been reported to patients who were before or after their pinctive therapy, (see paragraph 4.4)."</seg>
<seg id="2431">"ALIMTA (piezo) is a antineoplastic antifolat that breaks its effect by weight - dynamic-dependent metabolic processes that are necessary for cell replication."</seg>
<seg id="2432">"in vitro studies in vitro studies showed that Pleukemia synthesis (TS), Dihydroidriidriidriidriidriidriidriidriidrip - mylhasase (DHFT), the folatdependent key enzymes of the de novo Biosynthesis of Thymidl and Purinnuclei."</seg>
<seg id="2433">"EMPHACIS, a multi-centric, simply-blind phase 3 study by ALIMTA plus Cisplatin in chemical treatment with maligplurotheliom, that were treated with ALIMTA and Cisplatin in patients who had been used with Cisplatin."</seg>
<seg id="2434">The primary analysis of this study was carried out in the population of all patients that were treated in the treatment arm the test treatment (randomised and treated).</seg>
<seg id="2435">A statistically significant improvement of clinically relevant symptoms (pain and Dyspnoe) in connection with the malignant Pleuramesthetics (212 patients) were shown at the same cisine-arm in the ALIMTA / Cisplatin-arm (218 patients).</seg>
<seg id="2436">The differences between the two treatment arms rose by an improvement of the lungs in the ALIMTA / Cisplatin arm and a reduction of the lung function in time during the time period.</seg>
<seg id="2437">"a multicentric, randomised, open phase III study with ALIMTA against Docetaxel in patients with ALIMTA treated patients (Intent to Treat population n = 283), and by 7,9 months in with Docetaxel patients (ITT n = 288)."</seg>
<seg id="2438">"a analysis of the influence of the histology of the histology of the histology of the treatment of histological type (n = 678; 95% CI = 0.061-1,00, p = 0.01; 95% CI = 1,08-2,26, p = 0.018)."</seg>
<seg id="2439">"limited data of a separate randomised, controlled phase 3 study show that the effectiveness of the data (survival and progressive free survival) for pinctive use (n = 41) and without (n = 540) pre-treatment by Docetaxel is similar to Docetaxel."</seg>
<seg id="2440">"results appear ordered" "by relevance" "or" "by date" "(publication date),"</seg>
<seg id="2441">Level PFS was 4.8 months for combination ALIMTA Cisplatin compared to 5.4% (95% CI = 27.3 - 1.15) for combination ALIMTA Cisplatin compared to 28.2% (95% CI = 25,4 - 31.4) for the combination of mixtures in Cisplatin.</seg>
<seg id="2442">The analysis of the influence of the NSCLC history showed clinically relevant sub-relevant sub-sections according to the histology, see the table below. "</seg>
<seg id="2443">"= = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = =</seg>
<seg id="2444">"data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data. why buy this report? * Get a detailed picture of the Homeshopping market; * Pinpoint growth sectors and identify factors driving change; * Understand the competitive environment, the market's major players and leading brands;"</seg>
<seg id="2445">"in addition, the patients selects the gift of Eryutin / Darbopoetin (10,4%), G-CSF / GM-CSF (3,3%, p = 0.01%, p = 0.021), p = 0.021)."</seg>
<seg id="2446">"the pharmacokinetic properties of Pleuković were studied at 426 cancer patients with different solid tumors in cans from 0.2 to 838 mg / m ² in Infusi- over a period of 10 minutes."</seg>
<seg id="2447">"in the first half of the first half of the year, the first half of the year was the first half of the year in the first half of the year."</seg>
<seg id="2448">"in addition, a total of 91.8 ml / min and half-value time in plasma amounts to 3.5 hours in patients with normal kidney function (Kreatinin-Clearance 90 ml / min)."</seg>
<seg id="2449">"in a study with Beagle-dogs who received for 9 months intravenous Bolus injections, Testicultural changes were observed."</seg>
<seg id="2450">"unless otherwise agreed, the storage times and conditions according to the preparation of the users and should normally be 24 hours at 2 up to 8 ° C, unless the preparation / dilution has been controlled under controlled and valiant conditions."</seg>
<seg id="2451">Solve the content of the 100 mg water tank (9 mg / ml) without preservability (9 mg / ml) without preservability (9 mg / ml) without preservability.</seg>
<seg id="2452">"the high-quality solution is clear and the coloring is from colour to yellow or green yellow, without that the product quality is impaired."</seg>
<seg id="2453">"each flow bottle must be generated with 20 ml 0,9% of sodium chloride-injection solution (9 mg / ml), which makes a solution of 25 mg / ml."</seg>
<seg id="2454">"however, they have been used in clinical trials, including Myokardinfantigens, and diebrovascular events were usually associated with a different cytotoxic activity."</seg>
<seg id="2455">* * * Beans based on National Cancer Institute CTC version 2 for any toxicity except the event "Kreatinin Clearance" * * * Beverted on National Cancer Institute CTC (v2.0; NCI 1998) should have a variety of taste and hair - case only than degree 1 or 2 reported.</seg>
<seg id="2456">"for this table - de a threshold of 5% defined in the recording of all events, in which the buyer pays a connection with a single function and cisplatin for possible."</seg>
<seg id="2457">* * Beverages on National Cancer Institute CTC version 2 for any toxicity. * * Beverages on National Cancer Institute CTC (v2.0; NCI 1998) should not be reported to hair loss only as a degree 1 or 2.</seg>
<seg id="2458">"* * * Beverage based on National Cancer Institute CTC (v2.0; NCI 1998) for any toxicity, * * * Beaune on National Cancer Institute CTC (v2.0; NCI 1998) shall be a flavors and hair loss - case only than degree 1 or 2 reported."</seg>
<seg id="2459">"in some cases, clinically relevant antibodies that were reported in &lt; 1% (occasionally) of the patients, the range- dominized Cisplatin and publesions were investigated."</seg>
<seg id="2460">"a analysis of the influence of the histology of the histology in the treatment of histology in patients with NSCLC, modified HR = 1,78; 95% CI = 0.061-1,00, p = 0.08-1,00, p = 0.008-2,26, p = 0.018)."</seg>
<seg id="2461">"with 20 ml 0,9%, sodium chloride - injunction solution (9 mg / ml) without preservability (9 mg / ml) without preservability."</seg>
<seg id="2462">"the high-quality solution is clear and the colour - from colour to yellow or green yellow, without that the product quality is impaired."</seg>
<seg id="2463">Firm of the Year for Insolvency Administration Schneider Geiwitz & Partner Firm of the Year for Tax Gleiss Lutz Firm of the Year for White Collar Crime Redeker Sellner Dahs</seg>
<seg id="2464">"in the version 1.2 of Risk Management Plan (RMP), presented in the version 1.2 of Risk Management Plan, as agreed in the version 1.2 of Risk Management Plan (RMP), presented in modules 1.8.2. the approval of the RMP which were decided by CHMP and all the following updates of the RMP which were approved by CHMP."</seg>
<seg id="2465">"according to CHMP Guideline on Risk Management Systems for Medicinal products for human use" "must be submitted to the next" "periodic Safety update Report" (PSUR). "</seg>
<seg id="2466">"in addition, a updated RMP will have a updated RMP • If a new information will have a influence on the current safety - specifications, pharmaceutical manufacturers or risk of milestones and risk of milestones • View on request by EMEA."</seg>
<seg id="2467">ALIMTA 100 mg powder for the production of a concentrations of a proliferation system - ALIMTA 500 mg powder for the production of a concentrations of infusion</seg>
<seg id="2468">ALIMTA is used in patients who have no prior approval in patients who have no previous chemotherapy in combination with Cisplatin in combination with Cisplatin, a different medicine for treatment of cancer patients. "</seg>
<seg id="2469">"if you suffer a kidney or earlier, please discuss this to your doctor or hospital library as you may not receive ALIMTA."</seg>
<seg id="2470">"for you, any infusion examinations are carried out; it is checked whether your kidney and liver function is given, and whether you have enough blood circulation to receive ALIMTA."</seg>
<seg id="2471">Your doctor will may change the dose or treatment if it requires your general condition and if your blood values are low.</seg>
<seg id="2472">"if you are also Cisplatin, your doctor will ensure that your body is sufficient water and you will receive the necessary medicine to avoid the vomiting and after the cisplatin gift."</seg>
<seg id="2473">"if you have a liquid type in order to remove the lungs around the lungs, your doctor can cause your doctor to eliminate these liquid before you receive ALIMTA."</seg>
<seg id="2474">"if you would like to call for treatment or treatment in the first 6 months after treatment, please contact your doctor or pharmacist."</seg>
<seg id="2475">"interactions with other medicines may say to your doctor if you are taking medicine against pain or inflammation (swunc- gen), such as medicine, the" unsteroidale antiphlogistics "(NSAIDs), including drugs that are non-prescription drugs (like Ibuprofen)."</seg>
<seg id="2476">Depending on the planned Daos of your ALIMTA Infusion and / or the range of your kidney function will you say that other medicines can take you.</seg>
<seg id="2477">Please inform your doctor or pharmacist if you are taking other medicines if you are not able to use other medicines.</seg>
<seg id="2478">"a hospital library, the care staff or a doctor is the ALIMTA Powder with steriler 0,9% of sodium chloride-injection solution (9 mg / ml), before it is applied to you."</seg>
<seg id="2479">Your physician will write to you Kortison tablets (according to the day after the application of ALIMTA) day and day after the application of ALIMTA.</seg>
<seg id="2480">"your doctor will take you to the Folacid (a vitamin) for one or Multivitol, the Folacid is included (350 to 1000 microgram), write to the application during the application of ALIMTA."</seg>
<seg id="2481">"in the week before the application of ALIMTA and around 9 weeks (according to 3 cycles of the treatment with ALIMTA), you will also receive a injection of Vi- tamine B12 (1000 microgram)."</seg>
<seg id="2482">"in this use information, one side effect is described as" very often "," means that it was reported by at least 1 of 10 patients. "</seg>
<seg id="2483">"results appear ordered" "by relevance" "or" "by date" "(publication date),"</seg>
<seg id="2484">"this is described as" "occasionally," "indicates that it has been reported to at least 1 of 1,000 but less than 1 of 100 patients, this means that it was at least 1 of 10,000 but less than 1 of 1,000 patients."</seg>
<seg id="2485">Fever or infection (often): if you have a body temperature of 38 ° C or if you have a body temperature of 38 ° C or if you have less white blood cells than normal which is very common.</seg>
<seg id="2486">"if you're tired or weak, quickly in breathing or blass look (because you might have less hemoglobin than normal, what is very common)."</seg>
<seg id="2487">"if you have a blued of the tooth, the nose or mouth of the mouth, or another bloodshed, which is not for a break or a reddish or rosafarboretinor. (because you may have less blood tiles) than normal, what is very common."</seg>
<seg id="2488">"occasionally (at least 1 of 1,000 patients), but less than 1 of 100 patients) increased pulse rate Colitis (inflammation of the body tissue), which can be connected with blood pressure in the intestines and endars."</seg>
<seg id="2489">"rarely seen in more than 1 of 10,000 patients, but less than 1 of 1,000 patients)" Radiation Recall "(a skin show similar to a heavy sunburn), apparel on the skin, before (some days to years) of a radiant therapy."</seg>
<seg id="2490">"occasionally, patients who bought the ALIMTA usually in combination with other cancer cells, had received a stroke or stroke."</seg>
<seg id="2491">Patients who received before or after their ALIMTA treatment can be caused by radiation causing inflammation of the lung disease.</seg>
<seg id="2492">Please consult your doctor or pharmacist if one of the side effects of side effects or if you notice side effects that are not affected in these packages.</seg>
<seg id="2493">"as well, the chemical and physical stability of the thinthood and infusion solution in storage in the fridge or at 25 ° C for a period of 24 hours."</seg>
<seg id="2494">"categories Daily View Previous Day Saturday, October 28, 2017 Next Day"</seg>
<seg id="2495">"if you want to send us a question about this product, simply complete all the fields marked * and click" "Send". ""</seg>
<seg id="2496">Tel: + 34-91-623-1732-1732-1732-1732 France SAS Tél: + 33- (0) 1 55 49 34 34 Ireland Eli Lilly and Company (Ireland) Limited Editions + 353- (0) 1 661 4377 Ísland Icepharma hf.</seg>
<seg id="2497">"if you want to send us a question about this product, simply complete all the fields marked * and click" "Send". ""</seg>
<seg id="2498">"if you want to send us a question about this product, simply complete all the fields marked * and click" "Send". ""</seg>
<seg id="2499">Tel: + 421 220 663 111 Suomi / Finland Oy Eli Lilly Finland AB (0) 9 7378800 United Kingdom Eli Lilly and Company Limited (0) 1256 315999</seg>
<seg id="2500">"* Understand the competitive environment, the market's major players and leading brands; * Pinpoint growth sectors and identify factors driving change; * Understand the competitive environment, the market's major players and leading brands; * Use five-year forecasts to assess how the market is predicted to develop."</seg>
<seg id="2501">"* Understand the competitive environment, the market's major players and leading brands; * Pinpoint growth sectors and identify factors driving change; * Understand the competitive environment, the market's major players and leading brands; * Use five-year forecasts to assess how the market is predicted to develop."</seg>
<seg id="2502">"the high-quality solution is clear and the coloring is from colour to yellow or green yellow, without that the propulsion quality is affected."</seg>
<seg id="2503">It is applied in excessive adults with a body mass index (Body Mass Index - BMI) of ≥ 28 kg per square metres in conjunction with a calorie-poor health diet.</seg>
<seg id="2504">"patients who use Alli and after 12 weeks have no weight loss, should have to apply to their doctor or pharmacist."</seg>
<seg id="2505">"these enzymes are caused by these enzymes, they can not build up some fats in the food. thus, a quarter of food that happens to the food of the intestines."</seg>
<seg id="2506">"in a third study, Alli was compared with 391 overweight patients with a BMI between 25 and 28 kg / m2 with placebo."</seg>
<seg id="2507">"in the two studies in patients with a BMI of ≥ 28 kg / m2 / m2 patients, the Alli 60 mg of patients had a average weight loss of 4.8 kg, compared to 2.3 kg at the consumption of placebo."</seg>
<seg id="2508">The study with Alli patients with a BMI between 25 and 28 kg / m2 could not be observed for patients with a BMI between 25 and 28 kg / m2.</seg>
<seg id="2509">"the most commonly used side effects of Alli (observed in more than 1 of 10 patients) are magnified stains on the After Flatus, Stuff (winds) with Stuhlabs, Stuhldst, fethldst (winds), flatulence (winds), and smooth chairs."</seg>
<seg id="2510">This may not be applied in patients who are treated with Ciclosporin (for the prevention of organically grown) or with medication such as warnings.</seg>
<seg id="2511">This may not be applied in patients who suffer from the long-term malignant substances (not sufficient nutrients from the digestive) or to Cholestase (a liver disease) or for pregnant mothers.</seg>
<seg id="2512">America's strongest allies expect a clear commitment to the trans-Atlantic security partnership</seg>
<seg id="2513">"alli is used for weight reduction of adults with overweight (Body Mass Index BMI ≥ 28 kg / m2), and should be applied in connection with a slightly bitter-kaline diet."</seg>
<seg id="2514">"data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data. why buy this report? * Get a detailed picture of the Baby Food market; * Pinpoint growth sectors and identify factors driving change; * Understand the competitive environment, the market's major players and leading brands;"</seg>
<seg id="2515">"however, Orlistat is only minimal resumed, is necessary in the elderly and / or kidney function no adjustment of the dosage necessary."</seg>
<seg id="2516">• oversensitivity to the active ingredient or the other components of simultaneous treatment with Ciclosase • pregnancy (see paragraph 4.6) • What time (see paragraph 4.6) • Collaborative treatment with warts in or other orally antibodies (see Abbreviations 4.5 and 4.8)</seg>
<seg id="2517">"the likelihood of disastroastrointestinal disorders (see paragraph 4.8), if alli together with a fat-rich single-rich or low-rich diet."</seg>
<seg id="2518">"since the weight reduction in diabetes with an improved metabolic control can be observed, patients who take a medicine against diabetes at the beginning of a therapy with alli a physician or pharmacist because the dosage of the antidiabetics have to be adapted."</seg>
<seg id="2519">"patients, the alli as well as medicines for high blood pressure or increased cholesterol levels should be adapted to their doctor or pharmacist if the dosage of these medicines must be adapted."</seg>
<seg id="2520">"in the case of serious diarrhoea, it is recommended to make additional changes in the case of severe diarrhoea possible failure of the orbital contrasts (see paragraph 4.5)."</seg>
<seg id="2521">The Ciclosporin plasma was observed in several cases with simultaneous application of Orlistat and Ciclosporin plasma.</seg>
<seg id="2522">"results appear ordered" "by relevance" "or" "by date" "(publication date),"</seg>
<seg id="2523">"in most patients who were treated in clinical trials up to 4 full years, the concentrations of vitamins A, D, E and K as well as the beta carotin in a normal range."</seg>
<seg id="2524">"however, the patient should be recommended in front of the dormitment of Multivitaminase in order to ensure adequate vitaminase (see paragraph 4.4)."</seg>
<seg id="2525">"after the gift of a dodosis Amiodaron was given a limited number of volunteers who received the Orlistat, a slight decrease of the Amiodaron plasma concentrations."</seg>
<seg id="2526">"experimental studies showed no direct or indirect harmful effects on pregnancy, embryonic / fetal development, birth or postnatal development (see paragraph 5.3)."</seg>
<seg id="2527">The side effects of Orlistat are mainly gastrointestinal disorders.</seg>
<seg id="2528">The gastrointestinal allergic reactions were made from clinical trials with Orlistat 60 mg over a duration of 18 months to 2 years and were generally easy and temporarily.</seg>
<seg id="2529">"the frequencies are defined as follows: very often (≥ 1 / 10), occasionally (≥ 1 / 10), occasionally (≥ 1 / 100), occasionally (≥ 1 / 100), rarely (≥ 1 / 100), not known (&lt; 1 / 100), not known (&lt; 1 / 10,000), not known (&lt; 1 / 10,000), not known (&lt; 1 / 10,000), not known (&lt; 1 / 10,000), not known (&lt; 1 / 10,000), not known (&lt; 1 / 10,000), not known (&lt; 1 / 10,000)."</seg>
<seg id="2530">The frequency of the known side effects that were established by the side effects that were established after the launch of Orlistat was not known since these events are voluntary for a population of certain size.</seg>
<seg id="2531">It is obvious that the treatment with alli would lead the treatment with alli with regard to possible or actual gastrophic side effects.</seg>
<seg id="2532">"data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data. why buy this report? * Get a detailed picture of the Baby Food market; * Pinpoint growth sectors and identify factors driving change; * Understand the competitive environment, the market's major players and leading brands;"</seg>
<seg id="2533">"in the majority of the accumulated cases of Orlistat overdose, either side effects or similar side effects such as the recommended dose of Orlistat."</seg>
<seg id="2534">"based on investigations on human beings and animal can be caused by a quick reformation systemic effect, which can be caused by the lipassover properties of Orlistat."</seg>
<seg id="2535">The therapeutic effect is used in the lumens of the stomach and the top of the top of the intestine to the active Serin-rest of the gastriic and pankreatic lipases.</seg>
<seg id="2536">"in clinical trials, 60 mg of Orlistat, three times daily, the absorption of about 25% of food is blocked."</seg>
<seg id="2537">"two double blind, randomised, uncontrolled trials at adults with a BMI ≥ 28 kg / m2 and the effectiveness of 60 mg of Orlistat, the three times daily in combination with a hypokalful diet."</seg>
<seg id="2538">"the primary parameter, the change of the body weight to the output value (at the time of the boundary value) was evaluated as follows: as change of the body weight (table 1) and the share of the study, which have lost more than 5% or more than 10% of their output weight (table 2)."</seg>
<seg id="2539">"although in both studies the weight loss has been observed over 12 months, the biggest weight loss was observed in the first 6 months."</seg>
<seg id="2540">The average changes in the total amount of 3mg -2.4% (output value 5.20 mmol / l) and placebo + 2.8% (output value 5.26 mmol / l).</seg>
<seg id="2541">The average change of the LDL cholesterol (measured value 3,30 mmol / l) and placebo + 3.3% (output value 3,41 mmol / l). "</seg>
<seg id="2542">At the waist circumference of 4.5 cm with Orlistat 60 mg (output value 103.7 cm) and placebo -3.6 cm (output value 103.5 cm).</seg>
<seg id="2543">Plasma concentrations of non-metabolic Orlistat were 8 hours after the orals of 360 mg Orlistat not measurable (&lt; 5 ng / ml).</seg>
<seg id="2544">7 In general case of therapeutic dosage is not metabolic Orlistat at plasma only sporadically and in extremely low concentrations (&lt; 10 ng / ml or 0.02 µMol) and without signs of a Kumulation.</seg>
<seg id="2545">"in a study with adipous patients, the minimal systemically resorated dose could be identified two main metabolite, namely M1 (in position 4 hydrolyric-leucin group), were identified."</seg>
<seg id="2546">"based on the conventional studies on the conventional studies, toxicity, toxicity, toxicity and reproductive potential and reproductive data, no particular risk of clinical data is no particular danger for people."</seg>
<seg id="2547">Firm of the Year for Restructuring and Corporate Rescue Freshfields Bruckhaus Deringer Firm of the Year for Insolvency Administration Schneider Geiwitz & Partner Firm of the Year for Tax Gleiss Lutz</seg>
<seg id="2548">"the implementation of the Management Board of Management (RMP) of October 2008, according to the agreement of the risk management (RMP) of October 2008, will be agreed upon the agreement of the risk management system (RMP) as well as all other updates of the RMPs, which will be agreed with the Committee for Human Physicians (CHMP)."</seg>
<seg id="2549">"according to CHMP directives, the latest RMP must be submitted to the updated RMP at the next PST simultaneously with the next PSR (periodic Safety update Report)."</seg>
<seg id="2550">"Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems."</seg>
<seg id="2551">"12 PSURS The owner of the approval of the approval of the approval of the admission for the admission of the admission of the admission to the alli 60 mg of tungsten CURS are all 6 months, then for two years and after all three years."</seg>
<seg id="2552">"• If you are pregnant or breastfeeding or breastfeeding, • If you are pregnant or breastfeeding, • If you are sensitive to Cholestase (disease of liver, at the Galleflow flow), • if you have problems with the food intake (chronic Malabsorption syndrom)."</seg>
<seg id="2553">"• take three times per day every day with every main mains, the fat contains, a capsule with water. • you should not take a day before the sleep, a multivitamintette (with the vitamins A, D, E and K)."</seg>
<seg id="2554">"application: • take three times a day with every main mains of the fat, a capsule with water. • you should not take advantage of a multivitamintette (with the vitamins A, D, E and K)."</seg>
<seg id="2555">"maybe you would like to read this later again. • Questions your doctor or pharmacist if you need more information or advice. • If you have no weight loss, ask a doctor or pharmacist for advice."</seg>
<seg id="2556">"• If one of the listed side effects you are considerably affected or you should notice that no side effects that are not indicated in this use information, please inform your doctor or pharmacist."</seg>
<seg id="2557">You must be logged in to enter a comment. you must be logged in to enter a valid e-mail address</seg>
<seg id="2558">How can you take your weight loss? • How can you use your weight loss for your weight loss?</seg>
<seg id="2559">What side effects are possible? • What effects are possible? • serious side effects • effects on blood-effects • effects on blood analyses • How can you control the nutritional benefits?</seg>
<seg id="2560">"• For further information, please contact us on Tel.: + 49 5764 318 444. or contact us per email."</seg>
<seg id="2561">The weight loss is used for weight loss and is used with an important adult age from 18 years with an Body Mass Index (BMI) of 28 or above anendendet. alli should be used in connection with a fat and calorie diet.</seg>
<seg id="2562">The BMI helps you determine if you have a normal weight or is important.</seg>
<seg id="2563">"even if this illness does not lead to this illness, you should be able to ask you to ask your doctor to receive a control examination."</seg>
<seg id="2564">"for each of 2 kg body weight, you can lose weight loss in a diet, you can lose out by the help of alli."</seg>
<seg id="2565">Please inform your doctor or pharmacist if you have other medicines or are recently added if there are no prescription drugs.</seg>
<seg id="2566">"Ciclosporin is used for organ transplantations, with severe rheumatoid arthritis and certain severe skin disease. • Warning in or other medicines that have a blood dilution effect."</seg>
<seg id="2567">"if you have any queries, please contact us on Tel.: + 49 5764 318 444. or contact us per email."</seg>
<seg id="2568">Please contact your doctor or pharmacist if you are: • Amiodaron for treatment of cardiovascular disorders. • Acarbose for treatment of diabetes.</seg>
<seg id="2569">"if you take care of your doctor or pharmacist if you take medicine against blood pressure, as possibly the dosage must be adapted to a high cholesterol level as possibly the dosage must be adapted."</seg>
<seg id="2570">"if you want to send us a question about this product, simply complete all the fields marked * and click" "Send". ""</seg>
<seg id="2571">"if you leave a meal or a meal no fat, do not take one capsule. alli can only work if the food is fat."</seg>
<seg id="2572">"if you are taking the capsule in conjunction with a meal that contains a lot of fat, risk of nutritional benefits (see section 4)."</seg>
<seg id="2573">"in order to give your body to the new food habits, you begin to start the first line with a calorie and fetus diet."</seg>
<seg id="2574">"nutrition is effective, since you can eat as much you eat and it will probably be easier to change your nutritional habits."</seg>
<seg id="2575">"to achieve your target weight, you should specify two daily targets: one for the calories and one for the fat."</seg>
<seg id="2576">"• You can be fetched fetus to reduce the likelihood for food-related products, please see Section 4). • For you are looking to move more than you can start using the consumption of the capsules."</seg>
<seg id="2577">"please remember your doctor if you don't want physical exercise. • pencil, you will be active during the use and also after finishing the use of alli physically active."</seg>
<seg id="2578">• no longer can be taken for longer than 6 months. • If you can find any longer than 6 months of application you can find your doctor or pharmacist for advice.</seg>
<seg id="2579">"in circumstances you have to quit the use of alli quit. • With a successful weight loss, it is not necessary to return to the old habits and then return to the old habits."</seg>
<seg id="2580">• If less than one hour since the last meal has passed since the last meal of the meal. • If more than one hour since the last meal has passed since the last meal.</seg>
<seg id="2581">"blends with and without a genuine Austro, sudden or increased Stuhldrang and soft chair) are based on the mechanism mechanism (see section 1)."</seg>
<seg id="2582">"allergic reactions have been allergic to the following changes: heavy breathability, welds, skin cancers, itching in face, heart rate, circulatory work."</seg>
<seg id="2583">"29 Very frequent side-side effects that may occur in more than 1 of 10 people, the alli occur, occur. • Bled chair • sudden chair you should have increased your doctor or pharmacies, if one of these side effects or are considerably affected."</seg>
<seg id="2584">"frequent side-side effects This may occur at 1 of 10 people who are alli use, • Incontinence, • Incontinence, • Incontinence / liquid chair • incontinence / liquid chair • incontinence / liquid chair • incontinence / liquid chair • incontinence child or pharmacist if one of these side effects or are considerably affected."</seg>
<seg id="2585">The effects on blood examination is not known how often these effects occur. • Increase of certain liver cells have adverse effects on blood cells or other blood glucose (anticoagulism) medication.</seg>
<seg id="2586">Please inform your doctor or pharmacist if one of the listed side effects may be affected or side effects that are not indicated in this use.</seg>
<seg id="2587">The most commonly used side effects of capsules can be combined together with the active ingredient of the capsules and thereby reduce the fat of the body.</seg>
<seg id="2588">These side effects usually occur within the first weeks after treatment in the first weeks after treatment.</seg>
<seg id="2589">"• Learn more about the usual fat content of your favorite food, or better a week in order to take advantage of your favorite foods and over the size of the pores that you normally normally take."</seg>
<seg id="2590">"if you want to know exactly how much you eat, low the likelihood that you exceed your fat-limit."</seg>
<seg id="2591">"the amount of calories and fat you may take per meal, not to take part in the form of a low-rich value of the amount of value. • most people are done with the weight of weight loss, learn to control this with the time by adaptation of their diet."</seg>
<seg id="2592">• Contents for children unaccessible. • The bottle contains two white-controlled container with Silicent. • The bottle contains two white-controlled container with Silicante which can be used to keep the capsules dry.</seg>
<seg id="2593">Take advantage of this in no case. • You may use your daily dose of the blue transport box (shuttle bus) with itself which is added to this package.</seg>
<seg id="2594">"Famar, 190 11 Avlona, Greece Catalent UK Packaging Limited, Slatch, Headway, Headway, Northampton, Corby, Northampton, Corby, Northampton, Corby, Northamptonshire NN18 8HS, United Kingdom"</seg>
<seg id="2595">Risk has influence on your health and increases the risk for the formation of different serious diseases such as: • High blood pressure • diabetes • Heart diseases • Examples of cancer diseases • Osteoarthritis • Personnel for these diseases.</seg>
<seg id="2596">"a permanent weight loss, for instance by enhancing the nutrition and more movement, can prevent serious diseases and has a positive impact on your health."</seg>
<seg id="2597">"meals that contain a wide range of nutrients, and learn to make permanent healthy eating."</seg>
<seg id="2598">"energy is measured in kilojoule, which can also be found in kilojoule. • The recommended calorie supply indicates how many calorie you should take a maximum per day."</seg>
<seg id="2599">"note: the recommended dose of fat is the maximum quantity of fat, which you should take with each meal."</seg>
<seg id="2600">"• The reason for you is suitable for you, which is the number of calories which is suitable for you. • the reason of the capsule of the capsule is crucial for you."</seg>
<seg id="2601">If you have the same amount of fat as far as it can mean that your body can not be processed in fat.</seg>
<seg id="2602">"due to compliance with the recommended fatty supply, you can reduce the weight loss and at the same time the likelihood for food-related risks."</seg>
<seg id="2603">"34 This reduced calorie supply should enable you to lose weight and continuously approximately 0.5 kg per week, without frustration and disappointments."</seg>
<seg id="2604">"• If you are active, the higher is your recommended calorie supply. •" "Low physical activity" means that you are only little or not walk, staircase, e.g. by 3 km Walk, 30- until 45-minute garden work or 2 km running in 15 minutes. "</seg>
<seg id="2605">"• For a permanent weight loss, it is necessary to set realistic calorie and fat content. • forgot to move more, before you start using the use of alli."</seg>
<seg id="2606">The alli program for support of weight loss can be combined with a diet and a large number of further information material that can help you to be caloriously and fetols to be physically active in physically active.</seg>
<seg id="2607">"in conjunction with your type cut program to support the support of weight loss, you can help you to develop a healthier lifestyle and make your target weight."</seg>
<seg id="2608">"Aloha is applied on chemists who are strong inferior to nausea and vomiting (like Cisplatin), as well as in Chemotherapy, the excessive strain of nausea and vomiting (as Cyclophosphamide, Doxorubicin or Carboplatin)."</seg>
<seg id="2609">The efficacy of Aloha can be increased by the additional gift of a Corticosteroids (a medicine that can be used as antiemeology).</seg>
<seg id="2610">"the application of patients under 18 years are not recommended, since the effects in this age group does not have enough information."</seg>
<seg id="2611">"this means that the active ingredient of a chemical substance in the body, 5-hydroxytryptamine (5HT, also known as Serotonin known), to the receptors in the intestines."</seg>
<seg id="2612">"Aloha was investigated in three main studies at 1 842 adults, the chemists, which were strong and excessive strain for nausea and vomiting."</seg>
<seg id="2613">"with Chemists, the strong weakening of nausea and vomiting, showed 59% of patients who were treated with Aloha (132 of 223), compared to 57% of the patients with ondansetron treated patients (126 of 221)."</seg>
<seg id="2614">"with Chemists, the excessive strain on nausea and vomiting, showed 81% of patients who were treated with Aloha (153 of 189), compared to 69% of the patients with ondansetron in the 24 hours of chemotherapy."</seg>
<seg id="2615">"at a comparison with Dolasetron, this values at 63% for Aloha (119 by 189 patients) and 53% for Dolasetron (101 of 191 patients)."</seg>
<seg id="2616">"in March 2005, the European Commission sent the European Commission to the Company's Birex Pharmaceuticals Ltd. in the entire European Union."</seg>
<seg id="2617">Aloha is indiscribed for prevention of acute and vomiting with strong chemotherapy due to a cancer disease and for prevention of nausea and vomiting of disease due to a cancer surgery.</seg>
<seg id="2618">The efficacy of Aloha for prevention of nausea and vomiting which is caused by a strong emulation of chemotherapy.</seg>
<seg id="2619">"since Palonosetron was extend to extend patients with anamnestiture Obstipation or signs of an subacute Ileus after the injection of the injection."</seg>
<seg id="2620">"as with other 5HT3 antenna, please note that QT interval is extended or in patients with which the QT interval is extended or in patients where the QT- Intervall extended."</seg>
<seg id="2621">"except in connection with a further chemotherapy, Aloha in the days of chemotherapy neither the prevention of nausea and vomiting are used for treatment of nausea and vomiting."</seg>
<seg id="2622">"in the clinical trials, Palonosetron's disease was not observed (Cisplatin, cyclophosphamide, cyclophosphamide, doxorubicin and Mitomycin C)."</seg>
<seg id="2623">In a clinical study no significant pharmacokinetic interaction between a single intravenous dose Palonosetron and a Steady Minocloprorids, a CYP2D6 inhibitors. "</seg>
<seg id="2624">"in one of a population-based pharmacokinetic analysis, it was shown that the simultaneous translation of CYP2D6 inhibitors (Amiodaron, chlorine etin, cimoine, cimoine, cimoine, seronavir, Sertravir, Sertrine and Terbinafin) no significant impact on the Clearance of Palonosetron."</seg>
<seg id="2625">"the experience of Palonosetron was not applied in human beings, therefore, Palonosetron should not be applied in pregnant women, unless it is necessary to be treated by the treatment doctor."</seg>
<seg id="2626">Clinical trials were the most commonly used in clinical trials (in total 633 patients) which were at least partly with Aloha (9%) and Obstipation (5%).</seg>
<seg id="2627">"very rare cases (&lt; 1 / 10,000) of oversensitive deity and reactions to the location of the place (burning, disruptions, complaints and pain) were given in post-marketing - experience."</seg>
<seg id="2628">"in the group with the highest dosage, similar entries of unwanted events like in the other docking groups, there were no dose of active relations."</seg>
<seg id="2629">"data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data. why buy this report? * Get a detailed picture of the Baby Food market; * Pinpoint growth sectors and identify factors driving change; * Understand the competitive environment, the market's major players and leading brands;"</seg>
<seg id="2630">"in two randomised double blind studies were compared with ≤ 50 mg / m2 Cispline, Carboplatin, Carboplubicin and 250 microgram of Palonosron (half-value time: 3 hours)."</seg>
<seg id="2631">"in a randomised double-blind, total 667 patients, which were compared with the 60 mg / m2 Cyclophosphamide and Dacarborron, and 250 or 750 microgram Palonosetron was given to the day 1 intravengeron."</seg>
<seg id="2632">"results appear ordered" "by relevance" "or" "by date" "(publication date),"</seg>
<seg id="2633">"in clinical trials of chemotherapy and vomiting (CINV), the effects of Palonosetron in blood pressure, heart rate and ECG parameter including the Qtc-Intervalls with the appropriate effects of Ondansetron and Dolasetron."</seg>
<seg id="2634">"according to the findings of Palonosetron, the ability to block the ventricular Dedication and repolarisation of the Ionboard channels and the duration of action to be increased."</seg>
<seg id="2635">"the aim of the study at 221 healthy research study was the assessment of the ECG-effects of i.c, 0.75 and 2.25 mg."</seg>
<seg id="2636">Resortion.Buyer pays €10 for shipping.Attention european and german buyers: we allow you to bid on this auction, but you need to add the vat of 19%. shipping to a german destination is7 euros. [...] "</seg>
<seg id="2637">The average maximum plasma concentrations (CMAx) and the surface under the concentrations of time-curve (AUC0- PL) are in general in the entire Dosiszone range of 0,3- 90-g / kg and cancer patients. "</seg>
<seg id="2638">"after intravenous gift of Palonosetron 0,25 mg every second day for a total of 3 cans, the Palonosetron plasma concentrations of 42 ± 34%."</seg>
<seg id="2639">"from the pharmacokinetic simulations, that at once a daily intravenous gift of 0,25 mg Palonosetron was comparable to 3 consecutive days, but the CMAx after the working class was comparable to 0.75 mg of 0.75 mg."</seg>
<seg id="2640">"about 40% of the kidneys, and around 50% are converted into two primary metabolites, compared to Palonosetron more than 1% of the antagonist effect on the 5HT3 recipes."</seg>
<seg id="2641">"in vitro studies to Metabolism have shown that CYP2D6 and, in lower dimensions, the Isock CYP3A4 and CYP1A2 am involved in Metonosetron."</seg>
<seg id="2642">Elimination After an intravenous individual dosis of 10 micrograms / kg [14C] -Palonosetron was found approximately 80% of the dose within 144 hours.</seg>
<seg id="2643">"after a single intravenous Bolusines, the total body of 173 ± 73 ml / min and the renal Clearance 53 ± 29 ml / min."</seg>
<seg id="2644">"however, patients with severe liver dysfunction and the average systemic exposure time and the average systemic exposure time and the average systemic exposure with Palonosetron increases the dose of dose."</seg>
<seg id="2645">"in pre-clinical trials were observed only after expositions, which indicates a sufficient about the maximum human therapeutic exposure, which indicates a low relevance for clinical use."</seg>
<seg id="2646">10 From the clinical trials at least in very high concentrations of Ionosetron only in very high levels of ion and repolarisation are involved in the ventricular Dedication and repolarisation.</seg>
<seg id="2647">"high doses Palonosetron (every dose said in approximately 2 years of therapeutic exposure in humans), led to an increased frequency of liver cells, endocrile neoplasms (in thyroid, hypophyse, pankreas, outputmark) and skin types in rats."</seg>
<seg id="2648">"the underlying mechanisms are not fully well known, but due to the high degree of dosing and as Aloha when people use the unique application, the relevance of these results will be low as for people."</seg>
<seg id="2649">The owner of this approval must be submitted to the European Commission to inform the European Commission on the plans to inform the plans of this decision on the framework of this decision.</seg>
<seg id="2650">• If one of the listed side effects are considerably affected or you notice that no side effects that are not indicated in this use information, please inform your doctor. "</seg>
<seg id="2651">"• Aloxi is a clear, coloured injecting solution for injectors in a Vene. • The active ingredient (Palonosetron) belongs to a group of medicines that occur as Serotonin the chemical substance. • Aloxi is used for the prevention of nausea and vomiting that occur in connection with chemotherapy due to cancer."</seg>
<seg id="2652">"21 In application of Aloha with other medicines please inform your doctor if you are allowed to use other medicines, even if there are no prescription drugs."</seg>
<seg id="2653">"pregnancy If you are pregnant or believe, your doctor will not give you Aloha, unless it is clearly required."</seg>
<seg id="2654">Questions regarding your doctor or pharmacist for advice if you are pregnant or believe to be pregnant.</seg>
<seg id="2655">"in some rare cases it came to allergic reactions to Aloha, or to breastfeeding or pain at the insertion."</seg>
<seg id="2656">"as Aloha looks and content of the pack Aloxi injection solution is a clear, colourless solution and is available in a pack with 1 inch of glass, which contains 5 ml of solution."</seg>
<seg id="2657">"if you want to send us a question about this product, simply complete all the fields marked * and click" "Send". ""</seg>
<seg id="2658">* Pinpoint growth sectors and identify factors driving change; * Understand the competitive environment, the market's major players and leading brands; "</seg>
<seg id="2659">United Kingdom IS Office Village Chester Business Park Chester CH4 9QZ - UK Tel: + 44 1244 625 152</seg>
<seg id="2660">"June 2006, the Committee for Human Physicians (CHMP) is a negative expert in which the approval of the approval for the treatment of hepatitis C received by Alpheon 6 million IE / ml injectors."</seg>
<seg id="2661">This means that Alpheon a biological medicine called Roferon-A with the same oral-effective component should already be used in the EU (also "reference implementation").</seg>
<seg id="2662">Alpheon should be used for treatment of adult patients with chronic (long anticised) hepatitis C (one by a viral infection).</seg>
<seg id="2663">"in a microscopic examination, the liver tissue occurs, the values of liver tissue is increased in the blood pressure (ALT) in the blood."</seg>
<seg id="2664">It is produced by a yeast in which a gene (DNA) was produced for the formation of the drug.</seg>
<seg id="2665">"the manufacturer of Alpheon, which consists of Alpheon with Roferon-A (active structure, composition and purity of medication by means of effectiveness, safety and efficacy of hepatitis C)."</seg>
<seg id="2666">"in the study on patients with hepatitis C, the effectiveness of Alpheon is compared to 455 patients."</seg>
<seg id="2667">The study was measured as many patients after 12 of 48 treatment weeks as well as 6 months after setting the treatment in the blood.</seg>
<seg id="2668">"(44-20) 74 18 84 16 E-mail: email @ emea.eu.int, http: / / www.emea.eu.int http: / / www.emea.eu.int http: / / www.emea.eu.int http: / / www.emea.eu.int"</seg>
<seg id="2669">"furthermore, it concerns concerns that the data to stability of the active drug and the market are not guaranteed."</seg>
<seg id="2670">"the number of patients with hepatitis C who spoke to the treatment of Alpheon and Roferon-A, was similar to clinical trial."</seg>
<seg id="2671">"after setting the treatment with Alpheon flame retardant the disease in more patients again than at the reference implementation; also Alpheon more side effects."</seg>
<seg id="2672">"apart from that, in the study of the study of the question, how the drug forms a immune response (i.e. the body forms antibodies - special proteins - against the medicine)."</seg>
<seg id="2673">"it may be used for the treatment of Impetigo (one with rice infection) and small insurgents (cracks, cutting, cutting), deductions and genotyping wafers."</seg>
<seg id="2674">Altargo is not used to treat infections or probably due to methicillinus aureus (MRSA) because Alargo against this kind of infections may not work.</seg>
<seg id="2675">Altargo can be applied in patients at age of nine months as well as patients under 18 years ago the skin surface is not more than 2% of the body surface.</seg>
<seg id="2676">"in case of patient after two or three days, the patient should investigate the patient should examine the patient again and alternative treatments."</seg>
<seg id="2677">"it works through blockages of bacterial Ribosses (the parts of the bacterienzelle, in which proteins are produced) and hemmed by the growth of bacteria."</seg>
<seg id="2678">The assumption of full take-up tends to exaggerate the simulated increase in caseloads and fiscal costs of a social policy reform.</seg>
<seg id="2679">119 (85.6%) the 139 patients under Altargo and 37 (52.1%) of 71 patients under placebo.</seg>
<seg id="2680">"at the treatment of infected skin, Altargo and Cefalexin similar contact: if the results of both trials were taken in skin, they said about 90% of the patients of both groups on the treatment."</seg>
<seg id="2681">"in these two studies, it was found that Altargo is caused by abbreviation (egg-filled hollow) or of infections, which have been caused by MRSA, not effective enough."</seg>
<seg id="2682">The most common side effect with Altargo (which was observed in 1 to 10 of 100 patients) is a friction of the customer.</seg>
<seg id="2683">"the Committee for Human Physicians (CHMP) came to the end that the advantages of Altargo to the course of the result of the result: • Impetigo, the infected small defects, deductions or genders."</seg>
<seg id="2684">Firm of the Year for Restructuring and Corporate Rescue Freshfields Bruckhaus Deringer Firm of the Year for Insolvency Administration Schneider Geiwitz & Partner Firm of the Year for Tax Gleiss Lutz</seg>
<seg id="2685">"patients, which shows themselves within two to three days, no improvement in which two to three days are investigated. (see paragraph 4.4)."</seg>
<seg id="2686">"in case of a sensitivity or serious local irritation by the application of retinapamulin, the treatment is broken off, and a adequate alternative therapy of infection began."</seg>
<seg id="2687">"Retreamulin shall not be applied to the treatment of infections, where MRSA is known as Erotic (see section 5.1)."</seg>
<seg id="2688">"clinical trials in clinical studies in clinical trials, the efficacy of retinapamulin in patients with infections, which were caused by a methicillin-resistant polyhylococcus aureus (MRSA)."</seg>
<seg id="2689">The alternative therapy should be considered if after a 2- and 3-day treatment have no better or a disrupting of the inappropriate place.</seg>
<seg id="2690">The effect of simultaneous application of Retreamulin and other topical means of the same skin area is not examined and the simultaneous application of other topical medicine is not recommended.</seg>
<seg id="2691">"due to the low plasma concentrations, which have been reached by humans after topical application in vivo, is a clinically relevant inhibitory in vivo (see section 5.2)."</seg>
<seg id="2692">3-times daily dose of 2-times daily 200 mg Ketoconazol increased the middle retapamulin AUC (0-24) and CMAx after topical application of a healthy adult men around 81%.</seg>
<seg id="2693">"due to the low-systemic exposure to topical application in patients, Dosisates are not required for use when topical Retreamulin during a systemic treatment with CYP3A4 inhibitors."</seg>
<seg id="2694">Animal studies have shown a reproductive toxicity according to orisation and are inadequate in relation to a statement on the birth and the fale / postnatal development (see paragraph 5.3).</seg>
<seg id="2695">"Retreamulin Salbe should only be used during pregnancy, when a topical antibacterial therapy is clear, and the application of reapamides of the gift of a systemic antibiotics."</seg>
<seg id="2696">"with the decision, whether the breastfeeding / finished, or the therapy with Altargo, should be continued between the benefit of the benefit of the treatment and the benefit of the Altargo therapy for the woman."</seg>
<seg id="2697">"in clinical trials at 2150 patients with superficial skin infections, Altargo was the most commonly used evidence of Irritation on the basis for about 1% of the patients."</seg>
<seg id="2698">Inflammation of Retapamulin is a semi-synthetic derivatives of Pleuromutilin, a substance that is isolated by fermentation from Clitopilus-eckerianus. "</seg>
<seg id="2699">The mechanism of the retinapamulin is based on the selective inhibitory of bacterial protein synthesis by interaction with a specific binding agent of the bacterial infection of the bacterial infection.</seg>
<seg id="2700">"this paper investigates the impact of non-take-up for two hypothetical scenarios, namely increasing and decreasing the base amount of social assistance in Germany by €100 per month. IAB-Discussion Paper 20 / 2015"</seg>
<seg id="2701">"due to the binding of this Binding, Pleuromutiline made the Peptizer transfer, block partial P-Binding Interaction and prevent the normal formation of active consignation units."</seg>
<seg id="2702">"should not appear on the basis of the local prevalence of resistance the application of retinapamulin at least some infection processes, should be consulted by experts."</seg>
<seg id="2703">"there were no differences in in vitro activity of retinapamulin compared to S.aureus, regardless of whether the insulation are sensitive or resistant to methicillin."</seg>
<seg id="2704">"in case of a non-interest on the treatment at S.aureus, the presence of stables with additional virus factors (such as PVL = Panton-Valentine leucocidin) should be considered."</seg>
<seg id="2705">Resorption In a study with healthy adults has been rated 1% reapamulin Salbe daily under Okktiva day for up to 7 days.</seg>
<seg id="2706">"from 516 patients (adults and children), 1% retinapamulin Salbe twice daily for 5 days to the topical treatment of secondary vans, were formed."</seg>
<seg id="2707">The sampling was carried out on the days 3 or 4 during the adult patients at 0-12 hours after the last application.</seg>
<seg id="2708">"however, the maximum individual systemic recording on humans after topical application of 1% Salbe on 200 cm2 / ml; AUC (0-24) = 23ng / ml; AUC (0-24) = 90-times lower than the retapamulin IC50 for PGP-inhibitory."</seg>
<seg id="2709">Metabolism (in vitro oxidative Metabolism) in vitro is primed by CYP3C8 and CYP2D6 and CYP2D6 (see paragraph 4.5).</seg>
<seg id="2710">"studies on toxicity to rats (50, 150 or 450 mg / kg) which were performed over 14 days, there were signs of automated liver and thyroid hormone changes."</seg>
<seg id="2711">In-vitro review on Gendering and / or chromosomal effects in the mouse Lymphoma test or in cultures of human peripheral blood vessels as well as the rats microalgae test for in-vivo analysis chromosomal effects.</seg>
<seg id="2712">"there were neither in male yet with female rats."</seg>
<seg id="2713">"in an embryotoxicism study on rats have been observed with orals of ≥ 150 mg / kg / day (according to the ≥ 3-year of the estimated human exposure (see above), development of the fetus and delay, Ossification) and maternal toxicity."</seg>
<seg id="2714">The owner of the approval for the company has to ensure that a pharmaceutical industry has to be present and works as in the module 1.8.1 of the approval application (version 6.2) and works before the product is marketed and as long as the market market is applied.</seg>
<seg id="2715">"the owner of the approval of the company is obligated to carry out more detailed studies and additional pharmaceutical agents (RMP), and the additional updates of the RMP which are agreed with the CHMP."</seg>
<seg id="2716">"as in CHMP" Guideline on Risk Management System for Medicinal products for human use, "should be submitted to the updated RMP at the same time with the next periodic Safety update Report."</seg>
<seg id="2717">Friction or other signs and symptoms in the treatment place shall you end the application of Altargo, and to speak with your doctor. "</seg>
<seg id="2718">"don't worry about other salads, creams or lotions on the surface, which has been treated with Altargo, if it is not expressly prohibited from your doctor."</seg>
<seg id="2719">"it may not be used in the eyes, on mouth or on the lips, in the nose or in the female genital area."</seg>
<seg id="2720">"if the Salbe made out on one of these surfaces, wash the place with water and ask your doctor at advice, if complaints occur."</seg>
<seg id="2721">"according to the use of the Salbe, you can cover the affected area with a sterilen Association or a Gazedies, it is because your doctor has not to be able to cover the area."</seg>
<seg id="2722">"it is offered in a aluminum tube with a plastic cap, which contains 5, 10 or 15 grams of salt, or in a aluminium bag, which contains 0.5 g Salbe."</seg>
<seg id="2723">Ambirix is used to protect against hepatitis A and hepatitis B (diseases that affect the liver) in children aged between one and 15 years.</seg>
<seg id="2724">"the Ambirix is used in the framework of a two-existing vaccine vaccine, with a protection against hepatitis B may only be reached after the second dose."</seg>
<seg id="2725">"from this reason, Ambirix only uses a low risk of a hepatitis B infection and is ensured that the vaccine can be carried out of two cans vaccine plan."</seg>
<seg id="2726">If a driveaway from hepatitis A or B can be given, Ambirix or another hepatitis A- or B-vaccine can be given. "</seg>
<seg id="2727">"vaccines influence the immune system (natural immune to the body)," how it can become a disease. "</seg>
<seg id="2728">"after a child to receive the vaccine, the immune system has the viruses and surface antigens as" alien "and generates antibodies."</seg>
<seg id="2729">The Ambirix contains the same components such as the 1996-approved vaccination for adults and has been approved vaccine Twinrix children since 1996.</seg>
<seg id="2730">"the three vaccines are used for protection against the same diseases, but the Twinrix of adults and Twinrix children under the framework of a three-cans vaccination."</seg>
<seg id="2731">"the Ambirix and Twinrix of identical ingredients were included, some of the data that uses the application of Twinrix to be used as cover for the application of Ambirix."</seg>
<seg id="2732">Firm of the Year for Restructuring and Corporate Rescue Freshfields Bruckhaus Deringer Firm of the Year for Insolvency Administration Schneider Geiwitz & Partner Firm of the Year for Tax Gleiss Lutz</seg>
<seg id="2733">In an additional study with 208 children the effectiveness of the vaccine has been compared with a six-month distance between the two injections.</seg>
<seg id="2734">Ambirix led to a month after the last injunction of the last injections to the development of cultivation areas against hepatitis A and B.</seg>
<seg id="2735">The additional study showed that the degree of protective shield was similar to a six-month-month distance between the injections.</seg>
<seg id="2736">"the most common side effects of Ambirix (observed in more than 1 of 10 vaccines) are headaches, appraisal, pain at the injection point, tubes, mat and irritability."</seg>
<seg id="2737">Ambirix may be sensitive to patients who may have oversensitive (allergic) to the active substances that react to the other components or Neomycin (an antibiotic).</seg>
<seg id="2738">Firm of the Year for Insolvency Administration Schneider Geiwitz & Partner Firm of the Year for Tax Gleiss Lutz</seg>
<seg id="2739">The standardization plan for the previous dose is made of two vaccinations, with the first dose of choice and the second dose between six and twelve months after the first dose. "</seg>
<seg id="2740">For hepatitis B and hepatitis B is necessary for hepatitis B as well as for hepatitis B is required for hepatitis B.</seg>
<seg id="2741">"in the same size, anti-hepatitis B (anti-HBsAg) - and anti-hepatitis B virus (anti-HBsAg) - and anti-hepatitis A virus (anti-HBsAg) - and anti-hepatitis A virus (anti-HBsAg) - and anti-hepatitis A virus (anti-HBsAg) - and anti-hepatitis A virus (anti-HAV)."</seg>
<seg id="2742">"it is not completely guaranteed, whether our competent persons who have a hepatitis A- vaccination have been used as protection as a protection, as they may not be able to protect their antioxidants."</seg>
<seg id="2743">3 As for all injections of the rare case of a anaphylaktic response according to the gift of the vaccine it is always available immediately.</seg>
<seg id="2744">"if a faster protection against hepatitis B is required, the standardization process is recommended, the 360 ELISA units formalinactivated hepatitis A virus and 10 µg recombinable hepatitis B surface effects."</seg>
<seg id="2745">"with hemogalysis and individuals with disorders of the immune system, according to the previous circumstances, no sufficient anti-HAV- and anti-hbs antibodies, so that in these cases the gift of further vaccine can be required."</seg>
<seg id="2746">"as a intraocular injectors, or intrinsic injuncture, could lead to a subtle impairment to an subtle impairment should be avoided, this injectors will be avoided."</seg>
<seg id="2747">"in thrombocytopus, or blood clash disorders can be injected in injections, as it can be seen in these cases after insufficiency of blood."</seg>
<seg id="2748">"if Ambirix in the second year of life in the form of a separate injection, Tetanus-, azellulence and Haematics, the immune response was sufficient to all antigens (see section 5.1)."</seg>
<seg id="2749">Patients with immune diseases or patients with immune defences must be achieved that may not be sufficient immunity.</seg>
<seg id="2750">"in a clinical study, with 3 vaccinations of this formulation was the frequency of pain, tubes, swelling, headache, headache, headache and fever comparable to the former Thief saline and preservatives."</seg>
<seg id="2751">"in clinical trials were 2029 vaccine Ambirix at a total of 1027 vaccinations in age of 1 to 15, including 15 years."</seg>
<seg id="2752">"in a study with 300 participants in the age of 12 to 15, 15 and 15 years has been added to the Ambirix with the 3-cans combination."</seg>
<seg id="2753">The only exceptions were the higher frequencies of pain and mat in a calculation of a vaccine dose, but not on a calculation basis per person. "</seg>
<seg id="2754">"pain was observed after the gift of Ambirix at 50.7% of the subjects, compared with 39.1% of the subjects after the gift of a dose of the 3-cans combination."</seg>
<seg id="2755">"according to the complete new vaccination, 66,4% of the subjects, the Ambirix, had been given, over pain, compared to 63.3% of the subjects which were treated with the 3-Doscopic vitational protein."</seg>
<seg id="2756">"however, the frequency of Matching was comparable to high (level.) across the entire vaccine cycle with 39.6% of the subjects that were compared with 36,2% of the subjects that received the 3-cans combination."</seg>
<seg id="2757">The frequency of distinctive pain and mat was small and comparable to the course of the combination of combination with the 3-cans vaccines.</seg>
<seg id="2758">"in a comparative study of 1- up to 11 year old vaccination was comparable to the target of local actions and general support in the Ambiance group with 360 ELISA-units formalinactive hepatitis B-A virus and 10 µg recombinant hepatitis B cells."</seg>
<seg id="2759">"in case of vaccination, however, according to vaccination was a frequent occurrence of pain (at the injection point) per dose, not per prosy, reported."</seg>
<seg id="2760">"the share of vaccination, which are due to severe side effects during the 2-cans vaccine as with a Ambirix or during the 3-cans vaccine as with the combination of a 360 ELISA- units formalinactive hepatitis B and 10 µg recombinant hepatitis B, was statistically not different."</seg>
<seg id="2761">"in clinical trials that were performed at vaccine in the age of 1 to 15 years, the SeroConverter rates for anti-HAV 99,1% a month after the first dose and 100% a month after the second, to the month 6."</seg>
<seg id="2762">"the SeroConverter rates for anti-hbs were 74,2% a month after the first dose and 100% a month after the second, to the month 6."</seg>
<seg id="2763">"data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data. why buy this report? * Get a detailed picture of the Consumer Health market; * Pinpoint growth sectors and identify factors driving change; * Understand the competitive environment, the market's major players and leading brands;"</seg>
<seg id="2764">"in the 289 persons, the immune system was the seroprotational rates (SP in the table below) against hepatitis B in the month 2 and 6 after the gift of the 3-Dosenimetric flow."</seg>
<seg id="2765">The immunotherapies that have been achieved in a clinical comparison study with up to 11 years of the full vaccine series (i.e. in month 7) are listed in the following table.</seg>
<seg id="2766">"in both studies, the vaccine is either a 2-cans vaccine with a Ambirix or a 3-cans vaccine with a combination of 360 ELISA-units and 10µg recombinant hepatitis B surface surface."</seg>
<seg id="2767">"for people who were at the time of the previous production between 12 and 15 years old, the perceiving between anti-HAV- and Anti-hbs antibodies have been demonstrated on at least 24 months after the immunoid in 0-6 months vaccines."</seg>
<seg id="2768">"in this study the immune reaction against both antioxidants was comparable to both antioxidants, consisting of 360 ELISA units formalinactivate Hepatitizing A virus and 10 µg recombinant hepatitis B-surface effects in a Dosisvolume of 0.5 ml."</seg>
<seg id="2769">"Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems."</seg>
<seg id="2770">"if the first dose of Ambirix in the second lifetime of life in the second lifetime of life, Tetanus-, azellulence and 8 Haemophilus, the immune response was sufficient to all antigens."</seg>
<seg id="2771">"a clinical study that was carried out with 3 cans of the current formulation of adults, showed a similar formulation similar to Seroprotational - and Seroconverter rates, as for the earlier development."</seg>
<seg id="2772">"in addition, the vaccine is both prior to the resusory and / or physiological changes in any foreign language and / or physiological changes."</seg>
<seg id="2773">"according to the article 114 of the Directive 2001 / 83 / EC, the state-of-the-law will be made by a state-owned laboratory or one to this purpose."</seg>
<seg id="2774">Porn-Movie with DirtyAnja</seg>
<seg id="2775">Suspension springs for injection 1 finished parts without spray 1 finished spraying with Silicone Smooth with Nadja 50 finish with Nadja 1 dosage (1 ml)</seg>
<seg id="2776">EU / 1 / 02 / 224 / 224 1 manufacturing with needle EU / 1 / 02 / 224 / 224 10 Finish with Nadine EU / 1 / 02 / 224 10 Finish with Nadine EU / 1 / 02 / 224</seg>
<seg id="2777">"the hepatitis A virus is usually transmitted through virusel food and drinks, but can also be transferred by other ways, such as through bathing in wastewater."</seg>
<seg id="2778">"you can feel very tired, have a dark urine, a dark face, yellow skin and / or eyes (laughter) and other symptoms which may require a stationary treatment."</seg>
<seg id="2779">"as with all vaccines can be able to protect it from infection with hepatitis B or hepatitis B virus, even if the complete vaccine series has been completed with 2 cans."</seg>
<seg id="2780">"if you have been infected with hepatitis A- or hepatitis B virus (although you are infected with hepatitis A- or hepatitis B virus), (although you don't feel bad / feel) can not prevent vaccination to a vaccination."</seg>
<seg id="2781">"a protection against other infections, which cause the liver or symptoms that are similar to hepatitis B or hepatitis B-infection can not be studied."</seg>
<seg id="2782">• If you already have an allergic reaction to Ambirix or any part of this vaccines including Neomycin (an antibiotic).</seg>
<seg id="2783">• If you have a allergic reaction to hepatitis A or hepatitis B. • If you have a allergic reaction to hepatitis A or hepatitis B. • If you have an allergic reaction to hepatitis A or hepatitis B. • If you have an allergic reaction to hepatitis A or hepatitis B. • If you have a severe infection with fever.</seg>
<seg id="2784">• If you would like to have a protection against hepatitis B.</seg>
<seg id="2785">"with a possible risk of infection with hepatitis B between the first and second vaccination, the doctor will give you a child from a vaccination with Ambirix."</seg>
<seg id="2786">"instead, he will recommend you / your child 3 injections of a combined heat-A- / hepatitis B-vaccine, with a reduced content of effective hepatitis B-A virus and 10 microgram of a recombinant hepatitis B-surface antigens)."</seg>
<seg id="2787">The second vaccine of this vaccine tissue is usually a month after the first dose and should give you a vaccine protection against the vaccine series.</seg>
<seg id="2788">"if you suffer from individuals who suffer from serious blood dysfunction, among the skin and not in the muscle. • If you are / your child due to a disease or treatment in your body, or if you are aware of your child by a hemoralysis."</seg>
<seg id="2789">"it can be given in these cases, but the immune system cannot be sufficient, so that a blood test may be required to see how strong the reaction to the vaccination."</seg>
<seg id="2790">21 Saye your doctor if you are taking your child another medication (including those that you can get without disruption) or if you have received the child before recently added / or immigration lobuline (antibodies) have been planned.</seg>
<seg id="2791">"but it may be that in this case, immunity is not sufficient and the person has not protected against a or both hepatitis A and B viruses."</seg>
<seg id="2792">"if another vaccine has to be given with the Ambirix must be given to separate locations, and as possible to different Gliedoms."</seg>
<seg id="2793">"if the Ambirix to the same time or shortly before or after a injection of immigrants, it is likely that the reaction to the vaccine is still sufficient."</seg>
<seg id="2794">"however, it is usually necessary that it is necessary that they are needed both against hepatitis A and hepatitis B as well as hepatitis B."</seg>
<seg id="2795">Important information on certain other components of AmbitionPlease inform your doctor if your child already have an allergic reaction to Neomycin (antibiotic).</seg>
<seg id="2796">If you miss the agreed date for the second vaccination you talk to your doctor and arrange a new date as soon as possible.</seg>
<seg id="2797">"(users Viewing this Forum: 1) 1,506 194 Tauchschein?"</seg>
<seg id="2798">"results appear ordered" "by relevance" "or" "by date" "(publication date),"</seg>
<seg id="2799">"further side effects, the days or weeks after the vaccination with similar combination or individual impregnation against hepatitis A and hepatitis B very rare (less than 1 case per 10,000 verimed cans) are:"</seg>
<seg id="2800">"these include a limited number of pools, itching, or blaspheming, swelling of the eye, or swallow, swelling of the eye, or swallowing, sudden blood pressure loss and consciousness."</seg>
<seg id="2801">"flu-like disruptions, including bulk, muscle and articular pathologies, multiple sclerosis, diseases of vision, multiple headache and stiffness of the neck, interruption of normal brain functions"</seg>
<seg id="2802">"inflammation of the blood vessels, blood vessels, blood vessels, blood flow and abdominal pain, lymphobic digestion / blood cells, caused by waste of blood clash (blue spots), caused by waste of blood clashes."</seg>
<seg id="2803">Please consult your doctor or pharmacist if one of the listed side effects / your child may be affected or side effects that are not indicated in this package.</seg>
<seg id="2804">Ambirix is available in packages to 1 and 10 with or without nuts and bags in packaging.</seg>
<seg id="2805">"on the basis of the data that has become known for the establishment of the first name, the CHMP has become a view that the benefit of the benefit ratio of ambient positively."</seg>
<seg id="2806">"however, it is only limited in a member state (in the Netherlands since May 2003), the available safety data for this drug may be limited due to the low patient exposure."</seg>
<seg id="2807">Ammonominations can also be used in patients at age of over a month with complementary Enzymatic conjunctivist (brain-induced due to high ammonia concentrations) in the history of history.</seg>
<seg id="2808">Ammong will be split up to several individual dots in the stomach - split under the food and the stomach in the stomach of the stomach (by the nose in the stomach's leading hose) or a nasal surgery (through the nose to the stomach's leading hose).</seg>
<seg id="2809">"there are no significant study, the Ammonite cannot be compared with another treatment or placebo (a headache, i.e. without active ingredient)."</seg>
<seg id="2810">"ammong can also be used to Appedicals, a abbreviation, headache, headache, vomiting, diarrhea, vomiting, nausea, vomiting, skin rash, uncomfortable body weight or weight loss."</seg>
<seg id="2811">"the Committee for Human Physicians (CHMP) came to the end, the Ammonite in patients with disturbances of the urinary cycle is prevented."</seg>
<seg id="2812">Ammong was admitted under "exceptional circumstances because of the disease of the disease at the time of admission only limited information on this medicine.</seg>
<seg id="2813">"in all patients indiscrimined by all patients, with which a complete Enzymatic worker already has been manifested in Neueneta (within the first 28 living-age)."</seg>
<seg id="2814">"in patients with a delayed interruptive shape (incomplete tail, which can manifest after the first life of life) there is an indication of the use when in Anamnese a hyperammonomopathy."</seg>
<seg id="2815">AMMONAPS also available in Granulatform.</seg>
<seg id="2816">The daily dose is individually tolerated under consideration of protein tolerances and the development of the daily protein consumption of the patient.</seg>
<seg id="2817">"according to the previous clinical experience, the normal daily dose of sodium - 600 mg / kg / day for children with a body weight of less than 20 kg • 9.9 - 13.0 g / m ² / day for children with a body weight over 20 kg, as well as herangrowing and adults."</seg>
<seg id="2818">"patients who suffer from an early manifolds or Ornithintranscarbamides, the substrate of Citadel lin or Arginine in a dosage of 0,17 g / kg / day or 3.8 g / m ² / day."</seg>
<seg id="2819">Patients with a arginine synthase inhibitors must have to be found in a dosage of 0.4 - 0.7 g / kg / day or 8.8 - 15.4 g / m ² / day.</seg>
<seg id="2820">AMMONAPS tablets may not be used as a risk for the formation of Ösophagululine when the tablets are not immediately ready to reach the stomach.</seg>
<seg id="2821">"each tablet AMMONAPS contains 62 mg (2,7 mmol) sodium, according to 2.5 g (108 mmol) sodium per 20 g sodium, which corresponds to the maximum daily dose of daily dose."</seg>
<seg id="2822">AMMONAPS should therefore be applied to patients with congenital heart failure or severe kidney disease as well as with sodium and Ödema neurodegenerative disease.</seg>
<seg id="2823">AMMONAPS in patients with liver or kidney disease should only be applied in patients with liver or kidney failure.</seg>
<seg id="2824">The importance of these results in relation to pregnant women is not known; the use of AMMONAPS during pregnancy is therefore higher (see 4.3).</seg>
<seg id="2825">"in subtract of phenylacetate to young rats in high dosage (190 - 474 mg / kg), it came to a slowing of neonals and increased loss of neurons."</seg>
<seg id="2826">It also found a delayed delay of zerebrals and a reduced number of functional nerve disorders in the brain and thus a disability of the brain growth.</seg>
<seg id="2827">It could not be found whether phenylacetate is out of humans in the womb and from this reason is the use of AMMONAPS during the treatment time (see 4.3).</seg>
<seg id="2828">In clinical trials with AMMONAPS came at 56% of the patients at 56% of this undesirable event (AE) on and at 78% of this undesirable events came out that they were not with AMMONAPS in conjunction with AMMONAPS.</seg>
<seg id="2829">"the frequency is defined as follows: very often (≥ 1 / 10), often (≥ 1 / 100, &lt; 1 / 10) and occasionally (≥ 1 / 10, &lt; 1 / 100)."</seg>
<seg id="2830">Deprecated: function ereg _ replace () is deprecated in / www / htdocs / w00cec0c / webEdition / we / include / we _ modules / object / we _ listview _ multiobject.class.php on line 296</seg>
<seg id="2831">A case of an overdose came to a 5 months old age with a self-dose of 10 g (1370 mg / kg).</seg>
<seg id="2832">"these symptoms go with the accumulation of phenylacetate, which showed up to 400 mg / kg / day a dosistive neurotoxicity."</seg>
<seg id="2833">Phenylacetate is a meta active connection to phenylacetylamine with glutamine and phenylacetylutamine.</seg>
<seg id="2834">"pylacetylutamine is an phenylacetylutamine (both connections contain 2 nitrogen oxatome); phenylacetylutamine is therefore ideally suited as alternative strength for separating nitrogen.</seg>
<seg id="2835">5 patients with disturbances of the urinary cycle can be assumed that each grams is produced between 0.12 and 0.15 g phenylacetylutamine nitrogen can be produced.</seg>
<seg id="2836">It is essential that the diagnosis early and the treatment immediately will be started to improve the overlife opportunities and the clinical outcome.</seg>
<seg id="2837">The prognosis of the early manifolds of the disease with the appearance of the first symptoms in Neuenica was almost always inferior and the disease led itself in treatment with Peritonealdialysis and essential amino acids in the first lifetime of life.</seg>
<seg id="2838">"by hemenalysis, the use of alternative ways of nitrogen oxides (sodium chloride), sodium chloride and sodium polyphenyl acetate), proteinically reduced kost and possibly the substrate of essential amino acids, it is possible to increase the survival rate in postpartum (however within the first lifetime of life)."</seg>
<seg id="2839">"patients, whose disease was diagnosed in pregnancy and had been treated up to the first appearance of a hyperammonomic enzyme, was treated with the time with many spiritual disabilities or other neurological deficit disorder."</seg>
<seg id="2840">"in patients with a delayed treatment of the disease (including chronic patients with the heterozygintranscarbamylase-Manlio), which was treated with sodium chlorides and a prototyping diet, was the overlife rate 98%."</seg>
<seg id="2841">"results appear ordered" "by relevance" "or" "by date" "(publication date),"</seg>
<seg id="2842">"it is known that phenylacetyrat is used, which is used in liver and Niere enzymatic with glutamine with glutamine, with phenylacetylglutamine."</seg>
<seg id="2843">"concentrations of phenylbutyrat and its metabolites in plasma and urine were performed according to the gift of a single dose of 5 g sodium chloride, and with liver cirrhosis of up to 20 g / day (not controlled studies)."</seg>
<seg id="2844">The behaviour of phenylbutyrat and its metabolites was also investigated in cancer patients after intravenylbutyrat (up to 2 g / m ²) or phenylacetate.</seg>
<seg id="2845">"after a orating single dose of 5 g sodium chloride, 15 minutes after taking plasma concentrations of phenylbutyrat."</seg>
<seg id="2846">"due to the majority of patients with urinary cytoxic disorders or hemodyslexia (300-650 mg / kg / day) on the next morning after night, no Phenylacetate in plasma."</seg>
<seg id="2847">Three of six patients with liver cirrhoids (20 g / day oral in three single dots) were treated with sodium chloride concentration camp in the third day five times higher than after the first gifts.</seg>
<seg id="2848">"the medication is used within 24 hours, about 80 - 100% in form of conjugated product phenylacetylutamine over the kidneys."</seg>
<seg id="2849">"results appear ordered" "by relevance" "or" "by date" "(publication date),"</seg>
<seg id="2850">AMMONAPS Granules are either oral (minced meat) and children who are still unable to swallow (minced meat) or via a Gastrostomata or a nasal infection.</seg>
<seg id="2851">"according to the previous clinical experience, the normal daily dose of sodium chloride -600 mg / kg / day with a body weight of less than 20 kg • 9.9 - 13.0 g / m ² / day for children with a body weight over 20 kg, as well as to Herangrowing and adults."</seg>
<seg id="2852">"concentration of ammonia, arginine, essential amino acids (in particular, gtkettish amino acids), Carnitin and Serum protectors, should be kept within the normal area."</seg>
<seg id="2853">"patients who suffer from an early manifolds or Ornithintranscarbamides, the substrate of Citadel lin or Arginine in a dosage of 0,17 g / kg / day or 3.8 g / m ² / day."</seg>
<seg id="2854">AMMONAPS Granules contains 124 mg (5.4 mmol) sodium per grams of sodium chloride (108 mmol) sodium per 20 g sodium polyphenyrat which corresponds to the maximum daily dose of daily dose.</seg>
<seg id="2855">"the birth of phenylacetate (active metabolic rate of phenylbutyrat) were exposed to lymph cells of the brain, in the pyramids of the brain."</seg>
<seg id="2856">Deprecated: function ereg _ replace () is deprecated in / www / htdocs / w00cec0c / webEdition / we / include / we _ modules / object / we _ listview _ multiobject.class.php on line 296</seg>
<seg id="2857">Pylacetylutamine is a phenylacetylutamine (both connections contain 2 nitrogen oxatome); phenylacetylglutamine is therefore suitable as alternative to impedance of excess pressure</seg>
<seg id="2858">"based on examinations of phenylacetylutamine in patients with disorders of the urinary cycle can be assumed that for any grams of sodium chloride between 0,12 and 0.15 g phenylacetylutamine nitrogen can be produced."</seg>
<seg id="2859">"results appear ordered" "by relevance" "or" "by date" "(publication date),"</seg>
<seg id="2860">"after a orating single dose of 5 g sodium chloride form, 15 minutes after taking plasma concentrations of phenylbutyrat."</seg>
<seg id="2861">"during the duration of durability, the patient can keep the finished product once a period of 3 months at a temperature of not about 25 ° C."</seg>
<seg id="2862">"with this approach, the small measuring spoon 0.95 g, the middle measuring spoon 2.9 g and the large measuring spoon 8,6 g sodium polyphenyrat."</seg>
<seg id="2863">"if a patient has to receive the medicine via a probe, AMMONAPS before use in water (the solvents of sodium polyphenylene is up to 5 g in 10 ml water)."</seg>
<seg id="2864">"in patients with these rare diseases, certain liver enzymes, so that they are the stickresistant waste products that can not be avoided."</seg>
<seg id="2865">"if at your laboratory examinations must be made, you must inform the doctor that you are using AMMONAPS, since sodium polyphenols the results of certain laboratory examinations can be achieved."</seg>
<seg id="2866">"in addition to AMMONAPS with other medicines please inform your doctor or pharmacist if you have other medicines, even if there are no prescription drugs."</seg>
<seg id="2867">"during the trial period you may not use AMMONAPS, as the drug might cause milk into the womb and your baby harm."</seg>
<seg id="2868">"in rare cases, the function of a headache, headache, taste, dissemination, memory problems and an deterioration of existing neurological conditions."</seg>
<seg id="2869">"if you find any of these symptoms, please contact your doctor or by the emergency of your hospital for a corresponding treatment."</seg>
<seg id="2870">If you are forgotten by AMMONAPS you have forgotten your dose as soon as possible with the next meal.</seg>
<seg id="2871">"changes of blood circulation (red blood cells, Thrombocytes), reduced appetite, depression, irritability, irritability, irritability, irritability, irritability, irritability, impectile dysfunction, kidney disease, weight loss, weight loss, weight loss, weight loss, weight loss, weight loss, weight loss, weight loss, weight loss, weight loss, weight loss, weight loss."</seg>
<seg id="2872">Please inform your doctor or pharmacist if one of the listed side effects may be affected or side effects that are not indicated in this use.</seg>
<seg id="2873">You may not use AMMONAPS to the conversion box and the containers can no longer use.</seg>
<seg id="2874">"like AMMONAPS and content of the package AMMONAPS tablets are made of white color and oval shape, and they are provided with the" UCY 500 "." "</seg>
<seg id="2875">"30 If a laboratory examinations must be made, you must inform the doctor that you are using AMMONAPS, since sodium polyphenols the results of certain laboratory examinations can be achieved."</seg>
<seg id="2876">"in addition to AMMONAPS with other medicines please inform your doctor or pharmacist if you have other medicines, even if there are no prescription drugs."</seg>
<seg id="2877">"you should use AMMONAPS distributed to the same single drought or via a Magenfistel (hose, which is carried out directly into the stomach) or a nasensonde (hose, which is led by the nose in the stomach)."</seg>
<seg id="2878">"if you give your telephone number, we will also gladly call you back. if you want to send us a question about this product, simply complete all the fields marked * and click" "Send". ""</seg>
<seg id="2879">"angiox will apply to the treatment adult patients with" acute coronarrays "(ACS, reduced blood supply to the heart), for example in unstable angina (a form of pain in the chest with different strength) or Myokardinfine (heart attack)."</seg>
<seg id="2880">"Angiox will be applied to patients suffering from patients suffering from a PCI, a higher dose, and the infusion can be continued up to four hours after the procedure."</seg>
<seg id="2881">This may increase in patients with angina or heart attack to the maintenance of blood flow to the heart and increase the effectiveness of a PCI.</seg>
<seg id="2882">"for 14 000 patients participated in the main study on the treatment of ACS at any of some gifts or in conjunction with a glycoprotein / IIIA-inhibitor (GPI, a other medicines which was compared with the conventional combination of anagulans) and a GPI."</seg>
<seg id="2883">"during the PCI, the patient was frequently used a stent, which is used in the Arterie, to prevent a closure of blood vessels, and they also received other medicines to prevent blood clots, such as Abciximab and aspirin."</seg>
<seg id="2884">"at the treatment of ACS was Angiox - with or without the gift of GPI - when the prevention of new events (deaths, heart disease or reaskularisation) after 30 days or one year, as well as the conventional treatment."</seg>
<seg id="2885">"in patients with a PCI bus, Angiox was observed in relation to all indicators such as Heparin, except for heavy blood, when it was considerably more effective than Heparin."</seg>
<seg id="2886">"Angiox may not be applied to patients who may be oversensitive (allergic) against Bivalirudin, other shudine or other parts of other parts."</seg>
<seg id="2887">"it may not be used in patients who had been applied to patients who had a blood pressure, as well as with a strong blood pressure or severe kidney problems or a heart infection."</seg>
<seg id="2888">The Committee for Human Physicians (CHMP) came to the end that Angiox at the treatment of ACS and during a PCI an acceptable replacement for Heparin is.</seg>
<seg id="2889">"September 2004, the European Commission to the Company The Medicines Company UK Ltd was an approval for the Ingiox in the entire European Union."</seg>
<seg id="2890">"for treatment of adult patients with acute coronarist angina / non-ST-Hebron (IA / NSTEMI), if an early intervention is planned."</seg>
<seg id="2891">The recommended initialdosis of Angiox in patients with ACS is a intravenous bolt of 0.1 mg / kg followed by a infusion of 0.25 mg / kg / h.</seg>
<seg id="2892">"in case of the patient in other result, an additional Bolus should be given an additional Bolus of 0.5 mg / kg and the infusion for the duration of the surgery on 1.75 mg / kg / h."</seg>
<seg id="2893">After the PCI can be reduced by 0.25 mg / kg / h for 4 to 12 hours.</seg>
<seg id="2894">"immediately before the procedure, a bolt of 0.5 mg / kg, followed by a infusion of 1.75 mg / kg / h for duration of the period."</seg>
<seg id="2895">The recommended dosage of angiox in patients with a PCI consists of a initial intravenous bolt action of 0.75 mg / kg body weight and a dose of 1.75 mg / kg body weight / h at least for the duration of the surgery.</seg>
<seg id="2896">"the security and efficacy of a number of Bolus-gift of Angiox has not been investigated and is not recommended, even if a short PCI procedure is planned."</seg>
<seg id="2897">Is this value (ACT after 5 minutes) to 225 seconds should be made up to 0.3 mg / kg / body weight.</seg>
<seg id="2898">"in order to reduce the appearance of lower-lower values, the regenerative and fertilization before use carefully mixed and the Bolusdosis can be used quickly and used for intravengesis."</seg>
<seg id="2899">"once the ACT value is more than 225 seconds, another monitoring cannot be required, provided the 1.75 mg / kg infusion dose is correct."</seg>
<seg id="2900">"in patients with medium-severe kidney function (GFR 30-59 ml / min), which can be used with Bivalirudin against ACS or not), should be used for a lower price rate of 1.4 mg / kg / h."</seg>
<seg id="2901">The ACT-value under 225 seconds is a second Bolusdosis of 0.3 mg / kg and the ACT 5 minutes after the second Bolusdosis again.</seg>
<seg id="2902">"in patients with medium-severe kidney disorders, which led to the phase III- PCI-study (Replace-2), which led to approval, was included in the study 5 minutes after the course of the Bivalirudin-Bolus without Dosis--at the average of 366 ± 89 seconds."</seg>
<seg id="2903">3. patients with severe kidney compensation (GFR &lt; 30 ml / min) and even at dialysis patients (see below section 4.3).</seg>
<seg id="2904">Treatment with angiox can 30 minutes after finishing the intravenous gift of unfraction of Heparin or 8 hours after finishing the subwoofer of the subtle heparin of Heparin.</seg>
<seg id="2905">• well-sensitive hypersensitivity to the active ingredient or any other parts or against shudine • active blood risk or increased blood risk due to a fault of hemostasesthetics and / or irresistible bacterial problems due to a fault of hemostasesthetics and / or irresistible bacterial pathoditis. • severe kidney disorders (GFR &lt; 30 ml / min) and with dialysis patients</seg>
<seg id="2906">Patients are carefully chosen during treatment with regard to symptoms and signs of blood in combination with other antibodies in combination with another antibodies (see paragraph 4.5).</seg>
<seg id="2907">"even when using PCI-patients under Bivalirudin, most blood vessels can occur in patients who occur to a performative coronarisation (PCI), while the treatment principle may occur throughout the treatment."</seg>
<seg id="2908">"in patients, the warts are treated with Bivalirudin, a monitoring of the INR advertising should be drawn up to ensure that the value is reached from the treatment of the treatment with Bivalirudin."</seg>
<seg id="2909">"starting from the knowledge about the drug-mechanism of antioagulanical (Heparin, Warfarin, Thrombolysis or Thrombocytenants) can increase the blood flow from blood."</seg>
<seg id="2910">"at the combination of Bivalirudin with Thromboilers, clinical and antibodies are the clinical and biological harmostatics parameters in any case regularly."</seg>
<seg id="2911">"experimental examinations are in relation to the effects on the pregnancy, the embryonic / fetal development, the binding or postnatal development, see below paragraph 5.3)."</seg>
<seg id="2912">4612 were randomised to Bivalirudin plus GPIIb / IIIA Ininhibitor and 4603 were randomised to either unfraction of Heparin or Enoxinin plus GPIIb / IIIA Inspector.</seg>
<seg id="2913">"both in the Bivalirudin group as well as in the Heath-treatment groups came to women, as well as with patients more than 65 years more often too undesirable events than male or younger patients."</seg>
<seg id="2914">Heavy blood vessels have been defined after ACUITY and Timi for heavy bloodlines such as in the footnotes by table 2.</seg>
<seg id="2915">Both light and heavy blood vessels were significantly less than in the group with Heparin plus GPIIb / IIIA-inhibitor and bivalidated plus GPIIb / IIIA-inhibitor (see Table 2).</seg>
<seg id="2916">"a ACUITY heavy blood circulation was defined as one of the following events: insurgents, retroperitoneal, intraocular pressure, or blood pressure at the point of ≥ 3 g / dl without obvious blood circulation, reduction of blood products for transfusion, use of blood products for transfusion."</seg>
<seg id="2917">"further, less frequently observed blood localization, which were recorded in more than 0.1% (occasionally)," other "point points, retroperitoneal, ear, nose or neck."</seg>
<seg id="2918">The following information about side effects are based on the data of a clinical study with Bivalirudin at 6000 patients with a PCI bus.</seg>
<seg id="2919">"both in the Bivalirudin group as well as in the Heparin treatment groups came to women, as well as with patients more than 65 years more often too undesirable events than male or younger patients."</seg>
<seg id="2920">Both light and heavy blood cells were significantly less than in the comparative group under Heparin plus GPIIb / IIIA-inhibitor.</seg>
<seg id="2921">"the following side effects that are not listed above are listed above, according to extensive application in practice and are divided into table 6."</seg>
<seg id="2922">"in the case of a overdose, the treatment with Bivalirudin is immediately dismantled, and to monitor the patient training in regard to signs of blood pressure."</seg>
<seg id="2923">"Angiox contains Bivalirudin, a direct and specific Thrombinge, which connects both at the catalytic centre of Thrombin, regardless of whether Thrombin is bound in a liquid phase or to Germ."</seg>
<seg id="2924">"the binding of Bivalirudin in Thrombin, and thus its effect, is reformed, because thrombin part will be generated by Bivalirudin-Arg3-Pro4 slowly, causing the function of the active centre of Thrombin regenerated."</seg>
<seg id="2925">"in addition, Bivalirudin (HIT / HITTS) had come in the past, no Thrombocytes syndrome (HIT / HITTS) was created."</seg>
<seg id="2926">"in the case of healthy subjects and patients, Bivalirudin is a Dosistical and concentric effect which is associated with the extension of ACT, aPTT, PT, INR and TT."</seg>
<seg id="2927">"in case of the patients please leave a PCI, an additional Bolus of 0.5mg / kg Bivalirudin and the infusion for the duration of the surgery on 1.75mg / kg / h."</seg>
<seg id="2928">In the arm A of ACUITY study was unquestionted Heparin or Enoxie in accordance with the relevant guidelines for the treatment of acute Koronarsyndrom (ACS) in patients with unstable angina / non-ST-Hebron (IA / NSTEMI).</seg>
<seg id="2929">Patients in arm A and B were randomised to obtain a GPIIb / IIIA Inspector either at the beginning of the Angiography (at the time of the boundary) or at the PCI.</seg>
<seg id="2930">"in the ACUITY study, the characteristics of high risiky study were distributed within 72 hours to evacuate evenly over the 3 treatment."</seg>
<seg id="2931">"about 77% of patients had a reunification, 70%, dynamic EKG- changes or increased carcinogenic biomarker, 28% had diabetes and about 99% of all patients."</seg>
<seg id="2932">"the primary analysis and the results from the ACUITY study for the overall view (ITT) and the 1- annual end point for the overall age (ITT) and for the patient, the aspirin and Clopidogrel should be received in tables 7 and 8."</seg>
<seg id="2933">"ACUITY study; 30 days and 1 year risk factor for the combined use of the combined point and its components for patients, the aspirin and Clopidogrel according to the protocol *"</seg>
<seg id="2934">"patients, the aspirin and Clopidogrel according to the arm A arm B arm C UFH / Enox Bival B A C A biogas + GPIIb / IIIA risk of diff."</seg>
<seg id="2935">"the frequency of blood vessels are both in ACUITY- as well as in the Timi scale to day 30 for the overall age (ITT) and for patients, the aspirin and Clopidogrel according to the protocol is presented in table 9."</seg>
<seg id="2936">Implantation (N = 4612) GPIIb / IIIA NPIIb / IIIA alone GPIIb / IIIA NPIIb / IIIA NPIIb / IIIA NPIIb / IIIA NPIIb / IIIA NPIIb / IIIA NPIIb / IIIA NPIIb / IIIA NPIIb / IIIA NPIIb / IIIA NPIIb / IIIA NPIIb / IIIA NPIIb / IIIA NPIIb / IIIA NPIIb / IIIA NPIIb / IIIA NPIIb / IIIA NPIIb / IIIA NPIIb / IIIA NPIIb / IIIA NPIIb / IIIA NPIIb / IIIA NPIIb / IIIA NPIIb / IIIA NPIIb / IIIA NPIIb / IIIA NPIIb / IIIA NPIIb / IIIA NPIIb / IIIA NPIIb / IIIA NPIIb / IIIA NPIIb / IIIA NPIIb / IIIA NPIIb / IIIA NPIIb / IIIA NPIIb / IIIA NPIIb / IIIA NPIIb / IIIA NPIIb / IIIA NPIIb / IIIA NPIIb / IIIA NPIIb / IIIA NPIIb / IIIA NPIIb / IIIA NPIIb / IIIA NPIIb / IIIA NPIIb / IIIA NPIIb / IIIA NPIIb / IIIA NPIIb / IIIA NPIIb / IIIA NPIIb / IIIA</seg>
<seg id="2937">"* Clopidogrel before Angiography or from PCI 1 A ACUITY heavy blood circulation was defined as one of the following events: insurgents, retroperito blood, intraocular pressure, reduction of hemogging blood pressure, reduction of blood supply, reduction of blood products for transfusion."</seg>
<seg id="2938">"results appear ordered" "by relevance" "or" "by date" "(publication date),"</seg>
<seg id="2939">Clinical trials with a small number of patients are limited to patients with HIT / HITTS.</seg>
<seg id="2940">The pharmacokinetic properties of Bivalirudin were evaluated in patients with a performative correlation (PCI) and in patients with ACS.</seg>
<seg id="2941">It is expected that Bivalirudin is a Kattid in its amino acid parts with subsequent recovery of amino acids in the body pool.</seg>
<seg id="2942">The primary Metabolit which results from the split of the Arg3-Pro4-binding sequence due to thrombal sequence is due to the losses of its Affinity in the catalytic center of Thrombh.</seg>
<seg id="2943">The Elimination is carried out in patients with normal kidney function after a trial period of 25 ± 12 minutes.</seg>
<seg id="2944">"based on the conventional studies on the conventional studies of safety, toxicity, toxicity, toxicity, or reproductive, the clinical data does not have any special dangers for people."</seg>
<seg id="2945">Toxicity in animals with repeated or continuous exposure (1 day to 4 weeks) at a exposure time up to 10-year of the clinical steady state (1 day) to the 10-year of clinical steady surgery (1 day to 4 weeks).</seg>
<seg id="2946">"side effects due to a longer-term physiological strain as a reaction to a non-homoeostatic coagulation, after short-term exposure of the clinical application, even at very much higher dosage, not observed."</seg>
<seg id="2947">"if the production of the ready-finished solution does not occur under controlled and validated conditions, it is not longer than 24 hours at 2 ° C to 8 ° C."</seg>
<seg id="2948">Angiox is a delicious powder in single dosis tube from type-1-glass to 10 ml which is closed with a butyl gum and a cap made of pressed aluminium.</seg>
<seg id="2949">"5 ml bottle water for injectors are given in a water bottle, and easily dipped up until everything is completely removed and the solution is clear."</seg>
<seg id="2950">"5 ml used for injection molding, and continue with 5% of glucosmic solution for injectors or with 9 mg / ml (0.9%) sodium chloride in a total volume of 50 ml, to ensure a final density of g / ml Bivalirudin."</seg>
<seg id="2951">"the owner of the approval of the company is to bring the studies and pharmaceutical agents in the pharmaceutical industry, such as in version 4 of the risk management plan (RMP) and in module 1.8.2 of approval for the inbox, as well as any subsequent changes in the RMP which has been approved by CHMP."</seg>
<seg id="2952">"according to CHMP Guideline at risk management systems for analyzers, the RMP will be submitted with the next periodic Safety update Report (PSUR)."</seg>
<seg id="2953">• patients with chest pain due to a heart disease (acute Coronaroni - ACS) • patients suffering from closures in blood vessels (Angioplashing) and / or performane coronarangioplasty - PCI).</seg>
<seg id="2954">• You are pregnant or likely that you might be pregnant • You intend to be pregnant • You are currently breastfeeding.</seg>
<seg id="2955">There were no investigations of the impact on traffic and ability to serve machines. but you know that the effects of this drug is only short-term.</seg>
<seg id="2956">"should a blood may occur, the treatment with angiox is broken. • Before the beginning of the injection or infusion you will inform your doctor about the possible sign of a allergic reaction."</seg>
<seg id="2957">"such reactions are rarely seen in less than 1 of 1000 treated patients. • A particularly careful monitoring is carried out when you provide a beam therapy for vessels, the heart with blood supply (this treatment is referred to as Betina or Gamma-Brachytherapy). • The dose you will receive from your body weight and treatment of the therapy."</seg>
<seg id="2958">• 0.1 mg / kg body weight as injections followed by infusion (Tropfling) with 0.25 mg / kg body weight per hour (0.1 mg / kg body weight per hour means a quarter of a program for each kg body weight per hour).</seg>
<seg id="2959">(see section 2 "for application of Angiox with other medicines).</seg>
<seg id="2960">"results appear ordered" "by relevance" "or" "by date" "(publication date),"</seg>
<seg id="2961">This is an occasional outeffect (at less than 1 of 100 treated patients). • pain, blood and blood pressure at the point (after a PCI treatment). "</seg>
<seg id="2962">Inform your doctor if one of the listed side effects may be affected or side effects that are not indicated in this use.</seg>
<seg id="2963">"Angiox should be used after the label on the label and the carton on to" "use" "to the specified date of date."</seg>
<seg id="2964">"Polska The Medicines Company UK Ltd Ltd.: + 800 843 633 26 26 + 41 61 564 1320, with λ: + 30 210 5281700 E-mail:"</seg>
<seg id="2965">Apidra is used to treat adults and children from six years with diabetes that require a treatment with insulin.</seg>
<seg id="2966">"Apidra is subcutan (under the skin) into the abdominal wall, the upper arm or the upper arm injected or as continuous infusion with a insulin pump."</seg>
<seg id="2967">Diabetes is a disease in which the body is not sufficient insulin.</seg>
<seg id="2968">Insulin lulisation is very slightly different from alinulin inulin and the change means that it is faster and a shorter active time has been a short-effective approach.</seg>
<seg id="2969">"Apidra has been used in combination with a long-effective insulin insulin in patients with type-1 diabetes, in two studies with a total of 1 549 adults and in a study with 572 children aged between four and 17 years."</seg>
<seg id="2970">"type-2 diabetes, with which the body insulin is not effective, Apidra has been investigated in a study with 878 adults."</seg>
<seg id="2971">"the main indicator for the effectiveness was the change of the concentration of the substance in kosylized hemoglobin (HbA1c) in blood, which indicates how good the blood sugar is set."</seg>
<seg id="2972">"in the first study with type-1 diabetes, after six months a reduction of 0.14% (from 7,60% to 7,46%) compared to a reduction of 0.14% of insulin."</seg>
<seg id="2973">"in adults with type-2 diabetes, the reduction of HbA1c concentration 0.46% after six months with Apidra compared to 0.30% in humanising normal use."</seg>
<seg id="2974">Apidra must not be applied in patients who may be oversensitive (allergic) against insulin lulisation in or one of the other parts or in patients who already suffer from a hypoglycemia.</seg>
<seg id="2975">The cans of Apidra has to be adapted if it is given together with a number of other medicines that may affect your blood circulation.</seg>
<seg id="2976">"Swiss Hemp Initiative, collecting signatures at Paleo-Festival Nyon 2005 2004"</seg>
<seg id="2977">"Apidra is a subtle injectors either in the area of the abdominal belt, of the upper floor or the Deltamusel, or subcutaneous by continuous infusion in the area of the abdominal belt."</seg>
<seg id="2978">"due to the reduced carbon condensate capacity and reduced insulin insulin, the insulin needs may be reduced to patients with a limitation of liver function."</seg>
<seg id="2979">"any change of the active strength, the brand (Her- Exchange), the insintyps (normally, NPH, zinkdelay etc.), the type of insulin (animal insulin) and / or the manufacturing method can make a change of insulin requirements."</seg>
<seg id="2980">"3 A insufficient dosage or treatment of a treatment, especially in patients with an insulsive diabetes, can lead to a hyperglycemia and a diabetic ketoosis; these states are potential life threatening."</seg>
<seg id="2981">The adjustment of a patient is required by means of a different insulin type or insulin in another manufacturer should make a change of the dosage.</seg>
<seg id="2982">The time of occurrence of a Hypoglycemia depends on the activity profile of the used insulin and can therefore change the treatment of the treatment schemas.</seg>
<seg id="2983">"the substances that increase blood glucose levels can increase the blood glucose in-Converting enzymes (ACE) -Hemmer, Pentoxetin, Fibrate, dioxicin, Propoxylosis, Salizylate and Sulfonamide antibiotics."</seg>
<seg id="2984">"in addition, under the effect of sympathy such as Betabell, Clonidin, Guandin, Guanticdin and the symptoms of the adrendition of counter-ins are missing or missing."</seg>
<seg id="2985">"experimental studies have no differences between Insu-, lulisation in and Humanism in relation to pregnancy, the embryonic / fetal development, the birth or postnatal development (see paragraph 5.3)."</seg>
<seg id="2986">"it is not known to if insinglulisation into the human womb, but in general, insulin is neither into the mother's milk, nor after orbital application."</seg>
<seg id="2987">"the clinical trials are known from clinical trials that are listed in clinical trials (very often: ≥ 1 / 10, &lt; 1 / 10; rare: ≥ 1 / 100, &lt; 1 / 100; rare: &lt; 1 / 10,000; very rare: &lt; 1 / 10,000; very rare: &lt; 1 / 10,000; very rare: &lt; 1 / 10,000; very rare: &lt; 1 / 10,000; very rare: &lt; 1 / 10,000; very rare: &lt; 1 / 10,000); not known (frequency based on item number)."</seg>
<seg id="2988">"cold - welds, cool and blending skin, anxiety, nervousness or malignite, anxiety, concentration of vision, headache, nausea, nausea and heart attack."</seg>
<seg id="2989">Lipoystrophie appears to change the injection point within the injection range can be continuously to change in the sequence of a lickystrophie on the injections.</seg>
<seg id="2990">Severe hypoglyphs with consciousness can be given by an inappropriate person or submitting injections of glucose (0.5 up to 1 mg) which are treated by a doctor or intravenous gift of gluten.</seg>
<seg id="2991">"after a gluten sensitivity, the patient should be monitored by the patient in a hospital to determine the urine - to avoid severe hypokeratemia and similar games."</seg>
<seg id="2992">"insulin, reduces blood glucose levels by stimulating the peripheral muscles (especially by ski muscles and fat), as well as the inhibiting of glucose in the liver."</seg>
<seg id="2993">Studies with healthy volunteers and patients with diabetes have shown that with subcutlery Tbe of insinglulisation in the field of insulin.</seg>
<seg id="2994">"in a study with 18 male people at age of 21 to 50 years with type-1 diabetes melli- TuS showed insulin resistance in the therapeutic dosage of 0.075 to 0.15 E / kg, the effect of the effect of the effect of 0.075 to 0.15 E / kg or more."</seg>
<seg id="2995">Insulin lulisation in a double-fast impact on how to inulin inulin and achieved the full-lasting effect of about 2 hours earlier than Humanapinulin.</seg>
<seg id="2996">"in 2 minutes prior to the meal of insinglulisation in 2 minutes before the meal has reached a comparable posterior posterior order, like with humanising normal insulin, the 30 minutes before the meal."</seg>
<seg id="2997">Insinglulisation in 2 minutes before the meal has been given a better posterior control than with humanising normal use in 2 minutes before the meal was reached.</seg>
<seg id="2998">"insinglulisation in 15 minutes after the beginning of the meal - gearing, a comparable glycous control of the meal may be given before the meal (see figure 1)."</seg>
<seg id="2999">Insulin lulisation in a gift of 2 minutes (GLULISIN - previously) prior to the beginning of the meal (figure 1A) as well as compared to humanem normal bulin, the two minutes (NORMAL - previously) was given before a meal (figure 1B). "</seg>
<seg id="3000">Insulin lulisation in a gift of 15 minutes (GLULISIN) after the beginning of the meal in comparison to humanising North-malinsulin, the 2 minutes (NORMAL - previously) was given before the beginning of the meal (figure 1C). "</seg>
</doc>
</tstset>
